{
  "runSettings": {
    "temperature": 0.0,
    "model": "models/gemini-2.5-pro",
    "topP": 0.95,
    "topK": 64,
    "maxOutputTokens": 65536,
    "safetySettings": [{
      "category": "HARM_CATEGORY_HARASSMENT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_HATE_SPEECH",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_SEXUALLY_EXPLICIT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_DANGEROUS_CONTENT",
      "threshold": "OFF"
    }],
    "enableCodeExecution": false,
    "enableSearchAsATool": false,
    "enableBrowseAsATool": false,
    "enableAutoFunctionResponse": false,
    "thinkingBudget": 32768,
    "outputResolution": "1K"
  },
  "citations": [{
    "uri": "http://en.wikipedia.org/wiki/Cauda_equina"
  }],
  "systemInstruction": {
    "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n"
  },
  "chunkedPrompt": {
    "chunks": [{
      "driveDocument": {
        "id": "1eW-sbjfbVz_CEiKTI6LXVPyXeIu2SMel"
      },
      "role": "user",
      "tokenCount": 171853
    }, {
      "driveDocument": {
        "id": "1lHSoA6nfiJiZK1fLy6Uunx1_9lWE358i"
      },
      "role": "user",
      "tokenCount": 122479
    }, {
      "driveDocument": {
        "id": "11SVUK9T67ftaNRNTtYL9otLd48DEo7x7"
      },
      "role": "user",
      "tokenCount": 37550
    }, {
      "driveDocument": {
        "id": "1ZQ8IjyuiAt7pftxDl0VJTvjsyYfNx7IO"
      },
      "role": "user",
      "tokenCount": 181448
    }, {
      "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n\n\nNow process the first chunk:\n```json\n[\n  {\n    \"id\": \"dd11dde6\",\n    \"letter\": \"A\",\n    \"term\": \"Abducens nerve (CN VI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Abducens nerve (CN VI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ddbd2810\",\n        \"letter\": \"A\",\n        \"term\": \"damage to\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e damage to\"\n      },\n      {\n        \"id\": \"5ac9a13d\",\n        \"letter\": \"A\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e function and type\"\n      },\n      {\n        \"id\": \"c452852d\",\n        \"letter\": \"A\",\n        \"term\": \"intracranial hypertension effects\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e intracranial hypertension effects\"\n      },\n      {\n        \"id\": \"18a8c97a\",\n        \"letter\": \"A\",\n        \"term\": \"ocular motility\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e ocular motility\"\n      },\n      {\n        \"id\": \"80048429\",\n        \"letter\": \"A\",\n        \"term\": \"palsy\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e palsy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c0b7a1ca\",\n    \"letter\": \"A\",\n    \"term\": \"Abnormal motor posturing\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Abnormal motor posturing\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a0c128f4\",\n    \"letter\": \"A\",\n    \"term\": \"Absence (petit mal) seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence (petit mal) seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e62961a0\",\n    \"letter\": \"A\",\n    \"term\": \"Absence seizure anticonvulsants\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence seizure anticonvulsants\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8558c64b\",\n    \"letter\": \"A\",\n    \"term\": \"Acalculia\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Acalculia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f218aebf\",\n    \"letter\": \"A\",\n    \"term\": \"Accessory nerve (CN XI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Accessory nerve (CN XI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d854478f\",\n        \"letter\": \"A\",\n        \"term\": \"functions\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e functions\"\n      },\n      {\n        \"id\": \"dbb1948e\",\n        \"letter\": \"A\",\n        \"term\": \"lesions of\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e lesions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"81b5f5fe\",\n    \"letter\": \"A\",\n    \"term\": \"Accommodation (eye)\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Accommodation (eye)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1df262e8\",\n    \"letter\": \"A\",\n    \"term\": \"Acetazolamide\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetazolamide\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b450b802\",\n        \"letter\": \"A\",\n        \"term\": \"glaucoma therapy\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Acetazolamide \u003e glaucoma therapy\"\n      },\n      {\n        \"id\": \"62d0ba3f\",\n        \"letter\": \"A\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Acetazolamide \u003e hypertension\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6a005559\",\n    \"letter\": \"A\",\n    \"term\": \"Acetylcholine (ACh)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetylcholine (ACh)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c3eb18f9\",\n        \"letter\": \"A\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Acetylcholine (ACh) \u003e synthesis and change with diseases\"\n      }\n    ]\n  },\n  {\n    \"id\": \"87d19a70\",\n    \"letter\": \"A\",\n    \"term\": \"Achilles reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Achilles reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fcedc59f\",\n    \"letter\": \"A\",\n    \"term\": \"Action potential\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Action potential\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1095ddab\",\n        \"letter\": \"A\",\n        \"term\": \"neurons\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Action potential \u003e neurons\"\n      }\n    ]\n  },\n  {\n    \"id\": \"67e83e3b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute disseminated (postinfectious)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute disseminated (postinfectious)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7f9ae40d\",\n        \"letter\": \"A\",\n        \"term\": \"encephalomyelitis\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute disseminated (postinfectious) \u003e encephalomyelitis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ed52e40b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute inflammatory demyelinating\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute inflammatory demyelinating\",\n    \"sub_entries\": [\n      {\n        \"id\": \"026b3479\",\n        \"letter\": \"A\",\n        \"term\": \"polyneuropathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute inflammatory demyelinating \u003e polyneuropathy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d268ace0\",\n    \"letter\": \"A\",\n    \"term\": \"Acute pulmonary edema, opioid\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute pulmonary edema, opioid\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fc8f2199\",\n        \"letter\": \"A\",\n        \"term\": \"analgesics\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Acute pulmonary edema, opioid \u003e analgesics\"\n      }\n    ]\n  },\n  {\n    \"id\": \"76ba7f2e\",\n    \"letter\": \"A\",\n    \"term\": \"Adenohypophysis (anterior pituitary)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Adenohypophysis (anterior pituitary)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0e44cd2d\",\n        \"letter\": \"A\",\n        \"term\": \"hypothalamus and\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Adenohypophysis (anterior pituitary) \u003e hypothalamus and\"\n      }\n    ]\n  }\n]\n```\n",
      "role": "user",
      "tokenCount": 9477
    }, {
      "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
      "role": "model",
      "tokenCount": 2036,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n",
        "thought": true
      }, {
        "text": "**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to abduct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([[7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Contralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9914d433\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  },\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating \u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flexor) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract (flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Extensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., midbrain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a \u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flexion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F(Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus) --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Seizures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e; the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the \u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Ethosuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific, with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e (inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome, immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SCM)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral \u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ipsilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [[jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innervates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003eciliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers, allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e (non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones (due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [[3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B(Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\"\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetylcholine (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetylcholine (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapidly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neurotransmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release). Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lambert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  },\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, 2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses, and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_radiculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D[S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F(Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    \"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e, which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRepolarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperpolarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A(Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \"Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple, bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is \u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephalopathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E[Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias, BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAIDP (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e.g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 Areflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"schwann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Opioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury, and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum, and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C[Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flooding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \"title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pituitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e, or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngioma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFLAT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH, \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lactotrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular, in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e86633|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress, reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prolactin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10313,
      "parts": [{
        "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve"
      }, {
        "text": " (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"C"
      }, {
        "text": "ranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve"
      }, {
        "text": " (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eex"
      }, {
        "text": "clusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction"
      }, {
        "text": " of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor"
      }, {
        "text": " innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye"
      }, {
        "text": " movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes"
      }, {
        "text": " through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters"
      }, {
        "text": " the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to ab"
      }, {
        "text": "duct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d"
      }, {
        "text": "433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "ulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct"
      }, {
        "text": " brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome"
      }, {
        "text": "]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial"
      }, {
        "text": " nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy"
      }, {
        "text": " that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR"
      }, {
        "text": "; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e"
      }, {
        "text": " D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Cont"
      }, {
        "text": "ralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c7"
      }, {
        "text": "4\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9"
      }, {
        "text": "914d433\"\n      },\n      {\n        \"type\": \"is_affected_"
      }, {
        "text": "in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating "
      }, {
        "text": "\u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral"
      }, {
        "text": " cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flex"
      }, {
        "text": "or) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper"
      }, {
        "text": " extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027"
      }, {
        "text": "\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the"
      }, {
        "text": " red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract ("
      }, {
        "text": "flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Ext"
      }, {
        "text": "ensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., mid"
      }, {
        "text": "brain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a "
      }, {
        "text": "\u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e"
      }, {
        "text": " posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies"
      }, {
        "text": " a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flex"
      }, {
        "text": "ion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F("
      }, {
        "text": "Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus"
      }, {
        "text": ") --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47"
      }, {
        "text": "751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_"
      }, {
        "text": "in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Se"
      }, {
        "text": "izures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures"
      }, {
        "text": "\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for"
      }, {
        "text": " seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds"
      }, {
        "text": ". May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e;"
      }, {
        "text": " the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized"
      }, {
        "text": " 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often"
      }, {
        "text": " be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e"
      }, {
        "text": " treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and"
      }, {
        "text": " used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose"
      }, {
        "text": " teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave"
      }, {
        "text": " pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Absence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a"
      }, {
        "text": " pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific"
      }, {
        "text": " and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca"
      }, {
        "text": "2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3"
      }, {
        "text": "hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961"
      }, {
        "text": "a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|"
      }, {
        "text": "absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic"
      }, {
        "text": " \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the "
      }, {
        "text": "\u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T"
      }, {
        "text": "-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence"
      }, {
        "text": " seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is"
      }, {
        "text": " preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels"
      }, {
        "text": " and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain"
      }, {
        "text": " anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can"
      }, {
        "text": " \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a"
      }, {
        "text": " 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Eth"
      }, {
        "text": "osuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific,"
      }, {
        "text": " with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted"
      }, {
        "text": " blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple"
      }, {
        "text": " mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for"
      }, {
        "text": " a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome"
      }, {
        "text": ":\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e ("
      }, {
        "text": "inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-"
      }, {
        "text": "Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[1"
      }, {
        "text": "43bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome,"
      }, {
        "text": " immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia"
      }, {
        "text": "\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular"
      }, {
        "text": " gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa"
      }, {
        "text": "771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n"
      }, {
        "text": "        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f"
      }, {
        "text": "218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      "
      }, {
        "text": "\"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI"
      }, {
        "text": ")\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SC"
      }, {
        "text": "M)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging,"
      }, {
        "text": " respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral "
      }, {
        "text": "\u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ips"
      }, {
        "text": "ilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5"
      }, {
        "text": "). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [["
      }, {
        "text": "jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in"
      }, {
        "text": " turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes"
      }, {
        "text": " weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/"
      }, {
        "text": "mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle"
      }, {
        "text": " of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a"
      }, {
        "text": " lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B"
      }, {
        "text": " --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innerv"
      }, {
        "text": "ates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to"
      }, {
        "text": "\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f"
      }, {
        "text": "5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Phys"
      }, {
        "text": "iology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a"
      }, {
        "text": " reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003ec"
      }, {
        "text": "iliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to"
      }, {
        "text": " maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It"
      }, {
        "text": " is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers"
      }, {
        "text": ", allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePup"
      }, {
        "text": "illary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an"
      }, {
        "text": " [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via"
      }, {
        "text": " [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027"
      }, {
        "text": "s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN"
      }, {
        "text": " III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e"
      }, {
        "text": " Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor"
      }, {
        "text": " Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c669"
      }, {
        "text": "97\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to"
      }, {
        "text": "\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from"
      }, {
        "text": "_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce"
      }, {
        "text": " pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which"
      }, {
        "text": " reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle"
      }, {
        "text": " and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF"
      }, {
        "text": " production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e ("
      }, {
        "text": "non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones ("
      }, {
        "text": "due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [["
      }, {
        "text": "3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems"
      }, {
        "text": " from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B("
      }, {
        "text": "Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c"
      }, {
        "text": "--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6"
      }, {
        "text": "c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to"
      }, {
        "text": "\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetyl"
      }, {
        "text": "choline (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetyl"
      }, {
        "text": "choline (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that"
      }, {
        "text": " functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various"
      }, {
        "text": " sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synt"
      }, {
        "text": "hesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapid"
      }, {
        "text": "ly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS"
      }, {
        "text": " Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease"
      }, {
        "text": "]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels"
      }, {
        "text": " are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neuro"
      }, {
        "text": "transmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic"
      }, {
        "text": " postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027"
      }, {
        "text": "s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release)."
      }, {
        "text": " Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to"
      }, {
        "text": " treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose"
      }, {
        "text": " function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert"
      }, {
        "text": "]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes"
      }, {
        "text": " paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --"
      }, {
        "text": "ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{"
      }, {
        "text": "Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \""
      }, {
        "text": "to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_"
      }, {
        "text": "in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lam"
      }, {
        "text": "bert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in"
      }, {
        "text": "\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that"
      }, {
        "text": " involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and"
      }, {
        "text": " S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests"
      }, {
        "text": " the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, "
      }, {
        "text": "2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch"
      }, {
        "text": " receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses,"
      }, {
        "text": " and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex"
      }, {
        "text": ":\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a"
      }, {
        "text": " stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles"
      }, {
        "text": " reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_rad"
      }, {
        "text": "iculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple"
      }, {
        "text": " yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower"
      }, {
        "text": " and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e"
      }, {
        "text": " B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D["
      }, {
        "text": "S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F("
      }, {
        "text": "Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests"
      }, {
        "text": "_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    "
      }, {
        "text": "\"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical"
      }, {
        "text": " signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e"
      }, {
        "text": ", which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump"
      }, {
        "text": " and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:"
      }, {
        "text": "\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e"
      }, {
        "text": "+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRep"
      }, {
        "text": "olarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/"
      }, {
        "text": "mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyper"
      }, {
        "text": "polarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|"
      }, {
        "text": "Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated"
      }, {
        "text": " Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e"
      }, {
        "text": " causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling"
      }, {
        "text": " phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A("
      }, {
        "text": "Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na"
      }, {
        "text": "+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked"
      }, {
        "text": "_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \""
      }, {
        "text": "Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "emyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Dissemin"
      }, {
        "text": "ated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the"
      }, {
        "text": " central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an"
      }, {
        "text": " immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which"
      }, {
        "text": " is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other"
      }, {
        "text": " symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an"
      }, {
        "text": " antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple"
      }, {
        "text": ", bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is "
      }, {
        "text": "\u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephal"
      }, {
        "text": "opathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated En"
      }, {
        "text": "cephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --"
      }, {
        "text": "Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E["
      }, {
        "text": "Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelin"
      }, {
        "text": "ating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered"
      }, {
        "text": "_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e"
      }, {
        "text": "40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype"
      }, {
        "text": " of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or"
      }, {
        "text": " paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also"
      }, {
        "text": " CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial"
      }, {
        "text": " antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness"
      }, {
        "text": "/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias"
      }, {
        "text": ", BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e"
      }, {
        "text": " (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell"
      }, {
        "text": " count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAID"
      }, {
        "text": "P (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve"
      }, {
        "text": " myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting"
      }, {
        "text": " widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e"
      }, {
        "text": ".g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann"
      }, {
        "text": " Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 A"
      }, {
        "text": "reflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a"
      }, {
        "text": "0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"sch"
      }, {
        "text": "wann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Op"
      }, {
        "text": "ioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form"
      }, {
        "text": " of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized"
      }, {
        "text": " by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact"
      }, {
        "text": " mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury"
      }, {
        "text": ", and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum"
      }, {
        "text": ", and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadi"
      }, {
        "text": "ology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac"
      }, {
        "text": " silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non"
      }, {
        "text": "-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause"
      }, {
        "text": " is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with"
      }, {
        "text": " [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac"
      }, {
        "text": " cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high"
      }, {
        "text": " hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar"
      }, {
        "text": "-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C["
      }, {
        "text": "Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flo"
      }, {
        "text": "oding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute"
      }, {
        "text": "_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \""
      }, {
        "text": "to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \""
      }, {
        "text": "title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pit"
      }, {
        "text": "uitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e"
      }, {
        "text": ", or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from"
      }, {
        "text": " \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing"
      }, {
        "text": " and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called"
      }, {
        "text": " \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngi"
      }, {
        "text": "oma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFL"
      }, {
        "text": "AT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH,"
      }, {
        "text": " \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore"
      }, {
        "text": "), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lact"
      }, {
        "text": "otrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/"
      }, {
        "text": "LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal"
      }, {
        "text": " system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is"
      }, {
        "text": " most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular"
      }, {
        "text": ", in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e8663"
      }, {
        "text": "3|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress"
      }, {
        "text": ", reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --"
      }, {
        "text": "Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C"
      }, {
        "text": " --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prol"
      }, {
        "text": "actin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_regulated_by\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n"
      }, {
        "text": "      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "17n8z2MZ3gTilj82LshNiRO8_TlCssXTq"
      },
      "role": "user",
      "tokenCount": 1812
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "**Beginning Processing JSON Data**\n\nI\u0027m now diving into the next portion of the JSON data. My first step involves \"Adenovirus (aaeda12d),\" which I recognize as a microbe. My focus is going to be on crafting a card specifically about its neurological manifestation, conjunctivitis, as referenced in the index. I will do this before moving on to other entries.\n\n\n**Moving Through JSON Entries**\n\nI\u0027m now shifting my focus to the next JSON entries. Adrenoleukodystrophy, a demyelinating peroxisomal disease, will be next. I\u0027ll construct a thorough card addressing its genetic underpinnings, pathophysiology, and clinical presentation. I\u0027m skipping \"Adults\" since it\u0027s a demographic. Instead, I\u0027ll incorporate its sub-entries, \"causes of seizures in\" and \"primary brain tumors\", into relevant cards. Next is age-related macular degeneration, which will get a detailed card covering dry/wet forms, drusen, neovascularization, and clinical findings. Following that, I\u0027ll create a card for agraphia.\n\n\n**Processing Next JSON Entries**\n\nI\u0027m now ready to tackle the next batch of JSON entries. I\u0027ll start with Adenovirus, crafting a card focused on its neurological manifestation. Next up is Adrenoleukodystrophy; I\u0027ll build a card detailing its genetics, pathophysiology, and clinical presentation. The \"Adults\" entry is being skipped; its sub-entries will be integrated into relevant cards. Age-related macular degeneration is next on the list, followed by agraphia. Then, I\u0027ll move on to Akathisia, with a card defining it and detailing its causes. I\u0027ll then create a card for Alar plate development, explaining its role in neural development. Finally, I will make a card on albuminocytologic dissociation. The next is Alexia, and then I will focus on Alprazolam. I\u0027ll delve into the specifics of this benzodiazepine, covering its mechanism and use.\n\n\n**Charting JSON Data Progress**\n\nI\u0027m now progressing through the JSON entries. I have already drafted a detailed card for \"Adenovirus\" and its neurological manifestation. Next, I plan to focus on \"Adrenoleukodystrophy\", ensuring the card covers its genetic and pathophysiological aspects. \"Adults\" will still be skipped and sub-entries incorporated into their relevant cards. I will follow that by generating cards for \"Age-related macular degeneration\" and \"Agraphia\". After these, I will make cards for \"Akathisia\" and \"Alar plate development\". Finally, I will create cards for \"Albuminocytologic dissociation\", \"Alexia\", and \"Alprazolam\".\n\n\n**Analyzing Future JSON Data**\n\nNow, I\u0027m analyzing the next segment of JSON entries. I will first create a card for \"Adenovirus\" emphasizing its neurological manifestation. Next is \"Adrenoleukodystrophy,\" requiring a detailed card on its genetics, pathophysiology, and clinical presentation. After skipping \"Adults\", I\u0027ll create a card for \"Age-related macular degeneration,\" covering its various forms, pathophysiology, and clinical findings. Following this, a card for \"Agraphia\" will be generated, and then I will focus on \"Akathisia\" and define it and elaborate on its causes. Next, I will create cards for \"Alar plate development,\" \"Albuminocytologic dissociation,\" and \"Alexia.\" Finally, I\u0027ll tackle the benzodiazepine \"Alprazolam,\" detailing its mechanism and key properties, before moving on to \"Alzheimer disease\".\n\n\n",
      "role": "model",
      "tokenCount": 966,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Beginning Processing JSON Data**\n\nI\u0027m now diving into the next portion of the JSON data. My first step involves \"Adenovirus (aaeda12d),\" which I recognize as a microbe. My focus is going to be on crafting a card specifically about its neurological manifestation, conjunctivitis, as referenced in the index. I will do this before moving on to other entries.\n\n\n",
        "thought": true
      }, {
        "text": "**Moving Through JSON Entries**\n\nI\u0027m now shifting my focus to the next JSON entries. Adrenoleukodystrophy, a demyelinating peroxisomal disease, will be next. I\u0027ll construct a thorough card addressing its genetic underpinnings, pathophysiology, and clinical presentation. I\u0027m skipping \"Adults\" since it\u0027s a demographic. Instead, I\u0027ll incorporate its sub-entries, \"causes of seizures in\" and \"primary brain tumors\", into relevant cards. Next is age-related macular degeneration, which will get a detailed card covering dry/wet forms, drusen, neovascularization, and clinical findings. Following that, I\u0027ll create a card for agraphia.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing Next JSON Entries**\n\nI\u0027m now ready to tackle the next batch of JSON entries. I\u0027ll start with Adenovirus, crafting a card focused on its neurological manifestation. Next up is Adrenoleukodystrophy; I\u0027ll build a card detailing its genetics, pathophysiology, and clinical presentation. The \"Adults\" entry is being skipped; its sub-entries will be integrated into relevant cards. Age-related macular degeneration is next on the list, followed by agraphia. Then, I\u0027ll move on to Akathisia, with a card defining it and detailing its causes. I\u0027ll then create a card for Alar plate development, explaining its role in neural development. Finally, I will make a card on albuminocytologic dissociation. The next is Alexia, and then I will focus on Alprazolam. I\u0027ll delve into the specifics of this benzodiazepine, covering its mechanism and use.\n\n\n",
        "thought": true
      }, {
        "text": "**Charting JSON Data Progress**\n\nI\u0027m now progressing through the JSON entries. I have already drafted a detailed card for \"Adenovirus\" and its neurological manifestation. Next, I plan to focus on \"Adrenoleukodystrophy\", ensuring the card covers its genetic and pathophysiological aspects. \"Adults\" will still be skipped and sub-entries incorporated into their relevant cards. I will follow that by generating cards for \"Age-related macular degeneration\" and \"Agraphia\". After these, I will make cards for \"Akathisia\" and \"Alar plate development\". Finally, I will create cards for \"Albuminocytologic dissociation\", \"Alexia\", and \"Alprazolam\".\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Future JSON Data**\n\nNow, I\u0027m analyzing the next segment of JSON entries. I will first create a card for \"Adenovirus\" emphasizing its neurological manifestation. Next is \"Adrenoleukodystrophy,\" requiring a detailed card on its genetics, pathophysiology, and clinical presentation. After skipping \"Adults\", I\u0027ll create a card for \"Age-related macular degeneration,\" covering its various forms, pathophysiology, and clinical findings. Following this, a card for \"Agraphia\" will be generated, and then I will focus on \"Akathisia\" and define it and elaborate on its causes. Next, I will create cards for \"Alar plate development,\" \"Albuminocytologic dissociation,\" and \"Alexia.\" Finally, I\u0027ll tackle the benzodiazepine \"Alprazolam,\" detailing its mechanism and key properties, before moving on to \"Alzheimer disease\".\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"aaeda12d\": {\n    \"title\": \"Adenovirus\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Virology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a non-enveloped, double-stranded DNA virus that is a common cause of various infections, including pharyngitis, pneumonia, hemorrhagic cystitis, and notably, \u003ci\u003eviral conjunctivitis\u003c/i\u003e (pink eye).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Non-enveloped, icosahedral capsid with a linear dsDNA genome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission:\u003c/b\u003e Transmitted via respiratory droplets, fecal-oral route, and direct contact with contaminated surfaces (fomites). Highly stable in the environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Manifestation:\u003c/b\u003e The most common cause of viral [[c4d08c09|conjunctivitis]], presenting with a \u003cmark\u003ewatery discharge\u003c/mark\u003e, red eye, and often a swollen preauricular lymph node.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical Syndromes:\u003c/b\u003e Causes febrile pharyngitis, acute hemorrhagic cystitis, and pneumonia (especially in military recruits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a question describing a patient (often a child) with red, watery eyes and a recent history of a cold or attending daycare, Adenovirus is the most likely pathogen. The watery discharge is key to differentiating it from bacterial conjunctivitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a highly resilient DNA virus responsible for the majority of viral conjunctivitis cases, characterized by a watery discharge that distinguishes it from the purulent discharge of bacterial causes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Adenovirus] --\u003e B{Transmission}; B --\u003e B1[Respiratory Droplets]; B --\u003e B2[Fecal-Oral]; B --\u003e B3[Fomites]; A --\u003e C{Clinical Syndromes}; C --\u003e C1[Conjunctivitis]; C --\u003e C2[Pharyngitis]; C --\u003e C3[Pneumonia]; C --\u003e C4[Hemorrhagic Cystitis];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"c4d08c09\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dna_virus\"\n      }\n    ]\n  },\n  \"21d4b96a\": {\n    \"title\": \"Adrenoleukodystrophy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Endocrinology\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is an \u003ci\u003eX-linked recessive disorder\u003c/i\u003e caused by a mutation in the \u003cb\u003eABCD1\u003c/b\u003e gene, leading to impaired Œ≤-oxidation of very-long-chain fatty acids (VLCFAs) in peroxisomes. This results in the accumulation of VLCFAs in the adrenal glands, testes, and white matter of the brain, causing adrenal insufficiency and progressive demyelination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e X-linked recessive mutation in the \u003ci\u003eABCD1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Defective peroxisomal Œ≤-oxidation leads to the accumulation of \u003cmark\u003every-long-chain fatty acids (VLCFAs)\u003c/mark\u003e in various tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Manifestations:\u003c/b\u003e Progressive demyelination of the central nervous system, leading to cognitive decline, behavioral changes, spasticity, and vision/hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Manifestations:\u003c/b\u003e Adrenal insufficiency ([[addison_disease|Addison disease]]) is a common feature, presenting with fatigue, hyperpigmentation, and electrolyte abnormalities. Testicular atrophy and infertility can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette involves a young boy with new-onset behavioral problems or declining school performance who also shows signs of adrenal insufficiency (e.g., hyperpigmentation, low cortisol).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is a dual-system disease combining progressive CNS demyelination with adrenal failure, all stemming from a single X-linked genetic defect in peroxisomal fatty acid metabolism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ABCD1 Gene Mutation] --\u003e B(Defective Peroxisomal Œ≤-oxidation); B --\u003e C[Accumulation of VLCFAs]; C --\u003e D[Adrenal Cortex] --\u003e E(Adrenal Insufficiency); C --\u003e F[CNS White Matter] --\u003e G(Demyelination \u0026 Neurodegeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"peroxisomal_disorder\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"addison_disease\"\n      },\n      {\n        \"type\": \"has_inheritance_pattern\",\n        \"to\": \"x_linked_recessive\"\n      }\n    ]\n  },\n  \"c63255c8\": {\n    \"title\": \"Age-related Macular Degeneration (AMD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part of the retina, leading to the gradual loss of \u003ci\u003ecentral vision\u003c/i\u003e. It is the leading cause of irreversible blindness in older adults in developed countries.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e More common (~80%). Characterized by the slow breakdown of photoreceptors in the macula and the deposition of yellowish extracellular material called \u003cmark\u003edrusen\u003c/mark\u003e between Bruch\u0027s membrane and the retinal pigment epithelium. Causes gradual vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by rapid vision loss due to choroidal neovascularization. Abnormal blood vessels grow under the retina, leak fluid and blood, and can cause scarring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive loss of central vision, leading to scotomas (blind spots). A key early symptom of wet AMD is \u003cmark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopy reveals drusen (dry AMD) or hemorrhage/exudates (wet AMD). An Amsler grid is used to detect metamorphopsia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference: \u003cb\u003eDry AMD \u003d Drusen\u003c/b\u003e and gradual loss. \u003cb\u003eWet AMD \u003d Neovascularization\u003c/b\u003e and rapid loss. Central vision loss is the hallmark for both.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration\u003c/b\u003e specifically targets central, high-acuity vision by damaging the macula. The distinction between the slow, drusen-associated \u0027dry\u0027 form and the rapid, neovascular \u0027wet\u0027 form is critical for prognosis and management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aging \u0026 Genetic Factors] --\u003e B{Macular Damage}; B --\u003e C[Dry AMD]; C --\u003e D[Drusen Deposition \u0026 Atrophy]; D --\u003e E[Gradual Central Vision Loss]; B --\u003e F[Wet AMD]; F --\u003e G[Choroidal Neovascularization]; G --\u003e H[Hemorrhage \u0026 Exudate]; H --\u003e I[Rapid Central Vision Loss];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"macula\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"central_scotoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"metamorphopsia\"\n      }\n    ]\n  },\n  \"13d6bca7\": {\n    \"title\": \"Agraphia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is an acquired neurological disorder characterized by the \u003ci\u003eloss of the ability to communicate through writing\u003c/i\u003e, stemming from damage to specific brain areas involved in language processing and motor control of the hand.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Agraphia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAgraphia\u003c/b\u003e, \u003cb\u003e[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlexia with Agraphia:\u003c/b\u003e When a patient can neither read nor write, the lesion is typically in the dominant angular gyrus. This is distinct from [[fcf30c1b|alexia without agraphia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a question describes a patient who suddenly cannot write but has no other motor deficits in the hand, and also has trouble with math, think of a dominant parietal lobe lesion, likely from an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is not simply poor handwriting; it is a specific neurological deficit in the production of written language that, when paired with [[8558c64b|acalculia]], strongly points to a lesion in the dominant angular gyrus, a hallmark of [[38f3ed1f|Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"0d04bf44\": {\n    \"title\": \"Akathisia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAkathisia\u003c/b\u003e is a movement disorder characterized by a subjective feeling of inner restlessness and a compelling urge to be in constant motion, most commonly seen as an \u003ci\u003eextrapyramidal side effect\u003c/i\u003e of antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by dopamine receptor antagonists, particularly \u003cmark\u003efirst-generation (typical) antipsychotics\u003c/mark\u003e (e.g., haloperidol). It can also occur with second-generation antipsychotics and some antidepressants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients describe an inability to sit still, feeling like they need to \u0027jump out of their skin.\u0027 Objective signs include pacing, shuffling feet, and shifting from one foot to another.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e It is a subacute extrapyramidal symptom, typically developing days to weeks after starting or increasing the dose of an offending agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management involves reducing the dose of the antipsychotic, switching to an agent with a lower risk (e.g., quetiapine), or adding medications like \u003cmark\u003epropranolol\u003c/mark\u003e, benzodiazepines, or benztropine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate akathisia from psychotic agitation. Akathisia is a drug side effect causing restlessness, while agitation is a symptom of the underlying psychosis. Mistaking one for the other and increasing the antipsychotic dose will worsen akathisia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAkathisia\u003c/b\u003e is a distressing, drug-induced state of motor restlessness that must be distinguished from psychiatric agitation, as the treatment involves reducing or counteracting the offending antipsychotic, not increasing it.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopamine (D2) Receptor Blockade] --\u003e B(Disruption of Nigrostriatal Pathway); B --\u003e C[Subjective Restlessness \u0026 Compulsion to Move]; C --\u003e D(Akathisia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"propranolol\"\n      }\n    ]\n  },\n  \"43be7a6e\": {\n    \"title\": \"Alar Plate\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the dorsal part of the neural tube in the developing embryo, which differentiates into \u003ci\u003esensory neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of signaling molecules like bone morphogenetic proteins (BMPs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal (posterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003esensory\u003c/u\u003e components of the central nervous system. Mnemonic: Alar is dorsal, like the dorsal fin of a shark which senses things in the water.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by signaling molecules from the overlying ectoderm, primarily \u003cmark\u003eBone Morphogenetic Proteins (BMPs)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The ventral counterpart is the [[253e3efb|Basal Plate]], which develops into motor neurons under the influence of Sonic Hedgehog (SHH) from the notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eAlar \u003d Sensory \u003d Dorsal\u003c/b\u003e, and \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e. This organization persists in the adult spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the embryonic foundation for the sensory pathways of the CNS, establishing the fundamental dorsal-sensory and ventral-motor organization of the neural tube that is maintained throughout life.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"sensory_neurons\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"253e3efb\"\n      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"bone_morphogenetic_proteins\"\n      }\n    ]\n  },\n  \"a0f3ce4c\": {\n    \"title\": \"Albuminocytologic Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Diagnostics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is the pathognomonic finding in the cerebrospinal fluid (CSF) of patients with [[ed52e40b|Guillain-Barr√© Syndrome]], characterized by a significantly \u003ci\u003eelevated protein concentration\u003c/i\u003e in the presence of a \u003ci\u003enormal or near-normal white blood cell count\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This finding is the hallmark of [[ed52e40b|Guillain-Barr√© Syndrome (GBS)]], specifically the AIDP subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Widespread inflammation of the nerve roots (radiculopathy) disrupts the blood-nerve barrier, allowing protein (mainly albumin) to leak from the plasma into the CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Count:\u003c/b\u003e The cell count remains normal (typically \u003c10 cells/mm\u003csup\u003e3\u003c/sup\u003e) because the inflammatory process is primarily in the peripheral nerve roots, not within the CSF space itself (i.e., it is not meningitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e The protein level may be normal in the first few days of GBS and typically peaks 1-2 weeks after symptom onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with ascending paralysis after a recent infection (*C. jejuni* or viral URI) and a CSF report showing high protein but a normal cell count is a classic vignette for [[ed52e40b|Guillain-Barr√© Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is a powerful diagnostic clue for [[ed52e40b|Guillain-Barr√© Syndrome]], reflecting the unique pathophysiology of nerve root inflammation that increases blood-nerve barrier permeability to proteins without causing a significant cellular infiltrate into the CSF.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_found_in\",\n        \"to\": \"cerebrospinal_fluid\"\n      }\n    ]\n  },\n  \"fcf30c1b\": {\n    \"title\": \"Alexia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlexia\u003c/b\u003e is an acquired neurological disorder characterized by the \u003ci\u003einability to read or comprehend written language\u003c/i\u003e, resulting from a lesion in the brain\u0027s language or visual processing centers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlexia without Agraphia (Pure Alexia):\u003c/b\u003e A specific syndrome where the patient can write but cannot read what they have just written. This is a classic disconnection syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the \u003cmark\u003edominant (usually left) occipital lobe\u003c/mark\u003e that also damages the \u003cmark\u003esplenium of the corpus callosum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Visual information from the intact right occipital lobe cannot cross over to the dominant hemisphere\u0027s language areas (Wernicke\u0027s area, angular gyrus) for interpretation because the connecting fibers in the splenium are damaged. The dominant visual cortex is also damaged, so no visual information can be processed on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e This specific lesion is classically caused by a stroke in the territory of the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vignette of a patient who can write a sentence but is unable to read it back is pathognomonic for alexia without agraphia, pointing directly to a left PCA stroke affecting the occipital lobe and splenium.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlexia without agraphia\u003c/b\u003e is a quintessential disconnection syndrome where visual information is stranded in the non-dominant hemisphere, unable to reach the language centers in the dominant hemisphere because the connecting bridge (splenium of the corpus callosum) has been destroyed, typically by a PCA stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Written Word] --\u003e B(Eyes); B --\u003e C[Right Visual Cortex]; C --x D(Splenium of Corpus Callosum); D --x E[Left Language Areas]; B --\u003e F(Left Visual Cortex); F --x G[Lesion];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"occipital_lobe\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"corpus_callosum\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"b6a2cc31\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\": \"13d6bca7\"\n      }\n    ]\n  },\n  \"083094db\": {\n    \"title\": \"Alprazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e (trade name Xanax) is a potent, short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used primarily for the management of anxiety disorders, especially panic disorder, and for the short-term treatment of anxiety associated with depression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the [[gaba_a_receptor|GABA\u003csub\u003eA\u003c/sub\u003e receptor]]. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA binding, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is short-acting. Mnemonic for short-acting benzodiazepines: \u003cb\u003eATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for [[panic_disorder|panic disorder]] and [[generalized_anxiety_disorder|generalized anxiety disorder]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, and withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates. Has a higher addictive potential due to its short half-life.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because of its rapid onset and short duration, alprazolam is highly effective for acute panic attacks but also carries a high risk of dependence and severe withdrawal. Overdose is treated with [[flumazenil]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e is a high-potency, short-acting benzodiazepine that provides rapid relief for panic and anxiety by enhancing GABAergic inhibition, but its pharmacokinetic profile also contributes to a significant risk of dependence and withdrawal.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Alprazolam] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"panic_disorder\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common cause of \u003ci\u003edementia\u003c/i\u003e in older adults, a progressive neurodegenerative disorder characterized by the extracellular deposition of \u003cb\u003eamyloid-Œ≤ (AŒ≤) plaques\u003c/b\u003e and the intracellular accumulation of \u003cb\u003ehyperphosphorylated tau tangles\u003c/b\u003e, leading to widespread cortical atrophy and a significant cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology Hallmarks:\u003c/b\u003e Extracellular \u003cmark\u003esenile plaques\u003c/mark\u003e (composed of AŒ≤) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (composed of hyperphosphorylated tau protein). The number of tangles correlates with disease severity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Risk is increased by the \u003cmark\u003eApoE4\u003c/mark\u003e allele for the sporadic, late-onset form. Early-onset familial forms are associated with mutations in \u003ci\u003eAPP\u003c/i\u003e (chromosome 21), \u003ci\u003epresenilin-1\u003c/i\u003e (chromosome 14), and \u003ci\u003epresenilin-2\u003c/i\u003e (chromosome 1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Insidious onset of progressive short-term memory loss, followed by language deficits (aphasia), visuospatial difficulties, and executive dysfunction. Personality and behavioral changes are common in later stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Deficit:\u003c/b\u003e Marked decrease in [[6a005559|acetylcholine]] due to degeneration of cholinergic neurons in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome (Trisomy 21)\u003c/b\u003e have a greatly increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on chromosome 21, leading to a gene dosage effect and increased AŒ≤ production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe core pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves a dual-proteinopathy of extracellular amyloid plaques and intracellular tau tangles, which together trigger synaptic dysfunction and neuronal death, manifesting clinically as a progressive decline in memory and cognition due to widespread cortical and hippocampal atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[APP Gene on Chr 21] --Abnormal Cleavage--\u003e B(Amyloid-Œ≤ Monomers); B --\u003e C(Oligomers \u0026 Plaques); D[Tau Protein] --Hyperphosphorylation--\u003e E(Neurofibrillary Tangles); C \u0026 E --\u003e F(Synaptic Dysfunction \u0026 Neuronal Death); F --\u003e G(Cortical Atrophy); G --\u003e H(Dementia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"down_syndrome\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  },\n  \"9c9679ea\": {\n    \"title\": \"Amantadine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmantadine\u003c/b\u003e is a medication with multiple mechanisms of action, used primarily in neurology to treat [[58c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms, and historically as an antiviral agent for influenza A.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism (Parkinson\u0027s):\u003c/b\u003e Increases dopamine availability by \u003cmark\u003eenhancing dopamine release\u003c/mark\u003e and \u003cmark\u003einhibiting dopamine reuptake\u003c/mark\u003e in the CNS. It also has some anticholinergic properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for mild [[58c8ea03|Parkinson disease]] to improve tremor, rigidity, and bradykinesia. It is particularly useful for reducing levodopa-induced dyskinesias in advanced disease. Also used to treat acute dystonia caused by antipsychotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntiviral Use:\u003c/b\u003e Previously used for prophylaxis and treatment of Influenza A by blocking the M2 proton channel, but is no longer recommended due to widespread resistance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e CNS effects like confusion, hallucinations, and dizziness. A characteristic side effect is \u003cmark\u003elivedo reticularis\u003c/mark\u003e (a mottled, purplish skin discoloration) and peripheral edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For Parkinson\u0027s, amantadine is a \u0027weaker\u0027 drug but can be useful early on or for managing side effects of more potent therapies. The association with livedo reticularis is a classic board question clue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmantadine\u003c/b\u003e serves a niche role in managing [[58c8ea03|Parkinson disease]] by modestly increasing dopamine levels, but its utility is limited by CNS side effects and the unique dermatologic finding of livedo reticularis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"livedo_reticularis\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"f0aac1c3\": {\n    \"title\": \"Amaurosis Fugax\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmaurosis fugax\u003c/b\u003e (from Greek for \u0027darkening\u0027 and Latin for \u0027fleeting\u0027) is a painless, \u003ci\u003etransient monocular vision loss\u003c/i\u003e, classically described by patients as a \u003cmark\u003e\\\"curtain coming down over one eye.\\\"\u003c/mark\u003e It is a form of [[623ba776|transient ischemic attack (TIA)]] affecting the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus to the [[3334840f|central or branch retinal artery]], which temporarily obstructs blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSource of Emboli:\u003c/b\u003e The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. It can also be cardiogenic (e.g., from atrial fibrillation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a critical warning sign of underlying cerebrovascular disease and portends a high risk of a major [[c5da3c57|stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWorkup:\u003c/b\u003e Patients require urgent evaluation, including a carotid ultrasound (duplex) to assess for stenosis and an EKG/echocardiogram to rule out cardiac sources.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient with a history of hypertension and hyperlipidemia who experiences a sudden, painless, temporary \\\"curtain-like\\\" vision loss in one eye should immediately point to amaurosis fugax secondary to carotid artery disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmaurosis fugax\u003c/b\u003e is not just an eye problem but a neurological emergency; this transient \u0027curtain\u0027 of vision loss is a TIA of the retina, most often signaling significant atherosclerotic disease in the ipsilateral carotid artery and a high impending risk of stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Carotid Artery Plaque] --\u003e B(Embolus); B --\u003e C[Ophthalmic Artery]; C --\u003e D[Retinal Artery Occlusion]; D --\u003e E[Transient Monocular Vision Loss]; E --\u003e F(Amaurosis Fugax);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"623ba776\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"carotid_artery_stenosis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  },\n  \"a4a401c7\": {\n    \"title\": \"Amblyopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pediatric Ophthalmology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e, commonly known as \\\"lazy eye,\\\" is a neurodevelopmental disorder of vision characterized by \u003ci\u003edecreased visual acuity\u003c/i\u003e in one or both eyes that is not correctable by refractive means and is not due to any structural eye pathology. It results from abnormal visual experience during early childhood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a critical period of visual development (birth to ~7 years), the brain suppresses or ignores the input from one eye, leading to maldevelopment of the visual cortex corresponding to that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[cdcda821|Strabismus]] (Misalignment):\u003c/b\u003e The brain ignores the image from the deviating eye to avoid diplopia.\u003cbr\u003e2. \u003cb\u003eAnisometropia (Unequal Refractive Error):\u003c/b\u003e The brain favors the eye with better focus.\u003cbr\u003e3. \u003cb\u003eDeprivation:\u003c/b\u003e An obstruction like a congenital [[85f03b02|cataract]] or ptosis blocks a clear image from forming.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected during pediatric vision screening. The key finding is a difference in visual acuity between the two eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Must be initiated early in the critical period. Treatment involves correcting the underlying cause (e.g., glasses for refractive error, surgery for strabismus/cataract) and then forcing the brain to use the amblyopic eye, typically by \u003cmark\u003epatching the good eye\u003c/mark\u003e or using atropine drops to blur its vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Early detection and treatment are crucial. If not treated before the end of the critical period (~age 7-8), amblyopia can result in irreversible vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e is a \u0027brain\u0027 problem, not an \u0027eye\u0027 problem; it is the failure of the visual cortex to develop properly due to abnormal input from an eye during a critical developmental window, leading to vision loss that can only be reversed by forcing the brain to pay attention to the \u0027lazy\u0027 eye before that window closes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cdcda821\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"85f03b02\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ocular_patching\"\n      }\n    ]\n  },\n  \"9115b704\": {\n    \"title\": \"Amino Acids (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmino acids\u003c/b\u003e are organic compounds that serve as the building blocks of proteins and as precursors for many neurotransmitters. In the central nervous system, their passage from the blood into the brain is tightly regulated by the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Amino acids are generally lipid-insoluble and cannot diffuse freely across the [[dd47b9cc|blood-brain barrier]]. They require \u003cmark\u003ecarrier-mediated transport proteins\u003c/mark\u003e to enter the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Systems:\u003c/b\u003e There are specific transporters for different classes of amino acids (e.g., large neutral, basic, acidic). These transporters can become saturated and exhibit competition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Precursors:\u003c/b\u003e Many crucial neurotransmitters are synthesized from amino acids that must be transported into the brain. Examples include Tyrosine (precursor to [[90adc821|dopamine]], norepinephrine) and Tryptophan (precursor to [[5d3c2089|serotonin]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e In disorders like [[phenylketonuria|Phenylketonuria (PKU)]], high levels of one amino acid (phenylalanine) can saturate the large neutral amino acid transporter, impairing the transport of other essential amino acids (like tyrosine and tryptophan) into the brain, contributing to neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that both glucose and amino acids require specific carrier-mediated transport to cross the [[dd47b9cc|blood-brain barrier]]; they do not diffuse freely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain\u0027s supply of essential \u003cb\u003eamino acids\u003c/b\u003e, critical for both protein synthesis and neurotransmitter production, is entirely dependent on specialized carrier proteins at the [[dd47b9cc|blood-brain barrier]], a system that can be competitively inhibited in certain metabolic diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"crosses_via_transporters\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"transport_is_impaired_in\",\n        \"to\": \"phenylketonuria\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9275,
      "parts": [{
        "text": "```json\n{\n  \"aaeda12d\": {\n    \"title\": \"Adenovirus\",\n    \"primaryType"
      }, {
        "text": "\": \"microbe\",\n    \"tags\": [\n      \"Virology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"In"
      }, {
        "text": "fections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a non-en"
      }, {
        "text": "veloped, double-stranded DNA virus that is a common cause of various infections, including pharyngitis, pneumonia, hemorrhagic"
      }, {
        "text": " cystitis, and notably, \u003ci\u003eviral conjunctivitis\u003c/i\u003e (pink eye).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Non-enveloped, icosahedral capsid with a linear dsDNA genome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission"
      }, {
        "text": ":\u003c/b\u003e Transmitted via respiratory droplets, fecal-oral route, and direct contact with contaminated surfaces (fomites). Highly"
      }, {
        "text": " stable in the environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Manifestation:\u003c/b\u003e The most common cause of viral [[c4d0"
      }, {
        "text": "8c09|conjunctivitis]], presenting with a \u003cmark\u003ewatery discharge\u003c/mark\u003e, red eye, and"
      }, {
        "text": " often a swollen preauricular lymph node.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical Syndromes:\u003c/b\u003e Causes febrile pharyngitis, acute"
      }, {
        "text": " hemorrhagic cystitis, and pneumonia (especially in military recruits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a question describing"
      }, {
        "text": " a patient (often a child) with red, watery eyes and a recent history of a cold or attending daycare, Aden"
      }, {
        "text": "ovirus is the most likely pathogen. The watery discharge is key to differentiating it from bacterial conjunctivitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a highly resilient DNA virus responsible for the majority of viral conjunctivitis cases"
      }, {
        "text": ", characterized by a watery discharge that distinguishes it from the purulent discharge of bacterial causes.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Adenovirus] --\u003e B{Transmission}; B --\u003e B1[Respiratory Droplets]; B --\u003e B2"
      }, {
        "text": "[Fecal-Oral]; B --\u003e B3[Fomites]; A --\u003e C{Clinical Syndromes}; C --\u003e"
      }, {
        "text": " C1[Conjunctivitis]; C --\u003e C2[Pharyngitis]; C --\u003e C3[Pneumonia]; C --\u003e C4["
      }, {
        "text": "Hemorrhagic Cystitis];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"c4d08c09\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"dna_virus\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"21d4b96a\": {\n    \"title\": \"Adrenoleukodystrophy"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdrenoleukod"
      }, {
        "text": "ystrophy\u003c/b\u003e is an \u003ci\u003eX-linked recessive disorder\u003c/i\u003e caused by a mutation in the \u003cb\u003eABCD1\u003c/b\u003e gene, leading to impaired"
      }, {
        "text": " Œ≤-oxidation of very-long-chain fatty acids (VLCFAs) in peroxisomes. This results in the"
      }, {
        "text": " accumulation of VLCFAs in the adrenal glands, testes, and white matter of the brain, causing adrenal insufficiency and progressive dem"
      }, {
        "text": "yelination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e X-linked recessive mutation"
      }, {
        "text": " in the \u003ci\u003eABCD1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Defective peroxisomal Œ≤-oxidation leads"
      }, {
        "text": " to the accumulation of \u003cmark\u003every-long-chain fatty acids (VLCFAs)\u003c/mark\u003e in various tissues."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Manifestations:\u003c/b\u003e Progressive demyelination of the central nervous system, leading to cognitive decline, behavioral"
      }, {
        "text": " changes, spasticity, and vision/hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Manifestations:\u003c/b\u003e Adrenal insufficiency ([["
      }, {
        "text": "addison_disease|Addison disease]]) is a common feature, presenting with fatigue, hyperpigmentation, and electrolyte"
      }, {
        "text": " abnormalities. Testicular atrophy and infertility can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette involves a young"
      }, {
        "text": " boy with new-onset behavioral problems or declining school performance who also shows signs of adrenal insufficiency (e.g., hyper"
      }, {
        "text": "pigmentation, low cortisol).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is a"
      }, {
        "text": " dual-system disease combining progressive CNS demyelination with adrenal failure, all stemming from a single X-linked genetic defect in peroxisomal fatty"
      }, {
        "text": " acid metabolism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ABCD1 Gene Mutation] --\u003e B("
      }, {
        "text": "Defective Peroxisomal Œ≤-oxidation); B --\u003e C[Accumulation of VLCFAs]; C --\u003e D[Ad"
      }, {
        "text": "renal Cortex] --\u003e E(Adrenal Insufficiency); C --\u003e F[CNS White Matter] --\u003e G(Demyel"
      }, {
        "text": "ination \u0026 Neurodegeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"peroxisomal_disorder\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"addison_"
      }, {
        "text": "disease\"\n      },\n      {\n        \"type\": \"has_inheritance_pattern\",\n        \"to\":"
      }, {
        "text": " \"x_linked_recessive\"\n      }\n    ]\n  },\n  \"c63255c8\":"
      }, {
        "text": " {\n    \"title\": \"Age-related Macular Degeneration (AMD)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAge-related Mac"
      }, {
        "text": "ular Degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part of the retina"
      }, {
        "text": ", leading to the gradual loss of \u003ci\u003ecentral vision\u003c/i\u003e. It is the leading cause of irreversible blindness in older adults in developed countries.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e More common (~80%)."
      }, {
        "text": " Characterized by the slow breakdown of photoreceptors in the macula and the deposition of yellowish extracellular material called \u003cmark\u003edr"
      }, {
        "text": "usen\u003c/mark\u003e between Bruch\u0027s membrane and the retinal pigment epithelium. Causes gradual vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet"
      }, {
        "text": " (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by rapid vision loss due to choroidal neovascularization."
      }, {
        "text": " Abnormal blood vessels grow under the retina, leak fluid and blood, and can cause scarring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients"
      }, {
        "text": " report painless, progressive loss of central vision, leading to scotomas (blind spots). A key early symptom of wet AMD is \u003c"
      }, {
        "text": "mark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopy reveals dr"
      }, {
        "text": "usen (dry AMD) or hemorrhage/exudates (wet AMD). An Amsler grid is used to detect"
      }, {
        "text": " metamorphopsia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference: \u003cb\u003eDry AMD \u003d Drusen\u003c/b\u003e and"
      }, {
        "text": " gradual loss. \u003cb\u003eWet AMD \u003d Neovascularization\u003c/b\u003e and rapid loss. Central vision loss is the hallmark for both.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration\u003c/b\u003e specifically targets central, high-acuity vision by"
      }, {
        "text": " damaging the macula. The distinction between the slow, drusen-associated \u0027dry\u0027 form and the rapid, ne"
      }, {
        "text": "ovascular \u0027wet\u0027 form is critical for prognosis and management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aging"
      }, {
        "text": " \u0026 Genetic Factors] --\u003e B{Macular Damage}; B --\u003e C[Dry AMD]; C --\u003e D[Drusen Dep"
      }, {
        "text": "osition \u0026 Atrophy]; D --\u003e E[Gradual Central Vision Loss]; B --\u003e F[Wet AMD]; F --\u003e G["
      }, {
        "text": "Choroidal Neovascularization]; G --\u003e H[Hemorrhage \u0026 Exudate]; H --\u003e I[Rapid Central"
      }, {
        "text": " Vision Loss];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \""
      }, {
        "text": "macula\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"central_scotoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"metamorphopsia\"\n      }\n    ]\n  },\n  \"13d6bca7"
      }, {
        "text": "\": {\n    \"title\": \"Agraphia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e"
      }, {
        "text": " is an acquired neurological disorder characterized by the \u003ci\u003eloss of the ability to communicate through writing\u003c/i\u003e, stemming from damage to specific"
      }, {
        "text": " brain areas involved in language processing and motor control of the hand.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization"
      }, {
        "text": ":\u003c/b\u003e Agraphia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f"
      }, {
        "text": "|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAgraphia\u003c/b\u003e, \u003cb\u003e"
      }, {
        "text": "[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), \u003cb\u003eFinger"
      }, {
        "text": " Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlex"
      }, {
        "text": "ia with Agraphia:\u003c/b\u003e When a patient can neither read nor write, the lesion is typically in the dominant angular gyrus. This"
      }, {
        "text": " is distinct from [[fcf30c1b|alexia without agraphia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " If a question describes a patient who suddenly cannot write but has no other motor deficits in the hand, and also has trouble"
      }, {
        "text": " with math, think of a dominant parietal lobe lesion, likely from an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is not simply poor handwriting; it is a specific neurological deficit"
      }, {
        "text": " in the production of written language that, when paired with [[8558c64b|acalculia]],"
      }, {
        "text": " strongly points to a lesion in the dominant angular gyrus, a hallmark of [[38f3ed1f|"
      }, {
        "text": "Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"2"
      }, {
        "text": "6efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke"
      }, {
        "text": "_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0d04bf44\": {\n    \"title\": \"Akathisia\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAkathisia"
      }, {
        "text": "\u003c/b\u003e is a movement disorder characterized by a subjective feeling of inner restlessness and a compelling urge to be in constant motion, most"
      }, {
        "text": " commonly seen as an \u003ci\u003eextrapyramidal side effect\u003c/i\u003e of antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by dopamine receptor antagonists, particularly \u003cmark\u003efirst-generation ("
      }, {
        "text": "typical) antipsychotics\u003c/mark\u003e (e.g., haloperidol). It can also occur with second-generation antipsych"
      }, {
        "text": "otics and some antidepressants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients describe an inability to sit still, feeling like they need"
      }, {
        "text": " to \u0027jump out of their skin.\u0027 Objective signs include pacing, shuffling feet, and shifting from one foot to another.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Timeline:\u003c/b\u003e It is a subacute extrapyramidal symptom, typically developing days to weeks after starting or increasing the"
      }, {
        "text": " dose of an offending agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management involves reducing the dose of the antipsychotic, switching to an"
      }, {
        "text": " agent with a lower risk (e.g., quetiapine), or adding medications like \u003cmark\u003epropranolol\u003c/mark\u003e, benzodiazep"
      }, {
        "text": "ines, or benztropine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate akathisia from psychotic agitation."
      }, {
        "text": " Akathisia is a drug side effect causing restlessness, while agitation is a symptom of the underlying psychosis. Mistaking one for the other and"
      }, {
        "text": " increasing the antipsychotic dose will worsen akathisia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAkathisia"
      }, {
        "text": "\u003c/b\u003e is a distressing, drug-induced state of motor restlessness that must be distinguished from psychiatric agitation, as the treatment involves"
      }, {
        "text": " reducing or counteracting the offending antipsychotic, not increasing it.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[D"
      }, {
        "text": "opamine (D2) Receptor Blockade] --\u003e B(Disruption of Nigrostriatal Pathway); B --\u003e C[Subject"
      }, {
        "text": "ive Restlessness \u0026 Compulsion to Move]; C --\u003e D(Akathisia);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treated"
      }, {
        "text": "_by\",\n        \"to\": \"propranolol\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "3be7a6e\": {\n    \"title\": \"Alar Plate\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the dorsal part of the neural tube in the developing embryo,"
      }, {
        "text": " which differentiates into \u003ci\u003esensory neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of signaling molecules like bone"
      }, {
        "text": " morphogenetic proteins (BMPs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal ("
      }, {
        "text": "posterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003esensory\u003c/u\u003e"
      }, {
        "text": " components of the central nervous system. Mnemonic: Alar is dorsal, like the dorsal fin of a shark which senses things"
      }, {
        "text": " in the water.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by signaling molecules from the overlying ectoderm, primarily"
      }, {
        "text": " \u003cmark\u003eBone Morphogenetic Proteins (BMPs)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The ventral counterpart is the [[25"
      }, {
        "text": "3e3efb|Basal Plate]], which develops into motor neurons under the influence of Sonic Hedgehog (SHH"
      }, {
        "text": ") from the notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eAlar \u003d Sensory"
      }, {
        "text": " \u003d Dorsal\u003c/b\u003e, and \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e. This organization persists in the adult spinal cord."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the embryonic foundation for"
      }, {
        "text": " the sensory pathways of the CNS, establishing the fundamental dorsal-sensory and ventral-motor organization of the neural tube that"
      }, {
        "text": " is maintained throughout life.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Al"
      }, {
        "text": "ar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --"
      }, {
        "text": "BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C"
      }, {
        "text": "; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"develops_into\",\n        \"to\": \"sensory_neurons\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_counterpart_to\",\n        \"to\": \"253e3efb\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"bone_morph"
      }, {
        "text": "ogenetic_proteins\"\n      }\n    ]\n  },\n  \"a0f3ce4c\":"
      }, {
        "text": " {\n    \"title\": \"Albuminocytologic Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Diagnostics\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral"
      }, {
        "text": " Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlbuminocyt"
      }, {
        "text": "ologic dissociation\u003c/b\u003e is the pathognomonic finding in the cerebrospinal fluid (CSF) of patients with [[ed52e"
      }, {
        "text": "40b|Guillain-Barr√© Syndrome]], characterized by a significantly \u003ci\u003eelevated protein concentration\u003c/i\u003e in"
      }, {
        "text": " the presence of a \u003ci\u003enormal or near-normal white blood cell count\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This finding is the hallmark of [[ed52e40b|Gu"
      }, {
        "text": "illain-Barr√© Syndrome (GBS)]], specifically the AIDP subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e W"
      }, {
        "text": "idespread inflammation of the nerve roots (radiculopathy) disrupts the blood-nerve barrier, allowing protein (mainly albumin) to leak from the plasma"
      }, {
        "text": " into the CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Count:\u003c/b\u003e The cell count remains normal (typically \u003c10 cells/mm"
      }, {
        "text": "\u003csup\u003e3\u003c/sup\u003e) because the inflammatory process is primarily in the peripheral nerve roots, not within the CSF space itself (i"
      }, {
        "text": ".e., it is not meningitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e The protein level may be normal in the first few days of G"
      }, {
        "text": "BS and typically peaks 1-2 weeks after symptom onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with ascending"
      }, {
        "text": " paralysis after a recent infection (*C. jejuni* or viral URI) and a CSF report showing high protein but a"
      }, {
        "text": " normal cell count is a classic vignette for [[ed52e40b|Guillain-Barr√© Syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is a powerful diagnostic clue for"
      }, {
        "text": " [[ed52e40b|Guillain-Barr√© Syndrome]], reflecting the unique pathophysiology of nerve root inflammation that"
      }, {
        "text": " increases blood-nerve barrier permeability to proteins without causing a significant cellular infiltrate into the CSF.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        "
      }, {
        "text": "\"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_found_in\",\n        \"to\": \"cerebrospinal_fluid\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"fcf30c1b\": {\n    \"title\": \"Alexia\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"Stroke"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlexia\u003c/b\u003e"
      }, {
        "text": " is an acquired neurological disorder characterized by the \u003ci\u003einability to read or comprehend written language\u003c/i\u003e, resulting from a lesion in the brain\u0027"
      }, {
        "text": "s language or visual processing centers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlexia without Ag"
      }, {
        "text": "raphia (Pure Alexia):\u003c/b\u003e A specific syndrome where the patient can write but cannot read what they have just written."
      }, {
        "text": " This is a classic disconnection syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the \u003cmark"
      }, {
        "text": "\u003edominant (usually left) occipital lobe\u003c/mark\u003e that also damages the \u003cmark\u003esplenium of the corpus callosum\u003c/mark"
      }, {
        "text": "\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Visual information from the intact right occipital lobe cannot cross over to the dominant hemisphere\u0027s language areas"
      }, {
        "text": " (Wernicke\u0027s area, angular gyrus) for interpretation because the connecting fibers in the splenium are damaged. The dominant"
      }, {
        "text": " visual cortex is also damaged, so no visual information can be processed on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e This"
      }, {
        "text": " specific lesion is classically caused by a stroke in the territory of the [[b6a2cc31|Posterior Cerebral"
      }, {
        "text": " Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vignette of a patient who can write a sentence"
      }, {
        "text": " but is unable to read it back is pathognomonic for alexia without agraphia, pointing directly to a left"
      }, {
        "text": " PCA stroke affecting the occipital lobe and splenium.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlexia without agraph"
      }, {
        "text": "ia\u003c/b\u003e is a quintessential disconnection syndrome where visual information is stranded in the non-dominant hemisphere, unable to reach the language centers in the dominant"
      }, {
        "text": " hemisphere because the connecting bridge (splenium of the corpus callosum) has been destroyed, typically by a PCA stroke.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Written Word] --\u003e B(Eyes); B --\u003e C[Right Visual Cortex]; C --"
      }, {
        "text": "x D(Splenium of Corpus Callosum); D --x E[Left Language Areas]; B --\u003e F(Left Visual"
      }, {
        "text": " Cortex); F --x G[Lesion];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"occipital_lobe\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to"
      }, {
        "text": "\": \"corpus_callosum\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "_stroke_in\",\n        \"to\": \"b6a2cc31\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_distinct_from\",\n        \"to\": \"13d6bca7"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"083094db\": {\n    \"title\": \"Al"
      }, {
        "text": "prazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e (trade name Xanax) is a potent"
      }, {
        "text": ", short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used primarily for the management of anxiety disorders, especially panic disorder, and for"
      }, {
        "text": " the short-term treatment of anxiety associated with depression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e A positive allosteric modulator of the [[gaba_a_receptor|GABA\u003csub\u003e"
      }, {
        "text": "A\u003c/sub\u003e receptor]]. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA binding, leading to enhanced"
      }, {
        "text": " CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is short-acting. Mnemonic for short-acting benzodiazepines: \u003cb\u003e"
      }, {
        "text": "ATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazol"
      }, {
        "text": "am).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for [[panic_disorder|panic disorder]] and [[generalized_"
      }, {
        "text": "anxiety_disorder|generalized anxiety disorder]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance"
      }, {
        "text": ", and withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates. Has a higher addictive"
      }, {
        "text": " potential due to its short half-life.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because of its rapid onset and short duration"
      }, {
        "text": ", alprazolam is highly effective for acute panic attacks but also carries a high risk of dependence and severe withdrawal. Over"
      }, {
        "text": "dose is treated with [[flumazenil]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e is"
      }, {
        "text": " a high-potency, short-acting benzodiazepine that provides rapid relief for panic and anxiety by enhancing GABAergic inhibition, but its"
      }, {
        "text": " pharmacokinetic profile also contributes to a significant risk of dependence and withdrawal.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Alprazol"
      }, {
        "text": "am] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening"
      }, {
        "text": "); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS"
      }, {
        "text": " Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"panic_disorder\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common cause of \u003ci\u003ed"
      }, {
        "text": "ementia\u003c/i\u003e in older adults, a progressive neurodegenerative disorder characterized by the extracellular deposition of \u003cb\u003eamyloid-Œ≤ (AŒ≤) plaques\u003c/b\u003e and the"
      }, {
        "text": " intracellular accumulation of \u003cb\u003ehyperphosphorylated tau tangles\u003c/b\u003e, leading to widespread cortical atrophy and a significant cholinergic deficit.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology Hallmarks:\u003c/b\u003e Extracellular \u003cmark\u003esenile plaques\u003c/mark\u003e (composed"
      }, {
        "text": " of AŒ≤) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (composed of hyperphosphorylated tau protein"
      }, {
        "text": "). The number of tangles correlates with disease severity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Risk is increased by the \u003c"
      }, {
        "text": "mark\u003eApoE4\u003c/mark\u003e allele for the sporadic, late-onset form. Early-onset familial forms are associated"
      }, {
        "text": " with mutations in \u003ci\u003eAPP\u003c/i\u003e (chromosome 21), \u003ci\u003epresenilin-1\u003c/i\u003e (chromosome "
      }, {
        "text": "14), and \u003ci\u003epresenilin-2\u003c/i\u003e (chromosome 1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Ins"
      }, {
        "text": "idious onset of progressive short-term memory loss, followed by language deficits (aphasia), visuospatial difficulties,"
      }, {
        "text": " and executive dysfunction. Personality and behavioral changes are common in later stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Deficit:\u003c/b\u003e Marked"
      }, {
        "text": " decrease in [[6a005559|acetylcholine]] due to degeneration of cholinergic neurons in the [[36"
      }, {
        "text": "1438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients"
      }, {
        "text": " with \u003cb\u003eDown syndrome (Trisomy 21)\u003c/b\u003e have a greatly increased risk of early-onset Alzheimer\u0027"
      }, {
        "text": "s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on chromosome 21, leading to a gene dosage effect and increased AŒ≤ production.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe core pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves a dual-protein"
      }, {
        "text": "opathy of extracellular amyloid plaques and intracellular tau tangles, which together trigger synaptic dysfunction and neuronal death, manifesting clinically as a progressive"
      }, {
        "text": " decline in memory and cognition due to widespread cortical and hippocampal atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[APP"
      }, {
        "text": " Gene on Chr 21] --Abnormal Cleavage--\u003e B(Amyloid-Œ≤ Monomers); B --\u003e C(O"
      }, {
        "text": "ligomers \u0026 Plaques); D[Tau Protein] --Hyperphosphorylation--\u003e E(Neurofibrillary Tangles); C"
      }, {
        "text": " \u0026 E --\u003e F(Synaptic Dysfunction \u0026 Neuronal Death); F --\u003e G(Cortical Atrophy); G --\u003e H(D"
      }, {
        "text": "ementia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"down_syndrome\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"involves_deficiency_of\",\n        \"to\": \"6a0055"
      }, {
        "text": "59\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"4"
      }, {
        "text": "7d0372e\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"3"
      }, {
        "text": "61438f2\"\n      }\n    ]\n  },\n  \"9c9679ea\": {\n"
      }, {
        "text": "    \"title\": \"Amantadine\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAmantadine\u003c/b\u003e is a medication with multiple mechanisms of action, used primarily in neurology to treat [[5"
      }, {
        "text": "8c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms, and historically as"
      }, {
        "text": " an antiviral agent for influenza A.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism (Parkinson\u0027"
      }, {
        "text": "s):\u003c/b\u003e Increases dopamine availability by \u003cmark\u003eenhancing dopamine release\u003c/mark\u003e and \u003cmark\u003einhibiting dopamine reuptake\u003c/"
      }, {
        "text": "mark\u003e in the CNS. It also has some anticholinergic properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used"
      }, {
        "text": " for mild [[58c8ea03|Parkinson disease]] to improve tremor, rigidity, and bradykinesia. It is"
      }, {
        "text": " particularly useful for reducing levodopa-induced dyskinesias in advanced disease. Also used to treat acute dystonia caused"
      }, {
        "text": " by antipsychotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntiviral Use:\u003c/b\u003e Previously used for prophylaxis and treatment of Influenza A by blocking"
      }, {
        "text": " the M2 proton channel, but is no longer recommended due to widespread resistance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e CNS"
      }, {
        "text": " effects like confusion, hallucinations, and dizziness. A characteristic side effect is \u003cmark\u003elivedo reticularis\u003c/mark\u003e (a"
      }, {
        "text": " mottled, purplish skin discoloration) and peripheral edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For Parkinson\u0027s, am"
      }, {
        "text": "antadine is a \u0027weaker\u0027 drug but can be useful early on or for managing side effects of more potent therapies"
      }, {
        "text": ". The association with livedo reticularis is a classic board question clue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Amantadine\u003c/b\u003e serves a niche role in managing [[58c8ea03|Parkinson disease]] by modestly"
      }, {
        "text": " increasing dopamine levels, but its utility is limited by CNS side effects and the unique dermatologic finding of livedo reticularis.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes_adverse_effect\",\n        \"to\": \"livedo_reticularis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc"
      }, {
        "text": "821\"\n      }\n    ]\n  },\n  \"f0aac1c3\": {\n"
      }, {
        "text": "    \"title\": \"Amaurosis Fugax\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmaurosis"
      }, {
        "text": " fugax\u003c/b\u003e (from Greek for \u0027darkening\u0027 and Latin for \u0027fleeting\u0027) is a painless, \u003ci\u003etransient monocular vision loss\u003c/i\u003e"
      }, {
        "text": ", classically described by patients as a \u003cmark\u003e\\\"curtain coming down over one eye.\\\"\u003c/mark\u003e It is a form"
      }, {
        "text": " of [[623ba776|transient ischemic attack (TIA)]] affecting the retina.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus to the [["
      }, {
        "text": "3334840f|central or branch retinal artery]], which temporarily obstructs blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSource"
      }, {
        "text": " of Emboli:\u003c/b\u003e The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e."
      }, {
        "text": " It can also be cardiogenic (e.g., from atrial fibrillation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a critical warning"
      }, {
        "text": " sign of underlying cerebrovascular disease and portends a high risk of a major [[c5da3c57|stroke]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eWorkup:\u003c/b\u003e Patients require urgent evaluation, including a carotid ultrasound (duplex) to assess for stenosis and an"
      }, {
        "text": " EKG/echocardiogram to rule out cardiac sources.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient with a"
      }, {
        "text": " history of hypertension and hyperlipidemia who experiences a sudden, painless, temporary \\\"curtain-like\\\" vision loss in one eye should immediately"
      }, {
        "text": " point to amaurosis fugax secondary to carotid artery disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmaurosis"
      }, {
        "text": " fugax\u003c/b\u003e is not just an eye problem but a neurological emergency; this transient \u0027curtain\u0027 of vision loss is"
      }, {
        "text": " a TIA of the retina, most often signaling significant atherosclerotic disease in the ipsilateral carotid artery and a high impending"
      }, {
        "text": " risk of stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Carotid Artery Plaque] --\u003e B(Em"
      }, {
        "text": "bolus); B --\u003e C[Ophthalmic Artery]; C --\u003e D[Retinal Artery Occlusion]; D --\u003e E"
      }, {
        "text": "[Transient Monocular Vision Loss]; E --\u003e F(Amaurosis Fugax);\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"623ba776\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"car"
      }, {
        "text": "otid_artery_stenosis\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"a4a401c7\": {\n    \"title\": \"Amblyopia\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Pediatric Ophthalmology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e, commonly known as \\\"lazy eye,\\\""
      }, {
        "text": " is a neurodevelopmental disorder of vision characterized by \u003ci\u003edecreased visual acuity\u003c/i\u003e in one or both eyes that is not correct"
      }, {
        "text": "able by refractive means and is not due to any structural eye pathology. It results from abnormal visual experience during early childhood.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a critical period of visual development (birth to ~7 years), the"
      }, {
        "text": " brain suppresses or ignores the input from one eye, leading to maldevelopment of the visual cortex corresponding to that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon"
      }, {
        "text": " Causes:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[cdcda821|Strabismus]] (Misalignment):\u003c/b\u003e The brain"
      }, {
        "text": " ignores the image from the deviating eye to avoid diplopia.\u003cbr\u003e2. \u003cb\u003eAnisometropia (Une"
      }, {
        "text": "qual Refractive Error):\u003c/b\u003e The brain favors the eye with better focus.\u003cbr\u003e3. \u003cb\u003eDeprivation:"
      }, {
        "text": "\u003c/b\u003e An obstruction like a congenital [[85f03b02|cataract]] or ptosis blocks a"
      }, {
        "text": " clear image from forming.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected during pediatric vision screening. The key finding is a difference in visual acuity between the two eyes."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Must be initiated early in the critical period. Treatment involves correcting the underlying cause (e.g., glasses"
      }, {
        "text": " for refractive error, surgery for strabismus/cataract) and then forcing the brain to use the amblyopic eye,"
      }, {
        "text": " typically by \u003cmark\u003epatching the good eye\u003c/mark\u003e or using atropine drops to blur its vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Early detection and treatment are crucial. If not treated before the end of the critical period (~age 7-8),"
      }, {
        "text": " amblyopia can result in irreversible vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmblyopia"
      }, {
        "text": "\u003c/b\u003e is a \u0027brain\u0027 problem, not an \u0027eye\u0027 problem; it is the failure of the visual cortex to develop properly due to abnormal"
      }, {
        "text": " input from an eye during a critical developmental window, leading to vision loss that can only be reversed by forcing the brain to pay"
      }, {
        "text": " attention to the \u0027lazy\u0027 eye before that window closes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"cdcda821\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "\",\n        \"to\": \"85f03b02\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_treated_by\",\n        \"to\": \"ocular_patching\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"9115b704\": {\n    \"title\": \""
      }, {
        "text": "Amino Acids (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \""
      }, {
        "text": "Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmino acids\u003c/b\u003e are organic compounds that serve as the"
      }, {
        "text": " building blocks of proteins and as precursors for many neurotransmitters. In the central nervous system, their passage from the blood into the brain"
      }, {
        "text": " is tightly regulated by the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Amino acids are generally lipid-insoluble and cannot diffuse freely across the [["
      }, {
        "text": "dd47b9cc|blood-brain barrier]]. They require \u003cmark\u003ecarrier-mediated transport proteins\u003c/mark\u003e to"
      }, {
        "text": " enter the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Systems:\u003c/b\u003e There are specific transporters for different classes of amino acids (e.g., large neutral,"
      }, {
        "text": " basic, acidic). These transporters can become saturated and exhibit competition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Precursors:\u003c/b\u003e Many crucial"
      }, {
        "text": " neurotransmitters are synthesized from amino acids that must be transported into the brain. Examples include Tyrosine (precursor to [["
      }, {
        "text": "90adc821|dopamine]], norepinephrine) and Tryptophan (precursor to [[5d"
      }, {
        "text": "3c2089|serotonin]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e In disorders like [[phenylketonuria|"
      }, {
        "text": "Phenylketonuria (PKU)]], high levels of one amino acid (phenylalanine) can saturate the large neutral amino acid transporter, impair"
      }, {
        "text": "ing the transport of other essential amino acids (like tyrosine and tryptophan) into the brain, contributing to neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember that both glucose and amino acids require specific carrier-mediated transport to cross the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]]; they do not diffuse freely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain"
      }, {
        "text": "\u0027s supply of essential \u003cb\u003eamino acids\u003c/b\u003e, critical for both protein synthesis and neurotransmitter production, is entirely dependent on specialized"
      }, {
        "text": " carrier proteins at the [[dd47b9cc|blood-brain barrier]], a system that can be competitively inhibited"
      }, {
        "text": " in certain metabolic diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"crosses_via_transporters\",\n        \"to\": \"dd47b9cc\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \""
      }, {
        "text": "90adc821\"\n      },\n      {\n        \"type\": \"is_precursor_"
      }, {
        "text": "to\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"transport_is_impaired_in\",\n        \"to\": \"phenylketonuria\"\n      }\n    "
      }, {
        "text": "]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1_g61ciW51iPpPg8xm4wuaBZNSysG89Og"
      },
      "role": "user",
      "tokenCount": 2013
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"c6814506\": {\n    \"title\": \"Amitriptyline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e is a \u003ci\u003etricyclic antidepressant (TCA)\u003c/i\u003e that works by inhibiting the reuptake of serotonin and norepinephrine. Due to its significant side effect profile, its primary use has shifted from depression to treating neuropathic pain and providing prophylaxis for [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks reuptake of norepinephrine and serotonin. Also has potent antagonistic effects at muscarinic, Œ±1-adrenergic, and H1-histamine receptors, which account for its side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for prophylaxis of [[c8833bae|migraine headaches]] and for the management of chronic neuropathic pain (e.g., diabetic neuropathy, postherpetic neuralgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Strong anticholinergic effects (\u003cmark\u003edry mouth, constipation, urinary retention, confusion\u003c/mark\u003e), orthostatic hypotension (Œ±1 blockade), sedation (H1 blockade), and weight gain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e Overdose is life-threatening, causing QRS widening and ventricular arrhythmias due to Na\u003csup\u003e+\u003c/sup\u003e channel blockade. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Tri-C\u0027s\u0027 for TCA toxicity: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, \u003cb\u003eC\u003c/b\u003eardiotoxicity. Amitriptyline is a tertiary amine TCA, giving it more potent anticholinergic and antihistaminic effects compared to secondary amines like nortriptyline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e, a classic TCA, is now more valued for its role in migraine prevention and neuropathic pain than for depression, but its use is always tempered by a significant burden of anticholinergic, antihistaminic, and anti-adrenergic side effects, with cardiotoxicity being the most dangerous in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tricyclic_antidepressant\"\n      },\n      {\n        \"type\": \"used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      }\n    ]\n  },\n  \"a62c0c9f\": {\n    \"title\": \"Amnesia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmnesia\u003c/b\u003e is a deficit in memory caused by brain damage, disease, or psychological trauma. It can be categorized based on the temporal nature of the memory loss relative to the causative event.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterograde Amnesia:\u003c/b\u003e The inability to form \u003cu\u003enew\u003c/u\u003e memories after the event that caused the amnesia. Long-term memories from before the event remain intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterograde Lesion Site:\u003c/b\u003e Classically caused by bilateral damage to the \u003cmark\u003ehippocampus\u003c/mark\u003e, a key structure in the medial temporal lobe for memory consolidation. Seen in [[77ae6148|Alzheimer disease]] and [[herpes_simplex_encephalitis|herpes simplex encephalitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetrograde Amnesia:\u003c/b\u003e The loss of memories that were formed \u003cu\u003ebefore\u003c/u\u003e the onset of amnesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome:\u003c/b\u003e A classic example of a syndrome causing both anterograde and retrograde amnesia, along with confabulation. It is caused by thiamine (B1) deficiency, often in the context of chronic alcohol use, and involves damage to the \u003cmark\u003emammillary bodies\u003c/mark\u003e and thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal lesions (e.g., from an anoxic brain injury or HSV encephalitis) are the classic cause of profound anterograde amnesia. The patient can remember their childhood but not what they had for breakfast.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hippocampus is the brain\u0027s \u0027save button\u0027 for new memories; therefore, bilateral damage to this structure results in profound \u003cb\u003eanterograde amnesia\u003c/b\u003e, leaving the individual unable to consolidate new experiences into long-term memory.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brain Injury/Disease] --\u003e B{Amnesia}; B --\u003e C[Anterograde Amnesia]; C --\u003e D(Inability to form new memories); D --\u003e E[Lesion: Hippocampus]; B --\u003e F[Retrograde Amnesia]; F --\u003e G(Loss of past memories); G --\u003e H[Lesion: Widespread Cortex];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a0590674\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"f02cfaa1\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"d220fc3f\": {\n    \"title\": \"Amygdala\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e is an almond-shaped set of neurons located deep within the medial temporal lobe of the brain. It is a key component of the [[73ace357|limbic system]] and plays a central role in processing emotions, particularly fear, anxiety, and aggression, as well as in memory formation and decision-making.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The amygdala is the brain\u0027s emotional center, responsible for processing fear, pleasure, and anger. It links emotions to memories and influences social and sexual behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the medial temporal lobe, anterior to the [[a0590674|hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (Bilateral):\u003c/b\u003e Bilateral destruction of the amygdala results in \u003cmark\u003eKl√ºver-Bucy syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:\u003c/b\u003e Characterized by disinhibited behavior, including hyperorality (tendency to examine objects with the mouth), hypersexuality, hyperphagia, and visual agnosia. Patients also exhibit placidity (loss of fear response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic cause of bilateral amygdala damage leading to Kl√ºver-Bucy syndrome is [[herpes_simplex_encephalitis|Herpes Simplex Virus-1 (HSV-1) encephalitis]], which has a predilection for the temporal lobes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e acts as the brain\u0027s alarm system and emotional processor; its bilateral destruction unleashes primitive behaviors by removing the normal emotional filters, resulting in the dramatic and disinhibited presentation of Kl√ºver-Bucy syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sensory Input] --\u003e B(Amygdala); B --Fear/Emotion Processing--\u003e C[Hypothalamus \u0026 Brainstem]; C --\u003e D(Autonomic \u0026 Behavioral Response);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"bilateral_lesion_causes\",\n        \"to\": \"kluver_bucy_syndrome\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"herpes_simplex_encephalitis\"\n      }\n    ]\n  },\n  \"b374ebd6\": {\n    \"title\": \"Cerebral Amyloid Angiopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy (CAA)\u003c/b\u003e is a condition in which amyloid-Œ≤ protein deposits in the walls of small to medium-sized arteries of the cerebral cortex and leptomeninges, weakening the vessels and increasing the risk of spontaneous, recurrent \u003cmark\u003elobar\u003c/mark\u003e intraparenchymal hemorrhages.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deposition of \u003cmark\u003eamyloid-Œ≤\u003c/mark\u003e (the same protein found in [[77ae6148|Alzheimer\u0027s]] plaques) in the tunica media and adventitia of cortical and leptomeningeal vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Most commonly presents with recurrent, spontaneous lobar hemorrhages in older adults (\u003e65 years). These hemorrhages are typically located in the superficial cortex (lobar) rather than deep structures like the basal ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Hemorrhages are characteristically \u003cmark\u003elobar\u003c/mark\u003e (frontal, parietal, occipital, temporal lobes), contrasting with hypertensive hemorrhages which are typically deep (basal ganglia, thalamus, pons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociation:\u003c/b\u003e Strongly associated with [[77ae6148|Alzheimer disease]], although it can occur independently.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly patient with no history of significant hypertension who presents with a spontaneous, superficial (lobar) intracerebral hemorrhage should raise high suspicion for Cerebral Amyloid Angiopathy. Recurrent hemorrhages in different lobes are a key feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy\u003c/b\u003e is a major cause of lobar intracerebral hemorrhage in the elderly, resulting from amyloid-Œ≤ deposition that makes cortical blood vessels brittle and prone to rupture, distinct from the deep brain hemorrhages typically caused by hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Amyloid-Œ≤ Deposition] --\u003e B(Vessel Wall Weakening); B --\u003e C[Cortical \u0026 Leptomeningeal Arteries]; C --\u003e D(Rupture); D --\u003e E[Recurrent Lobar Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hypertensive_hemorrhage\"\n      }\n    ]\n  },\n  \"4ed629f9\": {\n    \"title\": \"Amyotrophic Lateral Sclerosis (ALS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Degenerative Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS)\u003c/b\u003e, also known as Lou Gehrig\u0027s disease, is a relentless and fatal neurodegenerative disorder characterized by the progressive loss of both \u003cu\u003eupper motor neurons\u003c/u\u003e (in the motor cortex) and \u003cu\u003elower motor neurons\u003c/u\u003e (in the brainstem and spinal cord).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Degeneration of corticospinal tracts (lateral sclerosis) and anterior horn cells (amyotrophy). The exact cause is unknown in most cases (sporadic), but some familial cases are linked to a mutation in the \u003cmark\u003esuperoxide dismutase 1 (SOD1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A hallmark of ALS is the combination of both \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e signs (spasticity, hyperreflexia, Babinski sign) and \u003cb\u003elower motor neuron (LMN)\u003c/b\u003e signs (fasciculations, atrophy, flaccid weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can present with asymmetric limb weakness (e.g., foot drop, hand weakness), dysarthria (difficulty speaking), and dysphagia (difficulty swallowing). Sensation, cognition, and eye movements are typically spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBulbar Involvement:\u003c/b\u003e When LMNs in the brainstem are affected, it leads to [[901f3180|bulbar palsy]], causing dysarthria, dysphagia, and tongue fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e [[riluzole|Riluzole]], a glutamate antagonist, may modestly increase survival. Management is largely supportive, focusing on respiratory support and nutrition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of UMN and LMN signs in the same patient is the key to diagnosing ALS. Look for a patient with weakness and atrophy in one arm (LMN) but hyperreflexia in the legs (UMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis\u003c/b\u003e is uniquely devastating because it attacks the entire voluntary motor system, from the brain to the muscle, combining the spasticity of UMN lesions with the muscle wasting of LMN lesions, while cruelly sparing the patient\u0027s intellect and senses.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[UMN Degeneration - Motor Cortex] --\u003e B(Spasticity, Hyperreflexia); C[LMN Degeneration - Anterior Horn] --\u003e D(Fasciculations, Atrophy); A \u0026 C --\u003e E(Progressive Motor Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"motor_neuron_disease\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"lower_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"riluzole\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\": \"sod1_gene\"\n      }\n    ]\n  },\n  \"ce2052d6\": {\n    \"title\": \"Anal Wink Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a superficial reflex involving the contraction of the external anal sphincter upon stroking the skin around the anus. It is used to test the integrity of the \u003cmark\u003eS3 and S4\u003c/mark\u003e spinal nerve roots and the pudendal nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cb\u003eS3-S4\u003c/b\u003e spinal cord segments. Mnemonic: S2, 3, 4 keep the penis off the floor (for erection), and S3, 4 are for the anal wink.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Stroking the perianal skin stimulates afferent fibers of the pudendal nerve. The signal travels to the S3-S4 spinal segments, synapses, and an efferent signal returns via the pudendal nerve to cause contraction of the external anal sphincter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An absent anal wink reflex is a key sign in \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency. It indicates damage to the S3-S4 nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e The reflex may also be absent in other conditions affecting the sacral nerve roots or spinal cord, such as spinal cord injury or spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with severe low back pain, saddle anesthesia, and bowel/bladder dysfunction, checking for the anal wink reflex is a critical step. Its absence strongly supports the diagnosis of [[2904b5c8|Cauda Equina Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a simple but vital physical exam maneuver for assessing the function of the lower sacral nerve roots (S3-S4); its absence is a red flag for [[2904b5c8|Cauda Equina Syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stroke Perianal Skin] --\u003e B(Afferent Signal via Pudendal N.); B --\u003e C[S3-S4 Spinal Cord]; C --\u003e D(Efferent Signal via Pudendal N.); D --\u003e E(External Anal Sphincter Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s3_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s4_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"2904b5c8\"\n      }\n    ]\n  },\n  \"5bcc9894\": {\n    \"title\": \"Anencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e is a severe and lethal congenital malformation, classified as an open \u003ci\u003eneural tube defect\u003c/i\u003e, resulting from the failure of the rostral (anterior) neuropore to close during the 4th week of embryonic development. This leads to the absence of the forebrain and a large portion of the skull (calvarium).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the rostral neuropore to close leads to an open calvarium and absence of the forebrain. The remaining brain tissue is exposed and degenerates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Incompatible with postnatal life; infants are stillborn or die shortly after birth. The fetus has a characteristic \u003cmark\u003e\\\"frog-like appearance\\\"\u003c/mark\u003e due to the absent cranial vault.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMaternal Findings:\u003c/b\u003e Associated with \u003cmark\u003epolyhydramnios\u003c/mark\u003e due to impaired fetal swallowing, as the neural control for swallowing is absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be detected prenatally via ultrasound. Maternal serum screening will show markedly \u003cmark\u003eelevated alpha-fetoprotein (AFP)\u003c/mark\u003e. Amniotic fluid will also have elevated AFP and acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e Risk is significantly reduced by maternal folic acid supplementation before conception and during early pregnancy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e represents a catastrophic failure of early neural development, where the absence of the forebrain and skull results in a condition incompatible with life, and is prenatally indicated by elevated maternal AFP and polyhydramnios.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Failure of Rostral Neuropore Closure] --\u003e B(Absence of Forebrain \u0026 Calvarium); B --\u003e C(Polyhydramnios); B --\u003e D(Lethal Outcome);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"polyhydramnios\"\n      },\n      {\n        \"type\": \"is_diagnosed_by\",\n        \"to\": \"alpha_fetoprotein\"\n      }\n    ]\n  },\n  \"a5295f1a\": {\n    \"title\": \"Anesthetics\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnesthetics\u003c/b\u003e are drugs that induce a reversible loss of sensation. They are broadly classified into \u003ci\u003egeneral anesthetics\u003c/i\u003e, which cause a reversible loss of consciousness, and \u003ci\u003elocal anesthetics\u003c/i\u003e, which block nerve transmission in a specific region of the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGeneral Anesthetics:\u003c/b\u003e Induce a state of unconsciousness, analgesia, amnesia, and muscle relaxation. They can be inhaled (e.g., sevoflurane, desflurane) or intravenous (e.g., propofol, ketamine, etomidate). Their potency is measured by the \u003cmark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocal Anesthetics:\u003c/b\u003e Block nerve conduction by inhibiting voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels. They are classified as esters (e.g., procaine, cocaine) or amides (e.g., lidocaine, bupivacaine). They are weak bases and are less effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Blockers:\u003c/b\u003e Often used with general anesthetics to achieve profound muscle relaxation (paralysis). They can be depolarizing (e.g., succinylcholine) or non-depolarizing (e.g., rocuronium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Hyperthermia:\u003c/b\u003e A rare, life-threatening hypermetabolic state triggered by inhaled anesthetics (except N\u003csub\u003e2\u003c/sub\u003eO) and succinylcholine in genetically susceptible individuals. Treated with [[dantrolene]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the key pharmacokinetic properties of inhaled anesthetics: low blood solubility (low blood:gas partition coefficient) leads to rapid induction and recovery, while high lipid solubility (high oil:gas partition coefficient) corresponds to high potency (low MAC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe field of \u003cb\u003eanesthesia\u003c/b\u003e relies on a combination of drugs to achieve a balanced state of unconsciousness, analgesia, and muscle relaxation, with general anesthetics acting on the CNS to induce sleep and local anesthetics acting on peripheral nerves to block pain signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"general_anesthetics\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"malignant_hyperthermia\"\n      }\n    ]\n  },\n  \"a7f97d7f\": {\n    \"title\": \"Cerebral Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral aneurysms\u003c/b\u003e are localized, abnormal dilations of blood vessels in the brain, which carry a significant risk of rupture, leading to life-threatening intracranial hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSaccular (Berry) Aneurysms:\u003c/b\u003e Most common type. Thin-walled outpouchings, typically occurring at arterial branch points in the [[e22300e8|Circle of Willis]]. Most common site is the junction of the [[bd802d22|anterior communicating artery]] and anterior cerebral artery. Rupture causes [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociations with Saccular Aneurysms:\u003c/b\u003e \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, Marfan syndrome, hypertension, smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCharcot-Bouchard Microaneurysms:\u003c/b\u003e Aneurysms of small, penetrating arteries (e.g., lenticulostriate arteries) associated with chronic hypertension. Rupture causes [[70b266c8|intraparenchymal hemorrhage]], typically in deep brain structures like the basal ganglia or thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRupture Presentation:\u003c/b\u003e Rupture of a saccular aneurysm classically presents as a sudden, severe \u003cmark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e (thunderclap headache), indicating a [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ADPKD who develops a sudden, severe headache should be immediately evaluated for a ruptured berry aneurysm. A PCom aneurysm can compress CN III, causing a \u0027down and out\u0027 eye with a \u0027blown\u0027 (dilated) pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eCerebral aneurysms are focal weaknesses in brain arteries; the larger \u003cb\u003esaccular (berry) aneurysms\u003c/b\u003e at the Circle of Willis rupture into the subarachnoid space, while the smaller \u003cb\u003eCharcot-Bouchard microaneurysms\u003c/b\u003e in deep brain structures rupture due to hypertension, causing intraparenchymal bleeds.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Aneurysm] --\u003e B{Types}; B --\u003e C[Saccular/Berry]; C --\u003e D(Circle of Willis); D --\u003e E[Rupture -\u003e Subarachnoid Hemorrhage]; B --\u003e F[Charcot-Bouchard]; F --\u003e G(Small Penetrating Arteries); G --\u003e H[Rupture -\u003e Intraparenchymal Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n  },\n  \"9c80344d\": {\n    \"title\": \"Angle-Closure Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is an ophthalmologic emergency characterized by a sudden, severe increase in intraocular pressure (IOP) due to the physical obstruction of aqueous humor outflow through the trabecular meshwork by the peripheral iris.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs in individuals with a pre-existing narrow anterior chamber angle. Pupillary dilation (mydriasis) causes the peripheral iris to bunch up and block the trabecular meshwork, acutely halting aqueous humor drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Any event causing mydriasis can trigger an attack, such as entering a dark room, stress, or administration of sympathomimetic or anticholinergic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e \u003cmark\u003eSudden onset of severe, unilateral eye pain\u003c/mark\u003e, headache, nausea/vomiting, and blurred vision with \u003cmark\u003ehalos around lights\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e The eye is red and hard to palpation (\u0027rock hard\u0027). The pupil is typically \u003cmark\u003emid-dilated and nonreactive\u003c/mark\u003e to light. The cornea may appear hazy or steamy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a true ophthalmic emergency. The classic presentation of a painful, red eye with a fixed, mid-dilated pupil and halos around lights is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is a mechanical plumbing problem of the eye where pupillary dilation in a predisposed individual causes the iris to act like a drain plug, leading to a rapid and painful spike in intraocular pressure that threatens vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Predisposing Narrow Angle] --Pupillary Dilation--\u003e B(Iris bunches at periphery); B --\u003e C(Blocks Trabecular Meshwork); C --\u003e D(‚Üì Aqueous Outflow); D --\u003e E(‚Üë‚Üë Intraocular Pressure); E --\u003e F(Acute Pain, Vision Loss, Red Eye);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"mydriasis\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5ea7b741\"\n      }\n    ]\n  },\n  \"ed8c1c37\": {\n    \"title\": \"Anhidrosis in Horner Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Autonomic\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnhidrosis\u003c/b\u003e, the inability to sweat normally, is one of the three classic signs of [[c19010a3|Horner syndrome]], resulting from the disruption of sympathetic innervation to the sweat glands of the face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHorner Syndrome Triad:\u003c/b\u003e The full triad is \u003cb\u003ePtosis\u003c/b\u003e (mild eyelid droop), \u003cb\u003eMiosis\u003c/b\u003e (constricted pupil), and \u003cb\u003eAnhidrosis\u003c/b\u003e (decreased sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Disruption of the oculosympathetic pathway prevents the release of acetylcholine from postganglionic sympathetic neurons that innervate sweat glands (a sympathetic exception).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization Value:\u003c/b\u003e The distribution of anhidrosis can help localize the lesion in the three-neuron sympathetic chain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Localization:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e1st Order (Central):\u003c/b\u003e Lesion in hypothalamus or brainstem/spinal cord. Anhidrosis affects the entire ipsilateral half of the body.\u003cbr\u003e - \u003cb\u003e2nd Order (Preganglionic):\u003c/b\u003e Lesion in the chest (e.g., Pancoast tumor). Anhidrosis affects the ipsilateral face and neck.\u003cbr\u003e - \u003cb\u003e3rd Order (Postganglionic):\u003c/b\u003e Lesion above the superior cervical ganglion (e.g., carotid dissection). Anhidrosis is often minimal or absent, affecting only a small patch on the forehead, because fibers to most facial sweat glands travel with the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A painful Horner syndrome (especially with neck pain) should raise suspicion for a carotid artery dissection, a 3rd order neuron lesion where anhidrosis is often absent.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile part of the classic triad, the presence and distribution of \u003cb\u003eanhidrosis\u003c/b\u003e in [[c19010a3|Horner syndrome]] is a subtle but powerful clue for localizing the lesion along the long oculosympathetic pathway, with widespread anhidrosis suggesting a central lesion and absent anhidrosis pointing towards a postganglionic (3rd order) problem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"sympathetic_pathway_disruption\"\n      }\n    ]\n  },\n  \"830c856c\": {\n    \"title\": \"Anterior Cerebral Artery (ACA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery (ACA)\u003c/b\u003e is a major artery of the brain that branches from the internal carotid artery and supplies the medial portion of the frontal and parietal lobes, as well as the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the bifurcation of the internal carotid artery. The left and right ACAs are connected by the [[bd802d22|anterior communicating artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Supplies the medial surface of the cerebral hemispheres. Based on the motor and sensory homunculus, this corresponds to the \u003cmark\u003elower extremities\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the ACA results in a characteristic stroke syndrome with \u003cmark\u003econtralateral motor and sensory deficits predominantly affecting the lower limb\u003c/mark\u003e (leg \u003e arm/face).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Stroke Signs:\u003c/b\u003e May also cause urinary incontinence due to damage to the paracentral lobule. Frontal lobe signs like abulia (lack of will/initiative) or personality changes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying an ACA stroke is the disproportionate weakness and sensory loss in the contralateral leg compared to the arm and face. This contrasts sharply with an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery\u003c/b\u003e is responsible for the medial brain territory, meaning its occlusion uniquely manifests as a stroke that \u0027kicks the leg out\u0027 from under the patient, with motor and sensory deficits primarily affecting the contralateral lower extremity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B(Anterior Cerebral Artery); B --\u003e C(Supplies Medial Cortex); C --\u003e D(Motor/Sensory Homunculus for Leg); B --Connects via AComA--\u003e E(Contralateral ACA);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"is_connected_to_contralateral_by\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"3c4b0ef7\": {\n    \"title\": \"Anterior Circulation Strokes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cerebrovascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e are ischemic events caused by occlusion of the internal carotid artery or its major branches, the [[830c856c|anterior cerebral artery (ACA)]] and the [[143bb23d|middle cerebral artery (MCA)]], leading to deficits related to the cerebral hemispheres.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVessels Involved:\u003c/b\u003e Internal carotid artery (ICA), [[143bb23d|Middle Cerebral Artery (MCA)]], [[830c856c|Anterior Cerebral Artery (ACA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMCA Stroke:\u003c/b\u003e The most common type of ischemic stroke. Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the face and upper limb more than the lower limb\u003c/mark\u003e. If the dominant (usually left) hemisphere is affected, it causes [[6bc9a567|aphasia]] (Broca\u0027s or Wernicke\u0027s). If the non-dominant hemisphere is affected, it causes hemineglect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eACA Stroke:\u003c/b\u003e Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the lower limb more than the upper limb\u003c/mark\u003e. May also cause urinary incontinence and frontal lobe signs (e.g., personality changes, abulia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e The key differentiator is the distribution of weakness based on the homunculus: MCA strokes affect the face/arm, while ACA strokes affect the leg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Aphasia is a \u0027cortical sign\u0027 that strongly points to an MCA stroke in the dominant hemisphere. Leg weakness greater than arm weakness is the classic sign of an ACA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e produce deficits that can be precisely localized by understanding the functional anatomy of the cerebral cortex and the homunculus; MCA strokes paralyze the contralateral face and arm, while ACA strokes paralyze the contralateral leg.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B(MCA); B --\u003e C(Contralateral Face/Arm Deficits, Aphasia/Neglect); A --\u003e D(ACA); D --\u003e E(Contralateral Leg Deficits, Incontinence);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"middle_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"276cefbc\"\n      }\n    ]\n  },\n  \"bd802d22\": {\n    \"title\": \"Anterior Communicating Artery (AComA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery (AComA)\u003c/b\u003e is a short blood vessel that connects the left and right [[830c856c|anterior cerebral arteries]], forming the anterior aspect of the [[e22300e8|Circle of Willis]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides collateral blood flow between the two anterior cerebral circulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the \u003cmark\u003emost common site\u003c/mark\u003e for the formation of saccular (berry) aneurysms in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAneurysm Complications:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eRupture:\u003c/b\u003e Leads to [[63f8b05f|subarachnoid hemorrhage]], presenting as a \\\"worst headache of my life.\\\"\u003cbr\u003e2. \u003cb\u003eCompression:\u003c/b\u003e A large, unruptured aneurysm can compress the adjacent \u003cmark\u003eoptic chiasm\u003c/mark\u003e, causing a [[6c3a980e|bitemporal hemianopia]] (tunnel vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a question mentions a saccular aneurysm, the AComA should be the first location you consider. If the patient has visual field defects, especially bitemporal hemianopia, an AComA aneurysm is a very likely cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery\u003c/b\u003e, while small, is clinically significant as the number one location for berry aneurysms, which can either rupture catastrophically into the subarachnoid space or compress the optic chiasm, causing tunnel vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left ACA] -- AComA --\u003e B[Right ACA]; C(AComA Aneurysm) --\u003e D(Rupture -\u003e SAH); C --\u003e E(Compression -\u003e Bitemporal Hemianopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"830c856c\"\n      },\n      {\n        \"type\": \"is_common_site_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"aneurysm_can_cause\",\n        \"to\": \"6c3a980e\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9686,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"c6814506\": {\n    \"title\": \"Amit"
      }, {
        "text": "riptyline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e is a \u003ci\u003etricyclic antidepressant (TCA)\u003c/i\u003e that works"
      }, {
        "text": " by inhibiting the reuptake of serotonin and norepinephrine. Due to its significant side effect profile, its primary use has shifted from"
      }, {
        "text": " depression to treating neuropathic pain and providing prophylaxis for [[c8833bae|migraine headaches]].\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks reuptake of norepinephrine and serotonin."
      }, {
        "text": " Also has potent antagonistic effects at muscarinic, Œ±1-adrenergic, and H1-histamine receptors, which"
      }, {
        "text": " account for its side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for prophylaxis of [[c8833"
      }, {
        "text": "bae|migraine headaches]] and for the management of chronic neuropathic pain (e.g., diabetic neuropathy, post"
      }, {
        "text": "herpetic neuralgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Strong anticholinergic effects (\u003cmark\u003edry mouth, constipation"
      }, {
        "text": ", urinary retention, confusion\u003c/mark\u003e), orthostatic hypotension (Œ±1 blockade), sedation (H1 blockade), and weight"
      }, {
        "text": " gain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e Overdose is life-threatening, causing QRS widening and ventricular arrhythmias due"
      }, {
        "text": " to Na\u003csup\u003e+\u003c/sup\u003e channel blockade. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027"
      }, {
        "text": "Tri-C\u0027s\u0027 for TCA toxicity: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, "
      }, {
        "text": "\u003cb\u003eC\u003c/b\u003eardiotoxicity. Amitriptyline is a tertiary amine TCA, giving it more potent anticholinergic and antihistamin"
      }, {
        "text": "ic effects compared to secondary amines like nortriptyline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e,"
      }, {
        "text": " a classic TCA, is now more valued for its role in migraine prevention and neuropathic pain than for depression, but its use"
      }, {
        "text": " is always tempered by a significant burden of anticholinergic, antihistaminic, and anti-adrenergic side effects, with"
      }, {
        "text": " cardiotoxicity being the most dangerous in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tricyclic_"
      }, {
        "text": "antidepressant\"\n      },\n      {\n        \"type\": \"used_for_prophylaxis_of\",\n"
      }, {
        "text": "        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"a62c0c9f\": {\n    \"title\": \"Amnesia\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmnesia\u003c/b\u003e is a deficit in memory caused by brain damage, disease, or psychological"
      }, {
        "text": " trauma. It can be categorized based on the temporal nature of the memory loss relative to the causative event.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterograde Amnesia:\u003c/b\u003e The inability to form \u003cu\u003enew\u003c/u\u003e memories after"
      }, {
        "text": " the event that caused the amnesia. Long-term memories from before the event remain intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterograde Les"
      }, {
        "text": "ion Site:\u003c/b\u003e Classically caused by bilateral damage to the \u003cmark\u003ehippocampus\u003c/mark\u003e, a key structure in the medial"
      }, {
        "text": " temporal lobe for memory consolidation. Seen in [[77ae6148|Alzheimer disease]] and [[her"
      }, {
        "text": "pes_simplex_encephalitis|herpes simplex encephalitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetrograde Amnesia:\u003c/b\u003e The loss of memories"
      }, {
        "text": " that were formed \u003cu\u003ebefore\u003c/u\u003e the onset of amnesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome:\u003c/b\u003e A classic"
      }, {
        "text": " example of a syndrome causing both anterograde and retrograde amnesia, along with confabulation. It is caused by th"
      }, {
        "text": "iamine (B1) deficiency, often in the context of chronic alcohol use, and involves damage to the \u003cmark\u003emamm"
      }, {
        "text": "illary bodies\u003c/mark\u003e and thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal lesions (e.g., from an"
      }, {
        "text": " anoxic brain injury or HSV encephalitis) are the classic cause of profound anterograde amnesia. The patient can remember their childhood"
      }, {
        "text": " but not what they had for breakfast.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hippocampus is the"
      }, {
        "text": " brain\u0027s \u0027save button\u0027 for new memories; therefore, bilateral damage to this structure results in profound \u003cb\u003eanterog"
      }, {
        "text": "rade amnesia\u003c/b\u003e, leaving the individual unable to consolidate new experiences into long-term memory.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Brain Injury/Disease] --\u003e B{Amnesia}; B --\u003e C[Anterograde Amnesia]; C"
      }, {
        "text": " --\u003e D(Inability to form new memories); D --\u003e E[Lesion: Hippocampus]; B --\u003e F"
      }, {
        "text": "[Retrograde Amnesia]; F --\u003e G(Loss of past memories); G --\u003e H[Lesion: Widespread Cortex"
      }, {
        "text": "];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_in\",\n        \"to\": \"a0590674\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"f02"
      }, {
        "text": "cfaa1\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_feature_of\",\n        \"to\": \"77ae6148\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"d220fc3f\": {\n    \"title\": \"Amygdala\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n"
      }, {
        "text": "      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e is an almond-shaped set of neurons"
      }, {
        "text": " located deep within the medial temporal lobe of the brain. It is a key component of the [[73ace357|limbic system]]"
      }, {
        "text": " and plays a central role in processing emotions, particularly fear, anxiety, and aggression, as well as in memory formation and decision"
      }, {
        "text": "-making.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The amygdala is the brain"
      }, {
        "text": "\u0027s emotional center, responsible for processing fear, pleasure, and anger. It links emotions to memories and influences social and"
      }, {
        "text": " sexual behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the medial temporal lobe, anterior to the [[a0590674|"
      }, {
        "text": "hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (Bilateral):\u003c/b\u003e Bilateral destruction of the amygdala results in \u003c"
      }, {
        "text": "mark\u003eKl√ºver-Bucy syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:"
      }, {
        "text": "\u003c/b\u003e Characterized by disinhibited behavior, including hyperorality (tendency to examine objects with the mouth), hypersex"
      }, {
        "text": "uality, hyperphagia, and visual agnosia. Patients also exhibit placidity (loss of fear response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The classic cause of bilateral amygdala damage leading to Kl√ºver-Bucy syndrome is [["
      }, {
        "text": "herpes_simplex_encephalitis|Herpes Simplex Virus-1 (HSV-1) encephalitis]], which has a pred"
      }, {
        "text": "ilection for the temporal lobes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e acts"
      }, {
        "text": " as the brain\u0027s alarm system and emotional processor; its bilateral destruction unleashes primitive behaviors by removing the normal emotional filters,"
      }, {
        "text": " resulting in the dramatic and disinhibited presentation of Kl√ºver-Bucy syndrome.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Sensory Input] --\u003e B(Amygdala); B --Fear/Emotion Processing--\u003e"
      }, {
        "text": " C[Hypothalamus \u0026 Brainstem]; C --\u003e D(Autonomic \u0026 Behavioral Response);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"bilateral_lesion_causes\",\n        \"to\": \"klu"
      }, {
        "text": "ver_bucy_syndrome\"\n      },\n      {\n        \"type\": \"is_damaged_"
      }, {
        "text": "in\",\n        \"to\": \"herpes_simplex_encephalitis\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"b374ebd6\": {\n    \"title\": \"Cerebral Amyloid Ang"
      }, {
        "text": "iopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy (CAA)\u003c/b\u003e is"
      }, {
        "text": " a condition in which amyloid-Œ≤ protein deposits in the walls of small to medium-sized arteries of the cerebral cortex and leptomeninges, weakening"
      }, {
        "text": " the vessels and increasing the risk of spontaneous, recurrent \u003cmark\u003elobar\u003c/mark\u003e intraparenchymal hemorrh"
      }, {
        "text": "ages.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deposition of \u003c"
      }, {
        "text": "mark\u003eamyloid-Œ≤\u003c/mark\u003e (the same protein found in [[77ae6148|"
      }, {
        "text": "Alzheimer\u0027s]] plaques) in the tunica media and adventitia of cortical and leptomeningeal vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Presentation:\u003c/b\u003e Most commonly presents with recurrent, spontaneous lobar hemorrhages in older adults (\u003e65 years). These"
      }, {
        "text": " hemorrhages are typically located in the superficial cortex (lobar) rather than deep structures like the basal ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e"
      }, {
        "text": " Hemorrhages are characteristically \u003cmark\u003elobar\u003c/mark\u003e (frontal, parietal, occipital, temporal lobes"
      }, {
        "text": "), contrasting with hypertensive hemorrhages which are typically deep (basal ganglia, thalamus, pons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociation"
      }, {
        "text": ":\u003c/b\u003e Strongly associated with [[77ae6148|Alzheimer disease]], although it can occur independently.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e An elderly patient with no history of significant hypertension who presents with a spontaneous, superficial (lobar) intrac"
      }, {
        "text": "erebral hemorrhage should raise high suspicion for Cerebral Amyloid Angiopathy. Recurrent hemorrhages in different lobes are a key"
      }, {
        "text": " feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy\u003c/b\u003e"
      }, {
        "text": " is a major cause of lobar intracerebral hemorrhage in the elderly, resulting from amyloid-Œ≤ deposition that makes cortical"
      }, {
        "text": " blood vessels brittle and prone to rupture, distinct from the deep brain hemorrhages typically caused by hypertension.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Amyloid-Œ≤ Deposition] --\u003e B(Vessel Wall Weakening); B"
      }, {
        "text": " --\u003e C[Cortical \u0026 Leptomeningeal Arteries]; C --\u003e D(Rupture); D --\u003e E"
      }, {
        "text": "[Recurrent Lobar Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"causes\",\n        \"to\": \"70b266c8\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_associated_with\",\n        \"to\": \"77ae61"
      }, {
        "text": "48\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"hypertensive_hemorrhage\"\n      }\n    ]\n  },\n  \"4ed629"
      }, {
        "text": "f9\": {\n    \"title\": \"Amyotrophic Lateral Sclerosis (ALS)\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Degenerative Disease\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS)\u003c/b\u003e, also known as Lou Gehrig\u0027s disease, is a relentless"
      }, {
        "text": " and fatal neurodegenerative disorder characterized by the progressive loss of both \u003cu\u003eupper motor neurons\u003c/u\u003e (in the motor cortex) and \u003cu\u003elower motor neurons"
      }, {
        "text": "\u003c/u\u003e (in the brainstem and spinal cord).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Degeneration of corticospinal tracts (lateral sclerosis) and anterior horn cells (amyotrophy). The"
      }, {
        "text": " exact cause is unknown in most cases (sporadic), but some familial cases are linked to a mutation in the \u003cmark\u003esuper"
      }, {
        "text": "oxide dismutase 1 (SOD1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A hallmark of ALS is the combination of both"
      }, {
        "text": " \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e signs (spasticity, hyperreflexia, Babinski sign) and \u003cb\u003elower motor neuron ("
      }, {
        "text": "LMN)\u003c/b\u003e signs (fasciculations, atrophy, flaccid weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can"
      }, {
        "text": " present with asymmetric limb weakness (e.g., foot drop, hand weakness), dysarthria (difficulty speaking), and dysph"
      }, {
        "text": "agia (difficulty swallowing). Sensation, cognition, and eye movements are typically spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBulbar Involvement:\u003c/b\u003e When"
      }, {
        "text": " LMNs in the brainstem are affected, it leads to [[901f3180|bulbar palsy]],"
      }, {
        "text": " causing dysarthria, dysphagia, and tongue fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e [[riluzole|"
      }, {
        "text": "Riluzole]], a glutamate antagonist, may modestly increase survival. Management is largely supportive, focusing on respiratory support and nutrition"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of UMN and LMN signs in the same patient is the key"
      }, {
        "text": " to diagnosing ALS. Look for a patient with weakness and atrophy in one arm (LMN) but hyperreflexia in the legs"
      }, {
        "text": " (UMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis\u003c/b\u003e is uniquely"
      }, {
        "text": " devastating because it attacks the entire voluntary motor system, from the brain to the muscle, combining the spasticity of UMN lesions"
      }, {
        "text": " with the muscle wasting of LMN lesions, while cruelly sparing the patient\u0027s intellect and senses.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[UMN Degeneration - Motor Cortex] --\u003e B(Spasticity, Hyperreflexia); C"
      }, {
        "text": "[LMN Degeneration - Anterior Horn] --\u003e D(Fasciculations, Atrophy); A \u0026 C --\u003e E("
      }, {
        "text": "Progressive Motor Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"motor_neuron_disease\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with\",\n        \"to\": \"upper_motor_neuron_signs\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"lower_motor"
      }, {
        "text": "_neuron_signs\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ril"
      }, {
        "text": "uzole\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in"
      }, {
        "text": "\",\n        \"to\": \"sod1_gene\"\n      }\n    ]\n  },\n  \"ce2"
      }, {
        "text": "052d6\": {\n    \"title\": \"Anal Wink Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink"
      }, {
        "text": " Reflex\u003c/b\u003e is a superficial reflex involving the contraction of the external anal sphincter upon stroking the skin around the anus. It is used"
      }, {
        "text": " to test the integrity of the \u003cmark\u003eS3 and S4\u003c/mark\u003e spinal nerve roots and the pudendal nerve.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cb\u003eS3-S4\u003c/b\u003e spinal"
      }, {
        "text": " cord segments. Mnemonic: S2, 3, 4 keep the penis off the floor (for erection),"
      }, {
        "text": " and S3, 4 are for the anal wink.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Stroking the perianal skin stimulates"
      }, {
        "text": " afferent fibers of the pudendal nerve. The signal travels to the S3-S4 spinal segments, synapses, and an"
      }, {
        "text": " efferent signal returns via the pudendal nerve to cause contraction of the external anal sphincter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An"
      }, {
        "text": " absent anal wink reflex is a key sign in \u003cmark\u003e[[2904b5c8|Cauda Equ"
      }, {
        "text": "ina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency. It indicates damage to the S3-S4 nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Conditions:\u003c/b\u003e The reflex may also be absent in other conditions affecting the sacral nerve roots or spinal cord, such as spinal cord injury"
      }, {
        "text": " or spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with severe low back pain, saddle anesthesia, and bowel"
      }, {
        "text": "/bladder dysfunction, checking for the anal wink reflex is a critical step. Its absence strongly supports the diagnosis of [[2904b5c8"
      }, {
        "text": "|Cauda Equina Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a simple"
      }, {
        "text": " but vital physical exam maneuver for assessing the function of the lower sacral nerve roots (S3-S4); its absence is"
      }, {
        "text": " a red flag for [[2904b5c8|Cauda Equina Syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Stroke Perianal Skin] --\u003e B(Afferent Signal via Pudendal N.); B --\u003e C["
      }, {
        "text": "S3-S4 Spinal Cord]; C --\u003e D(Efferent Signal via Pudendal N.); D --\u003e E(External Anal Sphinct"
      }, {
        "text": "er Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_ner"
      }, {
        "text": "ve_root\",\n        \"to\": \"s3_nerve_root\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "tests_nerve_root\",\n        \"to\": \"s4_nerve_root\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"2904b5c8\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"5bcc9894\": {\n    \"title\": \"Anencephaly\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neurology"
      }, {
        "text": "\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural"
      }, {
        "text": " Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnenceph"
      }, {
        "text": "aly\u003c/b\u003e is a severe and lethal congenital malformation, classified as an open \u003ci\u003eneural tube defect\u003c/i\u003e, resulting from the failure"
      }, {
        "text": " of the rostral (anterior) neuropore to close during the 4th week of embryonic development. This leads to the absence of the fore"
      }, {
        "text": "brain and a large portion of the skull (calvarium).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the rostral neuropore to close leads to an open calvarium and absence"
      }, {
        "text": " of the forebrain. The remaining brain tissue is exposed and degenerates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Incompatible with postnatal"
      }, {
        "text": " life; infants are stillborn or die shortly after birth. The fetus has a characteristic \u003cmark\u003e\\\"frog-like appearance\\\""
      }, {
        "text": "\u003c/mark\u003e due to the absent cranial vault.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMaternal Findings:\u003c/b\u003e Associated with \u003cmark\u003epoly"
      }, {
        "text": "hydramnios\u003c/mark\u003e due to impaired fetal swallowing, as the neural control for swallowing is absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis"
      }, {
        "text": ":\u003c/b\u003e Can be detected prenatally via ultrasound. Maternal serum screening will show markedly \u003cmark\u003eelevated alpha-fetoprotein"
      }, {
        "text": " (AFP)\u003c/mark\u003e. Amniotic fluid will also have elevated AFP and acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention"
      }, {
        "text": ":\u003c/b\u003e Risk is significantly reduced by maternal folic acid supplementation before conception and during early pregnancy.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e represents a catastrophic failure of early neural development, where the absence of the fore"
      }, {
        "text": "brain and skull results in a condition incompatible with life, and is prenatally indicated by elevated maternal AFP and polyhydramnios.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Failure of Rostral Neuropore Closure] --\u003e B(Abs"
      }, {
        "text": "ence of Forebrain \u0026 Calvarium); B --\u003e C(Polyhydramnios); B --\u003e D(Lethal Outcome"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_"
      }, {
        "text": "with\",\n        \"to\": \"polyhydramnios\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_diagnosed_by\",\n        \"to\": \"alpha_fetoprotein\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "a5295f1a\": {\n    \"title\": \"Anesthetics\",\n    \"primaryType\": \"concept\",\n    \""
      }, {
        "text": "tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnesthetics\u003c/b\u003e are drugs that induce"
      }, {
        "text": " a reversible loss of sensation. They are broadly classified into \u003ci\u003egeneral anesthetics\u003c/i\u003e, which cause a reversible loss of consciousness,"
      }, {
        "text": " and \u003ci\u003elocal anesthetics\u003c/i\u003e, which block nerve transmission in a specific region of the body.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGeneral Anesthetics:\u003c/b\u003e Induce a state of unconsciousness, analgesia, am"
      }, {
        "text": "nesia, and muscle relaxation. They can be inhaled (e.g., sevoflurane, desflurane"
      }, {
        "text": ") or intravenous (e.g., propofol, ketamine, etomidate). Their potency is measured by the \u003c"
      }, {
        "text": "mark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocal Anesthetics:\u003c/b\u003e Block nerve conduction by inhibiting"
      }, {
        "text": " voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels. They are classified as esters (e.g., procaine, cocaine"
      }, {
        "text": ") or amides (e.g., lidocaine, bupivacaine). They are weak bases and are less"
      }, {
        "text": " effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Blockers:\u003c/b\u003e Often used with general anesthetics to achieve"
      }, {
        "text": " profound muscle relaxation (paralysis). They can be depolarizing (e.g., succinylcholine) or non-depolarizing (e.g"
      }, {
        "text": "., rocuronium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Hyperthermia:\u003c/b\u003e A rare, life-threatening hypermetabolic state"
      }, {
        "text": " triggered by inhaled anesthetics (except N\u003csub\u003e2\u003c/sub\u003eO) and succinylcholine in genetically susceptible individuals. Treated with [["
      }, {
        "text": "dantrolene]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the key pharmacokinetic properties of inhaled anesthetics: low"
      }, {
        "text": " blood solubility (low blood:gas partition coefficient) leads to rapid induction and recovery, while high lipid solubility (high oil"
      }, {
        "text": ":gas partition coefficient) corresponds to high potency (low MAC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " field of \u003cb\u003eanesthesia\u003c/b\u003e relies on a combination of drugs to achieve a balanced state of unconsciousness, analgesia,"
      }, {
        "text": " and muscle relaxation, with general anesthetics acting on the CNS to induce sleep and local anesthetics acting on peripheral nerves to block pain"
      }, {
        "text": " signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"general_anesthetics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"local_anesthetics\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"malignant_hyperthermia\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"a7f97d7f\": {\n    \"title\":"
      }, {
        "text": " \"Cerebral Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "erebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eC"
      }, {
        "text": "erebral aneurysms\u003c/b\u003e are localized, abnormal dilations of blood vessels in the brain, which carry a significant risk of rupture, leading to life"
      }, {
        "text": "-threatening intracranial hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSaccular (Berry) Aneurysms:"
      }, {
        "text": "\u003c/b\u003e Most common type. Thin-walled outpouchings, typically occurring at arterial branch points in the [[e223"
      }, {
        "text": "00e8|Circle of Willis]]. Most common site is the junction of the [[bd802d2"
      }, {
        "text": "2|anterior communicating artery]] and anterior cerebral artery. Rupture causes [[63f8b05f|subarachnoid hemorrhage"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociations with Saccular Aneurysms:\u003c/b\u003e \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease ("
      }, {
        "text": "ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, Marfan syndrome, hypertension, smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChar"
      }, {
        "text": "cot-Bouchard Microaneurysms:\u003c/b\u003e Aneurysms of small, penetrating arteries (e.g., lent"
      }, {
        "text": "iculostriate arteries) associated with chronic hypertension. Rupture causes [[70b266c8|"
      }, {
        "text": "intraparenchymal hemorrhage]], typically in deep brain structures like the basal ganglia or thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eR"
      }, {
        "text": "upture Presentation:\u003c/b\u003e Rupture of a saccular aneurysm classically presents as a sudden, severe \u003cmark\u003e\\\"worst"
      }, {
        "text": " headache of my life\\\"\u003c/mark\u003e (thunderclap headache), indicating a [[63f8b05f|subarachnoid"
      }, {
        "text": " hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ADPKD who develops a sudden, severe headache should"
      }, {
        "text": " be immediately evaluated for a ruptured berry aneurysm. A PCom aneurysm can compress CN III, causing a \u0027down and out\u0027 eye"
      }, {
        "text": " with a \u0027blown\u0027 (dilated) pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eC"
      }, {
        "text": "erebral aneurysms are focal weaknesses in brain arteries; the larger \u003cb\u003esaccular (berry) aneurysms\u003c/b\u003e at"
      }, {
        "text": " the Circle of Willis rupture into the subarachnoid space, while the smaller \u003cb\u003eCharcot-Bouchard microaneur"
      }, {
        "text": "ysms\u003c/b\u003e in deep brain structures rupture due to hypertension, causing intraparenchymal bleeds.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Cerebral Aneurysm] --\u003e B{Types}; B --\u003e C[Saccular/"
      }, {
        "text": "Berry]; C --\u003e D(Circle of Willis); D --\u003e E[Rupture -\u003e Subarachnoid Hemorrhage];"
      }, {
        "text": " B --\u003e F[Charcot-Bouchard]; F --\u003e G(Small Penetrating Arteries); G --\u003e H["
      }, {
        "text": "Rupture -\u003e Intraparenchymal Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"rupture_causes\",\n        \"to\": \"70b266"
      }, {
        "text": "c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \""
      }, {
        "text": "to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"9c80344d\": {\n    \"title\": \"Angle-Closure Glaucoma\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency"
      }, {
        "text": " Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is an ophthalmologic emergency characterized by a sudden, severe increase in intra"
      }, {
        "text": "ocular pressure (IOP) due to the physical obstruction of aqueous humor outflow through the trabecular meshwork by the peripheral"
      }, {
        "text": " iris.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs in individuals"
      }, {
        "text": " with a pre-existing narrow anterior chamber angle. Pupillary dilation (mydriasis) causes the peripheral iris to bunch up and block the trab"
      }, {
        "text": "ecular meshwork, acutely halting aqueous humor drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Any event causing mydriasis can"
      }, {
        "text": " trigger an attack, such as entering a dark room, stress, or administration of sympathomimetic or anticholinergic drugs."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e \u003cmark\u003eSudden onset of severe, unilateral eye pain\u003c/mark\u003e, headache, nausea/"
      }, {
        "text": "vomiting, and blurred vision with \u003cmark\u003ehalos around lights\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e The eye"
      }, {
        "text": " is red and hard to palpation (\u0027rock hard\u0027). The pupil is typically \u003cmark\u003emid-dilated and non"
      }, {
        "text": "reactive\u003c/mark\u003e to light. The cornea may appear hazy or steamy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a true"
      }, {
        "text": " ophthalmic emergency. The classic presentation of a painful, red eye with a fixed, mid-dilated pupil and halos around"
      }, {
        "text": " lights is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma"
      }, {
        "text": "\u003c/b\u003e is a mechanical plumbing problem of the eye where pupillary dilation in a predisposed individual causes the iris to act like a drain"
      }, {
        "text": " plug, leading to a rapid and painful spike in intraocular pressure that threatens vision.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Predisposing Narrow Angle] --Pupillary Dilation--\u003e B(Iris bunches at periphery); B --\u003e C(Blocks"
      }, {
        "text": " Trabecular Meshwork); C --\u003e D(‚Üì Aqueous Outflow); D --\u003e E(‚Üë‚Üë Intraocular Pressure);"
      }, {
        "text": " E --\u003e F(Acute Pain, Vision Loss, Red Eye);\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"3ce6c035\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_triggered_by\",\n        \"to\": \"mydriasis\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5ea7b"
      }, {
        "text": "741\"\n      }\n    ]\n  },\n  \"ed8c1c37\": {\n    \"title\": \""
      }, {
        "text": "Anhidrosis in Horner Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neurology\",\n      \"Autonomic\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnhidrosis\u003c/b\u003e, the inability to sweat normally, is one"
      }, {
        "text": " of the three classic signs of [[c19010a3|Horner syndrome]], resulting from the disruption"
      }, {
        "text": " of sympathetic innervation to the sweat glands of the face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Horner Syndrome Triad:\u003c/b\u003e The full triad is \u003cb\u003ePtosis\u003c/b\u003e (mild eyelid droop), \u003cb\u003eMiosis\u003c/b\u003e ("
      }, {
        "text": "constricted pupil), and \u003cb\u003eAnhidrosis\u003c/b\u003e (decreased sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Disruption of the o"
      }, {
        "text": "culosympathetic pathway prevents the release of acetylcholine from postganglionic sympathetic neurons that innervate sweat glands (a sympathetic"
      }, {
        "text": " exception).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization Value:\u003c/b\u003e The distribution of anhidrosis can help localize the lesion in the three-neuron"
      }, {
        "text": " sympathetic chain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Localization:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e1st Order (Central):\u003c/b\u003e Lesion in"
      }, {
        "text": " hypothalamus or brainstem/spinal cord. Anhidrosis affects the entire ipsilateral half of the body.\u003cbr\u003e - \u003cb\u003e2nd Order"
      }, {
        "text": " (Preganglionic):\u003c/b\u003e Lesion in the chest (e.g., Pancoast tumor). Anhidrosis affects the ipsilateral face and"
      }, {
        "text": " neck.\u003cbr\u003e - \u003cb\u003e3rd Order (Postganglionic):\u003c/b\u003e Lesion above the superior cervical ganglion (e.g., carotid"
      }, {
        "text": " dissection). Anhidrosis is often minimal or absent, affecting only a small patch on the forehead, because fibers to most"
      }, {
        "text": " facial sweat glands travel with the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A painful Horner syndrome (especially"
      }, {
        "text": " with neck pain) should raise suspicion for a carotid artery dissection, a 3rd order neuron lesion where anhidrosis is often absent.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eWhile part of the classic triad, the presence and distribution of \u003cb\u003eanhid"
      }, {
        "text": "rosis\u003c/b\u003e in [[c19010a3|Horner syndrome]] is a subtle but powerful clue for"
      }, {
        "text": " localizing the lesion along the long oculosympathetic pathway, with widespread anhidrosis suggesting a central lesion and absent anhidrosis pointing"
      }, {
        "text": " towards a postganglionic (3rd order) problem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"sym"
      }, {
        "text": "pathetic_pathway_disruption\"\n      }\n    ]\n  },\n  \"830c8"
      }, {
        "text": "56c\": {\n    \"title\": \"Anterior Cerebral Artery (ACA)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery (ACA)\u003c/b\u003e is a major artery of the brain that branches"
      }, {
        "text": " from the internal carotid artery and supplies the medial portion of the frontal and parietal lobes, as well as the corpus callosum.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the bifurcation of the internal carotid artery. The left"
      }, {
        "text": " and right ACAs are connected by the [[bd802d22|anterior communicating artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Territory Supplied:\u003c/b\u003e Supplies the medial surface of the cerebral hemispheres. Based on the motor and sensory homunculus, this corresponds to the"
      }, {
        "text": " \u003cmark\u003elower extremities\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the ACA results in a characteristic"
      }, {
        "text": " stroke syndrome with \u003cmark\u003econtralateral motor and sensory deficits predominantly affecting the lower limb\u003c/mark\u003e (leg \u003e"
      }, {
        "text": " arm/face).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Stroke Signs:\u003c/b\u003e May also cause urinary incontinence due to damage to the paracentral lobule"
      }, {
        "text": ". Frontal lobe signs like abulia (lack of will/initiative) or personality changes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The key to identifying an ACA stroke is the disproportionate weakness and sensory loss in the contralateral leg compared to the arm and"
      }, {
        "text": " face. This contrasts sharply with an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery\u003c/b\u003e is responsible for the medial brain territory, meaning its occlusion"
      }, {
        "text": " uniquely manifests as a stroke that \u0027kicks the leg out\u0027 from under the patient, with motor and sensory deficits primarily"
      }, {
        "text": " affecting the contralateral lower extremity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B("
      }, {
        "text": "Anterior Cerebral Artery); B --\u003e C(Supplies Medial Cortex); C --\u003e D(Motor/Sensory Hom"
      }, {
        "text": "unculus for Leg); B --Connects via AComA--\u003e E(Contralateral ACA);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \""
      }, {
        "text": "anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "connected_to_contralateral_by\",\n        \"to\": \"bd802d22\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"3c4b0ef7\": {\n    \"title\":"
      }, {
        "text": " \"Anterior Circulation Strokes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Cerebrovascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eAnterior circulation strokes\u003c/b\u003e are ischemic events caused by occlusion of the internal carotid artery or its major branches, the [["
      }, {
        "text": "830c856c|anterior cerebral artery (ACA)]] and the [[143bb23d"
      }, {
        "text": "|middle cerebral artery (MCA)]], leading to deficits related to the cerebral hemispheres.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVessels Involved:\u003c/b\u003e Internal carotid artery (ICA), [[143bb23d|Middle"
      }, {
        "text": " Cerebral Artery (MCA)]], [[830c856c|Anterior Cerebral Artery (ACA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMCA Stroke:\u003c/b\u003e The most common type of ischemic stroke. Presents with \u003cmark\u003econtralateral hem"
      }, {
        "text": "iparesis and sensory loss affecting the face and upper limb more than the lower limb\u003c/mark\u003e. If the dominant ("
      }, {
        "text": "usually left) hemisphere is affected, it causes [[6bc9a567|aphasia]] (Broca\u0027s or W"
      }, {
        "text": "ernicke\u0027s). If the non-dominant hemisphere is affected, it causes hemineglect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eACA"
      }, {
        "text": " Stroke:\u003c/b\u003e Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the lower limb more than the upper limb\u003c/"
      }, {
        "text": "mark\u003e. May also cause urinary incontinence and frontal lobe signs (e.g., personality changes, abulia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction:\u003c/b\u003e The key differentiator is the distribution of weakness based on the homunculus: MCA strokes affect the face/arm, while ACA strokes affect the leg"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Aphasia is a \u0027cortical sign\u0027 that strongly points to an"
      }, {
        "text": " MCA stroke in the dominant hemisphere. Leg weakness greater than arm weakness is the classic sign of an ACA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e produce deficits that can be precisely localized by understanding the functional anatomy of the cerebral cortex"
      }, {
        "text": " and the homunculus; MCA strokes paralyze the contralateral face and arm, while ACA strokes paralyze the contralateral leg.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Internal Carotid Artery] --\u003e B(MCA); B --\u003e C(Contralateral Face"
      }, {
        "text": "/Arm Deficits, Aphasia/Neglect); A --\u003e D(ACA); D --\u003e E(Contralateral"
      }, {
        "text": " Leg Deficits, Incontinence);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"middle_cerebral_artery_stroke\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"differentiated_from\",\n        \"to\": \"276cefbc\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"bd802d22\": {\n    \"title\": \"Anterior Communicating Artery (A"
      }, {
        "text": "ComA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vascul"
      }, {
        "text": "ature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery"
      }, {
        "text": " (AComA)\u003c/b\u003e is a short blood vessel that connects the left and right [[830c856c|"
      }, {
        "text": "anterior cerebral arteries]], forming the anterior aspect of the [[e22300e8|Circle of Willis]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides collateral blood flow between the two anterior"
      }, {
        "text": " cerebral circulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the \u003cmark\u003emost common site\u003c/mark\u003e for the formation of sacc"
      }, {
        "text": "ular (berry) aneurysms in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAneurysm Complications:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eRupture:\u003c/b\u003e Leads to [[63f8b05f|subarachnoid hemorrhage]],"
      }, {
        "text": " presenting as a \\\"worst headache of my life.\\\"\u003cbr\u003e2. \u003cb\u003eCompression:\u003c/b\u003e A large, un"
      }, {
        "text": "ruptured aneurysm can compress the adjacent \u003cmark\u003eoptic chiasm\u003c/mark\u003e, causing a [[6c3a9"
      }, {
        "text": "80e|bitemporal hemianopia]] (tunnel vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When"
      }, {
        "text": " a question mentions a saccular aneurysm, the AComA should be the first location you consider. If the patient has"
      }, {
        "text": " visual field defects, especially bitemporal hemianopia, an AComA aneurysm is a very likely cause."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery\u003c/b\u003e, while"
      }, {
        "text": " small, is clinically significant as the number one location for berry aneurysms, which can either rupture catastrophically into"
      }, {
        "text": " the subarachnoid space or compress the optic chiasm, causing tunnel vision.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Left ACA] -- AComA --\u003e B[Right ACA]; C(ACom"
      }, {
        "text": "A Aneurysm) --\u003e D(Rupture -\u003e SAH); C --\u003e E(Compression -\u003e Bitemporal Hemianopia);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "e22300e8\"\n      },\n      {\n        \"type\": \"connects\","
      }, {
        "text": "\n        \"to\": \"830c856c\"\n      },\n      {\n        \"type\": \"is_common"
      }, {
        "text": "_site_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"aneurysm_can_cause\",\n        \"to\": \"6c3a980e\""
      }, {
        "text": "\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1pVT4Y7kv_9sdFdzwmjsSJupwrFAhzD4z"
      },
      "role": "user",
      "tokenCount": 2063
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"3c075343\": {\n    \"title\": \"Anterior Inferior Cerebellar Artery (AICA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Inferior Cerebellar Artery (AICA)\u003c/b\u003e is an artery in the brain that arises from the basilar artery and supplies blood to the anterior inferior portion of the cerebellum, as well as parts of the lateral pons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Typically arises from the lower third of the basilar artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Lateral pons, middle and inferior cerebellar peduncles, and the anterior inferior cerebellum. It also gives rise to the labyrinthine artery in most individuals, which supplies the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the AICA causes \u003cmark\u003eLateral Pontine Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of AICA Stroke:\u003c/b\u003e Mnemonic \u003cb\u003eAICA\u003c/b\u003e: \u003cb\u003eA\u003c/b\u003etaxia (ipsilateral, from cerebellar peduncle damage), \u003cb\u003eI\u003c/b\u003epsilateral facial paralysis (CN VII nucleus/fibers) and deafness/vertigo (CN VIII nucleus/labyrinthine artery), \u003cb\u003eC\u003c/b\u003eontralateral pain/temp loss (spinothalamic tract), \u003cb\u003eA\u003c/b\u003eutonomic signs (ipsilateral Horner syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to distinguishing an AICA stroke from a PICA stroke (Lateral Medullary Syndrome) is the presence of \u003cmark\u003efacial paralysis\u003c/mark\u003e and \u003cmark\u003edeafness\u003c/mark\u003e, which are specific to the pontine location of the AICA territory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eOcclusion of the \u003cb\u003eAnterior Inferior Cerebellar Artery\u003c/b\u003e results in Lateral Pontine Syndrome, a complex brainstem stroke characterized by a unique combination of cerebellar signs, contralateral body sensory loss, and ipsilateral facial deficits including paralysis and deafness, which localizes the lesion squarely to the lateral pons.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basilar Artery] --\u003e B(AICA); B --\u003e C(Lateral Pons); B --\u003e D(Anterior Inferior Cerebellum); B --\u003e E(Labyrinthine Artery); C --\u003e F(CN VII \u0026 VIII Nuclei); E --\u003e G(Inner Ear);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      \"type\": \"is_a_branch_of\",\n      \"to\": \"basilar_artery\"\n    },\n    {\n      \"type\": \"differentiated_from_stroke_in\",\n      \"to\": \"posterior_inferior_cerebellar_artery\"\n    }\n  },\n  \"eed3fda9\": {\n    \"title\": \"Anterior Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]] that plays a primary role in thermoregulation, specifically in dissipating heat to cool the body. It is part of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates heat dissipation (\u003cb\u003ecooling\u003c/b\u003e). Mnemonic: The \u003cb\u003eA\u003c/b\u003e/\u003cb\u003eC\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003enterior \u003cb\u003eC\u003c/b\u003eooling) is in the front of the house.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Senses when the body is too hot and initiates parasympathetic responses like cutaneous vasodilation and sweating to promote heat loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the anterior nucleus results in \u003cmark\u003ehyperthermia\u003c/mark\u003e, as the body loses its ability to cool itself down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[posterior_nucleus_of_hypothalamus|posterior nucleus of the hypothalamus]] is responsible for heat conservation and production (heating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functional pairing: Anterior hypothalamus \u003d Cooling (parasympathetic), Posterior hypothalamus \u003d Heating (sympathetic). A lesion in the anterior nucleus leads to an inability to cool down.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus of the hypothalamus\u003c/b\u003e functions as the body\u0027s thermostat for cooling; its destruction leads to uncontrolled hyperthermia because the primary mechanism for heat dissipation is lost.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Body Temperature] --\u003e B(Anterior Nucleus); B --Parasympathetic Output--\u003e C(Cutaneous Vasodilation \u0026 Sweating); C --\u003e D(Heat Dissipation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"thermoregulation\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"posterior_nucleus_of_hypothalamus\"\n      }\n    ]\n  },\n  \"1430f5b4\": {\n    \"title\": \"Anterior Spinal Artery (ASA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Spinal Artery (ASA)\u003c/b\u003e is a major artery that supplies the anterior two-thirds of the spinal cord. It originates from the vertebral arteries in the cranium and descends along the anterior surface of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed from the union of two branches of the vertebral arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Supplies the anterior two-thirds of the spinal cord, including the anterior and lateral corticospinal tracts, the spinothalamic tracts, and the anterior horns. It notably \u003cu\u003espares\u003c/u\u003e the [[e7f5cbbe|dorsal columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Spinal Cord):\u003c/b\u003e Occlusion causes \u003cmark\u003e[[b48b54d7|Anterior Spinal Artery Syndrome]]\u003c/mark\u003e, characterized by bilateral loss of motor function (flaccid paralysis at the level, UMN signs below) and pain/temperature sensation below the level of the lesion, with \u003cmark\u003epreserved proprioception and vibration sense\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Medulla):\u003c/b\u003e Occlusion of paramedian branches of the ASA or vertebral arteries causes \u003cmark\u003eMedial Medullary Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying an ASA stroke is the dissociation of sensory loss: pain and temperature are gone, but vibration and position sense are intact because the dorsal columns are spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Spinal Artery\u003c/b\u003e is the lifeline for the motor and pain/temperature pathways of the spinal cord; its occlusion creates a devastating syndrome of bilateral paralysis and sensory loss, sparing only the dorsal columns\u0027 functions of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B(Anterior Spinal Artery); B --\u003e C(Anterior 2/3 of Spinal Cord); C --\u003e D[Corticospinal Tracts]; C --\u003e E[Spinothalamic Tracts]; C --\u003e F[Anterior Horns];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"b48b54d7\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n  \"b48b54d7\": {\n    \"title\": \"Anterior Spinal Artery Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e is a spinal cord infarct resulting from occlusion of the [[1430f5b4|anterior spinal artery (ASA)]], which leads to ischemia of the anterior two-thirds of the spinal cord, causing a distinct pattern of neurological deficits below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by occlusion of the ASA, which can result from aortic surgery (e.g., repair of an aneurysm), severe hypotension (watershed infarct), or thromboembolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e Corticospinal tracts, spinothalamic tracts, and anterior horns.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Spared:\u003c/b\u003e The \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e are spared due to their separate blood supply from the posterior spinal arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMotor:\u003c/b\u003e Bilateral flaccid paralysis at the level of the lesion (LMN signs from anterior horn damage) and bilateral spastic paralysis below the lesion (UMN signs from corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Bilateral loss of pain and temperature sensation below the lesion (spinothalamic tract damage).\u003cbr\u003e - \u003cb\u003eSensation Preserved:\u003c/b\u003e \u003cmark\u003eProprioception, vibration, and fine touch are intact\u003c/mark\u003e because the dorsal columns are spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dissociation between loss of pain/temperature and preservation of vibration/proprioception is the pathognomonic feature of this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e creates a stark neurological divide, paralyzing the body and eliminating pain and temperature sensation below the lesion, while leaving the sense of position and vibration completely intact, a direct reflection of the spinal cord\u0027s vascular territories.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ASA Occlusion] --\u003e B(Infarct of Anterior 2/3 of Spinal Cord); B --\u003e C[Damage to Corticospinal \u0026 Spinothalamic Tracts]; B --Spares--\u003e D[Dorsal Columns]; C --\u003e E[Bilateral Paralysis \u0026 Loss of Pain/Temp]; D --\u003e F[Preserved Vibration/Proprioception];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"1430f5b4\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"4770b8a2\": {\n    \"title\": \"Anti-CGRP Monoclonal Antibodies\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e are a class of medications used for the prophylactic treatment of [[c8833bae|migraine headaches]]. They work by targeting either calcitonin gene-related peptide (CGRP) itself or its receptor, which are key players in the pathophysiology of migraines.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e These monoclonal antibodies bind to either the CGRP ligand (e.g., eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (e.g., erenumab), preventing CGRP from mediating its effects of vasodilation and pain transmission in the trigeminal nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the \u003cmark\u003eprevention (prophylaxis)\u003c/mark\u003e of episodic and chronic [[c8833bae|migraines]]. They are not used for acute treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered via subcutaneous injection or IV infusion, typically on a monthly or quarterly basis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. The most common side effects are injection site reactions. Constipation is notably associated with the CGRP receptor antagonists (e.g., erenumab).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Recognize these drugs by their \u0027-mab\u0027 suffix and their specific use for migraine \u003cu\u003eprophylaxis\u003c/u\u003e. They represent a targeted therapy based on the modern understanding of migraine pathophysiology involving CGRP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e represent a major advance in migraine prevention, offering a highly specific mechanism that directly neutralizes the CGRP pathway, a key driver of pain and inflammation in migraine attacks.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C(CGRP Receptor); C --\u003e D(Vasodilation \u0026 Pain Transmission); D --\u003e E(Migraine); F[Anti-CGRP mAbs] --x B; G[Anti-CGRP Receptor mAbs] --x C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"calcitonin_gene_related_peptide\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"monoclonal_antibody\"\n      }\n    ]\n  },\n  \"f91a0cfa\": {\n    \"title\": \"Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e, also known as antiepileptic drugs (AEDs), are a diverse group of medications used to treat epileptic [[64c08e92|seizures]]. They work by various mechanisms to suppress the rapid and excessive firing of neurons that initiate a seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMajor Mechanisms:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[5aea213f|Phenytoin]], [[eddd2bc5|Carbamazepine]], [[0d37e045|Valproate]], [[08d19a8f|Lamotrigine]].\u003cbr\u003e2. \u003cb\u003eEnhancement of GABAergic inhibition:\u003c/b\u003e Benzodiazepines, Barbiturates, [[valproic_acid|Valproate]].\u003cbr\u003e3. \u003cb\u003eCa\u003csup\u003e2+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] (T-type), Gabapentinoids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBroad-spectrum:\u003c/b\u003e [[valproic_acid|Valproic acid]], [[08d19a8f|lamotrigine]], [[2341f9c0|levetiracetam]], [[e1f5066c|topiramate]]. Effective for both focal and generalized seizures.\u003cbr\u003e - \u003cb\u003eNarrow-spectrum:\u003c/b\u003e [[eddd2bc5|Carbamazepine]], [[5aea213f|phenytoin]], gabapentinoids. Primarily for focal seizures. [[a90f6fb4|Ethosuximide]] is for absence seizures only.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Many anticonvulsants are also used for bipolar disorder, neuropathic pain, and [[c8833bae|migraine]] prophylaxis. Some are used in [[45dd6d19|multiple sclerosis]] for symptomatic treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common side effects include sedation, dizziness, and ataxia. Many carry a risk of serious skin reactions like \u003cmark\u003eStevens-Johnson syndrome (SJS)\u003c/mark\u003e, especially lamotrigine and carbamazepine. All are potentially teratogenic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the first-line treatments for specific seizure types: Absence -\u003e [[a90f6fb4|Ethosuximide]]; Tonic-clonic -\u003e [[valproic_acid|Valproic acid]], [[2341f9c0|levetiracetam]]; Status epilepticus -\u003e Benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e primarily work by either dampening neuronal excitability (e.g., blocking Na\u003csup\u003e+\u003c/sup\u003e channels) or enhancing neuronal inhibition (e.g., potentiating GABA), with the choice of drug critically depending on the type of seizure being treated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea213f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      }\n    ]\n  },\n  \"290a966b\": {\n    \"title\": \"Antidiuretic Hormone (ADH)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Renal\",\n      \"Physiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone (ADH)\u003c/b\u003e, also known as vasopressin, is a peptide hormone synthesized in the [[89e86633|hypothalamus]] and released from the posterior pituitary. Its primary functions are to regulate plasma osmolality by increasing water reabsorption in the kidneys and to regulate blood pressure via vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis \u0026 Release:\u003c/b\u003e Synthesized primarily in the \u003cmark\u003esupraoptic nucleus\u003c/mark\u003e of the [[89e86633|hypothalamus]], transported down axons, and stored/released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e Release is stimulated by \u003cmark\u003eincreased plasma osmolality\u003c/mark\u003e (detected by osmoreceptors in the hypothalamus) and, to a lesser extent, by decreased blood volume/pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRenal Action (V2 Receptors):\u003c/b\u003e Binds to V2 receptors on the basolateral membrane of principal cells in the renal collecting ducts. This activates a G\u003csub\u003es\u003c/sub\u003e-cAMP pathway, leading to the insertion of \u003cmark\u003eaquaporin-2\u003c/mark\u003e channels into the apical membrane, increasing water reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Action (V1 Receptors):\u003c/b\u003e Binds to V1 receptors on vascular smooth muscle, activating a G\u003csub\u003eq\u003c/sub\u003e-IP\u003csub\u003e3\u003c/sub\u003e/DAG pathway that causes vasoconstriction and increases blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pathologies are key: Deficiency of ADH or its receptor causes [[diabetes_insipidus]]. Excess ADH secretion causes [[syndrome_of_inappropriate_antidiuretic_hormone|SIADH]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone\u003c/b\u003e is the body\u0027s primary regulator of water balance, acting on the kidney\u0027s collecting ducts via V2 receptors to conserve water when osmolality is high, and on blood vessels via V1 receptors to raise blood pressure when volume is low.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Plasma Osmolality] --\u003e B(Hypothalamus); B --\u003e C(Posterior Pituitary); C --Release ADH--\u003e D; D --V2 Receptor--\u003e E[Kidney Collecting Duct]; E --\u003e F(‚Üë Aquaporin-2 Insertion); F --\u003e G(‚Üë Water Reabsorption); D --V1 Receptor--\u003e H[Vascular Smooth Muscle]; H --\u003e I(Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_released_from\",\n        \"to\": \"posterior_pituitary\"\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"diabetes_insipidus\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \"to\": \"syndrome_of_inappropriate_antidiuretic_hormone\"\n      }\n    ]\n  },\n  \"96e8bf39\": {\n    \"title\": \"Antimuscarinic Drugs\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e, also known as anticholinergics, are a class of medications that act as competitive antagonists at muscarinic acetylcholine receptors, thereby blocking the effects of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively block [[6a005559|acetylcholine]] at muscarinic receptors (M1, M2, M3). They do not affect nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Effects (Mnemonic):\u003c/b\u003e \\\"Hot as a hare, dry as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003cbr\u003e - \u003cb\u003eDry:\u003c/b\u003e ‚Üì Salivation, lacrimation, sweating.\u003cbr\u003e - \u003cb\u003eBlind:\u003c/b\u003e Mydriasis (pupil dilation) and cycloplegia (loss of accommodation).\u003cbr\u003e - \u003cb\u003eHot \u0026 Red:\u003c/b\u003e ‚Üì Sweating leads to hyperthermia and compensatory flushing.\u003cbr\u003e - \u003cb\u003eMad:\u003c/b\u003e CNS effects like delirium, confusion, hallucinations (especially with drugs that cross the BBB).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Used in [[58c8ea03|Parkinson disease]] (e.g., [[383f6fbe|benztropine]], trihexyphenidyl) to treat tremor and rigidity by rebalancing the cholinergic-dopaminergic systems. Also used to treat drug-induced extrapyramidal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Atropine (bradycardia), scopolamine (motion sickness), ipratropium (COPD), oxybutynin (overactive bladder).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be cautious using antimuscarinics in the elderly due to increased risk of confusion, hallucinations, and delirium. They are contraindicated in [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e function by blocking the \u0027rest and digest\u0027 functions of the parasympathetic nervous system, leading to a predictable constellation of side effects that are essentially the opposite of a cholinergic toxidrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetylcholine] --x B(Antimuscarinic Drugs); B --x C(Muscarinic Receptors); C --x D(Parasympathetic Effects);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"antagonizes_receptor_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"atropine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"383f6fbe\"\n      }\n    ]\n  },\n  \"af72aab5\": {\n    \"title\": \"Antispasmodics (Skeletal Muscle Relaxants)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e, or skeletal muscle relaxants, are a group of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A [[gaba_b_receptor|GABA\u003csub\u003eB\u003c/sub\u003e receptor]] agonist that acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits motor neuron activity. Used for spasticity. Can cause hypotension, sedation, and dry mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). \u003cu\u003eUsed to treat malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[baclofen]] and tizanidine for chronic spasticity (MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[dantrolene]] for life-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e reduce muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"d1c786e9\": {\n    \"title\": \"Anxiety Disorders\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Anxiety Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e are a group of mental health conditions characterized by excessive and persistent fear, anxiety, or worry that is disproportionate to the situation and impairs daily functioning. They are associated with altered activity in brain circuits involving the [[d220fc3f|amygdala]] and prefrontal cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Imbalance:\u003c/b\u003e Associated with decreased levels of [[5d3c2089|serotonin]] and [[gaba|GABA]], and increased levels of norepinephrine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneralized Anxiety Disorder (GAD):\u003c/b\u003e Chronic, uncontrollable worry about multiple issues.\u003cbr\u003e - \u003cb\u003ePanic Disorder:\u003c/b\u003e Recurrent, unexpected panic attacks.\u003cbr\u003e - \u003cb\u003ePhobias:\u003c/b\u003e Intense, irrational fear of a specific object or situation.\u003cbr\u003e - \u003cb\u003eSocial Anxiety Disorder:\u003c/b\u003e Fear of social situations and scrutiny.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Line Treatment:\u003c/b\u003e Cognitive Behavioral Therapy (CBT) and/or SSRIs/SNRIs are the \u003cu\u003efirst-line\u003c/u\u003e treatments for most anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Line/Adjunctive Treatment:\u003c/b\u003e [[14464617|Benzodiazepines]] (e.g., [[083094db|alprazolam]], lorazepam) are used for rapid relief of acute anxiety or panic attacks but are not preferred for long-term use due to dependence risk. Buspirone is a non-sedating anxiolytic used for GAD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For long-term management of anxiety, SSRIs/SNRIs are preferred. Benzodiazepines are for short-term or \u0027as-needed\u0027 use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e represent a dysregulation of the brain\u0027s fear and worry circuits, driven by an imbalance of key neurotransmitters. Modern treatment focuses on long-term modulation with SSRIs/SNRIs and CBT, reserving fast-acting benzodiazepines for acute, short-term management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Amygdala Hyperactivity] \u0026 B[Prefrontal Cortex Hypoactivity] --\u003e C(Dysregulated Fear/Worry Circuit); C --\u003e D(Anxiety Disorder);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"gaba\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ssris\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"6bc9a567\": {\n    \"title\": \"Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is an acquired language disorder resulting from damage to the language centers of the brain, typically in the dominant (usually left) hemisphere. It affects the ability to produce and/or comprehend spoken or written language, and is distinct from dysarthria (a motor speech disorder).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBroca\u0027s Aphasia (Expressive):\u003c/b\u003e Lesion in the inferior frontal gyrus ([[a3bbace2|Broca\u0027s area]]). Characterized by \u003cmark\u003enonfluent, telegraphic speech\u003c/mark\u003e with intact comprehension. Patients are often frustrated by their inability to speak. Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca (mouth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke\u0027s Aphasia (Receptive):\u003c/b\u003e Lesion in the superior temporal gyrus ([[wernicke_area|Wernicke\u0027s area]]). Characterized by \u003cmark\u003efluent but meaningless speech\u003c/mark\u003e (word salad) with severely impaired comprehension. Patients are often unaware of their deficit (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eConduction Aphasia:\u003c/b\u003e Lesion of the \u003cmark\u003earcuate fasciculus\u003c/mark\u003e, which connects Broca\u0027s and Wernicke\u0027s areas. Hallmark is poor repetition despite fluent speech and intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlobal Aphasia:\u003c/b\u003e Large lesion affecting both Broca\u0027s and Wernicke\u0027s areas, typically from a large [[143bb23d|MCA stroke]]. All language functions (fluency, comprehension, repetition) are severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most common cause of aphasia is an ischemic [[c5da3c57|stroke]] in the territory of the left [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is a disorder of language, not speech mechanics, with distinct subtypes that can be precisely localized within the dominant cerebral hemisphere: Broca\u0027s area for production, Wernicke\u0027s area for comprehension, and the arcuate fasciculus for repetition.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left MCA Stroke] --\u003e B{Aphasia Types}; B --\u003e C[Broca\u0027s - Nonfluent, Good Comprehension]; B --\u003e D[Wernicke\u0027s - Fluent, Poor Comprehension]; B --\u003e E[Conduction - Poor Repetition]; B --\u003e F[Global - All Impaired];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"2c4a6130\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"1ae850fe\"\n      }\n    ]\n  },\n  \"1a804e11\": {\n    \"title\": \"Apoptosis\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Cell Biology\",\n      \"Pathology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Injury\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is a form of programmed cell death that is a highly regulated and controlled process, essential for normal tissue turnover, embryonic development, and removal of damaged or infected cells. In the context of neurology, it is the primary mechanism of neuronal death in many neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e Characterized by cell shrinkage, chromatin condensation (pyknosis), membrane blebbing, and formation of apoptotic bodies, which are then phagocytosed. It is an ATP-dependent process and does \u003cu\u003enot\u003c/u\u003e induce inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathways:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eIntrinsic (Mitochondrial):\u003c/b\u003e Activated by cellular stress (e.g., DNA damage, misfolded proteins). Regulated by the Bcl-2 family of proteins. Pro-apoptotic proteins (Bax, Bak) create pores in the mitochondrial membrane, releasing cytochrome c, which activates caspases.\u003cbr\u003e - \u003cb\u003eExtrinsic (Death Receptor):\u003c/b\u003e Activated by external ligands (e.g., FasL, TNF-Œ±) binding to death receptors on the cell surface, directly activating caspases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCaspases:\u003c/b\u003e The central executioners of apoptosis are a family of cysteine proteases called caspases, which orchestrate the degradation of cellular components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance:\u003c/b\u003e Apoptosis of lower motor neurons is a key feature of [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]. It is also the mechanism of neuronal loss in [[ffd7e743|Huntington disease]] and [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contrast apoptosis with necrosis. Necrosis is uncontrolled cell death due to injury, causing cell swelling, membrane rupture, and inflammation. Apoptosis is clean, programmed, and non-inflammatory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is the cell\u0027s intrinsic suicide program, executed by caspases, which neatly packages the cell for disposal without triggering an inflammatory response; its dysregulation is a central theme in both cancer (too little apoptosis) and neurodegeneration (too much apoptosis).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A{Cellular Stress} --\u003e B(Intrinsic Pathway); B --\u003e C(Mitochondria); C --Cytochrome c--\u003e D; E{Death Ligands} --\u003e F(Extrinsic Pathway); F --\u003e D(Caspase Activation); D --\u003e G(Execution Phase); G --\u003e H(Apoptotic Body Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"necrosis\"\n      }\n    ]\n  },\n  \"c1f67280\": {\n    \"title\": \"Apraclonidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e is an \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used topically in ophthalmology to lower intraocular pressure (IOP), primarily for the short-term treatment of [[3ce6c035|glaucoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a selective Œ±\u003csub\u003e2\u003c/sub\u003e-agonist, it acts on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e receptors in the ciliary body to \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e. It also has some minor effect on increasing uveoscleral outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to lower IOP in patients with [[5ea7b741|open-angle glaucoma]]. It is particularly useful for preventing post-surgical IOP spikes. Its use is often limited to the short term due to tachyphylaxis (diminishing response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include blurry vision, ocular hyperemia (redness), foreign body sensation, and ocular allergic reactions. Systemic side effects are rare but can include dry mouth and fatigue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[brimonidine]], another Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used for glaucoma, but apraclonidine has a higher rate of tachyphylaxis and allergic reactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists (like apraclonidine and clonidine) work by reducing sympathetic outflow. In the eye, this translates to decreased production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e lowers intraocular pressure by acting as a \u0027brake\u0027 on aqueous humor production, stimulating Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the ciliary body to reduce fluid synthesis, making it a useful agent for short-term management of glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Apraclonidine] --\u003e B(Stimulates Œ±2 Receptors in Ciliary Body); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Aqueous Humor Synthesis); D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"2fcee185\"\n      }\n    ]\n  },\n  \"eb32eb82\": {\n    \"title\": \"Gait Apraxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a high-level gait disorder characterized by the inability to properly coordinate the motor sequences for walking, despite having normal motor, sensory, and cerebellar function. It is often described as a \u003cmark\u003e\\\"magnetic gait,\\\"\u003c/mark\u003e where the feet appear stuck to the floor.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have difficulty initiating walking. The gait is wide-based, shuffling, and slow, with the feet barely leaving the ground. Turning is particularly difficult and requires multiple small steps.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is considered a disorder of the frontal lobes or their connections, disrupting the cortical control of locomotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Gait apraxia is one of the three cardinal signs of \u003cmark\u003e[[7c59030e|Normal Pressure Hydrocephalus (NPH)]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNPH Triad:\u003c/b\u003e The classic triad is \\\"\u003cb\u003eW\u003c/b\u003eobbly, \u003cb\u003eW\u003c/b\u003eacky, and \u003cb\u003eW\u003c/b\u003eet\\\":\u003cbr\u003e1. \u003cb\u003eWobbly:\u003c/b\u003e Gait apraxia.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/dementia.\u003cbr\u003e3. \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a \u0027magnetic\u0027 or \u0027feet stuck to the floor\u0027 gait in an elderly patient, especially when combined with cognitive changes and urinary incontinence, is a classic vignette for [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a \u0027brain\u0027 problem, not a \u0027leg\u0027 problem; it represents a failure of the frontal lobe\u0027s motor programming for walking, famously manifesting as the \u0027magnetic\u0027 gait of [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"7c59030e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    ]\n  },\n  \"d595b0bf\": {\n    \"title\": \"Aqueous Humor Pathway\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e describes the continuous production, circulation, and drainage of aqueous humor, the clear fluid that fills the anterior and posterior chambers of the eye. The balance between production and drainage determines the intraocular pressure (IOP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:\u003c/b\u003e Aqueous humor is produced by the \u003cmark\u003enonpigmented epithelium of the ciliary body\u003c/mark\u003e. This process is decreased by Œ≤-blockers, Œ±\u003csub\u003e2\u003c/sub\u003e-agonists, and carbonic anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation:\u003c/b\u003e Fluid flows from the posterior chamber, through the pupil, into the anterior chamber.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathways:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eTrabecular Outflow (~90%):\u003c/b\u003e Fluid drains through the trabecular meshwork, into the Canal of Schlemm, and then into the episcleral vasculature. This pathway is enhanced by muscarinic agonists (e.g., pilocarpine).\u003cbr\u003e2. \u003cb\u003eUveoscleral Outflow (~10%):\u003c/b\u003e Fluid drains through the ciliary muscle and into the uveal and scleral tissues. This pathway is enhanced by prostaglandin analogs (e.g., latanoprost).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Imbalance in this pathway leads to [[3ce6c035|glaucoma]]. [[5ea7b741|Open-angle glaucoma]] involves increased resistance in the trabecular meshwork, while [[9c80344d|angle-closure glaucoma]] involves physical obstruction of the angle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different glaucoma medications target this pathway. Prostaglandins increase uveoscleral outflow, while Œ≤-blockers and acetazolamide decrease production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e is a dynamic circulatory system within the eye\u0027s anterior segment, where a delicate equilibrium between ciliary body production and dual-route (trabecular and uveoscleral) drainage is essential for maintaining normal intraocular pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ciliary Body Epithelium] --Produces--\u003e B(Aqueous Humor); B --\u003e C(Posterior Chamber); C --\u003e D(Anterior Chamber); D --\u003e E{Drainage}; E --\u003e F[Trabecular Outflow (90%)]; F --\u003e G[Canal of Schlemm]; E --\u003e H[Uveoscleral Outflow (10%)];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"glaucoma_drugs\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10734,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"3c075343\": {\n    \"title\": \"An"
      }, {
        "text": "terior Inferior Cerebellar Artery (AICA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Inferior Cerebellar Artery (AICA)\u003c/b\u003e is an artery in"
      }, {
        "text": " the brain that arises from the basilar artery and supplies blood to the anterior inferior portion of the cerebellum, as well as parts of the lateral"
      }, {
        "text": " pons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Typically arises from the lower third"
      }, {
        "text": " of the basilar artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Lateral pons, middle and inferior cerebellar peduncles, and the"
      }, {
        "text": " anterior inferior cerebellum. It also gives rise to the labyrinthine artery in most individuals, which supplies the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome"
      }, {
        "text": ":\u003c/b\u003e Occlusion of the AICA causes \u003cmark\u003eLateral Pontine Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of A"
      }, {
        "text": "ICA Stroke:\u003c/b\u003e Mnemonic \u003cb\u003eAICA\u003c/b\u003e: \u003cb\u003eA\u003c/b\u003etaxia (ipsilateral, from cerebellar"
      }, {
        "text": " peduncle damage), \u003cb\u003eI\u003c/b\u003epsilateral facial paralysis (CN VII nucleus/fibers) and deafness/vertigo (CN VIII nucleus/labyrinth"
      }, {
        "text": "ine artery), \u003cb\u003eC\u003c/b\u003eontralateral pain/temp loss (spinothalamic tract), \u003cb\u003eA"
      }, {
        "text": "\u003c/b\u003eutonomic signs (ipsilateral Horner syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to distinguishing an AICA stroke from a"
      }, {
        "text": " PICA stroke (Lateral Medullary Syndrome) is the presence of \u003cmark\u003efacial paralysis\u003c/mark\u003e and \u003cmark\u003ede"
      }, {
        "text": "afness\u003c/mark\u003e, which are specific to the pontine location of the AICA territory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eOcclusion of the \u003cb\u003eAnterior Inferior Cerebellar Artery\u003c/b\u003e results in Lateral Pontine Syndrome, a"
      }, {
        "text": " complex brainstem stroke characterized by a unique combination of cerebellar signs, contralateral body sensory loss, and ipsilateral facial deficits including"
      }, {
        "text": " paralysis and deafness, which localizes the lesion squarely to the lateral pons.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Basilar Artery] --\u003e B(AICA); B --\u003e C(Lateral Pons); B --\u003e D(An"
      }, {
        "text": "terior Inferior Cerebellum); B --\u003e E(Labyrinthine Artery); C --\u003e F(CN VII \u0026 VIII Nucle"
      }, {
        "text": "i); E --\u003e G(Inner Ear);\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"occlusion_causes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      \""
      }, {
        "text": "type\": \"is_a_branch_of\",\n      \"to\": \"basilar_artery\"\n    },\n"
      }, {
        "text": "    {\n      \"type\": \"differentiated_from_stroke_in\",\n      \"to\": \"posterior"
      }, {
        "text": "_inferior_cerebellar_artery\"\n    }\n  },\n  \"eed3fda9\": {\n    \"title\": \""
      }, {
        "text": "Anterior Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eAnterior Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]]"
      }, {
        "text": " that plays a primary role in thermoregulation, specifically in dissipating heat to cool the body. It is part of the parasympathetic nervous system.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates heat dissipation (\u003cb\u003ecooling\u003c/b\u003e). M"
      }, {
        "text": "nemonic: The \u003cb\u003eA\u003c/b\u003e/\u003cb\u003eC\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003enterior \u003cb\u003eC\u003c/b\u003eooling) is in"
      }, {
        "text": " the front of the house.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Senses when the body is too hot and initiates parasympathetic responses like"
      }, {
        "text": " cutaneous vasodilation and sweating to promote heat loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the anterior"
      }, {
        "text": " nucleus results in \u003cmark\u003ehyperthermia\u003c/mark\u003e, as the body loses its ability to cool itself down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e"
      }, {
        "text": " The [[posterior_nucleus_of_hypothalamus|posterior nucleus of the hypothalamus]] is responsible for heat conservation and"
      }, {
        "text": " production (heating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functional pairing: Anterior hypothalamus \u003d Cooling (parasympathetic),"
      }, {
        "text": " Posterior hypothalamus \u003d Heating (sympathetic). A lesion in the anterior nucleus leads to an inability to cool down.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus of the hypothalamus\u003c/b\u003e functions as the body\u0027s thermostat for cooling; its"
      }, {
        "text": " destruction leads to uncontrolled hyperthermia because the primary mechanism for heat dissipation is lost.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[‚Üë Body Temperature] --\u003e B(Anterior Nucleus); B --Parasympathetic Output--\u003e C(Cutaneous Vasodilation \u0026 Sweating);"
      }, {
        "text": " C --\u003e D(Heat Dissipation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"regulates\",\n        \"to\": \"thermoregulation\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "lesion_causes\",\n        \"to\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_counterpart_to\",\n        \"to\": \"posterior_nucleus_of_hypothalamus\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"1430f5b4\": {\n    \"title\": \"Anterior Spinal Artery (ASA"
      }, {
        "text": ")\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      "
      }, {
        "text": "\"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eAnterior Spinal Artery (ASA)\u003c/b\u003e is a major artery that supplies the anterior two-thirds of the spinal"
      }, {
        "text": " cord. It originates from the vertebral arteries in the cranium and descends along the anterior surface of the spinal cord.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed from the union of two branches of the vertebral arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied"
      }, {
        "text": ":\u003c/b\u003e Supplies the anterior two-thirds of the spinal cord, including the anterior and lateral corticospinal tracts, the spin"
      }, {
        "text": "othalamic tracts, and the anterior horns. It notably \u003cu\u003espares\u003c/u\u003e the [[e7f5cb"
      }, {
        "text": "be|dorsal columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Spinal Cord):\u003c/b\u003e Occlusion causes \u003cmark\u003e[["
      }, {
        "text": "b48b54d7|Anterior Spinal Artery Syndrome]]\u003c/mark\u003e, characterized by bilateral loss of motor function (fl"
      }, {
        "text": "accid paralysis at the level, UMN signs below) and pain/temperature sensation below the level of the lesion, with"
      }, {
        "text": " \u003cmark\u003epreserved proprioception and vibration sense\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Medulla):\u003c/b\u003e Occlusion of param"
      }, {
        "text": "edian branches of the ASA or vertebral arteries causes \u003cmark\u003eMedial Medullary Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key to identifying an ASA stroke is the dissociation of sensory loss: pain and temperature are gone, but"
      }, {
        "text": " vibration and position sense are intact because the dorsal columns are spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eAnterior Spinal Artery\u003c/b\u003e is the lifeline for the motor and pain/temperature pathways of the spinal cord;"
      }, {
        "text": " its occlusion creates a devastating syndrome of bilateral paralysis and sensory loss, sparing only the dorsal columns\u0027 functions of vibration and proprio"
      }, {
        "text": "ception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B("
      }, {
        "text": "Anterior Spinal Artery); B --\u003e C(Anterior 2/3 of Spinal Cord); C --\u003e D["
      }, {
        "text": "Corticospinal Tracts]; C --\u003e E[Spinothalamic Tracts]; C --\u003e F[Anterior Horns"
      }, {
        "text": "];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \""
      }, {
        "text": "b48b54d7\"\n      },\n      {\n        \"type\": \"occlusion_"
      }, {
        "text": "causes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"b48b54d7\": {\n    \"title\": \"Anterior Spinal Artery Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e is a spinal"
      }, {
        "text": " cord infarct resulting from occlusion of the [[1430f5b4|anterior spinal artery (ASA)]], which leads"
      }, {
        "text": " to ischemia of the anterior two-thirds of the spinal cord, causing a distinct pattern of neurological deficits below the level of the lesion.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by occlusion of the ASA,"
      }, {
        "text": " which can result from aortic surgery (e.g., repair of an aneurysm), severe hypotension (watershed infarct), or thrombo"
      }, {
        "text": "embolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e Corticospinal tracts, spinothalamic tracts, and anterior"
      }, {
        "text": " horns.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Spared:\u003c/b\u003e The \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e"
      }, {
        "text": " are spared due to their separate blood supply from the posterior spinal arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eMotor:\u003c/b\u003e Bilateral flaccid paralysis at the level of the lesion (LMN signs from anterior horn damage) and bilateral"
      }, {
        "text": " spastic paralysis below the lesion (UMN signs from corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Bil"
      }, {
        "text": "ateral loss of pain and temperature sensation below the lesion (spinothalamic tract damage).\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "ensation Preserved:\u003c/b\u003e \u003cmark\u003eProprioception, vibration, and fine touch are intact\u003c/mark\u003e because the dorsal columns are"
      }, {
        "text": " spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dissociation between loss of pain/temperature and preservation of vibration/proprioception is"
      }, {
        "text": " the pathognomonic feature of this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e"
      }, {
        "text": " creates a stark neurological divide, paralyzing the body and eliminating pain and temperature sensation below the lesion, while leaving the sense"
      }, {
        "text": " of position and vibration completely intact, a direct reflection of the spinal cord\u0027s vascular territories.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[ASA Occlusion] --\u003e B(Infarct of Anterior 2/3 of Spinal Cord); B"
      }, {
        "text": " --\u003e C[Damage to Corticospinal \u0026 Spinothalamic Tracts]; B --Spares--\u003e D["
      }, {
        "text": "Dorsal Columns]; C --\u003e E[Bilateral Paralysis \u0026 Loss of Pain/Temp]; D --\u003e F[Pres"
      }, {
        "text": "erved Vibration/Proprioception];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_occlusion_of\",\n        \"to\": \"1430f5b4"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef"
      }, {
        "text": "1\"\n      }\n    ]\n  },\n  \"4770b8a2\": {\n    \"title\": \""
      }, {
        "text": "Anti-CGRP Monoclonal Antibodies\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e are a class of medications used for"
      }, {
        "text": " the prophylactic treatment of [[c8833bae|migraine headaches]]. They work by targeting either calcitonin gene-related peptide"
      }, {
        "text": " (CGRP) itself or its receptor, which are key players in the pathophysiology of migraines.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e These monoclonal antibodies bind to either the CGRP ligand (e.g., e"
      }, {
        "text": "ptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (e.g.,"
      }, {
        "text": " erenumab), preventing CGRP from mediating its effects of vasodilation and pain transmission in the trigeminal nervous"
      }, {
        "text": " system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the \u003cmark\u003eprevention (prophylaxis)\u003c/mark\u003e of episodic"
      }, {
        "text": " and chronic [[c8833bae|migraines]]. They are not used for acute treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration"
      }, {
        "text": ":\u003c/b\u003e Administered via subcutaneous injection or IV infusion, typically on a monthly or quarterly basis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-toler"
      }, {
        "text": "ated. The most common side effects are injection site reactions. Constipation is notably associated with the CGRP receptor antagonists (e.g., erenumab"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Recognize these drugs by their \u0027-mab\u0027 suffix and their specific use for"
      }, {
        "text": " migraine \u003cu\u003eprophylaxis\u003c/u\u003e. They represent a targeted therapy based on the modern understanding of migraine pathophysiology involving CGRP.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e represent a major advance in migraine prevention, offering"
      }, {
        "text": " a highly specific mechanism that directly neutralizes the CGRP pathway, a key driver of pain and inflammation in migraine attacks.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C("
      }, {
        "text": "CGRP Receptor); C --\u003e D(Vasodilation \u0026 Pain Transmission); D --\u003e E(Migraine); F[Anti-CGRP mAbs"
      }, {
        "text": "] --x B; G[Anti-CGRP Receptor mAbs] --x C;\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"calcitonin_gene_related_peptide\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"monoclonal_antibody\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"f91a0cfa\": {\n    \"title\": \"Ant"
      }, {
        "text": "iconvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e, also known as antiepileptic drugs (AEDs), are a diverse"
      }, {
        "text": " group of medications used to treat epileptic [[64c08e92|seizures]]. They work by various"
      }, {
        "text": " mechanisms to suppress the rapid and excessive firing of neurons that initiate a seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Major Mechanisms:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[5aea2"
      }, {
        "text": "13f|Phenytoin]], [[eddd2bc5|Carbamazepine]], [[0d37"
      }, {
        "text": "e045|Valproate]], [[08d19a8f|Lamotrigine]]."
      }, {
        "text": "\u003cbr\u003e2. \u003cb\u003eEnhancement of GABAergic inhibition:\u003c/b\u003e Benzodiazepines, Barbiturates, [[val"
      }, {
        "text": "proic_acid|Valproate]].\u003cbr\u003e3. \u003cb\u003eCa\u003csup\u003e2+\u003c/sup\u003e Channel Blockade:"
      }, {
        "text": "\u003c/b\u003e [[a90f6fb4|Ethosuximide]] (T-type), Gabapentinoids"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBroad-spectrum:\u003c/b\u003e [[valproic_acid|Valproic"
      }, {
        "text": " acid]], [[08d19a8f|lamotrigine]], [[2341f9"
      }, {
        "text": "c0|levetiracetam]], [[e1f5066c|topiramate]]. Effective"
      }, {
        "text": " for both focal and generalized seizures.\u003cbr\u003e - \u003cb\u003eNarrow-spectrum:\u003c/b\u003e [[eddd2bc5|Carbamaz"
      }, {
        "text": "epine]], [[5aea213f|phenytoin]], gabapentinoids. Primarily for focal seizures. [["
      }, {
        "text": "a90f6fb4|Ethosuximide]] is for absence seizures only.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses"
      }, {
        "text": ":\u003c/b\u003e Many anticonvulsants are also used for bipolar disorder, neuropathic pain, and [[c8833bae|migraine"
      }, {
        "text": "]] prophylaxis. Some are used in [[45dd6d19|multiple sclerosis]] for symptomatic treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:"
      }, {
        "text": "\u003c/b\u003e Common side effects include sedation, dizziness, and ataxia. Many carry a risk of serious skin reactions like \u003cmark\u003eStevens-Johnson syndrome ("
      }, {
        "text": "SJS)\u003c/mark\u003e, especially lamotrigine and carbamazepine. All are potentially teratogenic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Know the first-line treatments for specific seizure types: Absence -\u003e [[a90f6fb4|Eth"
      }, {
        "text": "osuximide]]; Tonic-clonic -\u003e [[valproic_acid|Valproic acid]], [[2341f9c0|"
      }, {
        "text": "levetiracetam]]; Status epilepticus -\u003e Benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnticonv"
      }, {
        "text": "ulsants\u003c/b\u003e primarily work by either dampening neuronal excitability (e.g., blocking Na\u003csup\u003e+\u003c/sup\u003e channels) or enhancing"
      }, {
        "text": " neuronal inhibition (e.g., potentiating GABA), with the choice of drug critically depending on the type of seizure being"
      }, {
        "text": " treated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea213f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2bc"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"290a966b\": {\n    \"title\": \""
      }, {
        "text": "Antidiuretic Hormone (ADH)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      "
      }, {
        "text": "\"Renal\",\n      \"Physiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone ("
      }, {
        "text": "ADH)\u003c/b\u003e, also known as vasopressin, is a peptide hormone synthesized in the [[89e866"
      }, {
        "text": "33|hypothalamus]] and released from the posterior pituitary. Its primary functions are to regulate plasma osmolality by"
      }, {
        "text": " increasing water reabsorption in the kidneys and to regulate blood pressure via vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis"
      }, {
        "text": " \u0026 Release:\u003c/b\u003e Synthesized primarily in the \u003cmark\u003esupraoptic nucleus\u003c/mark\u003e of the [[89e86633"
      }, {
        "text": "|hypothalamus]], transported down axons, and stored/released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Regulation:\u003c/b\u003e Release is stimulated by \u003cmark\u003eincreased plasma osmolality\u003c/mark\u003e (detected by osmoreceptors"
      }, {
        "text": " in the hypothalamus) and, to a lesser extent, by decreased blood volume/pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRenal Action"
      }, {
        "text": " (V2 Receptors):\u003c/b\u003e Binds to V2 receptors on the basolateral membrane of principal cells in the renal"
      }, {
        "text": " collecting ducts. This activates a G\u003csub\u003es\u003c/sub\u003e-cAMP pathway, leading to the insertion of \u003cmark\u003eaquaporin-2\u003c/"
      }, {
        "text": "mark\u003e channels into the apical membrane, increasing water reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Action (V1 Receptors):\u003c/b\u003e B"
      }, {
        "text": "inds to V1 receptors on vascular smooth muscle, activating a G\u003csub\u003eq\u003c/sub\u003e-IP\u003csub\u003e3\u003c/sub\u003e/DAG pathway that"
      }, {
        "text": " causes vasoconstriction and increases blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pathologies are key: Deficiency of ADH or"
      }, {
        "text": " its receptor causes [[diabetes_insipidus]]. Excess ADH secretion causes [[syndrome_of_inappropriate_antidiuretic_horm"
      }, {
        "text": "one|SIADH]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone\u003c/b\u003e is"
      }, {
        "text": " the body\u0027s primary regulator of water balance, acting on the kidney\u0027s collecting ducts via V2 receptors to conserve"
      }, {
        "text": " water when osmolality is high, and on blood vessels via V1 receptors to raise blood pressure when volume is low.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[‚Üë Plasma Osmolality] --\u003e B(Hypothalamus); B --\u003e C("
      }, {
        "text": "Posterior Pituitary); C --Release ADH--\u003e D; D --V2 Receptor--\u003e E[Kidney Collecting Duct]; E --\u003e F"
      }, {
        "text": "(‚Üë Aquaporin-2 Insertion); F --\u003e G(‚Üë Water Reabsorption); D --V1 Receptor--\u003e H"
      }, {
        "text": "[Vascular Smooth Muscle]; H --\u003e I(Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_synthesized_in\",\n        \"to\": \"89e86633\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_released_from\",\n        \"to\": \"posterior_pituitary\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"diabetes"
      }, {
        "text": "_insipidus\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \""
      }, {
        "text": "to\": \"syndrome_of_inappropriate_antidiuretic_hormone\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"96e8bf39\": {\n    \"title\": \"Antimuscarinic Drugs\",\n"
      }, {
        "text": "    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e, also known as anticholinergics,"
      }, {
        "text": " are a class of medications that act as competitive antagonists at muscarinic acetylcholine receptors, thereby blocking the effects of the parasympathetic nervous system.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively block [[6a"
      }, {
        "text": "005559|acetylcholine]] at muscarinic receptors (M1, M2, M3"
      }, {
        "text": "). They do not affect nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Effects (Mnemonic):\u003c/b\u003e \\\"Hot as a hare, dry"
      }, {
        "text": " as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eDry:\u003c/b\u003e ‚Üì Salivation, lacrimation, sweating.\u003cbr\u003e - \u003cb\u003eBlind:\u003c/b\u003e M"
      }, {
        "text": "ydriasis (pupil dilation) and cycloplegia (loss of accommodation).\u003cbr\u003e - \u003cb\u003eHot"
      }, {
        "text": " \u0026 Red:\u003c/b\u003e ‚Üì Sweating leads to hyperthermia and compensatory flushing.\u003cbr\u003e - \u003cb\u003eMad:\u003c/b\u003e CNS"
      }, {
        "text": " effects like delirium, confusion, hallucinations (especially with drugs that cross the BBB).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Used in [["
      }, {
        "text": "58c8ea03|Parkinson disease]] (e.g., [[383f6fbe|benztrop"
      }, {
        "text": "ine]], trihexyphenidyl) to treat tremor and rigidity by rebalancing the cholinergic-dopaminergic systems"
      }, {
        "text": ". Also used to treat drug-induced extrapyramidal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Atropine (br"
      }, {
        "text": "adycardia), scopolamine (motion sickness), ipratropium (COPD), oxybutynin (over"
      }, {
        "text": "active bladder).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be cautious using antimuscarinics in the elderly due to increased"
      }, {
        "text": " risk of confusion, hallucinations, and delirium. They are contraindicated in [[9c80344d|angle"
      }, {
        "text": "-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e function"
      }, {
        "text": " by blocking the \u0027rest and digest\u0027 functions of the parasympathetic nervous system, leading to a predictable constellation of side effects that"
      }, {
        "text": " are essentially the opposite of a cholinergic toxidrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetyl"
      }, {
        "text": "choline] --x B(Antimuscarinic Drugs); B --x C(Muscarinic Receptors); C --"
      }, {
        "text": "x D(Parasympathetic Effects);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"antagonizes"
      }, {
        "text": "_receptor_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"atropine\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"383f6fbe\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"af72aab5\": {\n    \"title\":"
      }, {
        "text": " \"Antispasmodics (Skeletal Muscle Relaxants)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e, or skeletal muscle relaxants, are a group"
      }, {
        "text": " of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or"
      }, {
        "text": " directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A [["
      }, {
        "text": "gaba_b_receptor|GABA\u003csub\u003eB\u003c/sub\u003e receptor]] agonist that acts on the spinal cord to suppress hyper"
      }, {
        "text": "active reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenz"
      }, {
        "text": "aprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal"
      }, {
        "text": " conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist"
      }, {
        "text": " that inhibits motor neuron activity. Used for spasticity. Can cause hypotension, sedation, and dry mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Dantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum ("
      }, {
        "text": "inhibits ryanodine receptor). \u003cu\u003eUsed to treat malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[baclofen]] and tizanidine for chronic spasticity ("
      }, {
        "text": "MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[dantrolene]] for life"
      }, {
        "text": "-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e reduce"
      }, {
        "text": " muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to"
      }, {
        "text": " direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"d1"
      }, {
        "text": "c786e9\": {\n    \"title\": \"Anxiety Disorders\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Anxiety Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders"
      }, {
        "text": "\u003c/b\u003e are a group of mental health conditions characterized by excessive and persistent fear, anxiety, or worry that is disproportionate to the situation and impairs"
      }, {
        "text": " daily functioning. They are associated with altered activity in brain circuits involving the [[d220fc3f|amygdala]] and pre"
      }, {
        "text": "frontal cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Imbalance:\u003c/b\u003e Associated with decreased"
      }, {
        "text": " levels of [[5d3c2089|serotonin]] and [[gaba|GABA]], and"
      }, {
        "text": " increased levels of norepinephrine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneralized Anxiety Disorder (GAD):\u003c/b\u003e Chronic"
      }, {
        "text": ", uncontrollable worry about multiple issues.\u003cbr\u003e - \u003cb\u003ePanic Disorder:\u003c/b\u003e Recurrent, unexpected panic attacks.\u003cbr\u003e - \u003cb\u003ePh"
      }, {
        "text": "obias:\u003c/b\u003e Intense, irrational fear of a specific object or situation.\u003cbr\u003e - \u003cb\u003eSocial Anxiety Disorder:\u003c/b\u003e Fear"
      }, {
        "text": " of social situations and scrutiny.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Line Treatment:\u003c/b\u003e Cognitive Behavioral Therapy (CBT) and/"
      }, {
        "text": "or SSRIs/SNRIs are the \u003cu\u003efirst-line\u003c/u\u003e treatments for most anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond"
      }, {
        "text": "-Line/Adjunctive Treatment:\u003c/b\u003e [[14464617|Benzodiazepines]] (e.g., [[0"
      }, {
        "text": "83094db|alprazolam]], lorazepam) are used for rapid relief of acute anxiety or panic attacks but are"
      }, {
        "text": " not preferred for long-term use due to dependence risk. Buspirone is a non-sedating anxiolytic used"
      }, {
        "text": " for GAD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For long-term management of anxiety, SSRIs/SNRIs are preferred"
      }, {
        "text": ". Benzodiazepines are for short-term or \u0027as-needed\u0027 use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e represent a dysregulation of the brain\u0027s fear and worry circuits, driven"
      }, {
        "text": " by an imbalance of key neurotransmitters. Modern treatment focuses on long-term modulation with SSRIs/SNRIs and CBT"
      }, {
        "text": ", reserving fast-acting benzodiazepines for acute, short-term management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Amygdala Hyperactivity] \u0026 B[Prefrontal Cortex Hypoactivity] --\u003e C(Dysregulated Fear/W"
      }, {
        "text": "orry Circuit); C --\u003e D(Anxiety Disorder);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"involves_dysregulation_of\",\n        \"to\": \"5d3c2"
      }, {
        "text": "089\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of"
      }, {
        "text": "\",\n        \"to\": \"gaba\"\n      },\n      {\n        \"type\": \"invol"
      }, {
        "text": "ves_dysregulation_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treated_by\",\n        \"to\": \"ssris\"\n      },\n      {\n        \"type\": \"treated_"
      }, {
        "text": "by\",\n        \"to\": \"14464617\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6bc9a567\": {\n    \"title\": \"Aphasia\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is an acquired language disorder resulting from damage to the language centers of the brain, typically in the dominant"
      }, {
        "text": " (usually left) hemisphere. It affects the ability to produce and/or comprehend spoken or written language, and is distinct from dys"
      }, {
        "text": "arthria (a motor speech disorder).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBroca\u0027s Aphasia ("
      }, {
        "text": "Expressive):\u003c/b\u003e Lesion in the inferior frontal gyrus ([[a3bbace2|Broca\u0027s area"
      }, {
        "text": "]]). Characterized by \u003cmark\u003enonfluent, telegraphic speech\u003c/mark\u003e with intact comprehension. Patients are often frustrated"
      }, {
        "text": " by their inability to speak. Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken"
      }, {
        "text": " \u003cb\u003eB\u003c/b\u003eoca (mouth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke\u0027s Aphasia (Receptive):\u003c/b\u003e Les"
      }, {
        "text": "ion in the superior temporal gyrus ([[wernicke_area|Wernicke\u0027s area]]). Characterized by \u003cmark\u003efluent"
      }, {
        "text": " but meaningless speech\u003c/mark\u003e (word salad) with severely impaired comprehension. Patients are often unaware of their deficit (anosognosia).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eConduction Aphasia:\u003c/b\u003e Lesion of the \u003cmark\u003earcuate fasciculus\u003c/mark\u003e,"
      }, {
        "text": " which connects Broca\u0027s and Wernicke\u0027s areas. Hallmark is poor repetition despite fluent speech and intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlobal"
      }, {
        "text": " Aphasia:\u003c/b\u003e Large lesion affecting both Broca\u0027s and Wernicke\u0027s areas, typically from a large [["
      }, {
        "text": "143bb23d|MCA stroke]]. All language functions (fluency, comprehension, repetition) are severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The most common cause of aphasia is an ischemic [[c5da3c57|stroke]] in the territory"
      }, {
        "text": " of the left [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is a disorder of language, not speech mechanics, with distinct subtypes that can be precisely localized within"
      }, {
        "text": " the dominant cerebral hemisphere: Broca\u0027s area for production, Wernicke\u0027s area for comprehension, and the arcuate fascicul"
      }, {
        "text": "us for repetition.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left MCA Stroke] --\u003e B{"
      }, {
        "text": "Aphasia Types}; B --\u003e C[Broca\u0027s - Nonfluent, Good Comprehension]; B --\u003e D[W"
      }, {
        "text": "ernicke\u0027s - Fluent, Poor Comprehension]; B --\u003e E[Conduction - Poor Repetition]; B --\u003e F[Global - All"
      }, {
        "text": " Impaired];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"2c4a6130\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"1ae850fe\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"1a804e11\": {\n    \"title\": \"Apoptosis\",\n    \"primary"
      }, {
        "text": "Type\": \"physiology\",\n    \"tags\": [\n      \"Cell Biology\",\n      \"Pathology\",\n      \"Physiology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Cellular Injury\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAp"
      }, {
        "text": "optosis\u003c/b\u003e is a form of programmed cell death that is a highly regulated and controlled process, essential for normal tissue turnover, embryonic"
      }, {
        "text": " development, and removal of damaged or infected cells. In the context of neurology, it is the primary mechanism of neuronal death"
      }, {
        "text": " in many neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e Character"
      }, {
        "text": "ized by cell shrinkage, chromatin condensation (pyknosis), membrane blebbing, and formation of apoptotic bodies, which are then phagocytosed."
      }, {
        "text": " It is an ATP-dependent process and does \u003cu\u003enot\u003c/u\u003e induce inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathways:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eIntrinsic (Mitochondrial):\u003c/b\u003e Activated by cellular stress (e.g., DNA damage,"
      }, {
        "text": " misfolded proteins). Regulated by the Bcl-2 family of proteins. Pro-apoptotic proteins (Bax, Bak"
      }, {
        "text": ") create pores in the mitochondrial membrane, releasing cytochrome c, which activates caspases.\u003cbr\u003e - \u003cb\u003eExtrinsic ("
      }, {
        "text": "Death Receptor):\u003c/b\u003e Activated by external ligands (e.g., FasL, TNF-Œ±) binding to death receptors on the cell surface,"
      }, {
        "text": " directly activating caspases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCaspases:\u003c/b\u003e The central executioners of apoptosis are a family of cysteine proteases called"
      }, {
        "text": " caspases, which orchestrate the degradation of cellular components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance:\u003c/b\u003e Apoptosis of"
      }, {
        "text": " lower motor neurons is a key feature of [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]."
      }, {
        "text": " It is also the mechanism of neuronal loss in [[ffd7e743|Huntington disease]] and [[58c8ea03|"
      }, {
        "text": "Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contrast apoptosis with necrosis. Necrosis is uncontrolled cell death due"
      }, {
        "text": " to injury, causing cell swelling, membrane rupture, and inflammation. Apoptosis is clean, programmed, and non-inflammatory."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is the cell\u0027s intrinsic suicide program"
      }, {
        "text": ", executed by caspases, which neatly packages the cell for disposal without triggering an inflammatory response; its dysregulation is a central"
      }, {
        "text": " theme in both cancer (too little apoptosis) and neurodegeneration (too much apoptosis).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A{Cellular Stress} --\u003e B(Intrinsic Pathway); B --\u003e C(Mitochondria); C --Cy"
      }, {
        "text": "tochrome c--\u003e D; E{Death Ligands} --\u003e F(Extrinsic Pathway); F --\u003e D(Caspase Activation); D --\u003e G("
      }, {
        "text": "Execution Phase); G --\u003e H(Apoptotic Body Formation);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"4ed629f9\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n"
      }, {
        "text": "        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_contr"
      }, {
        "text": "asted_with\",\n        \"to\": \"necrosis\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"c1f67280\": {\n    \"title\": \"Apraclonidine\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e is an \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist"
      }, {
        "text": "\u003c/i\u003e used topically in ophthalmology to lower intraocular pressure (IOP), primarily for the short-term treatment of [[3"
      }, {
        "text": "ce6c035|glaucoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e As a selective Œ±\u003csub\u003e2\u003c/sub\u003e-agonist, it acts on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e receptors"
      }, {
        "text": " in the ciliary body to \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e. It also has some minor effect on increasing uve"
      }, {
        "text": "oscleral outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to lower IOP in patients with [[5ea7b7"
      }, {
        "text": "41|open-angle glaucoma]]. It is particularly useful for preventing post-surgical IOP spikes. Its use is often"
      }, {
        "text": " limited to the short term due to tachyphylaxis (diminishing response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects include blurry vision, ocular hyperemia (redness), foreign body sensation, and ocular allergic reactions. Systemic side"
      }, {
        "text": " effects are rare but can include dry mouth and fatigue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[brimonidine]],"
      }, {
        "text": " another Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used for glaucoma, but apraclonidine has a higher rate of tachyphylaxis and allergic reactions.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists (like apraclonidine and clonidine) work"
      }, {
        "text": " by reducing sympathetic outflow. In the eye, this translates to decreased production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e lowers intraocular pressure by acting as a \u0027brake\u0027 on aqueous humor production"
      }, {
        "text": ", stimulating Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the ciliary body to reduce fluid synthesis, making it a useful agent"
      }, {
        "text": " for short-term management of glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Apraclonidine] --\u003e B(Stim"
      }, {
        "text": "ulates Œ±2 Receptors in Ciliary Body); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Aqueous"
      }, {
        "text": " Humor Synthesis); D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"2"
      }, {
        "text": "fcee185\"\n      }\n    ]\n  },\n  \"eb32eb82\": {\n    \"title\":"
      }, {
        "text": " \"Gait Apraxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a high-level gait"
      }, {
        "text": " disorder characterized by the inability to properly coordinate the motor sequences for walking, despite having normal motor, sensory, and cerebellar function. It is often"
      }, {
        "text": " described as a \u003cmark\u003e\\\"magnetic gait,\\\"\u003c/mark\u003e where the feet appear stuck to the floor.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have difficulty initiating walking. The gait is wide-based, shuffling, and slow,"
      }, {
        "text": " with the feet barely leaving the ground. Turning is particularly difficult and requires multiple small steps.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It"
      }, {
        "text": " is considered a disorder of the frontal lobes or their connections, disrupting the cortical control of locomotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association"
      }, {
        "text": ":\u003c/b\u003e Gait apraxia is one of the three cardinal signs of \u003cmark\u003e[[7c59030"
      }, {
        "text": "e|Normal Pressure Hydrocephalus (NPH)]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNPH Triad:\u003c/b\u003e The classic"
      }, {
        "text": " triad is \\\"\u003cb\u003eW\u003c/b\u003eobbly, \u003cb\u003eW\u003c/b\u003eacky, and \u003cb\u003eW\u003c/b\u003eet\\\":\u003cbr\u003e1. \u003cb\u003eWobbly"
      }, {
        "text": ":\u003c/b\u003e Gait apraxia.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/dementia.\u003cbr\u003e3."
      }, {
        "text": " \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a \u0027magnetic\u0027 or \u0027"
      }, {
        "text": "feet stuck to the floor\u0027 gait in an elderly patient, especially when combined with cognitive changes and urinary incontinence, is a"
      }, {
        "text": " classic vignette for [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a \u0027brain\u0027 problem, not a \u0027leg\u0027 problem;"
      }, {
        "text": " it represents a failure of the frontal lobe\u0027s motor programming for walking, famously manifesting as the \u0027magnetic\u0027 gait of [["
      }, {
        "text": "7c59030e|Normal Pressure Hydrocephalus]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"7c59030e\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_lesion_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"d595b0bf\": {\n    \"title\": \"Aqueous Humor Pathway\",\n    "
      }, {
        "text": "\"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e describes the continuous production,"
      }, {
        "text": " circulation, and drainage of aqueous humor, the clear fluid that fills the anterior and posterior chambers of the eye. The balance between production and drainage determines"
      }, {
        "text": " the intraocular pressure (IOP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:\u003c/b\u003e"
      }, {
        "text": " Aqueous humor is produced by the \u003cmark\u003enonpigmented epithelium of the ciliary body\u003c/mark\u003e. This process is decreased"
      }, {
        "text": " by Œ≤-blockers, Œ±\u003csub\u003e2\u003c/sub\u003e-agonists, and carbonic anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation:\u003c/b\u003e Fluid"
      }, {
        "text": " flows from the posterior chamber, through the pupil, into the anterior chamber.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathways:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eTrabecular Outflow (~90%):\u003c/b\u003e Fluid drains through the trabecular meshwork,"
      }, {
        "text": " into the Canal of Schlemm, and then into the episcleral vasculature. This pathway is enhanced by muscarinic agonists (e.g.,"
      }, {
        "text": " pilocarpine).\u003cbr\u003e2. \u003cb\u003eUveoscleral Outflow (~10%):\u003c/b\u003e Fluid"
      }, {
        "text": " drains through the ciliary muscle and into the uveal and scleral tissues. This pathway is enhanced by prostaglandin analogs (e.g.,"
      }, {
        "text": " latanoprost).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Imbalance in this pathway leads to [[3ce6c035|"
      }, {
        "text": "glaucoma]]. [[5ea7b741|Open-angle glaucoma]] involves increased resistance in the trabecular mesh"
      }, {
        "text": "work, while [[9c80344d|angle-closure glaucoma]] involves physical obstruction of the angle"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different glaucoma medications target this pathway. Prostaglandins increase uve"
      }, {
        "text": "oscleral outflow, while Œ≤-blockers and acetazolamide decrease production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e is a dynamic circulatory system within the eye\u0027s anterior segment, where a"
      }, {
        "text": " delicate equilibrium between ciliary body production and dual-route (trabecular and uveoscleral) drainage is essential for"
      }, {
        "text": " maintaining normal intraocular pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ciliary Body Epithelium] --"
      }, {
        "text": "Produces--\u003e B(Aqueous Humor); B --\u003e C(Posterior Chamber); C --\u003e D(Anterior Chamber); D --\u003e E{"
      }, {
        "text": "Drainage}; E --\u003e F[Trabecular Outflow (90%)]; F --\u003e G[Canal of Schlemm]; E --\u003e"
      }, {
        "text": " H[Uveoscleral Outflow (10%)];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"3ce6c03"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\":"
      }, {
        "text": " \"glaucoma_drugs\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1IUj4vb-O4WV4f0wAQiP7WMlD2b7S96t3"
      },
      "role": "user",
      "tokenCount": 1890
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"b7b67074\": {\n    \"title\": \"Arachnoid Granulations\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e (or arachnoid villi) are microscopic protrusions of the [[46e279b9|arachnoid mater]] through the dura mater into the superior sagittal sinus and other [[21f1c955|dural venous sinuses]], functioning as one-way valves for the drainage of cerebrospinal fluid (CSF) from the subarachnoid space into the venous circulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary site for \u003cmark\u003eCSF reabsorption\u003c/mark\u003e into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e CSF flows from the subarachnoid space into the venous sinus down a pressure gradient. The structure acts as a one-way valve, preventing venous blood from entering the subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most numerous along the \u003cmark\u003esuperior sagittal sinus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Impaired function or obstruction of arachnoid granulations (e.g., from scarring after meningitis or subarachnoid hemorrhage) can lead to \u003cmark\u003e[[aa4115c7|communicating hydrocephalus]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CSF is produced by the choroid plexus and reabsorbed by the arachnoid granulations. A problem with reabsorption (communicating hydrocephalus) is distinct from a blockage of flow within the ventricles (non-communicating hydrocephalus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e are the critical drainage ports for cerebrospinal fluid, acting as sophisticated one-way valves that allow CSF to exit the subarachnoid space and return to the venous system, thereby maintaining intracranial pressure homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Produces--\u003e B(CSF); B --\u003e C(Ventricular System); C --\u003e D(Subarachnoid Space); D --\u003e E(Arachnoid Granulations); E --Reabsorption--\u003e F[Dural Venous Sinuses];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved_in_reabsorption_of\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_a_protrusion_of\",\n        \"to\": \"46e279b9\"\n      },\n      {\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"aa4115c7\"\n      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"21f1c955\"\n      }\n    ]\n  },\n  \"46e279b9\": {\n    \"title\": \"Arachnoid Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e is the middle layer of the three meninges that surround the brain and spinal cord. It is a delicate, avascular membrane located between the outer [[5bbe3597|dura mater]] and the inner [[pia_mater|pia mater]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of a web-like network of collagen and elastic fibers, from which it gets its name (from Greek \u0027arachne\u0027 for spider).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryologic Origin:\u003c/b\u003e Derived from the [[14c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Space:\u003c/b\u003e The space between the arachnoid mater and the pia mater is the \u003cmark\u003esubarachnoid space\u003c/mark\u003e, which contains cerebrospinal fluid (CSF) and major cerebral blood vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eArachnoid Granulations:\u003c/b\u003e Protrusions of the arachnoid mater through the dura into the superior sagittal sinus, responsible for CSF reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Rupture of an artery in the subarachnoid space (e.g., from a berry aneurysm) causes a [[63f8b05f|subarachnoid hemorrhage]]. A [[e98ea0ba|meningioma]], a common benign brain tumor, arises from arachnoid cap cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e forms a crucial boundary, creating the subarachnoid space that houses the CSF and cerebral vasculature, and its specialized granulations are essential for CSF drainage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull] --\u003e B[Dura Mater]; B --\u003e C(Arachnoid Mater); C --\u003e D[Subarachnoid Space - CSF]; D --\u003e E[Pia Mater]; E --\u003e F[Brain];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_layer_of\",\n        \"to\": \"meninges\"\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"5bbe3597\"\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"pia_mater\"\n      },\n      {\n        \"type\": \"gives_rise_to\",\n        \"to\": \"e98ea0ba\"\n      }\n    ]\n  },\n  \"5dd343d3\": {\n    \"title\": \"Area Postrema\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e is a highly vascularized structure in the medulla oblongata, located on the floor of the fourth ventricle, that functions as the \u003cmark\u003echemoreceptor trigger zone (CTZ)\u003c/mark\u003e for vomiting. It is one of the circumventricular organs, meaning it lacks a complete [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal surface of the medulla oblongata at the caudal end of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Detects emetogenic toxins in the blood and CSF and sends signals to the [[74b651ab|vomiting center]] (nucleus tractus solitarius) to induce emesis (vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e Its fenestrated capillaries allow it to directly sample the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Rich in various receptors, including dopamine D\u003csub\u003e2\u003c/sub\u003e, serotonin 5-HT\u003csub\u003e3\u003c/sub\u003e, and neurokinin-1 (NK-1) receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e This is the site of action for many antiemetic drugs. For example, [[ondansetron]] is a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist, and [[metoclopramide]] is a D\u003csub\u003e2\u003c/sub\u003e antagonist. It is also the area stimulated by toxins during chemotherapy, leading to chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e serves as the brain\u0027s chemical surveillance system for the blood; its lack of a blood-brain barrier allows it to detect toxins and trigger the protective reflex of vomiting, making it a key target for antiemetic medications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Emetogenic Toxins in Blood] --\u003e B(Area Postrema/CTZ); B --\u003e C(Vomiting Center - NTS); C --\u003e D(Vomiting Reflex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"circumventricular_organ\"\n      },\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"chemoreceptor_trigger_zone\"\n      },\n      {\n        \"type\": \"sends_signals_to\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"ondansetron\"\n      }\n    ]\n  },\n  \"08cb577f\": {\n    \"title\": \"Argyll Robertson Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a specific type of pupillary abnormality characterized by bilateral small pupils that constrict when the patient focuses on a near object (accommodation reflex) but do \u003cu\u003enot\u003c/u\u003e constrict when exposed to bright light (light reflex). This phenomenon is known as \u003cmark\u003elight-near dissociation\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Mnemonic:\u003c/b\u003e Often called the \\\"prostitute\u0027s pupil\\\" because it \\\"accommodates but does not react.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is thought to be in the \u003cmark\u003epretectal nucleus\u003c/mark\u003e in the superior colliculus of the midbrain, which interrupts the afferent limb of the pupillary light reflex pathway before it reaches the Edinger-Westphal nuclei bilaterally. The pathway for accommodation, which is more complex and involves the cerebral cortex, is spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a highly specific sign of late-stage, or tertiary, \u003cmark\u003eneurosyphilis\u003c/mark\u003e, particularly [[71daebd6|tabes dorsalis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e While classic for syphilis, it can also be seen in other conditions causing midbrain lesions, such as diabetes mellitus or Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ataxia, a positive Romberg sign, and pupils that accommodate but don\u0027t react to light is a classic presentation of [[71daebd6|tabes dorsalis]] due to neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a pathognomonic sign of neurosyphilis, representing a selective lesion in the midbrain that disconnects the pupillary light reflex pathway while preserving the separate, cortically-driven accommodation pathway, resulting in the classic light-near dissociation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Optic Nerve); B --\u003e C(Pretectal Nucleus); C --x Lesion; C --x D(Edinger-Westphal Nucleus); E[Near Object] --\u003e F(Visual Cortex); F --\u003e G(Accommodation Pathway); G --\u003e D; D --\u003e H(Pupillary Constriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurosyphilis\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"pretectal_nucleus\"\n      },\n      {\n        \"type\": \"is_an_example_of\",\n        \"to\": \"light_near_dissociation\"\n      }\n    ]\n  },\n  \"09db7b12\": {\n    \"title\": \"Aspirin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Stroke Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAspirin\u003c/b\u003e (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, primarily used at low doses for its antiplatelet effects in the prevention of cardiovascular and cerebrovascular events.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e \u003cu\u003eIrreversibly\u003c/u\u003e acetylates and inhibits both COX-1 and COX-2. Its antiplatelet effect is due to inhibition of COX-1 in platelets, which blocks the synthesis of \u003cmark\u003eThromboxane A\u003csub\u003e2\u003c/sub\u003e (TXA\u003csub\u003e2\u003c/sub\u003e)\u003c/mark\u003e, a potent promoter of platelet aggregation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for secondary prevention of [[c5da3c57|ischemic stroke]] and [[623ba776|transient ischemic attacks (TIAs)]]. It is a cornerstone of antiplatelet therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress (gastritis, ulcers), bleeding, tinnitus (a sign of toxicity), and Reye syndrome in children with viral illness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReye Syndrome:\u003c/b\u003e A rare but severe condition of acute encephalopathy and fatty liver failure in children given aspirin for a viral infection (e.g., influenza, varicella). \u003cu\u003eAspirin is contraindicated in children\u003c/u\u003e for this reason (except in Kawasaki disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The irreversibility of aspirin\u0027s effect on platelets is key. Since platelets lack a nucleus, they cannot synthesize new COX enzyme, so the antiplatelet effect lasts for the life of the platelet (~7-10 days).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAspirin\u0027s\u003c/b\u003e primary role in stroke prevention stems from its unique ability to \u003cu\u003eirreversibly\u003c/u\u003e inhibit platelet COX-1, effectively silencing thromboxane A\u003csub\u003e2\u003c/sub\u003e production for the platelet\u0027s entire lifespan and thus reducing the risk of thrombotic occlusion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aspirin] --Irreversibly Inhibits--\u003e B(Platelet COX-1); B --x C(Arachidonic Acid -\u003e Thromboxane A2); C --x D(Platelet Aggregation); D --x E(Thrombus Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"prevents\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"623ba776\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"cyclooxygenase\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"reye_syndrome\"\n      }\n    ]\n  },\n  \"b564ac97\": {\n    \"title\": \"Asterixis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a type of negative myoclonus characterized by a brief, flapping tremor of the hands, typically elicited by having the patient extend their arms and dorsiflex their wrists. It is a classic sign of metabolic encephalopathy.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient holds their arms out with wrists extended (\u0027stop traffic\u0027 pose). The \u0027flap\u0027 is a sudden, brief loss of postural tone, causing the hands to drop, followed by a rapid, jerky return to the original position.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is not a true tremor but a failure of the brain to maintain a sustained posture, thought to be due to abnormal function of the diencephalic motor centers that regulate posture and tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Most commonly associated with \u003cmark\u003ehepatic encephalopathy\u003c/mark\u003e due to liver failure, where high ammonia levels are neurotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other metabolic encephalopathies, including uremia (renal failure), CO\u003csub\u003e2\u003c/sub\u003e narcosis (hypercapnia), and drug intoxication. It is also a feature of [[wilson_disease|Wilson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of cirrhosis who presents with confusion and a \u0027flapping tremor\u0027 of the hands has hepatic encephalopathy. The tremor is asterixis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a \u0027negative\u0027 movement disorder‚Äîa brief lapse in muscle tone rather than an active contraction‚Äîthat serves as a crucial physical exam finding for metabolic encephalopathies, most classically hepatic encephalopathy from hyperammonemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"hepatic_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"uremia\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"wilson_disease\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n      }\n    ]\n  },\n  \"18cff34e\": {\n    \"title\": \"Astigmatism\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a common refractive error of the eye where vision is blurred or distorted at all distances. It occurs when the cornea or lens has an irregular, non-spherical curvature, causing light rays to focus at multiple points rather than a single point on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The cornea, which should be shaped like a sphere, is instead shaped more like a football (toric). This causes light entering the eye to have different focal points in different planes (e.g., vertical vs. horizontal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Blurred or distorted vision, eye strain, and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed during a standard eye exam using a phoropter and keratometer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with eyeglasses or contact lenses that have a \u003cmark\u003ecylindrical lens\u003c/mark\u003e to compensate for the irregular curvature. It can also be corrected with refractive surgery (e.g., LASIK).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from other refractive errors: [[myopia|myopia]] (nearsightedness) and [[hyperopia|hyperopia]] (farsightedness) are caused by the length of the eyeball relative to its focusing power, while astigmatism is caused by an irregularly shaped cornea or lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a refractive error caused by an asymmetrically shaped cornea or lens, which acts like a warped mirror, scattering light to multiple focal points and resulting in blurred vision that requires a cylindrical lens for correction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"myopia\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hyperopia\"\n      }\n    ]\n  },\n  \"8192f595\": {\n    \"title\": \"Astrocytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the most abundant type of glial cell in the central nervous system. These star-shaped cells perform a wide variety of essential supportive and homeostatic functions for neurons, and are the origin of the most common primary brain tumor in adults, [[b6bbd0bc|glioblastoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e Physical support for neurons, repair (gliosis/scar formation), component of the [[dd47b9cc|blood-brain barrier]] (via foot processes), removal of excess neurotransmitters (especially glutamate), and maintenance of the ionic environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistological Marker:\u003c/b\u003e They are identified by their expression of \u003cmark\u003eGlial Fibrillary Acidic Protein (GFAP)\u003c/mark\u003e, an intermediate filament protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactive Gliosis:\u003c/b\u003e In response to CNS injury (e.g., stroke, trauma), astrocytes proliferate and hypertrophy to form a \u003cmark\u003eglial scar\u003c/mark\u003e, which walls off the damaged area but can also impede axonal regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTumor Origin:\u003c/b\u003e Astrocytes are the cell of origin for astrocytomas, including the highly malignant [[b6bbd0bc|glioblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember GFAP as the key marker for astrocytes and astrocytic tumors. The formation of a glial scar by astrocytes is the CNS equivalent of fibrosis in other tissues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the indispensable \u0027housekeepers\u0027 of the CNS, providing structural, metabolic, and homeostatic support to neurons, forming the blood-brain barrier, and orchestrating the glial scar response to injury, but they can also give rise to the most aggressive brain tumors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Astrocyte]; A --\u003e B(Physical Support); A --\u003e C(Blood-Brain Barrier); A --\u003e D(Neurotransmitter Uptake); A --\u003e E(Ion Buffering); A --\u003e F(Repair/Gliosis); A --Neoplastic Transformation--\u003e G(Astrocytoma/Glioblastoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"glial_scar\"\n      }\n    ]\n  },\n  \"9767fd6b\": {\n    \"title\": \"Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a neurological sign consisting of a lack of voluntary coordination of muscle movements, leading to a clumsy, unsteady gait and impaired balance. It can be caused by damage to the cerebellum, the vestibular system, or sensory pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCerebellar Ataxia:\u003c/b\u003e Caused by damage to the cerebellum. \u003cbr\u003e - \u003cb\u003eTruncal Ataxia:\u003c/b\u003e Affects the midline, causing an unsteady, wide-based (\u0027drunken sailor\u0027) gait. Associated with lesions of the cerebellar vermis.\u003cbr\u003e - \u003cb\u003eLimb Ataxia:\u003c/b\u003e Affects the extremities, causing dysmetria (overshooting/undershooting targets) and intention tremor. Associated with lesions of the cerebellar hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Ataxia:\u003c/b\u003e Caused by loss of proprioception, typically from damage to the [[e7f5cbbe|dorsal columns]] of the spinal cord or peripheral nerves. Patients have a positive [[47a0f3d1|Romberg sign]] (worsening of balance with eyes closed) and a stomping gait. Seen in [[71daebd6|tabes dorsalis]] and [[6f5bea90|subacute combined degeneration]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular Ataxia:\u003c/b\u003e Caused by dysfunction of the vestibular system. Associated with vertigo, nystagmus, and nausea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating the type of ataxia is key. A positive [[47a0f3d1|Romberg sign]] points to a sensory (dorsal column) cause, not a cerebellar cause. Patients with cerebellar ataxia are unsteady with their eyes open or closed.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a sign of discoordination that can be localized by its characteristics: truncal and limb incoordination points to the cerebellum, a positive Romberg sign points to sensory loss in the dorsal columns, and associated vertigo points to the vestibular system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"dorsal_column_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"vestibular_dysfunction\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"71daebd6\"\n      }\n    ]\n  },\n  \"19272e70\": {\n    \"title\": \"Athetosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a type of involuntary movement disorder characterized by slow, writhing, snake-like movements, particularly affecting the distal extremities (fingers and hands). It is a symptom of damage to the [[ed462927|basal ganglia]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Slow, twisting, and writhing movements that are continuous and non-rhythmic. It is often described as being \u0027snake-like.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by lesions in the [[ed462927|basal ganglia]], particularly the striatum (caudate and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Athetosis is a characteristic feature of [[ffd7e743|Huntington disease]], where it often co-occurs with chorea (termed choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in conditions like cerebral palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see a description of slow, writhing, \u0027snake-like\u0027 movements of the fingers in a patient with other signs of a basal ganglia disorder (like chorea or dementia), think of athetosis, especially in the context of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a specific and visually distinct sign of basal ganglia dysfunction, representing a failure of motor control that manifests as slow, ceaseless, writhing movements, most classically seen in [[ffd7e743|Huntington disease]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"ed7a236f\": {\n    \"title\": \"Atonic Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e, also known as \\\"drop attacks\\\" or \\\"drop seizures,\\\" are a type of generalized seizure characterized by a sudden loss of muscle tone, causing the individual to collapse to the ground. The loss of consciousness is typically very brief.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A sudden, complete loss of postural muscle tone lasting 1-2 seconds. This can cause the head to drop, the jaw to slacken, or the entire body to fall limply to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk of Injury:\u003c/b\u003e There is a high risk of head and facial injuries from the sudden falls. Patients may need to wear protective helmets.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e While they can occur in various epilepsy syndromes, atonic seizures are a hallmark feature of \u003cmark\u003eLennox-Gastaut syndrome\u003c/mark\u003e, a severe form of childhood epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The EEG may show brief, generalized spike-and-wave discharges followed by diffuse slow waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a child with developmental delay who has multiple seizure types, including sudden falls leading to injury, is highly suggestive of Lennox-Gastaut syndrome, with atonic seizures being a key component.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e are dramatic \u0027drop attacks\u0027 caused by a sudden, global loss of muscle tone, posing a significant risk of injury and often signaling a severe underlying epilepsy syndrome like Lennox-Gastaut.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"lennox_gastaut_syndrome\"\n      }\n    ]\n  },\n  \"52194edb\": {\n    \"title\": \"Atracurium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e used in anesthesia to induce skeletal muscle relaxation and paralysis, facilitating endotracheal intubation and surgical procedures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e, a spontaneous, non-enzymatic degradation at physiological pH and temperature. This makes its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Ideal for patients with \u003cmark\u003erenal or hepatic failure\u003c/mark\u003e because its elimination does not depend on these organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause histamine release, leading to hypotension, flushing, and bronchoconstriction. Its metabolite, laudanosine, can lower the seizure threshold, but this is rarely clinically significant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The neuromuscular blockade can be reversed by [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., neostigmine), which increase the concentration of acetylcholine in the synaptic cleft to outcompete the blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of atracurium (and its stereoisomer, cisatracurium) is its Hoffmann elimination, making it the neuromuscular blocker of choice for patients with organ dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing neuromuscular blocker distinguished by its unique Hoffmann elimination pathway, a spontaneous chemical breakdown that makes it a safe and predictable choice for inducing paralysis in patients with kidney or liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atracurium] --Competitively Antagonizes--\u003e B(Nicotinic ACh Receptors); B --x C(ACh Binding); C --x D(Muscle Contraction); A --Hoffmann Elimination--\u003e E(Inactive Metabolites);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"hoffmann_elimination\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitors\"\n      }\n    ]\n  },\n  \"0c2b4642\": {\n    \"title\": \"Atrophy\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cell Biology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Adaptations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a cellular adaptation characterized by a decrease in the size of a cell, organ, or tissue after it has reached its normal mature size. It results from a decrease in cell substance and can be either physiologic or pathologic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Atrophy occurs via a decrease in protein synthesis and an increase in protein degradation. The main pathway for protein degradation is the \u003cmark\u003eubiquitin-proteasome pathway\u003c/mark\u003e. It can also involve autophagy, where the cell digests its own components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Common causes include disuse, denervation, loss of endocrine stimulation, inadequate nutrition, and ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance (Denervation Atrophy):\u003c/b\u003e When a muscle loses its nerve supply (denervation), it undergoes rapid and profound atrophy. This is a key sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN vs. LMN Lesions:\u003c/b\u003e Significant muscle atrophy is a hallmark of LMN lesions (e.g., polio, [[4ed629f9|ALS]], peripheral nerve injury). In contrast, upper motor neuron (UMN) lesions cause only mild disuse atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of marked muscle wasting (atrophy) and fasciculations strongly points towards an LMN component of a disease process.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a reduction in cell size and substance, most often driven by the ubiquitin-proteasome pathway. In neurology, denervation atrophy is a critical sign that localizes a lesion to the lower motor neuron, distinguishing it from upper motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cellular_adaptation\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"ubiquitin_proteasome_pathway\"\n      }\n    ]\n  },\n  \"b1873d5b\": {\n    \"title\": \"Auditory Anatomy and Physiology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAuditory anatomy and physiology\u003c/b\u003e describes the structures and mechanisms by which sound waves are collected, transmitted, transduced into neural signals, and processed by the brain to produce the sensation of hearing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOuter Ear:\u003c/b\u003e The pinna and external auditory canal collect sound waves and funnel them to the tympanic membrane (eardrum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Ear:\u003c/b\u003e An air-filled cavity containing the ossicles (malleus, incus, stapes). The ossicles amplify the vibrations from the tympanic membrane and transmit them to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInner Ear:\u003c/b\u003e The [[001c359f|cochlea]], a fluid-filled, snail-shaped structure, contains the organ of Corti. Vibrations from the stapes create pressure waves in the cochlear fluid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransduction:\u003c/b\u003e These pressure waves cause the basilar membrane to vibrate at specific locations depending on the frequency (tonotopy). High frequencies vibrate the base, low frequencies vibrate the apex. This vibration bends the stereocilia of hair cells in the organ of Corti, opening ion channels and generating a neural signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels from the hair cells via the cochlear nerve (part of CN VIII) to the cochlear nuclei in the brainstem, then through a complex pathway (superior olive, lateral lemniscus, inferior colliculus, medial geniculate nucleus of the thalamus) to the [[d24b6af6|auditory cortex]] in the temporal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe auditory system is a remarkable transducer, converting mechanical energy (sound waves) into mechanical vibration (ossicles), then into hydraulic waves (cochlear fluid), and finally into electrical signals (hair cells) that the brain interprets as sound.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sound Waves] --\u003e B(Outer Ear); B --\u003e C(Tympanic Membrane); C --\u003e D(Middle Ear Ossicles); D --\u003e E(Oval Window); E --\u003e F(Cochlear Fluid); F --\u003e G(Basilar Membrane Vibration); G --\u003e H(Hair Cell Transduction); H --\u003e I(CN VIII); I --\u003e J(Brain); \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \"001c359f\"\n      },\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \"vestibulocochlear_nerve\"\n      },\n      {\n        \"type\": \"culminates_in\",\n        \"to\": \"d24b6af6\"\n      }\n    ]\n  },\n  \"d24b6af6\": {\n    \"title\": \"Auditory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the region of the cerebral cortex responsible for processing auditory information. It is located in the superior temporal gyrus of the temporal lobe and includes the primary auditory cortex (Brodmann areas 41 and 42) and surrounding auditory association areas.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Superior temporal gyrus in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary auditory cortex is responsible for the perception of basic sound characteristics like pitch and volume. The surrounding association areas, including [[wernicke_area|Wernicke\u0027s area]] in the dominant hemisphere, are involved in the interpretation and comprehension of complex sounds, particularly speech.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e It receives its primary input from the \u003cmark\u003emedial geniculate nucleus (MGN)\u003c/mark\u003e of the [[afc0a64b|thalamus]]. Mnemonic: \u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonotopic Organization:\u003c/b\u003e The auditory cortex is organized tonotopically, meaning that different frequencies of sound are processed in different, specific areas of the cortex, mirroring the organization of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the primary auditory cortex does not typically cause complete deafness in one ear, as auditory information from each ear is processed bilaterally in the brain. However, a lesion in [[wernicke_area|Wernicke\u0027s area]] (an auditory association cortex) will cause receptive aphasia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the final destination for sound processing in the brain, receiving signals from the medial geniculate nucleus and interpreting them, with specialized areas like Wernicke\u0027s area in the dominant hemisphere being crucial for language comprehension.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cochlea] --\u003e B(CN VIII); B --\u003e C(Brainstem Nuclei); C --\u003e D(Medial Geniculate Nucleus); D --\u003e E(Auditory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"temporal_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"medial_geniculate_nucleus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9733,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"b7b67074\": {\n    \"title"
      }, {
        "text": "\": \"Arachnoid Granulations\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"M"
      }, {
        "text": "eninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eArachnoid gran"
      }, {
        "text": "ulations\u003c/b\u003e (or arachnoid villi) are microscopic protrusions of the [[46e279b9|"
      }, {
        "text": "arachnoid mater]] through the dura mater into the superior sagittal sinus and other [[21f1c95"
      }, {
        "text": "5|dural venous sinuses]], functioning as one-way valves for the drainage of cerebrospinal fluid (CSF) from the sub"
      }, {
        "text": "arachnoid space into the venous circulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e The primary site for \u003cmark\u003eCSF reabsorption\u003c/mark\u003e into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e CSF"
      }, {
        "text": " flows from the subarachnoid space into the venous sinus down a pressure gradient. The structure acts as a one-way valve,"
      }, {
        "text": " preventing venous blood from entering the subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most numerous along the \u003cmark\u003esuperior sagittal sinus\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Impaired function or obstruction of arachnoid granulations (e.g"
      }, {
        "text": "., from scarring after meningitis or subarachnoid hemorrhage) can lead to \u003cmark\u003e[[aa4115"
      }, {
        "text": "c7|communicating hydrocephalus]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CSF is produced by the chor"
      }, {
        "text": "oid plexus and reabsorbed by the arachnoid granulations. A problem with reabsorption (communicating hydrocephalus) is"
      }, {
        "text": " distinct from a blockage of flow within the ventricles (non-communicating hydrocephalus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e are the critical drainage ports for cerebrospinal fluid, acting as sophisticated"
      }, {
        "text": " one-way valves that allow CSF to exit the subarachnoid space and return to the venous system, thereby maintaining intracranial"
      }, {
        "text": " pressure homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Produces"
      }, {
        "text": "--\u003e B(CSF); B --\u003e C(Ventricular System); C --\u003e D(Subarachnoid Space); D --\u003e E"
      }, {
        "text": "(Arachnoid Granulations); E --Reabsorption--\u003e F[Dural Venous Sinuses];\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_involved_in_reabsorption_of\",\n        \"to"
      }, {
        "text": "\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_protrusion_of\",\n        \"to\": \"46e279b9\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"aa4115c7\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"21f1c955\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"46e279b9\": {\n    \"title\": \"Ar"
      }, {
        "text": "achnoid Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e is the middle layer of the three meninges that"
      }, {
        "text": " surround the brain and spinal cord. It is a delicate, avascular membrane located between the outer [[5bbe359"
      }, {
        "text": "7|dura mater]] and the inner [[pia_mater|pia mater]].\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of a web-like network of collagen and elastic fibers, from which it gets"
      }, {
        "text": " its name (from Greek \u0027arachne\u0027 for spider).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryologic Origin:\u003c/b\u003e Derived from the [[1"
      }, {
        "text": "4c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Space:\u003c/b\u003e The space between the arach"
      }, {
        "text": "noid mater and the pia mater is the \u003cmark\u003esubarachnoid space\u003c/mark\u003e, which contains cerebrospinal fluid (CSF"
      }, {
        "text": ") and major cerebral blood vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eArachnoid Granulations:\u003c/b\u003e Protrusions of the arachnoid mater"
      }, {
        "text": " through the dura into the superior sagittal sinus, responsible for CSF reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Rupture of an"
      }, {
        "text": " artery in the subarachnoid space (e.g., from a berry aneurysm) causes a [[63f8"
      }, {
        "text": "b05f|subarachnoid hemorrhage]]. A [[e98ea0ba|meningioma]],"
      }, {
        "text": " a common benign brain tumor, arises from arachnoid cap cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eArachnoid Mater\u003c/b\u003e forms a crucial boundary, creating the subarachnoid space that houses the CSF"
      }, {
        "text": " and cerebral vasculature, and its specialized granulations are essential for CSF drainage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull"
      }, {
        "text": "] --\u003e B[Dura Mater]; B --\u003e C(Arachnoid Mater); C --\u003e D[Subarachnoid Space -"
      }, {
        "text": " CSF]; D --\u003e E[Pia Mater]; E --\u003e F[Brain];\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_layer_of\",\n        \"to\": \"meninges\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_located_between\",\n        \"to\": \"5bbe3597\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \""
      }, {
        "text": "pia_mater\"\n      },\n      {\n        \"type\": \"gives_rise_to\",\n        "
      }, {
        "text": "\"to\": \"e98ea0ba\"\n      }\n    ]\n  },\n  \"5dd"
      }, {
        "text": "343d3\": {\n    \"title\": \"Area Postrema\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e is a highly vascularized structure in the medulla oblongata,"
      }, {
        "text": " located on the floor of the fourth ventricle, that functions as the \u003cmark\u003echemoreceptor trigger zone (CTZ)\u003c/mark\u003e for vomiting"
      }, {
        "text": ". It is one of the circumventricular organs, meaning it lacks a complete [[dd47b9cc|blood-brain barrier]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal surface of the medulla oblongata at"
      }, {
        "text": " the caudal end of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Detects emetogenic toxins in the blood and CSF"
      }, {
        "text": " and sends signals to the [[74b651ab|vomiting center]] (nucleus tractus solitarius"
      }, {
        "text": ") to induce emesis (vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e Its fenestrated capillaries allow it to directly"
      }, {
        "text": " sample the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Rich in various receptors, including dopamine D\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, serotonin 5-HT\u003csub\u003e3\u003c/sub\u003e, and neurokinin-1 (NK-1) receptors."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e This is the site of action for many antiemetic drugs. For example, [["
      }, {
        "text": "ondansetron]] is a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist, and [[metoclopramide]] is a D"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e antagonist. It is also the area stimulated by toxins during chemotherapy, leading to chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e serves as the brain\u0027s chemical"
      }, {
        "text": " surveillance system for the blood; its lack of a blood-brain barrier allows it to detect toxins and trigger the protective reflex"
      }, {
        "text": " of vomiting, making it a key target for antiemetic medications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[E"
      }, {
        "text": "metogenic Toxins in Blood] --\u003e B(Area Postrema/CTZ); B --\u003e C(Vomiting Center -"
      }, {
        "text": " NTS); C --\u003e D(Vomiting Reflex);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a\",\n        \"to\": \"circumventricular_organ\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"chemoreceptor_trigger"
      }, {
        "text": "_zone\"\n      },\n      {\n        \"type\": \"sends_signals_to\",\n        "
      }, {
        "text": "\"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_target_of\",\n        \"to\": \"ondansetron\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "08cb577f\": {\n    \"title\": \"Argyll Robertson Pupil\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a specific type of pupillary abnormality characterized by bilateral small"
      }, {
        "text": " pupils that constrict when the patient focuses on a near object (accommodation reflex) but do \u003cu\u003enot\u003c/u\u003e constrict when exposed"
      }, {
        "text": " to bright light (light reflex). This phenomenon is known as \u003cmark\u003elight-near dissociation\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Mnemonic:\u003c/b\u003e Often called the \\\"prostitute\u0027s pupil\\\" because it \\\"accommodates but"
      }, {
        "text": " does not react.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is thought to be in the \u003cmark\u003epretectal nucleus"
      }, {
        "text": "\u003c/mark\u003e in the superior colliculus of the midbrain, which interrupts the afferent limb of the pupillary light reflex pathway before"
      }, {
        "text": " it reaches the Edinger-Westphal nuclei bilaterally. The pathway for accommodation, which is more complex and involves the"
      }, {
        "text": " cerebral cortex, is spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a highly specific sign of late-stage,"
      }, {
        "text": " or tertiary, \u003cmark\u003eneurosyphilis\u003c/mark\u003e, particularly [[71daebd6|tabes dorsalis]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e While classic for syphilis, it can also be seen in other conditions causing midbrain lesions, such as diabetes mellitus"
      }, {
        "text": " or Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ataxia, a positive Romberg sign,"
      }, {
        "text": " and pupils that accommodate but don\u0027t react to light is a classic presentation of [[71daebd6|tabes"
      }, {
        "text": " dorsalis]] due to neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a pathognomonic sign of neurosyphilis, representing a selective lesion"
      }, {
        "text": " in the midbrain that disconnects the pupillary light reflex pathway while preserving the separate, cortically-driven accommodation pathway,"
      }, {
        "text": " resulting in the classic light-near dissociation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light]"
      }, {
        "text": " --\u003e B(Optic Nerve); B --\u003e C(Pretectal Nucleus); C --x Lesion; C"
      }, {
        "text": " --x D(Edinger-Westphal Nucleus); E[Near Object] --\u003e F(Visual Cortex); F --\u003e G"
      }, {
        "text": "(Accommodation Pathway); G --\u003e D; D --\u003e H(Pupillary Constriction);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurosyphilis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_caused_by_"
      }, {
        "text": "lesion_in\",\n        \"to\": \"pretectal_nucleus\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_example_of\",\n        \"to\": \"light_near_diss"
      }, {
        "text": "ociation\"\n      }\n    ]\n  },\n  \"09db7b12\": {\n    \"title\":"
      }, {
        "text": " \"Aspirin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Stroke Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAspirin\u003c/b\u003e (acetylsalicylic acid) is a nonsteroidal"
      }, {
        "text": " anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, primarily used at low doses for its anti"
      }, {
        "text": "platelet effects in the prevention of cardiovascular and cerebrovascular events.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eMechanism of Action:\u003c/b\u003e \u003cu\u003eIrreversibly\u003c/u\u003e acetylates and inhibits both COX-1 and COX-2."
      }, {
        "text": " Its antiplatelet effect is due to inhibition of COX-1 in platelets, which blocks the synthesis of \u003cmark\u003eTh"
      }, {
        "text": "romboxane A\u003csub\u003e2\u003c/sub\u003e (TXA\u003csub\u003e2\u003c/sub\u003e)\u003c/mark\u003e, a potent promoter of platelet aggregation.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for secondary prevention of [[c5da3c57|ischemic stroke]] and"
      }, {
        "text": " [[623ba776|transient ischemic attacks (TIAs)]]. It is a cornerstone of anti"
      }, {
        "text": "platelet therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress (gastritis, ulcers), bleeding, tinnitus ("
      }, {
        "text": "a sign of toxicity), and Reye syndrome in children with viral illness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReye Syndrome:\u003c/b\u003e A rare"
      }, {
        "text": " but severe condition of acute encephalopathy and fatty liver failure in children given aspirin for a viral infection (e.g., influenza,"
      }, {
        "text": " varicella). \u003cu\u003eAspirin is contraindicated in children\u003c/u\u003e for this reason (except in Kawasaki disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The irreversibility of aspirin\u0027s effect on platelets is key. Since platelets lack a nucleus, they cannot synthesize"
      }, {
        "text": " new COX enzyme, so the antiplatelet effect lasts for the life of the platelet (~7-10 days).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAspirin\u0027s\u003c/b\u003e primary role in stroke prevention stems from its unique ability"
      }, {
        "text": " to \u003cu\u003eirreversibly\u003c/u\u003e inhibit platelet COX-1, effectively silencing thromboxane A\u003csub\u003e2\u003c/sub\u003e production for"
      }, {
        "text": " the platelet\u0027s entire lifespan and thus reducing the risk of thrombotic occlusion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[A"
      }, {
        "text": "spirin] --Irreversibly Inhibits--\u003e B(Platelet COX-1); B --x C(Ar"
      }, {
        "text": "achidonic Acid -\u003e Thromboxane A2); C --x D(Platelet Aggregation); D --x E(Throm"
      }, {
        "text": "bus Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"prevents\","
      }, {
        "text": "\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"prevents\",\n        "
      }, {
        "text": "\"to\": \"623ba776\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "inhibits\",\n        \"to\": \"cyclooxygenase\"\n      },\n      {\n        \"type\": \"causes_adverse"
      }, {
        "text": "_effect\",\n        \"to\": \"reye_syndrome\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"b564ac97\": {\n    \"title\": \"Asterixis\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"Physical"
      }, {
        "text": " Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Asterixis\u003c/b\u003e is a type of negative myoclonus characterized by a brief, flapping tremor of the hands,"
      }, {
        "text": " typically elicited by having the patient extend their arms and dorsiflex their wrists. It is a classic sign of metabolic encephalopathy.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient holds their arms out"
      }, {
        "text": " with wrists extended (\u0027stop traffic\u0027 pose). The \u0027flap\u0027 is a sudden, brief loss of postural tone, causing the hands to drop,"
      }, {
        "text": " followed by a rapid, jerky return to the original position.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is not a true"
      }, {
        "text": " tremor but a failure of the brain to maintain a sustained posture, thought to be due to abnormal function of the diencephalic"
      }, {
        "text": " motor centers that regulate posture and tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Most commonly associated with \u003cmark\u003ehepatic encephalopathy"
      }, {
        "text": "\u003c/mark\u003e due to liver failure, where high ammonia levels are neurotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can"
      }, {
        "text": " also be seen in other metabolic encephalopathies, including uremia (renal failure), CO\u003csub\u003e2\u003c/sub\u003e narcosis (hyper"
      }, {
        "text": "capnia), and drug intoxication. It is also a feature of [[wilson_disease|Wilson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient with a history of cirrhosis who presents with confusion and a \u0027flapping tremor\u0027 of the hands has hepatic"
      }, {
        "text": " encephalopathy. The tremor is asterixis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a \u0027"
      }, {
        "text": "negative\u0027 movement disorder‚Äîa brief lapse in muscle tone rather than an active contraction‚Äîthat serves as a crucial physical exam"
      }, {
        "text": " finding for metabolic encephalopathies, most classically hepatic encephalopathy from hyperammonemia.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"hepatic_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_sign"
      }, {
        "text": "_of\",\n        \"to\": \"uremia\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_sign_of\",\n        \"to\": \"wilson_disease\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"18cff34e\": {\n    \"title\": \"Astigmatism\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a common refractive error of the eye where vision is blurred or distorted at"
      }, {
        "text": " all distances. It occurs when the cornea or lens has an irregular, non-spherical curvature, causing light rays to focus"
      }, {
        "text": " at multiple points rather than a single point on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The cornea, which should be shaped like a sphere, is instead shaped more like a football (tor"
      }, {
        "text": "ic). This causes light entering the eye to have different focal points in different planes (e.g., vertical vs. horizontal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e Blurred or distorted vision, eye strain, and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed during a standard"
      }, {
        "text": " eye exam using a phoropter and keratometer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with eyeglasses or contact lenses that have"
      }, {
        "text": " a \u003cmark\u003ecylindrical lens\u003c/mark\u003e to compensate for the irregular curvature. It can also be corrected with refractive"
      }, {
        "text": " surgery (e.g., LASIK).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from other refractive errors:"
      }, {
        "text": " [[myopia|myopia]] (nearsightedness) and [[hyperopia|hyperopia]] (farsightedness)"
      }, {
        "text": " are caused by the length of the eyeball relative to its focusing power, while astigmatism is caused by an irregularly shaped cornea or"
      }, {
        "text": " lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a refractive error caused by an"
      }, {
        "text": " asymmetrically shaped cornea or lens, which acts like a warped mirror, scattering light to multiple focal points and resulting in blurred"
      }, {
        "text": " vision that requires a cylindrical lens for correction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"myopia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hyperopia\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"8192f595\": {\n    \"title\": \""
      }, {
        "text": "Astrocytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Hist"
      }, {
        "text": "ology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the most abundant type of glial cell"
      }, {
        "text": " in the central nervous system. These star-shaped cells perform a wide variety of essential supportive and homeostatic functions for neurons, and"
      }, {
        "text": " are the origin of the most common primary brain tumor in adults, [[b6bbd0bc|glioblastoma]].\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e Physical support for neurons, repair (gliosis/"
      }, {
        "text": "scar formation), component of the [[dd47b9cc|blood-brain barrier]] (via foot processes), removal of excess"
      }, {
        "text": " neurotransmitters (especially glutamate), and maintenance of the ionic environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistological Marker:\u003c/b\u003e They are identified"
      }, {
        "text": " by their expression of \u003cmark\u003eGlial Fibrillary Acidic Protein (GFAP)\u003c/mark\u003e, an intermediate filament protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactive"
      }, {
        "text": " Gliosis:\u003c/b\u003e In response to CNS injury (e.g., stroke, trauma), astrocytes proliferate and hypertrophy to form a \u003c"
      }, {
        "text": "mark\u003eglial scar\u003c/mark\u003e, which walls off the damaged area but can also impede axonal regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTum"
      }, {
        "text": "or Origin:\u003c/b\u003e Astrocytes are the cell of origin for astrocytomas, including the highly malignant [[b6bbd0bc|glio"
      }, {
        "text": "blastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember GFAP as the key marker for astrocytes and astrocytic tumors. The"
      }, {
        "text": " formation of a glial scar by astrocytes is the CNS equivalent of fibrosis in other tissues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAst"
      }, {
        "text": "rocytes\u003c/b\u003e are the indispensable \u0027housekeepers\u0027 of the CNS, providing structural, metabolic, and homeostatic support to neurons, forming"
      }, {
        "text": " the blood-brain barrier, and orchestrating the glial scar response to injury, but they can also give rise to the"
      }, {
        "text": " most aggressive brain tumors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Astrocyte]; A --\u003e B(Physical"
      }, {
        "text": " Support); A --\u003e C(Blood-Brain Barrier); A --\u003e D(Neurotransmitter Uptake); A --\u003e E("
      }, {
        "text": "Ion Buffering); A --\u003e F(Repair/Gliosis); A --Neoplastic Transformation--\u003e G(Astrocytoma/"
      }, {
        "text": "Glioblastoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"b6bb"
      }, {
        "text": "d0bc\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"glial_"
      }, {
        "text": "scar\"\n      }\n    ]\n  },\n  \"9767fd6b\": {\n    \"title\":"
      }, {
        "text": " \"Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Physical Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a neurological sign consisting of a lack of voluntary"
      }, {
        "text": " coordination of muscle movements, leading to a clumsy, unsteady gait and impaired balance. It can be caused by damage to the cerebellum, the"
      }, {
        "text": " vestibular system, or sensory pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCerebellar Ataxia:\u003c/b\u003e Ca"
      }, {
        "text": "used by damage to the cerebellum. \u003cbr\u003e - \u003cb\u003eTruncal Ataxia:\u003c/b\u003e Affects the midline, causing"
      }, {
        "text": " an unsteady, wide-based (\u0027drunken sailor\u0027) gait. Associated with lesions of the cerebellar vermis.\u003cbr\u003e - \u003cb\u003eL"
      }, {
        "text": "imb Ataxia:\u003c/b\u003e Affects the extremities, causing dysmetria (overshooting/undershooting targets) and intention"
      }, {
        "text": " tremor. Associated with lesions of the cerebellar hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Ataxia:\u003c/b\u003e Caused by loss of proprio"
      }, {
        "text": "ception, typically from damage to the [[e7f5cbbe|dorsal columns]] of the spinal cord or peripheral nerves"
      }, {
        "text": ". Patients have a positive [[47a0f3d1|Romberg sign]] (worsening of balance"
      }, {
        "text": " with eyes closed) and a stomping gait. Seen in [[71daebd6|tabes dorsalis]] and"
      }, {
        "text": " [[6f5bea90|subacute combined degeneration]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular Ataxia:\u003c/b\u003e Caused by"
      }, {
        "text": " dysfunction of the vestibular system. Associated with vertigo, nystagmus, and nausea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating"
      }, {
        "text": " the type of ataxia is key. A positive [[47a0f3d1|Romberg sign]] points"
      }, {
        "text": " to a sensory (dorsal column) cause, not a cerebellar cause. Patients with cerebellar ataxia are unsteady with their"
      }, {
        "text": " eyes open or closed.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a sign"
      }, {
        "text": " of discoordination that can be localized by its characteristics: truncal and limb incoordination points to the cerebellum, a"
      }, {
        "text": " positive Romberg sign points to sensory loss in the dorsal columns, and associated vertigo points to the vestibular system.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "sign_of\",\n        \"to\": \"cerebellar_lesion\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"dorsal_column_lesion\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"vestibular_dysfunction\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"71daebd6"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"19272e70\": {\n    \"title"
      }, {
        "text": "\": \"Athetosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a type of involuntary movement disorder characterized by slow, writhing,"
      }, {
        "text": " snake-like movements, particularly affecting the distal extremities (fingers and hands). It is a symptom of damage to the [["
      }, {
        "text": "ed462927|basal ganglia]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription"
      }, {
        "text": ":\u003c/b\u003e Slow, twisting, and writhing movements that are continuous and non-rhythmic. It is often described as being"
      }, {
        "text": " \u0027snake-like.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by lesions in the [[ed46292"
      }, {
        "text": "7|basal ganglia]], particularly the striatum (caudate and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e A"
      }, {
        "text": "thetosis is a characteristic feature of [[ffd7e743|Huntington disease]], where it often co-occurs with chorea (ter"
      }, {
        "text": "med choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in conditions like cerebral palsy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see a description of slow, writhing, \u0027snake-like\u0027 movements of"
      }, {
        "text": " the fingers in a patient with other signs of a basal ganglia disorder (like chorea or dementia), think of athetosis,"
      }, {
        "text": " especially in the context of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a specific and visually distinct sign of basal ganglia dysfunction, representing a failure of motor"
      }, {
        "text": " control that manifests as slow, ceaseless, writhing movements, most classically seen in [[ffd7e743|Hunting"
      }, {
        "text": "ton disease]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ffd7e74"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in"
      }, {
        "text": "\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"ed7a236f\": {\n    \"title\": \"Atonic Se"
      }, {
        "text": "izures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e, also known as \\\"drop attacks"
      }, {
        "text": "\\\" or \\\"drop seizures,\\\" are a type of generalized seizure characterized by a sudden loss of muscle tone, causing the individual to collapse"
      }, {
        "text": " to the ground. The loss of consciousness is typically very brief.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e A sudden, complete loss of postural muscle tone lasting 1-2 seconds. This can cause the head to drop"
      }, {
        "text": ", the jaw to slacken, or the entire body to fall limply to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk of Injury:\u003c/b\u003e There"
      }, {
        "text": " is a high risk of head and facial injuries from the sudden falls. Patients may need to wear protective helmets.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Syndromes:\u003c/b\u003e While they can occur in various epilepsy syndromes, atonic seizures are a hallmark feature of \u003cmark\u003eLennox-"
      }, {
        "text": "Gastaut syndrome\u003c/mark\u003e, a severe form of childhood epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The EEG may show brief"
      }, {
        "text": ", generalized spike-and-wave discharges followed by diffuse slow waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette"
      }, {
        "text": " describing a child with developmental delay who has multiple seizure types, including sudden falls leading to injury, is highly suggestive of Lennox-Gastaut syndrome,"
      }, {
        "text": " with atonic seizures being a key component.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e are dramatic"
      }, {
        "text": " \u0027drop attacks\u0027 caused by a sudden, global loss of muscle tone, posing a significant risk of injury and often signaling"
      }, {
        "text": " a severe underlying epilepsy syndrome like Lennox-Gastaut.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6"
      }, {
        "text": "4c08e92\"\n      },\n      {\n        \"type\": \"is_a_feature"
      }, {
        "text": "_of\",\n        \"to\": \"lennox_gastaut_syndrome\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"52194edb\": {\n    \"title\": \"Atracurium\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e"
      }, {
        "text": " used in anesthesia to induce skeletal muscle relaxation and paralysis, facilitating endotracheal intubation and surgical procedures.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction,"
      }, {
        "text": " preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMet"
      }, {
        "text": "abolism:\u003c/b\u003e Undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e, a spontaneous, non-enzymatic degradation at physiological pH and"
      }, {
        "text": " temperature. This makes its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Ideal for patients with \u003c"
      }, {
        "text": "mark\u003erenal or hepatic failure\u003c/mark\u003e because its elimination does not depend on these organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause histamine"
      }, {
        "text": " release, leading to hypotension, flushing, and bronchoconstriction. Its metabolite, laudanosine, can lower the seizure threshold,"
      }, {
        "text": " but this is rarely clinically significant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The neuromuscular blockade can be reversed by [[acetylcholinesterase_"
      }, {
        "text": "inhibitors|acetylcholinesterase inhibitors]] (e.g., neostigmine), which increase the concentration of acetylcholine"
      }, {
        "text": " in the synaptic cleft to outcompete the blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of at"
      }, {
        "text": "racurium (and its stereoisomer, cisatracurium) is its Hoffmann elimination, making it the neuromuscular blocker"
      }, {
        "text": " of choice for patients with organ dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrac"
      }, {
        "text": "urium\u003c/b\u003e is a non-depolarizing neuromuscular blocker distinguished by its unique Hoffmann elimination pathway, a spontaneous chemical breakdown that makes it a"
      }, {
        "text": " safe and predictable choice for inducing paralysis in patients with kidney or liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atr"
      }, {
        "text": "acurium] --Competitively Antagonizes--\u003e B(Nicotinic ACh Receptors); B --x C(A"
      }, {
        "text": "Ch Binding); C --x D(Muscle Contraction); A --Hoffmann Elimination--\u003e E(Inactive Metabolites);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "undergoes\",\n        \"to\": \"hoffmann_elimination\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitors\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0c2b4642\": {\n    \"title\": \"Atrophy\",\n    \"primary"
      }, {
        "text": "Type\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cell Biology\",\n      \"Neurology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Cellular Adaptations\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a cellular adaptation characterized by a decrease in the size of a cell, organ"
      }, {
        "text": ", or tissue after it has reached its normal mature size. It results from a decrease in cell substance and can be either"
      }, {
        "text": " physiologic or pathologic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Atrophy occurs via"
      }, {
        "text": " a decrease in protein synthesis and an increase in protein degradation. The main pathway for protein degradation is the \u003cmark\u003eubiquitin-prote"
      }, {
        "text": "asome pathway\u003c/mark\u003e. It can also involve autophagy, where the cell digests its own components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Common causes include disuse, denervation, loss of endocrine stimulation, inadequate nutrition, and ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeu"
      }, {
        "text": "rologic Relevance (Denervation Atrophy):\u003c/b\u003e When a muscle loses its nerve supply (denervation), it undergoes rapid and profound atrophy"
      }, {
        "text": ". This is a key sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN"
      }, {
        "text": " vs. LMN Lesions:\u003c/b\u003e Significant muscle atrophy is a hallmark of LMN lesions (e.g., polio"
      }, {
        "text": ", [[4ed629f9|ALS]], peripheral nerve injury). In contrast, upper motor neuron (UMN"
      }, {
        "text": ") lesions cause only mild disuse atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of marked"
      }, {
        "text": " muscle wasting (atrophy) and fasciculations strongly points towards an LMN component of a disease process.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a reduction in cell size and substance, most often driven by the"
      }, {
        "text": " ubiquitin-proteasome pathway. In neurology, denervation atrophy is a critical sign that localizes a lesion to the lower"
      }, {
        "text": " motor neuron, distinguishing it from upper motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cellular_adaptation"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \""
      }, {
        "text": "to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_mediated_by\",\n        \"to\": \"ubiquitin_proteasome_pathway\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"b1873d5b\": {\n    \"title\": \"Auditory Anatomy and Physiology\",\n"
      }, {
        "text": "    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \""
      }, {
        "text": "Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAud"
      }, {
        "text": "itory anatomy and physiology\u003c/b\u003e describes the structures and mechanisms by which sound waves are collected, transmitted, transduced into neural signals, and processed"
      }, {
        "text": " by the brain to produce the sensation of hearing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOuter Ear:\u003c/b\u003e The"
      }, {
        "text": " pinna and external auditory canal collect sound waves and funnel them to the tympanic membrane (eardrum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Ear"
      }, {
        "text": ":\u003c/b\u003e An air-filled cavity containing the ossicles (malleus, incus, stapes). The ossicles amplify"
      }, {
        "text": " the vibrations from the tympanic membrane and transmit them to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInner Ear:\u003c/b\u003e The [["
      }, {
        "text": "001c359f|cochlea]], a fluid-filled, snail-shaped structure, contains the organ"
      }, {
        "text": " of Corti. Vibrations from the stapes create pressure waves in the cochlear fluid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransduction:\u003c/b\u003e These"
      }, {
        "text": " pressure waves cause the basilar membrane to vibrate at specific locations depending on the frequency (tonotopy). High frequencies vibrate the base, low frequencies vibrate"
      }, {
        "text": " the apex. This vibration bends the stereocilia of hair cells in the organ of Corti, opening ion channels and generating a"
      }, {
        "text": " neural signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels from the hair cells via the cochlear nerve (part"
      }, {
        "text": " of CN VIII) to the cochlear nuclei in the brainstem, then through a complex pathway (superior olive, lateral"
      }, {
        "text": " lemniscus, inferior colliculus, medial geniculate nucleus of the thalamus) to the [[d24b"
      }, {
        "text": "6af6|auditory cortex]] in the temporal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " auditory system is a remarkable transducer, converting mechanical energy (sound waves) into mechanical vibration (ossicles), then into hydraulic"
      }, {
        "text": " waves (cochlear fluid), and finally into electrical signals (hair cells) that the brain interprets as sound.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Sound Waves] --\u003e B(Outer Ear); B --\u003e C(Tympanic Membrane); C --\u003e D(Middle"
      }, {
        "text": " Ear Ossicles); D --\u003e E(Oval Window); E --\u003e F(Cochlear Fluid); F --\u003e G("
      }, {
        "text": "Basilar Membrane Vibration); G --\u003e H(Hair Cell Transduction); H --\u003e I(CN VIII); I --\u003e J(Brain);"
      }, {
        "text": " \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \""
      }, {
        "text": "001c359f\"\n      },\n      {\n        \"type\": \"involves"
      }, {
        "text": "_structure\",\n        \"to\": \"vestibulocochlear_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"culminates_in\",\n        \"to\": \"d24b6af6\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"d24b6af6\": {\n    \"title"
      }, {
        "text": "\": \"Auditory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the"
      }, {
        "text": " region of the cerebral cortex responsible for processing auditory information. It is located in the superior temporal gyrus of the temporal lobe and"
      }, {
        "text": " includes the primary auditory cortex (Brodmann areas 41 and 42) and surrounding auditory association areas.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Superior temporal gyrus in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e The primary auditory cortex is responsible for the perception of basic sound characteristics like pitch and volume. The surrounding association areas,"
      }, {
        "text": " including [[wernicke_area|Wernicke\u0027s area]] in the dominant hemisphere, are involved in the"
      }, {
        "text": " interpretation and comprehension of complex sounds, particularly speech.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e It receives its primary input"
      }, {
        "text": " from the \u003cmark\u003emedial geniculate nucleus (MGN)\u003c/mark\u003e of the [[afc0a64"
      }, {
        "text": "b|thalamus]]. Mnemonic: \u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTon"
      }, {
        "text": "otopic Organization:\u003c/b\u003e The auditory cortex is organized tonotopically, meaning that different frequencies of sound are processed in different,"
      }, {
        "text": " specific areas of the cortex, mirroring the organization of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A lesion in the primary auditory cortex does not typically cause complete deafness in one ear, as auditory"
      }, {
        "text": " information from each ear is processed bilaterally in the brain. However, a lesion in [[wernicke_area|Wern"
      }, {
        "text": "icke\u0027s area]] (an auditory association cortex) will cause receptive aphasia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eAuditory Cortex\u003c/b\u003e is the final destination for sound processing in the brain, receiving signals from the medial geniculate nucleus and"
      }, {
        "text": " interpreting them, with specialized areas like Wernicke\u0027s area in the dominant hemisphere being crucial for language comprehension.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Cochlea] --\u003e B(CN VIII); B --\u003e C(Brainstem Nucle"
      }, {
        "text": "i); C --\u003e D(Medial Geniculate Nucleus); D --\u003e E(Auditory Cortex);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"temporal_lobe\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"medial_genic"
      }, {
        "text": "ulate_nucleus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"w"
      }, {
        "text": "ernicke_area\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1Y32k5ure9CkmtHP7u-jZBsKurzJvsDU1"
      },
      "role": "user",
      "tokenCount": 2881
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"4f0ade90\": {\n    \"title\": \"Autonomic Nervous System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System (ANS)\u003c/b\u003e is the division of the peripheral nervous system that controls involuntary bodily functions, such as heart rate, digestion, respiratory rate, and pupillary response. It is subdivided into the sympathetic, parasympathetic, and enteric systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSympathetic Division:\u003c/b\u003e Mediates the \\\"fight or flight\\\" response. Preganglionic neurons are short and release [[6a005559|acetylcholine]] onto nicotinic receptors in the paravertebral ganglia. Postganglionic neurons are long and primarily release norepinephrine onto adrenergic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Division:\u003c/b\u003e Mediates the \\\"rest and digest\\\" response. Preganglionic neurons are long and release [[6a005559|acetylcholine]] onto nicotinic receptors in ganglia near or within target organs. Postganglionic neurons are short and release [[6a005559|acetylcholine]] onto muscarinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Control:\u003c/b\u003e The ANS is regulated by higher centers in the CNS, including the [[89e86633|hypothalamus]] and the [[73ace357|limbic system]], which modulate autonomic outflow in response to emotional and environmental stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Autonomic dysregulation is a feature of many neurological disorders, including [[ed52e40b|Guillain-Barr√© syndrome]] (acute inflammatory demyelinating polyneuropathy), which can cause life-threatening cardiac irregularities and blood pressure instability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the neurotransmitter/receptor pairings: All preganglionic neurons use ACh (nicotinic). Parasympathetic postganglionic neurons use ACh (muscarinic). Most sympathetic postganglionic neurons use norepinephrine (adrenergic), with the key exception being sweat glands (ACh, muscarinic).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System\u003c/b\u003e maintains homeostasis through a balance of its sympathetic (\u0027gas pedal\u0027) and parasympathetic (\u0027brake pedal\u0027) divisions, utilizing a two-neuron chain with distinct neurotransmitters and receptor targets to exert involuntary control over virtually every organ system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CNS] --\u003e B(Preganglionic Neuron); B --ACh--\u003e C(Autonomic Ganglion); C --NE/ACh--\u003e D(Target Organ);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  },\n  \"174cf2c0\": {\n    \"title\": \"Axonal Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Trauma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e refers to damage to the axons of neurons, which can occur from trauma, ischemia, or neurodegenerative processes. The neuronal response to injury and the potential for regeneration depend on whether the injury is in the central or peripheral nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eWallerian Degeneration:\u003c/b\u003e The process of degeneration of the axon \u003cu\u003edistal\u003c/u\u003e to the site of injury. The axon disintegrates and its myelin sheath breaks down, cleared by Schwann cells (PNS) or microglia (CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e Changes occurring in the neuronal cell body \u003cu\u003eproximal\u003c/u\u003e to the injury. The cell body swells, the nucleus is displaced to the periphery, and Nissl bodies disperse. This reflects an increase in protein synthesis for repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiffuse Axonal Injury (DAI):\u003c/b\u003e A severe form of traumatic brain injury caused by shearing forces from rapid acceleration/deceleration. It involves widespread damage to axons in the white matter tracts. MRI shows multiple punctate hemorrhages. Often results in coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegeneration:\u003c/b\u003e Axonal regeneration is limited in the CNS due to inhibitory factors from oligodendrocytes and glial scar formation by astrocytes. Regeneration is more successful in the PNS, guided by the remaining Schwann cells and endoneurial tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference in response to injury: Wallerian degeneration occurs distal to the cut, while axonal reaction (chromatolysis) occurs in the proximal cell body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e triggers a cascade of degenerative and regenerative processes, with the outcome largely determined by the location; peripheral nerves have a significant capacity for regeneration guided by Schwann cells, whereas central nervous system axons are largely unable to regenerate due to an inhibitory environment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Axon Injury] --\u003e B(Proximal Segment); B --\u003e C(Axonal Reaction/Chromatolysis); A --\u003e D(Distal Segment); D --\u003e E(Wallerian Degeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"wallerian_degeneration\"\n      },\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"central_chromatolysis\"\n      }\n    ]\n  },\n  \"8947da55\": {\n    \"title\": \"Babinski Reflex (Plantar Reflex)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBabinski reflex\u003c/b\u003e (or sign) is the dorsiflexion of the great toe and fanning of the other toes in response to stroking the plantar surface of the foot. While a normal primitive reflex in infants, its presence in an adult is a pathognomonic sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTechnique:\u003c/b\u003e The sole of the foot is stroked with a blunt object from the heel along the lateral aspect to the ball of the foot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response (Adult):\u003c/b\u003e Plantar flexion (downward curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Babinski Sign):\u003c/b\u003e Extension (dorsiflexion) of the great toe and fanning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The sign indicates damage to the corticospinal tract, which normally suppresses this primitive reflex after infancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key physical exam finding that helps differentiate UMN lesions from LMN lesions. It is a sign of \u003cmark\u003eupper motor neuron damage\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In an adult, a positive Babinski sign is \u003cu\u003ealways\u003c/u\u003e abnormal. It points to a lesion anywhere along the corticospinal tract, from the motor cortex down to the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBabinski sign\u003c/b\u003e is a clinical indicator of corticospinal tract dysfunction, representing the re-emergence of a primitive reflex that is normally suppressed by mature upper motor neurons; its presence in an adult is a definitive sign of a UMN lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"1ddc3f08\": {\n    \"title\": \"Baclofen\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e is a centrally acting skeletal muscle relaxant (antispasmodic) that functions as a GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist, primarily used to treat muscle spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as an agonist at \u003cmark\u003eGABA\u003csub\u003eB\u003c/sub\u003e receptors\u003c/gmark\u003e in the spinal cord. This activation leads to hyperpolarization of motor neurons by increasing K\u003csup\u003e+\u003c/sup\u003e conductance, which reduces the release of excitatory neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of spasticity associated with [[45dd6d19|multiple sclerosis]], spinal cord injuries, and [[171ca00b|cerebral palsy]]. It is not typically used for acute muscle spasms from injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Can be administered orally or intrathecally (directly into the CSF) via a pump for severe spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, drowsiness, dizziness, and muscle weakness. Abrupt withdrawal of intrathecal baclofen can be life-threatening, causing high fever, rebound spasticity, and seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that baclofen acts on the \u0027\u003cb\u003ebac\u003c/b\u003ek\u0027 (spinal cord) at GABA\u003cb\u003e\u003csub\u003eB\u003c/sub\u003e\u003c/b\u003e receptors. Differentiate its use for chronic spasticity from drugs like cyclobenzaprine used for acute muscle spasms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e effectively reduces chronic muscle spasticity by mimicking GABA\u0027s inhibitory effects at GABA\u003csub\u003eB\u003c/sub\u003e receptors specifically within the spinal cord, thereby dampening the hyperactive reflexes that cause stiffness and spasms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Baclofen] --\u003e B(Activates GABA-B Receptors in Spinal Cord); B --\u003e C(‚Üë K+ Conductance); C --\u003e D(Hyperpolarization of Motor Neurons); D --\u003e E(‚Üì Spasticity);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"gaba_b_receptor\"\n      }\n    ]\n  },\n  \"52564aea\": {\n    \"title\": \"Barbiturates\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e (e.g., phenobarbital, pentobarbital, thiopental) are a class of sedative-hypnotic drugs that act as central nervous system depressants by enhancing the effects of the neurotransmitter GABA.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to the GABA\u003csub\u003eA\u003c/sub\u003e receptor at a different site than GABA or benzodiazepines. They increase the \u003cmark\u003e\u003cu\u003eduration\u003c/u\u003e\u003c/mark\u003e of chloride channel opening. Mnemonic: Barbi\u003cb\u003edurates\u003c/b\u003e increase the \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Formerly used for anxiety and insomnia but now largely replaced by benzodiazepines due to a worse safety profile. Current uses include: \u003cbr\u003e - \u003cb\u003eAnticonvulsant:\u003c/b\u003e [[phenobarbital]] for seizures.\u003cbr\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Thiopental for induction of anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Significant CNS and respiratory depression, which can be fatal in overdose and is potentiated by alcohol. High potential for dependence and abuse. Induces cytochrome P450 enzymes, leading to numerous drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e in patients with porphyria, as they induce Œ¥-ALA synthase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key difference from benzodiazepines is the mechanism (duration vs. frequency) and the lack of a ceiling effect on CNS depression, making overdose much more dangerous. There is no specific antidote for barbiturate overdose; treatment is supportive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e are potent CNS depressants that enhance GABAergic inhibition by prolonging the opening of chloride channels, but their narrow therapeutic index and high risk of fatal respiratory depression have relegated them to niche uses like seizure control and anesthesia induction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Barbiturate] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Duration of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"porphyria\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"ed462927\": {\n    \"title\": \"Basal Ganglia\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e are a group of subcortical nuclei in the forebrain that are crucial for motor control, particularly in selecting and initiating voluntary movements, while suppressing unwanted movements. They also play a role in procedural learning, habit formation, and emotion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The main components are the \u003cb\u003eStriatum\u003c/b\u003e (caudate nucleus + putamen), \u003cb\u003eGlobus Pallidus\u003c/b\u003e (internal and external segments), \u003cb\u003eSubthalamic Nucleus\u003c/b\u003e, and \u003cb\u003eSubstantia Nigra\u003c/b\u003e (pars compacta and pars reticulata).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The basal ganglia modulate motor output from the cortex via feedback loops. They do not directly connect to the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect Pathway:\u003c/b\u003e Facilitates movement. Cortical activation stimulates the striatum, which inhibits the globus pallidus internus (GPi), thereby disinhibiting the [[afc0a64b|thalamus]] and allowing it to excite the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect Pathway:\u003c/b\u003e Inhibits movement. This more complex loop ultimately results in stimulation of the GPi, which increases inhibition of the [[afc0a64b|thalamus]], thus suppressing cortical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Lesions in the basal ganglia lead to movement disorders. \u003cbr\u003e - [[58c8ea03|Parkinson disease]]: Loss of dopaminergic neurons in the substantia nigra pars compacta leads to bradykinesia and tremor (hypokinetic).\u003cbr\u003e - [[ffd7e743|Huntington disease]]: Degeneration of the striatum leads to chorea (hyperkinetic).\u003cbr\u003e - Hemiballismus: Lesion of the subthalamic nucleus leads to wild, flinging movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e function as a sophisticated \u0027gatekeeper\u0027 for motor commands, using a balance between a \u0027go\u0027 (direct) pathway and a \u0027no-go\u0027 (indirect) pathway to fine-tune voluntary movement; disruption of this balance is the fundamental cause of movement disorders like Parkinson\u0027s and Huntington\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[Cortex] --\u003e B(Striatum); B --|Direct Pathway (Go)|--\u003e C(‚Üì GPi/SNr Inhibition); C --\u003e D(‚Üë Thalamic Excitation); D --\u003e A; B --|Indirect Pathway (No-Go)|--\u003e E(‚Üë GPi/SNr Inhibition); E --\u003e F(‚Üì Thalamic Excitation); F --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"hemiballismus\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },\n  \"361438f2\": {\n    \"title\": \"Basal Nucleus of Meynert\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain Nuclei\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is a group of neurons located in the substantia innominata of the basal forebrain. It is the primary source of cholinergic ([[6a005559|acetylcholine]]) innervation to the entire cerebral cortex, playing a vital role in cognitive functions like memory and attention.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Basal forebrain, part of the substantia innominata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e Synthesizes and releases [[6a005559|acetylcholine (ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Provides widespread cholinergic projections to the neocortex and hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Modulates cortical excitability, arousal, attention, and is critical for learning and memory formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e There is significant degeneration and loss of cholinergic neurons in the Basal Nucleus of Meynert in \u003cmark\u003e[[77ae6148|Alzheimer disease]]\u003c/mark\u003e. This loss of cortical ACh is a major contributor to the cognitive and memory deficits seen in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degeneration of the Basal Nucleus of Meynert and the resulting cholinergic deficit is a key pathophysiological feature of [[77ae6148|Alzheimer disease]] and is the rationale for using [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., [[47d0372e|donepezil]]) as a symptomatic treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is the brain\u0027s main cholinergic hub for the cortex; its profound degeneration in [[77ae6148|Alzheimer disease]] leads to a cortical acetylcholine deficit that underlies the hallmark cognitive decline of the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Nucleus of Meynert] --ACh Projections--\u003e B(Cerebral Cortex \u0026 Hippocampus); B --\u003e C(Arousal, Memory, Attention); A --x Degeneration in Alzheimer\u0027s; \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"basal_forebrain\"\n      }\n    ]\n  },\n  \"253e3efb\": {\n    \"title\": \"Basal Plate\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the ventral part of the neural tube in the developing embryo, which differentiates into \u003ci\u003emotor neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of the signaling molecule Sonic Hedgehog (SHH).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Ventral (anterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003emotor\u003c/u\u003e components of the central nervous system, including the anterior horn of the spinal cord and the motor nuclei of the cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, a signaling molecule secreted by the underlying notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The dorsal counterpart is the [[43be7a6e|Alar Plate]], which develops into sensory neurons under the influence of Bone Morphogenetic Proteins (BMPs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e, and \u003cb\u003eAlar \u003d Sensory \u003d Dorsal\u003c/b\u003e. This fundamental organization persists into the adult CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the embryonic blueprint for the motor output of the CNS, established by Sonic Hedgehog signaling from the notochord, which sets up the ventral-motor organization of the neural tube that is conserved throughout the nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"motor_neurons\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"sonic_hedgehog\"\n      }\n    ]\n  },\n  \"c335e16d\": {\n    \"title\": \"Basement Membrane (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, the \u003cb\u003ebasement membrane\u003c/b\u003e is a thin, specialized layer of the extracellular matrix that surrounds cerebral capillaries and, along with astrocyte foot processes and endothelial tight junctions, forms a critical component of the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of Type IV collagen, laminin, and proteoglycans.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides structural support to the capillary endothelium and acts as a selective filter, regulating the passage of molecules from the blood into the brain parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Blood-Brain Barrier:\u003c/b\u003e The basement membrane, together with endothelial [[tight_junctions|tight junctions]] and astrocyte end-feet, creates the highly restrictive [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Thickening of the basement membrane is a feature of chronic hyperglycemia in diabetes, contributing to microvascular complications like [[73b00ab0|diabetic retinopathy]]. In [[goodpasture_syndrome|Goodpasture syndrome]], autoantibodies target Type IV collagen in the basement membranes of the kidneys and lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The three key components of the blood-brain barrier are: 1) Tight junctions between non-fenestrated endothelial cells, 2) The basement membrane, and 3) Astrocyte foot processes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ebasement membrane\u003c/b\u003e of CNS capillaries is a crucial structural and functional element of the [[dd47b9cc|blood-brain barrier]], acting as both scaffolding and a selective filter to maintain the tightly controlled environment of the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"type_iv_collagen\"\n      },\n      {\n        \"type\": \"is_thickened_in\",\n        \"to\": \"diabetes_mellitus\"\n      }\n    ]\n  },\n  \"e7a90cd9\": {\n    \"title\": \"Basilar Artery\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is a critical artery at the base of the brain, formed by the union of the two vertebral arteries. It ascends along the anterior surface of the pons and is a key component of the posterior circulation, supplying the brainstem, cerebellum, and occipital lobes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Formed by the confluence of the left and right vertebral arteries at the pontomedullary junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBranches:\u003c/b\u003e Gives rise to the [[3c075343|anterior inferior cerebellar artery (AICA)]], superior cerebellar artery (SCA), and numerous small pontine arteries. It terminates by bifurcating into the two [[b6a2cc31|posterior cerebral arteries (PCAs)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Brainstem (pons, midbrain), cerebellum, and via its terminal branches (PCAs), the occipital and inferior temporal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBasilar Artery Occlusion:\u003c/b\u003e Can be catastrophic, leading to \u003cmark\u003e\\\"locked-in syndrome\\\"\u003c/mark\u003e if the ventral pons is infarcted bilaterally. This causes quadriplegia and mutism, with preserved consciousness and vertical eye movements.\u003cbr\u003e - \u003cb\u003eTop of the Basilar Syndrome:\u003c/b\u003e Embolic occlusion of the distal basilar artery affects the midbrain, thalamus, and temporal/occipital lobes, causing visual and behavioral disturbances with minimal motor deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke causing quadriplegia but sparing consciousness and vertical eye movements is pathognomonic for basilar artery occlusion leading to locked-in syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is the central trunk of the posterior circulation; its occlusion can lead to devastating brainstem strokes, most notably the \u0027locked-in syndrome,\u0027 which severs the brain\u0027s motor output while leaving consciousness intact.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B(Basilar Artery); B --\u003e C(Pontine Arteries); B --\u003e D(AICA); B --\u003e E(SCA); B --\u003e F(PCAs);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"posterior_circulation\"\n      },\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"vertebral_arteries\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"locked_in_syndrome\"\n      },\n      {\n        \"type\": \"bifurcates_into\",\n        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  \"91fcdbc5\": {\n    \"title\": \"REM Sleep Behavior Disorder\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal muscle atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally induce muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump out of bed during sleep, corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±-synucleinopathies\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports acting out violent dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prodromal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning sign of an underlying Œ±-synucleinopathy, where the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson\u0027s by many years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"parasomnia\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"alpha_synucleinopathies\"\n      }\n    ]\n  },\n  \"b0a6f66e\": {\n    \"title\": \"Behavior Modulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e refers to the complex neural processes by which the brain regulates and controls behavior, integrating emotional, cognitive, and homeostatic inputs to produce appropriate responses. This function is primarily orchestrated by the [[73ace357|limbic system]] and its connections with the prefrontal cortex and [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLimbic System\u0027s Role:\u003c/b\u003e The [[73ace357|limbic system]] (including the [[d220fc3f|amygdala]], [[a0590674|hippocampus]], and cingulate gyrus) is central to emotion, memory, and motivation, which are the core drivers of behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e Processes fear, aggression, and reward. Lesions can lead to placidity or disinhibited behavior (e.g., [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypothalamus:\u003c/b\u003e Integrates autonomic and endocrine responses with behavior, governing fundamental drives like hunger, thirst, and sexual behavior (the \u0027Four Fs\u0027: Feeding, Fleeing, Fighting, and sexual Functioning).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex:\u003c/b\u003e Provides top-down executive control, inhibiting impulsive behaviors and guiding actions based on goals and social context. Lesions can cause disinhibition and impaired judgment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The mnemonic for limbic system functions, the \u00275 F\u0027s\u0027 (Feeding, Fleeing, Fighting, Feeling, and Sex), highlights its role in modulating fundamental behaviors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e is a dynamic interplay between the primitive drives of the [[73ace357|limbic system]] and [[89e86633|hypothalamus]] and the executive oversight of the prefrontal cortex, with the final behavioral output reflecting the balance of these competing influences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Limbic System - Emotion/Drives] --\u003e C{Behavioral Output}; B[Prefrontal Cortex - Executive Control] --\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"prefrontal_cortex\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 8071,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"4f0ade90\": {\n    \"title"
      }, {
        "text": "\": \"Autonomic Nervous System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System (ANS)\u003c/b\u003e is the"
      }, {
        "text": " division of the peripheral nervous system that controls involuntary bodily functions, such as heart rate, digestion, respiratory rate, and pup"
      }, {
        "text": "illary response. It is subdivided into the sympathetic, parasympathetic, and enteric systems.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSympathetic Division:\u003c/b\u003e Mediates the \\\"fight or flight\\\" response. Preganglionic neurons are"
      }, {
        "text": " short and release [[6a005559|acetylcholine]] onto nicotinic receptors in the paravertebral ganglia. Postgangl"
      }, {
        "text": "ionic neurons are long and primarily release norepinephrine onto adrenergic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Division:\u003c/b\u003e Mediates the \\\"rest"
      }, {
        "text": " and digest\\\" response. Preganglionic neurons are long and release [[6a005559|acetylcholine]] onto nicotinic receptors"
      }, {
        "text": " in ganglia near or within target organs. Postganglionic neurons are short and release [[6a005559"
      }, {
        "text": "|acetylcholine]] onto muscarinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Control:\u003c/b\u003e The ANS is regulated by higher centers in the CNS"
      }, {
        "text": ", including the [[89e86633|hypothalamus]] and the [[73ace3"
      }, {
        "text": "57|limbic system]], which modulate autonomic outflow in response to emotional and environmental stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance"
      }, {
        "text": ":\u003c/b\u003e Autonomic dysregulation is a feature of many neurological disorders, including [[ed52e40b|Gu"
      }, {
        "text": "illain-Barr√© syndrome]] (acute inflammatory demyelinating polyneuropathy), which can cause life-threatening cardiac"
      }, {
        "text": " irregularities and blood pressure instability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the neurotransmitter/receptor pairings: All pre"
      }, {
        "text": "ganglionic neurons use ACh (nicotinic). Parasympathetic postganglionic neurons use ACh (muscarinic). Most"
      }, {
        "text": " sympathetic postganglionic neurons use norepinephrine (adrenergic), with the key exception being sweat glands (ACh, muscarinic).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System\u003c/b\u003e maintains homeostasis through a balance of its"
      }, {
        "text": " sympathetic (\u0027gas pedal\u0027) and parasympathetic (\u0027brake pedal\u0027) divisions, utilizing a two-neuron chain with distinct neurotransmitters"
      }, {
        "text": " and receptor targets to exert involuntary control over virtually every organ system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[CNS] --\u003e B(Preganglionic Neuron); B --ACh--\u003e C(Autonomic Ganglion); C --NE"
      }, {
        "text": "/ACh--\u003e D(Target Organ);\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_regulated_by\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \""
      }, {
        "text": "73ace357\"\n      },\n      {\n        \"type\": \"is_dysregulated_"
      }, {
        "text": "in\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"174cf2c0\": {\n    \"title\": \"Axonal Injury\",\n    \"primaryType\": \""
      }, {
        "text": "pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Trauma\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eAxonal injury\u003c/b\u003e refers to damage to the axons of neurons, which can occur from trauma, ischemia, or neuro"
      }, {
        "text": "degenerative processes. The neuronal response to injury and the potential for regeneration depend on whether the injury is in the central or peripheral nervous system.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eWallerian Degeneration:\u003c/b\u003e The process of degeneration of"
      }, {
        "text": " the axon \u003cu\u003edistal\u003c/u\u003e to the site of injury. The axon disintegrates and its myelin sheath breaks down,"
      }, {
        "text": " cleared by Schwann cells (PNS) or microglia (CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e Changes"
      }, {
        "text": " occurring in the neuronal cell body \u003cu\u003eproximal\u003c/u\u003e to the injury. The cell body swells, the nucleus is displaced"
      }, {
        "text": " to the periphery, and Nissl bodies disperse. This reflects an increase in protein synthesis for repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiffuse"
      }, {
        "text": " Axonal Injury (DAI):\u003c/b\u003e A severe form of traumatic brain injury caused by shearing forces from rapid acceleration/deceleration. It involves widespread"
      }, {
        "text": " damage to axons in the white matter tracts. MRI shows multiple punctate hemorrhages. Often results in coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReg"
      }, {
        "text": "eneration:\u003c/b\u003e Axonal regeneration is limited in the CNS due to inhibitory factors from oligodendrocytes and glial scar formation by astrocytes. Regeneration"
      }, {
        "text": " is more successful in the PNS, guided by the remaining Schwann cells and endoneurial tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the key difference in response to injury: Wallerian degeneration occurs distal to the cut, while axonal reaction (chromatolysis) occurs in"
      }, {
        "text": " the proximal cell body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e triggers a cascade of degenerative"
      }, {
        "text": " and regenerative processes, with the outcome largely determined by the location; peripheral nerves have a significant capacity for regeneration guided by Schwann cells, whereas central nervous"
      }, {
        "text": " system axons are largely unable to regenerate due to an inhibitory environment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Axon Injury] --\u003e B(Proximal Segment); B --\u003e C(Axonal Reaction/Chromatolysis); A --\u003e"
      }, {
        "text": " D(Distal Segment); D --\u003e E(Wallerian Degeneration);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"involves_process\",\n        \"to\": \"wallerian_degeneration\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"central_chromatolysis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"8947da55\": {\n    \"title\": \"Babinski Reflex (Pl"
      }, {
        "text": "antar Reflex)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eBabinski reflex\u003c/b\u003e (or sign) is the dorsiflexion of the great toe and"
      }, {
        "text": " fanning of the other toes in response to stroking the plantar surface of the foot. While a normal primitive reflex in infants,"
      }, {
        "text": " its presence in an adult is a pathognomonic sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTechnique:\u003c/b\u003e The sole of the foot is stroked with a blunt object from"
      }, {
        "text": " the heel along the lateral aspect to the ball of the foot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response (Adult):\u003c/b\u003e Plantar flexion ("
      }, {
        "text": "downward curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Babinski Sign):\u003c/b\u003e Extension (dorsiflexion) of the"
      }, {
        "text": " great toe and fanning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The sign indicates damage to the cortic"
      }, {
        "text": "ospinal tract, which normally suppresses this primitive reflex after infancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key"
      }, {
        "text": " physical exam finding that helps differentiate UMN lesions from LMN lesions. It is a sign of \u003cmark\u003eupper motor neuron damage"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In an adult, a positive Babinski sign is \u003cu\u003ealways\u003c/u\u003e abnormal. It points"
      }, {
        "text": " to a lesion anywhere along the corticospinal tract, from the motor cortex down to the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eBabinski sign\u003c/b\u003e is a clinical indicator of corticospinal tract dysfunction, representing the re"
      }, {
        "text": "-emergence of a primitive reflex that is normally suppressed by mature upper motor neurons; its presence in an adult is a definitive sign of a"
      }, {
        "text": " UMN lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_les"
      }, {
        "text": "ion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"primitive_reflex\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to"
      }, {
        "text": "\": \"lower_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "ddc3f08\": {\n    \"title\": \"Baclofen\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"S"
      }, {
        "text": "keletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e is a centrally acting"
      }, {
        "text": " skeletal muscle relaxant (antispasmodic) that functions as a GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist, primarily used to treat"
      }, {
        "text": " muscle spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts"
      }, {
        "text": " as an agonist at \u003cmark\u003eGABA\u003csub\u003eB\u003c/sub\u003e receptors\u003c/gmark\u003e in the spinal cord. This activation"
      }, {
        "text": " leads to hyperpolarization of motor neurons by increasing K\u003csup\u003e+\u003c/sup\u003e conductance, which reduces the release of excitatory neurotransmitters."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of spasticity associated with [[45dd6d19|multiple sclerosis]],"
      }, {
        "text": " spinal cord injuries, and [[171ca00b|cerebral palsy]]. It is not typically used for acute"
      }, {
        "text": " muscle spasms from injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Can be administered orally or intrathecally (directly into the CSF) via"
      }, {
        "text": " a pump for severe spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, drowsiness, dizziness, and muscle weakness."
      }, {
        "text": " Abrupt withdrawal of intrathecal baclofen can be life-threatening, causing high fever, rebound spasticity, and"
      }, {
        "text": " seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that baclofen acts on the \u0027\u003cb\u003ebac\u003c/b\u003ek\u0027 (spinal"
      }, {
        "text": " cord) at GABA\u003cb\u003e\u003csub\u003eB\u003c/sub\u003e\u003c/b\u003e receptors. Differentiate its use for chronic spasticity from drugs like cyclobenzaprine used"
      }, {
        "text": " for acute muscle spasms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e effectively reduces chronic"
      }, {
        "text": " muscle spasticity by mimicking GABA\u0027s inhibitory effects at GABA\u003csub\u003eB\u003c/sub\u003e receptors specifically within the spinal cord, thereby damp"
      }, {
        "text": "ening the hyperactive reflexes that cause stiffness and spasms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Bac"
      }, {
        "text": "lofen] --\u003e B(Activates GABA-B Receptors in Spinal Cord); B --\u003e C(‚Üë K+"
      }, {
        "text": " Conductance); C --\u003e D(Hyperpolarization of Motor Neurons); D --\u003e E(‚Üì Spasticity);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "acts_as_agonist_at\",\n        \"to\": \"gaba_b_receptor\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"52564aea\": {\n    \"title\": \"Barbiturates\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anest"
      }, {
        "text": "hesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e (e.g., phenobarbital, pent"
      }, {
        "text": "obarbital, thiopental) are a class of sedative-hypnotic drugs that act as central nervous system depressants by"
      }, {
        "text": " enhancing the effects of the neurotransmitter GABA.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind"
      }, {
        "text": " to the GABA\u003csub\u003eA\u003c/sub\u003e receptor at a different site than GABA or benzodiazepines. They increase the \u003cmark\u003e\u003cu\u003e"
      }, {
        "text": "duration\u003c/u\u003e\u003c/mark\u003e of chloride channel opening. Mnemonic: Barbi\u003cb\u003edurates\u003c/b\u003e increase the \u003cb\u003eduration\u003c/b\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Formerly used for anxiety and insomnia but now largely replaced by benzodiazepines due to a worse"
      }, {
        "text": " safety profile. Current uses include: \u003cbr\u003e - \u003cb\u003eAnticonvulsant:\u003c/b\u003e [[phenobarbital]] for"
      }, {
        "text": " seizures.\u003cbr\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Thiopental for induction of anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse"
      }, {
        "text": " Effects:\u003c/b\u003e Significant CNS and respiratory depression, which can be fatal in overdose and is potentiated by alcohol. High potential for dependence"
      }, {
        "text": " and abuse. Induces cytochrome P450 enzymes, leading to numerous drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely"
      }, {
        "text": " contraindicated\u003c/u\u003e in patients with porphyria, as they induce Œ¥-ALA synthase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " key difference from benzodiazepines is the mechanism (duration vs. frequency) and the lack of a ceiling effect on CNS depression, making"
      }, {
        "text": " overdose much more dangerous. There is no specific antidote for barbiturate overdose; treatment is supportive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e are potent CNS depressants that enhance GABAergic inhibition by prolonging the opening"
      }, {
        "text": " of chloride channels, but their narrow therapeutic index and high risk of fatal respiratory depression have relegated them to niche uses like seizure"
      }, {
        "text": " control and anesthesia induction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Barbiturate] --\u003e B(B"
      }, {
        "text": "inds to GABA-A Receptor); B --\u003e C(‚Üë Duration of Cl- Channel Opening); C --\u003e D(‚Üë Cl"
      }, {
        "text": "- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a"
      }, {
        "text": "_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        "
      }, {
        "text": "\"to\": \"porphyria\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome"
      }, {
        "text": "_p450\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"14464617\"\n      }\n    ]\n  },\n  \"ed4"
      }, {
        "text": "62927\": {\n    \"title\": \"Basal Ganglia\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e are"
      }, {
        "text": " a group of subcortical nuclei in the forebrain that are crucial for motor control, particularly in selecting and initiating voluntary movements, while"
      }, {
        "text": " suppressing unwanted movements. They also play a role in procedural learning, habit formation, and emotion.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The main components are the \u003cb\u003eStriatum\u003c/b\u003e (caudate nucleus"
      }, {
        "text": " + putamen), \u003cb\u003eGlobus Pallidus\u003c/b\u003e (internal and external segments), \u003cb\u003eSubthalamic Nucleus\u003c/b\u003e,"
      }, {
        "text": " and \u003cb\u003eSubstantia Nigra\u003c/b\u003e (pars compacta and pars reticulata).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The basal ganglia modulate motor output"
      }, {
        "text": " from the cortex via feedback loops. They do not directly connect to the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect Pathway:\u003c/b\u003e Facilit"
      }, {
        "text": "ates movement. Cortical activation stimulates the striatum, which inhibits the globus pallidus internus (GPi), thereby"
      }, {
        "text": " disinhibiting the [[afc0a64b|thalamus]] and allowing it to excite the motor"
      }, {
        "text": " cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect Pathway:\u003c/b\u003e Inhibits movement. This more complex loop ultimately results in stimulation of the GPi, which increases"
      }, {
        "text": " inhibition of the [[afc0a64b|thalamus]], thus suppressing cortical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology"
      }, {
        "text": ":\u003c/b\u003e Lesions in the basal ganglia lead to movement disorders. \u003cbr\u003e - [[58c8ea03|Parkinson disease"
      }, {
        "text": "]]: Loss of dopaminergic neurons in the substantia nigra pars compacta leads to bradykinesia and tremor (hyp"
      }, {
        "text": "okinetic).\u003cbr\u003e - [[ffd7e743|Huntington disease]]: Degeneration of the striatum leads to chore"
      }, {
        "text": "a (hyperkinetic).\u003cbr\u003e - Hemiballismus: Lesion of the subthalamic nucleus leads to wild"
      }, {
        "text": ", flinging movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e function"
      }, {
        "text": " as a sophisticated \u0027gatekeeper\u0027 for motor commands, using a balance between a \u0027go\u0027 (direct) pathway and a"
      }, {
        "text": " \u0027no-go\u0027 (indirect) pathway to fine-tune voluntary movement; disruption of this balance is the fundamental cause"
      }, {
        "text": " of movement disorders like Parkinson\u0027s and Huntington\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[C"
      }, {
        "text": "ortex] --\u003e B(Striatum); B --|Direct Pathway (Go)|--\u003e C(‚Üì GPi/SN"
      }, {
        "text": "r Inhibition); C --\u003e D(‚Üë Thalamic Excitation); D --\u003e A; B --|Indirect Pathway (No"
      }, {
        "text": "-Go)|--\u003e E(‚Üë GPi/SNr Inhibition); E --\u003e F(‚Üì Thalamic Excitation); F --\u003e"
      }, {
        "text": " A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to"
      }, {
        "text": "\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "implicated_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_implicated_in\",\n        \"to\": \"hemiballismus\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"afc0a64b"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"361438f2\": {\n    \"title\":"
      }, {
        "text": " \"Basal Nucleus of Meynert\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain Nuclei\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is a group of neurons"
      }, {
        "text": " located in the substantia innominata of the basal forebrain. It is the primary source of cholinergic ([[6a005559|"
      }, {
        "text": "acetylcholine]]) innervation to the entire cerebral cortex, playing a vital role in cognitive functions like memory and attention.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Basal forebrain, part of the substantia innominata."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e Synthesizes and releases [[6a005559|acetylcholine ("
      }, {
        "text": "ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Provides widespread cholinergic projections to the neocortex and hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Modulates cortical excitability, arousal, attention, and is critical for learning and memory formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e There"
      }, {
        "text": " is significant degeneration and loss of cholinergic neurons in the Basal Nucleus of Meynert in \u003cmark\u003e[[7"
      }, {
        "text": "7ae6148|Alzheimer disease]]\u003c/mark\u003e. This loss of cortical ACh is a major contributor to the cognitive"
      }, {
        "text": " and memory deficits seen in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degeneration of the Basal Nucleus of Mey"
      }, {
        "text": "nert and the resulting cholinergic deficit is a key pathophysiological feature of [[77ae6148|Alzheimer disease]] and"
      }, {
        "text": " is the rationale for using [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., [["
      }, {
        "text": "47d0372e|donepezil]]) as a symptomatic treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is the brain\u0027s main cholinergic hub"
      }, {
        "text": " for the cortex; its profound degeneration in [[77ae6148|Alzheimer disease]] leads to a cortical"
      }, {
        "text": " acetylcholine deficit that underlies the hallmark cognitive decline of the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Basal Nucleus of Meynert] --ACh Projections--\u003e B(Cerebral Cortex \u0026 Hippocampus); B"
      }, {
        "text": " --\u003e C(Arousal, Memory, Attention); A --x Degeneration in Alzheimer\u0027s; \"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"produces\",\n        \"to\": \"6a005559\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"77ae614"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"basal_forebrain\"\n      }\n    ]\n  },\n  \"253e3"
      }, {
        "text": "efb\": {\n    \"title\": \"Basal Plate\",\n    \"primaryType\": \"anatomy\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural"
      }, {
        "text": " Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the ventral"
      }, {
        "text": " part of the neural tube in the developing embryo, which differentiates into \u003ci\u003emotor neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of"
      }, {
        "text": " the signaling molecule Sonic Hedgehog (SHH).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Ventral ("
      }, {
        "text": "anterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003emotor\u003c/u\u003e components"
      }, {
        "text": " of the central nervous system, including the anterior horn of the spinal cord and the motor nuclei of the cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing"
      }, {
        "text": " Signal:\u003c/b\u003e Development is induced by \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, a signaling molecule secreted by the underlying"
      }, {
        "text": " notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The dorsal counterpart is the [[43be7a6e"
      }, {
        "text": "|Alar Plate]], which develops into sensory neurons under the influence of Bone Morphogenetic Proteins (BMPs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e, and \u003cb\u003eAlar \u003d Sensory"
      }, {
        "text": " \u003d Dorsal\u003c/b\u003e. This fundamental organization persists into the adult CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Basal Plate\u003c/b\u003e is the embryonic blueprint for the motor output of the CNS, established by Sonic Hedgehog signaling from the not"
      }, {
        "text": "ochord, which sets up the ventral-motor organization of the neural tube that is conserved throughout the nervous system.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Vent"
      }, {
        "text": "ral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Noto"
      }, {
        "text": "chord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"motor_neurons\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"43be7a6e\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"sonic"
      }, {
        "text": "_hedgehog\"\n      }\n    ]\n  },\n  \"c335e16d\": {\n    \"title"
      }, {
        "text": "\": \"Basement Membrane (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-"
      }, {
        "text": "Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, the \u003cb\u003ebas"
      }, {
        "text": "ement membrane\u003c/b\u003e is a thin, specialized layer of the extracellular matrix that surrounds cerebral capillaries and, along with astrocyte foot processes and endothelial"
      }, {
        "text": " tight junctions, forms a critical component of the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of Type IV collagen, laminin, and proteoglycans.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Function:\u003c/b\u003e Provides structural support to the capillary endothelium and acts as a selective filter, regulating the passage of molecules from the blood into the brain"
      }, {
        "text": " parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Blood-Brain Barrier:\u003c/b\u003e The basement membrane, together with endothelial [[tight_junctions|"
      }, {
        "text": "tight junctions]] and astrocyte end-feet, creates the highly restrictive [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology:\u003c/b\u003e Thickening of the basement membrane is a feature of chronic hyperglycemia in diabetes, contributing to microvascular complications like"
      }, {
        "text": " [[73b00ab0|diabetic retinopathy]]. In [[goodpasture_syndrome|Goodpasture syndrome]], auto"
      }, {
        "text": "antibodies target Type IV collagen in the basement membranes of the kidneys and lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " three key components of the blood-brain barrier are: 1) Tight junctions between non-fenestrated endothelial cells, 2)"
      }, {
        "text": " The basement membrane, and 3) Astrocyte foot processes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ebasement membrane\u003c/b\u003e of CNS capillaries is a crucial structural and functional element of the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]], acting as both scaffolding and a selective filter to maintain the tightly controlled environment of the brain.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \""
      }, {
        "text": "to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "composed_of\",\n        \"to\": \"type_iv_collagen\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_thickened_in\",\n        \"to\": \"diabetes_mellitus\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"e7a90cd9\": {\n    \"title\": \"Basilar"
      }, {
        "text": " Artery\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is a critical artery at"
      }, {
        "text": " the base of the brain, formed by the union of the two vertebral arteries. It ascends along the anterior surface of the pons and is"
      }, {
        "text": " a key component of the posterior circulation, supplying the brainstem, cerebellum, and occipital lobes.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Formed by the confluence of the left and right vertebral arteries at the pont"
      }, {
        "text": "omedullary junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBranches:\u003c/b\u003e Gives rise to the [[3c075343|anterior inferior"
      }, {
        "text": " cerebellar artery (AICA)]], superior cerebellar artery (SCA), and numerous small pontine arteries. It terminates by"
      }, {
        "text": " bifurcating into the two [[b6a2cc31|posterior cerebral arteries (PCAs)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerr"
      }, {
        "text": "itory Supplied:\u003c/b\u003e Brainstem (pons, midbrain), cerebellum, and via its terminal branches (PCAs), the occipital and"
      }, {
        "text": " inferior temporal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBasilar Artery Occlusion:"
      }, {
        "text": "\u003c/b\u003e Can be catastrophic, leading to \u003cmark\u003e\\\"locked-in syndrome\\\"\u003c/mark\u003e if the ventral pons is infar"
      }, {
        "text": "cted bilaterally. This causes quadriplegia and mutism, with preserved consciousness and vertical eye movements.\u003cbr\u003e - \u003cb\u003eTop"
      }, {
        "text": " of the Basilar Syndrome:\u003c/b\u003e Embolic occlusion of the distal basilar artery affects the midbrain, thalamus, and temporal"
      }, {
        "text": "/occipital lobes, causing visual and behavioral disturbances with minimal motor deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " stroke causing quadriplegia but sparing consciousness and vertical eye movements is pathognomonic for basilar artery occlusion leading to locked-in syndrome.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is the central trunk of the posterior"
      }, {
        "text": " circulation; its occlusion can lead to devastating brainstem strokes, most notably the \u0027locked-in syndrome,\u0027 which severs the brain\u0027"
      }, {
        "text": "s motor output while leaving consciousness intact.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arter"
      }, {
        "text": "ies] --\u003e B(Basilar Artery); B --\u003e C(Pontine Arteries); B --\u003e D(A"
      }, {
        "text": "ICA); B --\u003e E(SCA); B --\u003e F(PCAs);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_part_of\",\n        \"to\": \"posterior_circulation\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"vertebral_arteries\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"locked_in_"
      }, {
        "text": "syndrome\"\n      },\n      {\n        \"type\": \"bifurcates_into\",\n"
      }, {
        "text": "        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"91fcdbc5\": {\n    \"title\": \"REM Sleep Behavior Disorder\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal muscle"
      }, {
        "text": " atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally induce"
      }, {
        "text": " muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump out of bed during sleep"
      }, {
        "text": ", corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±-synucleinopathies"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|"
      }, {
        "text": "Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years"
      }, {
        "text": " or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports acting out violent"
      }, {
        "text": " dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prod"
      }, {
        "text": "romal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM Sleep"
      }, {
        "text": " Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning sign of an underlying Œ±-synucleinopathy, where"
      }, {
        "text": " the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson\u0027s by many"
      }, {
        "text": " years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"parasomnia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \""
      }, {
        "text": "to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"alpha_synucleinopathies\"\n      }\n    ]\n  },\n  \"b0a6"
      }, {
        "text": "f66e\": {\n    \"title\": \"Behavior Modulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e refers to the complex"
      }, {
        "text": " neural processes by which the brain regulates and controls behavior, integrating emotional, cognitive, and homeostatic inputs to produce appropriate responses. This function"
      }, {
        "text": " is primarily orchestrated by the [[73ace357|limbic system]] and its connections with the prefrontal cortex and [["
      }, {
        "text": "89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eLimbic System\u0027s Role:\u003c/b\u003e The [[73ace357|limbic system]] ("
      }, {
        "text": "including the [[d220fc3f|amygdala]], [[a0590674|hipp"
      }, {
        "text": "ocampus]], and cingulate gyrus) is central to emotion, memory, and motivation, which are the core drivers of behavior.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e Processes fear, aggression, and reward. Lesions can lead to placidity or dis"
      }, {
        "text": "inhibited behavior (e.g., [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome]]).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eHypothalamus:\u003c/b\u003e Integrates autonomic and endocrine responses with behavior, governing fundamental drives like hunger, thirst, and sexual"
      }, {
        "text": " behavior (the \u0027Four Fs\u0027: Feeding, Fleeing, Fighting, and sexual Functioning).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex"
      }, {
        "text": ":\u003c/b\u003e Provides top-down executive control, inhibiting impulsive behaviors and guiding actions based on goals and social context. Lesions can cause"
      }, {
        "text": " disinhibition and impaired judgment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The mnemonic for limbic system functions, the \u00275 F\u0027"
      }, {
        "text": "s\u0027 (Feeding, Fleeing, Fighting, Feeling, and Sex), highlights its role in modulating fundamental behaviors."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e is a dynamic interplay between the primitive drives"
      }, {
        "text": " of the [[73ace357|limbic system]] and [[89e86633"
      }, {
        "text": "|hypothalamus]] and the executive oversight of the prefrontal cortex, with the final behavioral output reflecting the balance of"
      }, {
        "text": " these competing influences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Limbic System - Emotion/"
      }, {
        "text": "Drives] --\u003e C{Behavioral Output}; B[Prefrontal Cortex - Executive Control] --\u003e C;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"73ace35"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        "
      }, {
        "text": "\"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "function_of\",\n        \"to\": \"prefrontal_cortex\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"c7ce09b2\": {\n    \"title\": \"Benzocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is an ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used topically to numb surfaces such as the skin, mouth, and throat. It works by blocking voltage-gated sodium channels in nerve membranes, thereby preventing the propagation of action potentials.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve depolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. Patients with allergies to esters (e.g., procaine) may also react to benzocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly found in over-the-counter products for teething pain, sore throats (sprays), and sunburn relief. Used in medical settings as a topical anesthetic for procedures like endoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e A well-known cause of acquired \u003cmark\u003emethemoglobinemia\u003c/mark\u003e, especially in infants and young children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMethemoglobinemia:\u003c/b\u003e Benzocaine oxidizes the iron in hemoglobin from the ferrous (Fe\u003csup\u003e2+\u003c/sup\u003e) to the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state. Methemoglobin cannot bind oxygen, leading to functional anemia and cyanosis that does not improve with supplemental oxygen. Blood appears \u0027chocolate brown\u0027. Treated with methylene blue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient who develops cyanosis and shortness of breath shortly after an endoscopic procedure (where a topical anesthetic spray was used) should immediately raise suspicion for benzocaine-induced methemoglobinemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is a widely used topical anesthetic that carries the rare but life-threatening risk of inducing methemoglobinemia, a condition where hemoglobin\u0027s iron is oxidized, rendering it unable to transport oxygen and causing a characteristic \u0027chocolate brown\u0027 blood appearance and cyanosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"methemoglobinemia\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"14464617\": {\n    \"title\": \"Benzodiazepines\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are a class of psychoactive drugs that act as positive allosteric modulators of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to an allosteric site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of chloride channel opening in response to GABA. Mnemonic: \u003cb\u003eFre\u003c/b\u003enzodiazepines increase \u003cb\u003efre\u003c/b\u003equency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e Anxiety disorders, panic attacks, status epilepticus (lorazepam, diazepam), alcohol withdrawal, insomnia, and procedural sedation/anesthesia (midazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Classified by duration of action. Short-acting (e.g., [[083094db|alprazolam]], midazolam) have higher abuse potential. Long-acting (e.g., diazepam, chlordiazepoxide) are preferred for alcohol withdrawal. Those not metabolized by the liver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam - \u0027Outside The Liver\u0027) are safer in patients with hepatic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Overdose can be treated with \u003cmark\u003eflumazenil\u003c/mark\u003e, a competitive antagonist at the benzodiazepine binding site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[52564aea|barbiturates]], which increase the \u003cu\u003eduration\u003c/u\u003e of channel opening and have a higher risk of fatal respiratory depression.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are versatile CNS depressants that enhance GABA\u0027s inhibitory effects by increasing the frequency of chloride channel opening, but their use is tempered by the significant risks of dependence and additive depression with other substances.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Benzodiazepine] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  },\n  \"383f6fbe\": {\n    \"title\": \"Benztropine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e is a centrally acting \u003ci\u003eantimuscarinic (anticholinergic) drug\u003c/i\u003e used primarily to treat the symptoms of [[58c8ea03|Parkinson disease]] and to manage extrapyramidal side effects (EPS) caused by antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at central muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed462927|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has little effect on bradykinesia. Mnemonic: \u0027\u003cb\u003eTri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and \u003cb\u003eBenz\u003c/b\u003etropine for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (EPS):\u003c/b\u003e Effective for treating \u003cmark\u003eacute dystonia\u003c/mark\u003e and drug-induced parkinsonism caused by dopamine antagonists (antipsychotics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/delirium, especially in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Benztropine is the go-to drug for treating a patient who develops an acute dystonic reaction (e.g., torticollis, oculogyric crisis) after starting an antipsychotic like haloperidol.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e combats the motor symptoms of Parkinson\u0027s and antipsychotic side effects by blocking central acetylcholine activity, thereby counteracting the relative cholinergic overactivity that results from dopamine deficiency or blockade in the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"acute_dystonia\"\n      }\n    ]\n  },\n  \"a9f6d703\": {\n    \"title\": \"Berry Aneurysm\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBerry Aneurysm\u003c/b\u003e, also known as a saccular aneurysm, is a thin-walled, sac-like outpouching of a cerebral artery, typically located at arterial branch points within the [[e22300e8|Circle of Willis]]. Its rupture is the most common cause of non-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [[bd802d22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to form due to a congenital weakness in the vessel wall (lack of tunica media) at arterial bifurcations, which is exacerbated over time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f|subarachnoid hemorrhage]], presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A PComA aneurysm can compress the ipsilateral [[68c66997|oculomotor nerve (CN III)]], causing a painful third nerve palsy with a dilated, nonreactive pupil (\u0027blown pupil\u0027). This is a neurosurgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBerry aneurysms\u003c/b\u003e are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating subarachnoid hemorrhage, classically presenting as a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Arterial Bifurcation in Circle of Willis] --\u003e B(Congenital Wall Weakness); B --Hypertension--\u003e C(Berry Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E[Subarachnoid Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type\": \"most_common_location_is\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"43508d57\": {\n    \"title\": \"Betaxolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e is a \u003ci\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective adrenergic antagonist\u003c/i\u003e (beta-blocker) used primarily in ophthalmology as eye drops to treat [[3ce6c035|glaucoma]] and ocular hypertension. It is also available in oral form for the treatment of systemic hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Glaucoma):\u003c/b\u003e When applied topically to the eye, it blocks Œ≤-adrenergic receptors on the ciliary epithelium, leading to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e and thus lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e As a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker, it has less of an effect on Œ≤\u003csub\u003e2\u003c/sub\u003e receptors in the lungs compared to non-selective beta-blockers like timolol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat [[5ea7b741|open-angle glaucoma]]. Its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity makes it a safer option for patients with asthma or COPD compared to non-selective beta-blockers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular effects can include stinging and burning. Although it is Œ≤\u003csub\u003e1\u003c/sub\u003e-selective, systemic absorption can still occur and may cause bradycardia, hypotension, and fatigue. Caution is still advised in patients with respiratory conditions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a glaucoma patient with a history of asthma, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker like betaxolol is a more appropriate choice than a non-selective one like timolol to minimize the risk of bronchoconstriction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e lowers intraocular pressure in glaucoma by reducing aqueous humor production, and its key feature is its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity, which offers a safer profile for patients with underlying pulmonary disease compared to non-selective beta-blockers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"beta_1_adrenergic_receptor\"\n      }\n    ]\n  },\n  \"f36cfe18\": {\n    \"title\": \"Biceps Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow when the biceps brachii tendon is tapped. It is used to test the integrity of the \u003cmark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the musculocutaneous nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC5\u003c/b\u003e nerve root, with a contribution from C6. Mnemonic: C\u003cb\u003e5\u003c/b\u003e, 6, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the biceps tendon stretches the muscle spindle in the biceps muscle. The afferent signal travels via the musculocutaneous nerve to the C5/C6 spinal cord segments. It synapses with a motor neuron, and the efferent signal returns via the musculocutaneous nerve to cause contraction of the biceps muscle and elbow flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C5 root or a peripheral neuropathy affecting the musculocutaneous nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The biceps reflex, along with sensation over the lateral arm and deltoid/biceps strength, is a key part of the C5 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a fundamental component of the neurological exam, providing a quick and reliable assessment of the C5 and C6 nerve roots and the integrity of the reflex arc through the cervical spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Biceps Tendon] --\u003e B(Stretch Biceps Muscle); B --\u003e C(Afferent Signal via Musculocutaneous N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Musculocutaneous N.); E --\u003e F(Biceps Contraction/Elbow Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"188b4a47\": {\n    \"title\": \"Bimatoprost\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a \u003ci\u003eprostaglandin analog\u003c/i\u003e used topically as an eye drop to reduce intraocular pressure (IOP) in patients with [[5ea7b741|open-angle glaucoma]] or ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic prostamide analog that mimics the action of prostaglandins (specifically PGF\u003csub\u003e2Œ±\u003c/sub\u003e). It lowers IOP by \u003cmark\u003eincreasing the outflow of aqueous humor\u003c/mark\u003e through the secondary, or \u003cmark\u003euveoscleral pathway\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent for the treatment of [[5ea7b741|open-angle glaucoma]] due to its high efficacy and once-daily dosing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are ocular hyperemia (redness), stinging, and a notable cosmetic side effect of \u003cmark\u003eincreased eyelash growth\u003c/mark\u003e (length and darkness). A permanent side effect can be darkening of the iris color (browning).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Other prostaglandin analogs include latanoprost and travoprost, all sharing a similar mechanism and side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The unique side effect of eyelash growth has been exploited for cosmetic use (Latisse). Remember that prostaglandin analogs work by increasing outflow, whereas beta-blockers decrease production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a highly effective first-line glaucoma medication that lowers eye pressure by enhancing the uveoscleral outflow of aqueous humor, with the well-known and cosmetically exploited side effect of promoting eyelash growth.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Bimatoprost] --\u003e B(Acts on Prostaglandin Receptors); B --\u003e C(‚Üë Uveoscleral Outflow); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      }\n    ]\n  },\n  \"6c3a980e\": {\n    \"title\": \"Bitemporal Hemianopia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is a specific type of partial blindness characterized by the loss of vision in the outer (temporal) halves of the visual fields of both eyes. It is classically caused by a lesion compressing the central part of the \u003cmark\u003eoptic chiasm\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Loss of the temporal (lateral) visual fields in both eyes, often described as \\\"tunnel vision.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The optic chiasm is where the nasal retinal fibers from each eye decussate (cross over). These nasal fibers are responsible for perceiving the temporal visual fields. A midline lesion at the chiasm selectively damages these crossing fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most common cause is a \u003cmark\u003e[[5f3188bd|pituitary adenoma]]\u003c/mark\u003e growing upward from the sella turcica and compressing the chiasm from below.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other suprasellar masses like a [[7048db1e|craniopharyngioma]] or an aneurysm of the [[bd802d22|anterior communicating artery]] can also cause this defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with \\\"tunnel vision\\\" or complaining of bumping into things on either side, especially if accompanied by endocrine symptoms (e.g., galactorrhea, acromegaly), is a classic vignette for a [[5f3188bd|pituitary adenoma]] causing bitemporal hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is the quintessential sign of optic chiasm compression, resulting from the selective damage to the crossing nasal retinal fibers and creating a characteristic \u0027tunnel vision\u0027 that points directly to a midline suprasellar pathology like a pituitary adenoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion at Optic Chiasm] --Compresses--\u003e B(Crossing Nasal Retinal Fibers); B --\u003e C(Loss of Temporal Visual Fields); C --\u003e D(Bitemporal Hemianopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_at\",\n        \"to\": \"optic_chiasm\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"7048db1e\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"8056ce48\": {\n    \"title\": \"Blepharitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a common inflammatory condition of the eyelids, typically involving the part of the eyelid where the eyelashes grow. It is characterized by inflammation, irritation, itching, and crusting of the eyelid margins.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Blepharitis:\u003c/b\u003e Affects the outside front of the eyelid, where the eyelashes are attached. Often caused by bacteria (\u003ci\u003eStaphylococcus\u003c/i\u003e) or seborrheic dermatitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Blepharitis:\u003c/b\u003e Affects the inner eyelid (the moist part that makes contact with the eye). Caused by dysfunction of the meibomian glands (Meibomian Gland Dysfunction - MGD). Associated with skin conditions like rosacea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Red, swollen, or itchy eyelids; gritty or burning sensation in the eyes; crusty debris at the base of the eyelashes upon waking; flaking of skin around the eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[hordeolum|hordeola (styes)]], [[193c24ec|chalazia]], dry eyes, or chronic conjunctivitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The cornerstone of treatment is \u003cmark\u003eeyelid hygiene\u003c/mark\u003e, including warm compresses and gentle scrubbing of the eyelid margins. Topical antibiotics or steroids may be used in some cases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for a patient complaining of chronic eye irritation with crusting on the eyelashes, especially in the morning. This is a classic description of blepharitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a chronic inflammation of the eyelid margins, akin to dandruff of the eyelashes, which is managed primarily through diligent eyelid hygiene to control symptoms and prevent complications like styes and chalazia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"eyelid_disorder\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"193c24ec\"\n      }\n    ]\n  },\n  \"dd47b9cc\": {\n    \"title\": \"Blood-Brain Barrier (BBB)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier (BBB)\u003c/b\u003e is a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system where neurons reside.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Components:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[5206aa83|Tight junctions]]\u003c/b\u003e between non-fenestrated capillary endothelial cells.\u003cbr\u003e2. A thick \u003cb\u003e[[c335e16d|Basement Membrane]]\u003c/b\u003e.\u003cbr\u003e3. \u003cb\u003eAstrocyte foot processes\u003c/b\u003e that surround the capillary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protects the brain from circulating toxins, pathogens, and fluctuations in plasma composition. It maintains a stable CNS environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Across BBB:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLipid-soluble\u003c/b\u003e substances (e.g., O\u003csub\u003e2\u003c/sub\u003e, CO\u003csub\u003e2\u003c/sub\u003e, anesthetics) can diffuse freely.\u003cbr\u003e - \u003cb\u003eWater-soluble\u003c/b\u003e substances (e.g., glucose, [[9115b704|amino acids]]) require specific \u003cmark\u003ecarrier-mediated transport\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircumventricular Organs:\u003c/b\u003e Areas of the brain that lack a BBB, allowing them to monitor the chemical composition of the blood. These include the [[5dd343d3|area postrema]] (chemoreceptor trigger zone for vomiting) and parts of the [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Breakdown of the BBB leads to vasogenic edema. Some antibiotics (e.g., penicillins) have poor CNS penetration but can cross an inflamed BBB during meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier\u003c/b\u003e is a sophisticated neurovascular unit, not just a simple wall, that uses tight junctions, a robust basement membrane, and astrocyte support to create a highly regulated interface, ensuring the brain\u0027s chemical environment remains pristine and protected.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Capillary Lumen] --\u003e B(Endothelial Cell); B --Tight Junctions--\u003e B; B --\u003e C(Basement Membrane); C --\u003e D(Astrocyte Foot Processes); D --\u003e E[Brain Parenchyma];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"5206aa83\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"c335e16d\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"5dd343d3\"\n      }\n    ]\n  },\n  \"03ba9967\": {\n    \"title\": \"Blood-Nerve Barrier\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e is a physiological barrier in the peripheral nervous system that regulates the passage of substances from the blood into the endoneurial space, maintaining a stable microenvironment for peripheral nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The main cellular component is the \u003cmark\u003eperineurium\u003c/mark\u003e, which consists of layers of flattened perineurial cells joined by tight junctions. Tight junctions between endothelial cells of the endoneurial capillaries also contribute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protects peripheral nerves from toxins, pathogens, and inflammatory cells, similar to the role of the [[dd47b9cc|blood-brain barrier]] in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to BBB:\u003c/b\u003e While analogous to the BBB, the blood-nerve barrier is generally considered less restrictive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Breakdown of the blood-nerve barrier is a key feature of inflammatory neuropathies like [[ed52e40b|Guillain-Barr√© syndrome]]. This breakdown allows inflammatory cells and proteins to enter the endoneurial space, leading to demyelination and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The breakdown of the blood-nerve barrier in [[ed52e40b|Guillain-Barr√© syndrome]] explains the classic CSF finding of [[a0f3ce4c|albuminocytologic dissociation]]‚Äîhigh protein (leaking from the blood) with a normal cell count.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e, formed primarily by the tight junctions of the perineurium, serves as the protective gatekeeper for peripheral nerves; its disruption in inflammatory conditions like Guillain-Barr√© syndrome allows an autoimmune assault on the nerves.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_analogous_to\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_disrupted_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"perineurium\"\n      }\n    ]\n  },\n  \"6ab4b0f2\": {\n    \"title\": \"Blown Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003e\\\"blown pupil\\\"\u003c/b\u003e is a clinical term for a fixed, dilated pupil (mydriasis) that is nonreactive to light. It is a critical sign of compression of the [[68c66997|oculomotor nerve (CN III)]], often indicating a life-threatening increase in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The parasympathetic fibers that control pupillary constriction run along the superficial, peripheral aspect of the [[68c66997|oculomotor nerve]]. These fibers are highly susceptible to external compression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e \u003cmark\u003eUncal herniation\u003c/mark\u003e, where the uncus of the temporal lobe herniates over the tentorium cerebelli and compresses the ipsilateral CN III.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Aneurysm of the \u003cmark\u003eposterior communicating artery (PComA)\u003c/mark\u003e, which is anatomically close to CN III, can also cause compression and a blown pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A unilateral blown pupil is an ominous sign of rapidly increasing intracranial pressure and impending brainstem compression. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Often accompanied by other signs of a CN III palsy, such as ptosis and a \\\"down and out\\\" deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with head trauma and a deteriorating level of consciousness, the sudden appearance of a unilateral fixed and dilated pupil indicates uncal herniation and requires immediate intervention.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblown pupil\u003c/b\u003e is a neurological red flag, signaling compression of the parasympathetic fibers on the outside of the oculomotor nerve, most often by uncal herniation or a PComA aneurysm, and indicates a dire, time-sensitive emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Uncal Herniation); B --Compresses--\u003e C(CN III Parasympathetic Fibers); C --\u003e D(Loss of Pupillary Constriction); D --\u003e E(Fixed, Dilated Pupil);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_nerve_compression\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }\n    ]\n  },\n  \"aebb10eb\": {\n    \"title\": \"Blowout Fracture\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Trauma\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a traumatic fracture of the walls of the orbit, most commonly the orbital floor, caused by a sudden increase in intraorbital pressure from a direct blow to the globe (e.g., from a fist or a ball).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e A blunt, non-penetrating force strikes the globe, transmitting pressure throughout the orbit. The thin orbital floor (roof of the maxillary sinus) and/or medial wall (lamina papyracea of the ethmoid sinus) fracture, or \u0027blow out.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with periorbital pain, swelling, and ecchymosis. Key signs include \u003cmark\u003ediplopia on upward gaze\u003c/mark\u003e and numbness of the cheek and upper teeth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle Entrapment:\u003c/b\u003e The fracture can entrap the \u003cmark\u003einferior rectus muscle\u003c/mark\u003e and/or orbital fat. This entrapment restricts upward movement of the eye, causing vertical diplopia, especially on upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Injury:\u003c/b\u003e The fracture of the orbital floor can damage the \u003cmark\u003einfraorbital nerve\u003c/mark\u003e (a branch of CN V\u003csub\u003e2\u003c/sub\u003e), leading to paresthesia or numbness of the ipsilateral cheek, upper lip, and upper gingiva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a history of blunt eye trauma, diplopia on upward gaze, and numbness of the cheek is classic for an orbital blowout fracture with inferior rectus entrapment and infraorbital nerve injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a hydraulic fracture of the thin orbital floor, where the force of a blow to the eye is transmitted to the surrounding bone, leading to entrapment of the inferior rectus muscle and injury to the infraorbital nerve, manifesting as an inability to look up and a numb cheek.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause_entrapment_of\",\n        \"to\": \"inferior_rectus_muscle\"\n      },\n      {\n        \"type\": \"can_cause_injury_to\",\n        \"to\": \"infraorbital_nerve\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9914d433\"\n      }\n    ]\n  },\n  \"869535a9\": {\n    \"title\": \"Bone Morphogenetic Protein (BMP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Developmental Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Proteins (BMPs)\u003c/b\u003e are a group of growth factors belonging to the transforming growth factor-beta (TGF-Œ≤) superfamily. In neuroembryology, they play a crucial role in establishing the dorsal-ventral axis of the neural tube by inducing the development of the dorsal structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the overlying ectoderm, BMPs act as a signaling molecule that patterns the dorsal neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsalization:\u003c/b\u003e High concentrations of BMPs induce the formation of the \u003cmark\u003e[[43be7a6e|alar plate]]\u003c/mark\u003e, which gives rise to sensory neurons in the dorsal horn of the spinal cord and sensory nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The ventralizing signal is \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, which is secreted by the notochord and induces the formation of the [[253e3efb|basal plate]] (motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGradient Effect:\u003c/b\u003e The opposing gradients of BMP (high dorsally) and SHH (high ventrally) establish the distinct sensory (dorsal) and motor (ventral) domains of the developing central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the source and effect: BMP from the ectoderm (roof) induces the dorsal/sensory alar plate. SHH from the notochord (floor) induces the ventral/motor basal plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Protein\u003c/b\u003e acts as the key \u0027dorsalizing\u0027 signal in the developing neural tube, instructing the dorsal region to become the sensory [[43be7a6e|alar plate]], thereby establishing the fundamental sensory-motor polarity of the central nervous system in opposition to the ventralizing signal, Sonic Hedgehog.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ectoderm] --Secretes--\u003e B(BMPs); B --Induces--\u003e C(Dorsal Neural Tube); C --\u003e D(Alar Plate); D --\u003e E(Sensory Neurons);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to\": \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_counteracted_by\",\n        \"to\": \"sonic_hedgehog\"\n      },\n      {\n        \"type\": \"is_secreted_by\",\n        \"to\": \"ectoderm\"\n      }\n    ]\n  },\n  \"84b10400\": {\n    \"title\": \"Botulinum Toxin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e is a potent neurotoxin produced by the bacterium \u003ci\u003eClostridium botulinum\u003c/i\u003e. It causes flaccid paralysis by inhibiting the presynaptic release of [[6a005559|acetylcholine]] at the neuromuscular junction. In small, purified doses, it is used therapeutically for a variety of medical and cosmetic purposes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The toxin is a protease that cleaves \u003cmark\u003eSNARE proteins\u003c/mark\u003e (e.g., SNAP-25, synaptobrevin), which are essential for the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This prevents ACh release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSpasticity/Dystonia:\u003c/b\u003e Treats focal dystonias (e.g., torticollis, blepharospasm), spasticity in [[171ca00b|cerebral palsy]] and [[45dd6d19|multiple sclerosis]].\u003cbr\u003e - \u003cb\u003ePain:\u003c/b\u003e Prophylaxis for chronic [[c8833bae|migraine headaches]].\u003cbr\u003e - \u003cb\u003eOther:\u003c/b\u003e Hyperhidrosis (excessive sweating), strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCosmetic Use:\u003c/b\u003e Injected to reduce facial wrinkles by temporarily paralyzing underlying muscles (Botox).\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Botulism):\u003c/b\u003e Ingestion of the toxin (e.g., from improperly canned foods) causes botulism, a life-threatening illness characterized by descending flaccid paralysis, diplopia, dysphagia, and respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that botulinum toxin causes a \u003cu\u003epresynaptic\u003c/u\u003e blockade of ACh release, which contrasts with myasthenia gravis (postsynaptic receptor blockade) and Lambert-Eaton syndrome (presynaptic Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e induces paralysis by enzymatically snipping the SNARE proteins required for acetylcholine release at the neuromuscular junction; this potent biological mechanism is harnessed in medicine to selectively weaken overactive muscles in conditions from dystonia to cosmetic wrinkles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Botulinum Toxin] --\u003e B(Cleaves SNARE Proteins); B --x C(Vesicle Fusion); C --x D(ACh Release); D --x E(Muscle Contraction); E --\u003e F(Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"inhibits_release_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"dystonia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"clostridium_botulinum\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10179,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"c7ce09b2\": {\n    \"title"
      }, {
        "text": "\": \"Benzocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is an"
      }, {
        "text": " ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used topically to numb surfaces such as the skin, mouth, and throat. It works"
      }, {
        "text": " by blocking voltage-gated sodium channels in nerve membranes, thereby preventing the propagation of action potentials.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve"
      }, {
        "text": " depolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. Patients with allergies to esters (e.g., procaine) may"
      }, {
        "text": " also react to benzocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly found in over-the-counter products for teething"
      }, {
        "text": " pain, sore throats (sprays), and sunburn relief. Used in medical settings as a topical anesthetic for procedures like endoscopy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e A well-known cause of acquired \u003cmark\u003emethemoglobinemia\u003c/mark\u003e,"
      }, {
        "text": " especially in infants and young children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMethemoglobinemia:\u003c/b\u003e Benzocaine oxidizes the iron in hemoglobin from"
      }, {
        "text": " the ferrous (Fe\u003csup\u003e2+\u003c/sup\u003e) to the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state. Methemoglobin cannot"
      }, {
        "text": " bind oxygen, leading to functional anemia and cyanosis that does not improve with supplemental oxygen. Blood appears \u0027chocolate brown\u0027. Treated"
      }, {
        "text": " with methylene blue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient who develops cyanosis and shortness of breath shortly"
      }, {
        "text": " after an endoscopic procedure (where a topical anesthetic spray was used) should immediately raise suspicion for benzocaine-induced methemoglobinemia."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is a widely used topical anesthetic that carries"
      }, {
        "text": " the rare but life-threatening risk of inducing methemoglobinemia, a condition where hemoglobin\u0027s iron is oxidized,"
      }, {
        "text": " rendering it unable to transport oxygen and causing a characteristic \u0027chocolate brown\u0027 blood appearance and cyanosis.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"causes_adverse_effect\",\n        \"to\": \"methemoglobinemia\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"14464617\": {\n    \"title\": \"Benzodiazepines\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are a class of psychoactive drugs that act as positive allosteric modulators of the GABA"
      }, {
        "text": "\u003csub\u003eA\u003c/sub\u003e receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to an allosteric site on the GABA\u003csub\u003e"
      }, {
        "text": "A\u003c/sub\u003e receptor, increasing the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of chloride channel opening in response to GABA."
      }, {
        "text": " Mnemonic: \u003cb\u003eFre\u003c/b\u003enzodiazepines increase \u003cb\u003efre\u003c/b\u003equency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e Anxiety"
      }, {
        "text": " disorders, panic attacks, status epilepticus (lorazepam, diazepam), alcohol withdrawal, insomnia, and procedural sedation/"
      }, {
        "text": "anesthesia (midazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Classified by duration of action. Short-acting ("
      }, {
        "text": "e.g., [[083094db|alprazolam]], midazolam) have higher abuse potential. Long-acting (e"
      }, {
        "text": ".g., diazepam, chlordiazepoxide) are preferred for alcohol withdrawal. Those not metabolized by the liver (\u003cb\u003e"
      }, {
        "text": "O\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam - \u0027Outside The Liver\u0027) are safer"
      }, {
        "text": " in patients with hepatic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, withdrawal symptoms. Add"
      }, {
        "text": "itive CNS depression with other depressants like alcohol and barbiturates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Overdose can be treated"
      }, {
        "text": " with \u003cmark\u003eflumazenil\u003c/mark\u003e, a competitive antagonist at the benzodiazepine binding site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[52564aea|barbiturates]],"
      }, {
        "text": " which increase the \u003cu\u003eduration\u003c/u\u003e of channel opening and have a higher risk of fatal respiratory depression.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are versatile CNS depressants that enhance GABA\u0027s inhibitory effects by increasing the frequency"
      }, {
        "text": " of chloride channel opening, but their use is tempered by the significant risks of dependence and additive depression with other substances.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Benzodiazepine] --\u003e B(Binds to GABA-A Receptor); B --\u003e C"
      }, {
        "text": "(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyper"
      }, {
        "text": "polarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"52564aea\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"383f6fbe\": {\n    \"title\":"
      }, {
        "text": " \"Benztropine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease"
      }, {
        "text": " Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e is a centrally acting \u003ci\u003e"
      }, {
        "text": "antimuscarinic (anticholinergic) drug\u003c/i\u003e used primarily to treat the symptoms of [[58c8"
      }, {
        "text": "ea03|Parkinson disease]] and to manage extrapyramidal side effects (EPS) caused by antipsychotic medications"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at central"
      }, {
        "text": " muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed4629"
      }, {
        "text": "27|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily"
      }, {
        "text": " effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has little effect on bradykinesia. Mnemonic: \u0027"
      }, {
        "text": "\u003cb\u003eTri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and"
      }, {
        "text": " \u003cb\u003eBenz\u003c/b\u003etropine for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (EPS):\u003c/b\u003e Effective"
      }, {
        "text": " for treating \u003cmark\u003eacute dystonia\u003c/mark\u003e and drug-induced parkinsonism caused by dopamine antagonists (antipsychotics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/"
      }, {
        "text": "delirium, especially in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Benztropine is the go"
      }, {
        "text": "-to drug for treating a patient who develops an acute dystonic reaction (e.g., torticollis, oculogyric crisis) after"
      }, {
        "text": " starting an antipsychotic like haloperidol.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e combats"
      }, {
        "text": " the motor symptoms of Parkinson\u0027s and antipsychotic side effects by blocking central acetylcholine activity, thereby counteracting the relative cholinergic"
      }, {
        "text": " overactivity that results from dopamine deficiency or blockade in the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treats\",\n        \"to\": \"acute_dystonia\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"a9f6d703\": {\n    \"title\": \"Berry Aneurysm\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBerry Aneurysm\u003c/b\u003e, also known as a saccular aneurysm,"
      }, {
        "text": " is a thin-walled, sac-like outpouching of a cerebral artery, typically located at arterial branch points within"
      }, {
        "text": " the [[e22300e8|Circle of Willis]]. Its rupture is the most common cause of non"
      }, {
        "text": "-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [[bd802d"
      }, {
        "text": "22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior"
      }, {
        "text": " communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to form"
      }, {
        "text": " due to a congenital weakness in the vessel wall (lack of tunica media) at arterial bifurcations, which is exacerbated"
      }, {
        "text": " over time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAut"
      }, {
        "text": "osomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and"
      }, {
        "text": " Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f"
      }, {
        "text": "|subarachnoid hemorrhage]], presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e"
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A PComA aneurysm can compress the ipsilateral [[68c669"
      }, {
        "text": "97|oculomotor nerve (CN III)]], causing a painful third nerve palsy with a dilated, nonreactive"
      }, {
        "text": " pupil (\u0027blown pupil\u0027). This is a neurosurgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBerry aneur"
      }, {
        "text": "ysms\u003c/b\u003e are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating"
      }, {
        "text": " subarachnoid hemorrhage, classically presenting as a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Arterial Bifurcation in Circle of Willis] --\u003e B(Congenital Wall Weak"
      }, {
        "text": "ness); B --Hypertension--\u003e C(Berry Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E["
      }, {
        "text": "Subarachnoid Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polyc"
      }, {
        "text": "ystic_kidney_disease\"\n      },\n      {\n        \"type\": \"most_common_location_is\","
      }, {
        "text": "\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "3508d57\": {\n    \"title\": \"Betaxolol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e is a \u003ci\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective adrenergic antagonist\u003c/i\u003e"
      }, {
        "text": " (beta-blocker) used primarily in ophthalmology as eye drops to treat [[3ce6c035|"
      }, {
        "text": "glaucoma]] and ocular hypertension. It is also available in oral form for the treatment of systemic hypertension.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Glaucoma):\u003c/b\u003e When applied topically to the eye, it blocks"
      }, {
        "text": " Œ≤-adrenergic receptors on the ciliary epithelium, leading to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e"
      }, {
        "text": " and thus lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e As a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker, it has less of"
      }, {
        "text": " an effect on Œ≤\u003csub\u003e2\u003c/sub\u003e receptors in the lungs compared to non-selective beta-blockers like timolol.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat [[5ea7b741|open-angle glaucoma]]. Its"
      }, {
        "text": " Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity makes it a safer option for patients with asthma or COPD compared to non-selective beta-blockers"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular effects can include stinging and burning. Although it is Œ≤\u003csub\u003e1\u003c/sub\u003e-selective, systemic"
      }, {
        "text": " absorption can still occur and may cause bradycardia, hypotension, and fatigue. Caution is still advised in patients with respiratory conditions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e For a glaucoma patient with a history of asthma, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker like betaxolol is a more"
      }, {
        "text": " appropriate choice than a non-selective one like timolol to minimize the risk of bronchoconstriction.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e lowers intraocular pressure in glaucoma by reducing aqueous humor production, and"
      }, {
        "text": " its key feature is its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity, which offers a safer profile for patients with underlying pulmonary disease compared to non-selective beta-"
      }, {
        "text": "blockers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6"
      }, {
        "text": "c035\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\":"
      }, {
        "text": " \"beta_1_adrenergic_receptor\"\n      }\n    ]\n  },\n  \"f36"
      }, {
        "text": "cfe18\": {\n    \"title\": \"Biceps Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sp"
      }, {
        "text": "inal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a"
      }, {
        "text": " deep tendon reflex that causes flexion of the elbow when the biceps brachii tendon is tapped. It is used to test the integrity of the \u003c"
      }, {
        "text": "mark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the musculocutaneous nerve.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC5\u003c/b\u003e nerve root, with a"
      }, {
        "text": " contribution from C6. Mnemonic: C\u003cb\u003e5\u003c/b\u003e, 6, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Tapping the biceps tendon stretches the muscle spindle in the biceps muscle. The afferent signal travels via the muscul"
      }, {
        "text": "ocutaneous nerve to the C5/C6 spinal cord segments. It synapses with a motor neuron, and the eff"
      }, {
        "text": "erent signal returns via the musculocutaneous nerve to cause contraction of the biceps muscle and elbow flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDim"
      }, {
        "text": "inished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C5 root"
      }, {
        "text": " or a peripheral neuropathy affecting the musculocutaneous nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggest"
      }, {
        "text": "s an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The biceps reflex, along with sensation over the lateral arm and deltoid/biceps strength, is a key"
      }, {
        "text": " part of the C5 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a fundamental"
      }, {
        "text": " component of the neurological exam, providing a quick and reliable assessment of the C5 and C6 nerve roots and the integrity"
      }, {
        "text": " of the reflex arc through the cervical spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap"
      }, {
        "text": " Biceps Tendon] --\u003e B(Stretch Biceps Muscle); B --\u003e C(Afferent Signal via Musculocutaneous"
      }, {
        "text": " N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Musculocut"
      }, {
        "text": "aneous N.); E --\u003e F(Biceps Contraction/Elbow Flexion);\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_"
      }, {
        "text": "root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \""
      }, {
        "text": "to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"188b4a47\": {\n    \"title\": \"Bimatoprost\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eBimatoprost\u003c/b\u003e is a \u003ci\u003eprostaglandin analog\u003c/i\u003e used topically as an eye drop to"
      }, {
        "text": " reduce intraocular pressure (IOP) in patients with [[5ea7b741|open-angle glaucoma]]"
      }, {
        "text": " or ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic"
      }, {
        "text": " prostamide analog that mimics the action of prostaglandins (specifically PGF\u003csub\u003e2Œ±\u003c/sub\u003e). It lowers IOP by \u003cmark\u003eincreasing"
      }, {
        "text": " the outflow of aqueous humor\u003c/mark\u003e through the secondary, or \u003cmark\u003euveoscleral pathway\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e A first-line agent for the treatment of [[5ea7b741|open-angle glaucoma]]"
      }, {
        "text": " due to its high efficacy and once-daily dosing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are ocular"
      }, {
        "text": " hyperemia (redness), stinging, and a notable cosmetic side effect of \u003cmark\u003eincreased eyelash growth\u003c/mark\u003e (length and darkness)."
      }, {
        "text": " A permanent side effect can be darkening of the iris color (browning).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Other prostaglandin analogs include"
      }, {
        "text": " latanoprost and travoprost, all sharing a similar mechanism and side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " unique side effect of eyelash growth has been exploited for cosmetic use (Latisse). Remember that prostaglandin analogs work by increasing outflow, whereas"
      }, {
        "text": " beta-blockers decrease production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a highly"
      }, {
        "text": " effective first-line glaucoma medication that lowers eye pressure by enhancing the uveoscleral outflow of aqueous humor, with the well"
      }, {
        "text": "-known and cosmetically exploited side effect of promoting eyelash growth.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Bimatoprost] --\u003e B(Acts on Prostaglandin Receptors); B --\u003e C(‚Üë Uveoscleral Outflow);"
      }, {
        "text": " C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6c3a980e\": {\n    \"title\": \"Bitemporal Hemian"
      }, {
        "text": "opia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is a specific"
      }, {
        "text": " type of partial blindness characterized by the loss of vision in the outer (temporal) halves of the visual fields of both eyes. It is"
      }, {
        "text": " classically caused by a lesion compressing the central part of the \u003cmark\u003eoptic chiasm\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Loss of the temporal (lateral) visual fields in both eyes, often described as \\\"tunnel vision.\\\"\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The optic chiasm is where the nasal retinal fibers from each eye decussate (cross over"
      }, {
        "text": "). These nasal fibers are responsible for perceiving the temporal visual fields. A midline lesion at the chiasm selectively damages these crossing"
      }, {
        "text": " fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most common cause is a \u003cmark\u003e[[5f318"
      }, {
        "text": "8bd|pituitary adenoma]]\u003c/mark\u003e growing upward from the sella turcica and compressing the ch"
      }, {
        "text": "iasm from below.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other suprasellar masses like a [[7048"
      }, {
        "text": "db1e|craniopharyngioma]] or an aneurysm of the [[bd802d22|anterior communicating artery]]"
      }, {
        "text": " can also cause this defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with \\\"tunnel vision\\\" or complaining"
      }, {
        "text": " of bumping into things on either side, especially if accompanied by endocrine symptoms (e.g., galactorrhea, ac"
      }, {
        "text": "romegaly), is a classic vignette for a [[5f3188bd|pituitary adenoma]] causing"
      }, {
        "text": " bitemporal hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBitempor"
      }, {
        "text": "al hemianopia\u003c/b\u003e is the quintessential sign of optic chiasm compression, resulting from the selective damage to the crossing nasal retinal fibers and"
      }, {
        "text": " creating a characteristic \u0027tunnel vision\u0027 that points directly to a midline suprasellar pathology like a pituitary adenoma.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Lesion at Optic Chiasm] --Compresses--\u003e B(Crossing"
      }, {
        "text": " Nasal Retinal Fibers); B --\u003e C(Loss of Temporal Visual Fields); C --\u003e D(Bitemporal Hemianopia);\"\n"
      }, {
        "text": "    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_at\",\n        \"to\": \"optic_chiasm\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"5f3188bd\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \""
      }, {
        "text": "7048db1e\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"bd802d22\"\n      }\n    ]\n  },\n  \"8056ce"
      }, {
        "text": "48\": {\n    \"title\": \"Blepharitis\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a common inflammatory condition of the eyelids, typically involving the part of the eyelid where the eyelashes grow."
      }, {
        "text": " It is characterized by inflammation, irritation, itching, and crusting of the eyelid margins.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Blepharitis:\u003c/b\u003e Affects the outside front of the eyelid, where the eyelashes are attached. Often"
      }, {
        "text": " caused by bacteria (\u003ci\u003eStaphylococcus\u003c/i\u003e) or seborrheic dermatitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Blepharitis"
      }, {
        "text": ":\u003c/b\u003e Affects the inner eyelid (the moist part that makes contact with the eye). Caused by dysfunction of the meibom"
      }, {
        "text": "ian glands (Meibomian Gland Dysfunction - MGD). Associated with skin conditions like rosacea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e Red, swollen, or itchy eyelids; gritty or burning sensation in the eyes; crusty debris at the base of the eyelashes upon"
      }, {
        "text": " waking; flaking of skin around the eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[hordeol"
      }, {
        "text": "um|hordeola (styes)]], [[193c24ec|chalazia]], dry eyes"
      }, {
        "text": ", or chronic conjunctivitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The cornerstone of treatment is \u003cmark\u003eeyelid hygiene\u003c/"
      }, {
        "text": "mark\u003e, including warm compresses and gentle scrubbing of the eyelid margins. Topical antibiotics or steroids may be used in some cases.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for a patient complaining of chronic eye irritation with crusting on the eyelashes, especially in the morning. This is a"
      }, {
        "text": " classic description of blepharitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a"
      }, {
        "text": " chronic inflammation of the eyelid margins, akin to dandruff of the eyelashes, which is managed primarily through diligent eyelid hygiene to control"
      }, {
        "text": " symptoms and prevent complications like styes and chalazia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"eyelid_disorder\"\n      },\n      {\n        \"type\": \"can_lead"
      }, {
        "text": "_to\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_lead_to\",\n        \"to\": \"193c24ec\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"dd47b9cc\": {\n    \"title\": \"Blood-Brain Barrier ("
      }, {
        "text": "BBB)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier (BBB)\u003c/b\u003e is"
      }, {
        "text": " a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into"
      }, {
        "text": " the extracellular fluid of the central nervous system where neurons reside.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Components:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[5206aa83|Tight junctions]]\u003c/b\u003e between non-fen"
      }, {
        "text": "estrated capillary endothelial cells.\u003cbr\u003e2. A thick \u003cb\u003e[[c335e16d|Bas"
      }, {
        "text": "ement Membrane]]\u003c/b\u003e.\u003cbr\u003e3. \u003cb\u003eAstrocyte foot processes\u003c/b\u003e that surround the capillary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protect"
      }, {
        "text": "s the brain from circulating toxins, pathogens, and fluctuations in plasma composition. It maintains a stable CNS environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport"
      }, {
        "text": " Across BBB:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLipid-soluble\u003c/b\u003e substances (e.g., O\u003csub\u003e2\u003c/sub\u003e, CO\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, anesthetics) can diffuse freely.\u003cbr\u003e - \u003cb\u003eWater-soluble\u003c/b\u003e substances (e.g.,"
      }, {
        "text": " glucose, [[9115b704|amino acids]]) require specific \u003cmark\u003ecarrier-mediated transport\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircumventricular Organs:\u003c/b\u003e Areas of the brain that lack a BBB, allowing them to monitor"
      }, {
        "text": " the chemical composition of the blood. These include the [[5dd343d3|area postrema]] (che"
      }, {
        "text": "moreceptor trigger zone for vomiting) and parts of the [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Breakdown of the BBB leads to vasogenic edema. Some antibiotics (e.g., pen"
      }, {
        "text": "icillins) have poor CNS penetration but can cross an inflamed BBB during meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eBlood-Brain Barrier\u003c/b\u003e is a sophisticated neurovascular unit, not just a simple wall, that uses tight junctions"
      }, {
        "text": ", a robust basement membrane, and astrocyte support to create a highly regulated interface, ensuring the brain\u0027s chemical environment remains pristine and"
      }, {
        "text": " protected.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Capillary Lumen] --\u003e B(Endothelial Cell"
      }, {
        "text": "); B --Tight Junctions--\u003e B; B --\u003e C(Basement Membrane); C --\u003e D(Astrocyte Foot Processes"
      }, {
        "text": "); D --\u003e E[Brain Parenchyma];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_composed_of\",\n        \"to\": \"5206aa83\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_composed_of\",\n        \"to\": \"c335e"
      }, {
        "text": "16d\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        "
      }, {
        "text": "\"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_abs"
      }, {
        "text": "ent_in\",\n        \"to\": \"5dd343d3\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"03ba9967\": {\n    \"title\": \"Blood-N"
      }, {
        "text": "erve Barrier\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e is a physiological"
      }, {
        "text": " barrier in the peripheral nervous system that regulates the passage of substances from the blood into the endoneurial space, maintaining"
      }, {
        "text": " a stable microenvironment for peripheral nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The"
      }, {
        "text": " main cellular component is the \u003cmark\u003eperineurium\u003c/mark\u003e, which consists of layers of flattened perineurial cells joined"
      }, {
        "text": " by tight junctions. Tight junctions between endothelial cells of the endoneurial capillaries also contribute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Protects peripheral nerves from toxins, pathogens, and inflammatory cells, similar to the role of the [[dd47b9cc|blood-"
      }, {
        "text": "brain barrier]] in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to BBB:\u003c/b\u003e While analogous to the BBB, the blood-nerve barrier is generally considered"
      }, {
        "text": " less restrictive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Breakdown of the blood-nerve barrier is a key feature of inflammatory neuropath"
      }, {
        "text": "ies like [[ed52e40b|Guillain-Barr√© syndrome]]. This breakdown allows inflammatory cells and proteins to enter the end"
      }, {
        "text": "oneurial space, leading to demyelination and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The breakdown of the blood"
      }, {
        "text": "-nerve barrier in [[ed52e40b|Guillain-Barr√© syndrome]] explains the classic"
      }, {
        "text": " CSF finding of [[a0f3ce4c|albuminocytologic dissociation]]‚Äîhigh protein (leaking from the"
      }, {
        "text": " blood) with a normal cell count.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e"
      }, {
        "text": ", formed primarily by the tight junctions of the perineurium, serves as the protective gatekeeper for peripheral nerves; its disruption"
      }, {
        "text": " in inflammatory conditions like Guillain-Barr√© syndrome allows an autoimmune assault on the nerves.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_analogous_to\",\n        \"to"
      }, {
        "text": "\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_dis"
      }, {
        "text": "rupted_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_formed_by\",\n        \"to\": \"perineurium\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"6ab4b0f2\": {\n    \"title\":"
      }, {
        "text": " \"Blown Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003e\\\"blown pupil\\\"\u003c/b\u003e is a clinical term for a fixed, dilated"
      }, {
        "text": " pupil (mydriasis) that is nonreactive to light. It is a critical sign of compression of the [[6"
      }, {
        "text": "8c66997|oculomotor nerve (CN III)]], often indicating a life-threatening increase"
      }, {
        "text": " in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The parasympathetic fibers that control"
      }, {
        "text": " pupillary constriction run along the superficial, peripheral aspect of the [[68c66997|oculomotor nerve]]."
      }, {
        "text": " These fibers are highly susceptible to external compression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e \u003cmark\u003eUncal herniation\u003c/mark\u003e, where"
      }, {
        "text": " the uncus of the temporal lobe herniates over the tentorium cerebelli and compresses the ipsilateral CN III.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Aneurysm of the \u003cmark\u003eposterior communicating artery (PComA)\u003c/mark\u003e, which is"
      }, {
        "text": " anatomically close to CN III, can also cause compression and a blown pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A unilateral"
      }, {
        "text": " blown pupil is an ominous sign of rapidly increasing intracranial pressure and impending brainstem compression. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs"
      }, {
        "text": ":\u003c/b\u003e Often accompanied by other signs of a CN III palsy, such as ptosis and a \\\"down and out\\\" deviation"
      }, {
        "text": " of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with head trauma and a deteriorating level of consciousness, the"
      }, {
        "text": " sudden appearance of a unilateral fixed and dilated pupil indicates uncal herniation and requires immediate intervention.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eA \u003cb\u003eblown pupil\u003c/b\u003e is a neurological red flag, signaling compression of the parasympathetic fibers on"
      }, {
        "text": " the outside of the oculomotor nerve, most often by uncal herniation or a PComA aneurysm, and indicates"
      }, {
        "text": " a dire, time-sensitive emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Un"
      }, {
        "text": "cal Herniation); B --Compresses--\u003e C(CN III Parasympathetic Fibers); C --\u003e D(Loss of Pupillary Const"
      }, {
        "text": "riction); D --\u003e E(Fixed, Dilated Pupil);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_ner"
      }, {
        "text": "ve_compression\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        "
      }, {
        "text": "\"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"aebb10eb\": {\n    \"title\": \"Blowout Fracture"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Tra"
      }, {
        "text": "uma\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Trauma\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a traumatic fracture of the walls"
      }, {
        "text": " of the orbit, most commonly the orbital floor, caused by a sudden increase in intraorbital pressure from a direct blow to the globe ("
      }, {
        "text": "e.g., from a fist or a ball).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e"
      }, {
        "text": " A blunt, non-penetrating force strikes the globe, transmitting pressure throughout the orbit. The thin orbital floor (roof"
      }, {
        "text": " of the maxillary sinus) and/or medial wall (lamina papyracea of the ethmoid sinus) fracture,"
      }, {
        "text": " or \u0027blow out.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with periorbital pain, swelling, and ecchymosis."
      }, {
        "text": " Key signs include \u003cmark\u003ediplopia on upward gaze\u003c/mark\u003e and numbness of the cheek and upper teeth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle"
      }, {
        "text": " Entrapment:\u003c/b\u003e The fracture can entrap the \u003cmark\u003einferior rectus muscle\u003c/mark\u003e and/or orbital fat"
      }, {
        "text": ". This entrapment restricts upward movement of the eye, causing vertical diplopia, especially on upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Injury:\u003c/b\u003e The fracture of the orbital floor can damage the \u003cmark\u003einfraorbital nerve\u003c/mark\u003e (a branch"
      }, {
        "text": " of CN V\u003csub\u003e2\u003c/sub\u003e), leading to paresthesia or numbness of the ipsilateral cheek, upper lip, and upper"
      }, {
        "text": " gingiva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a history of blunt eye trauma, diplopia on upward gaze,"
      }, {
        "text": " and numbness of the cheek is classic for an orbital blowout fracture with inferior rectus entrapment and infraorbital nerve injury.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a hydraulic fracture of the thin orbital floor"
      }, {
        "text": ", where the force of a blow to the eye is transmitted to the surrounding bone, leading to entrapment of the inferior rectus"
      }, {
        "text": " muscle and injury to the infraorbital nerve, manifesting as an inability to look up and a numb cheek.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause_"
      }, {
        "text": "entrapment_of\",\n        \"to\": \"inferior_rectus_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_cause_injury_to\",\n        \"to\": \"infraorbital_nerve"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9"
      }, {
        "text": "914d433\"\n      }\n    ]\n  },\n  \"86953"
      }, {
        "text": "5a9\": {\n    \"title\": \"Bone Morphogenetic Protein (BMP)\",\n    \"primaryType\": \""
      }, {
        "text": "molecule\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Developmental Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Proteins (BMPs)\u003c/b\u003e are a group of growth"
      }, {
        "text": " factors belonging to the transforming growth factor-beta (TGF-Œ≤) superfamily. In neuroembryology, they play a crucial role"
      }, {
        "text": " in establishing the dorsal-ventral axis of the neural tube by inducing the development of the dorsal structures.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the overlying ectoderm, BMPs act as a signaling"
      }, {
        "text": " molecule that patterns the dorsal neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsalization:\u003c/b\u003e High concentrations of BMPs induce the formation of the"
      }, {
        "text": " \u003cmark\u003e[[43be7a6e|alar plate]]\u003c/mark\u003e, which gives rise to sensory neurons"
      }, {
        "text": " in the dorsal horn of the spinal cord and sensory nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The ventral"
      }, {
        "text": "izing signal is \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, which is secreted by the notochord and induces"
      }, {
        "text": " the formation of the [[253e3efb|basal plate]] (motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGradient"
      }, {
        "text": " Effect:\u003c/b\u003e The opposing gradients of BMP (high dorsally) and SHH (high ventrally) establish the distinct"
      }, {
        "text": " sensory (dorsal) and motor (ventral) domains of the developing central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Remember the source and effect: BMP from the ectoderm (roof) induces the dorsal/sensory al"
      }, {
        "text": "ar plate. SHH from the notochord (floor) induces the ventral/motor basal plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Protein\u003c/b\u003e acts as the key \u0027dorsalizing\u0027 signal in the"
      }, {
        "text": " developing neural tube, instructing the dorsal region to become the sensory [[43be7a6e|alar plate]],"
      }, {
        "text": " thereby establishing the fundamental sensory-motor polarity of the central nervous system in opposition to the ventralizing signal, Sonic Hedgehog.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Ectoderm] --Secretes--\u003e B(BMPs); B --Induces--\u003e C"
      }, {
        "text": "(Dorsal Neural Tube); C --\u003e D(Alar Plate); D --\u003e E(Sensory Neurons);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to\":"
      }, {
        "text": " \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_counter"
      }, {
        "text": "acted_by\",\n        \"to\": \"sonic_hedgehog\"\n      },\n      {\n        \"type\": \"is_secreted"
      }, {
        "text": "_by\",\n        \"to\": \"ectoderm\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "84b10400\": {\n    \"title\": \"Botulinum Toxin\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Microbiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e is a potent neurotoxin produced by the bacterium \u003ci\u003eClostridium"
      }, {
        "text": " botulinum\u003c/i\u003e. It causes flaccid paralysis by inhibiting the presynaptic release of [[6a005"
      }, {
        "text": "559|acetylcholine]] at the neuromuscular junction. In small, purified doses, it is used therapeutically for a"
      }, {
        "text": " variety of medical and cosmetic purposes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The"
      }, {
        "text": " toxin is a protease that cleaves \u003cmark\u003eSNARE proteins\u003c/mark\u003e (e.g., SNAP-25,"
      }, {
        "text": " synaptobrevin), which are essential for the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This prevents ACh"
      }, {
        "text": " release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSpasticity/Dystonia:\u003c/b\u003e Treats"
      }, {
        "text": " focal dystonias (e.g., torticollis, blepharospasm), spasticity in [[17"
      }, {
        "text": "1ca00b|cerebral palsy]] and [[45dd6d19|multiple sclerosis]].\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003ePain:\u003c/b\u003e Prophylaxis for chronic [[c8833bae|migraine headaches]].\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Other:\u003c/b\u003e Hyperhidrosis (excessive sweating), strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCosmetic Use:\u003c/b\u003e In"
      }, {
        "text": "jected to reduce facial wrinkles by temporarily paralyzing underlying muscles (Botox).\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Botulism):\u003c/b\u003e In"
      }, {
        "text": "gestion of the toxin (e.g., from improperly canned foods) causes botulism, a life-threatening illness"
      }, {
        "text": " characterized by descending flaccid paralysis, diplopia, dysphagia, and respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember that botulinum toxin causes a \u003cu\u003epresynaptic\u003c/u\u003e blockade of ACh release, which contrasts with myasthenia gravis ("
      }, {
        "text": "postsynaptic receptor blockade) and Lambert-Eaton syndrome (presynaptic Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e induces paralysis by enzymatically snipping the SNARE proteins required for acetylcholine"
      }, {
        "text": " release at the neuromuscular junction; this potent biological mechanism is harnessed in medicine to selectively weaken overactive muscles in conditions from dystonia to cosmetic"
      }, {
        "text": " wrinkles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Botulinum Toxin] --\u003e B("
      }, {
        "text": "Cleaves SNARE Proteins); B --x C(Vesicle Fusion); C --x D(ACh Release); D --"
      }, {
        "text": "x E(Muscle Contraction); E --\u003e F(Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"inhibits_release_of\",\n        \"to\": \"6a005559\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"dystonia\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_produced_by\",\n        \"to\": \"clostridium_botulinum\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "role": "user",
      "tokenCount": 2212,
      "inlineFile": {
        "mimeType": "application/json",
        "data": "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"
      }
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"ac55d026\": {\n    \"title\": \"Brachioradialis Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow and supination of the forearm when the brachioradialis tendon is tapped at the styloid process of the radius. It is used to test the integrity of the \u003cmark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC6\u003c/b\u003e nerve root, with a contribution from C5. Mnemonic: C5, \u003cb\u003e6\u003c/b\u003e, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the brachioradialis muscle. The afferent signal travels via the radial nerve to the C5/C6 spinal cord segments, synapses with a motor neuron, and the efferent signal returns via the radial nerve to cause muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C6 root or a peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5/C6 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The brachioradialis reflex, along with the biceps reflex, is a key part of assessing the C5 and C6 nerve roots.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a specific test for the C5-C6 nerve roots, elicited by tapping the distal radius, which provides valuable information for localizing lesions within the cervical spine and brachial plexus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Brachioradialis Tendon] --\u003e B(Stretch Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Elbow Flexion/Forearm Supination);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"a584135d\": {\n    \"title\": \"Brain\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the central organ of the human nervous system, responsible for thought, memory, emotion, touch, motor skills, vision, breathing, temperature, hunger, and every process that regulates our body. It is composed of the cerebrum, cerebellum, and brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Develops from the rostral part of the neural tube, which differentiates into the forebrain (prosencephalon), midbrain (mesencephalon), and hindbrain (rhombencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Parts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebrum:\u003c/b\u003e The largest part, divided into two hemispheres, responsible for higher cognitive functions.\u003cbr\u003e - \u003cb\u003eCerebellum:\u003c/b\u003e Located under the cerebrum, coordinates muscle movements and balance.\u003cbr\u003e - \u003cb\u003eBrainstem:\u003c/b\u003e Connects the cerebrum and cerebellum to the spinal cord, controlling many automatic functions like breathing and heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the anterior circulation (from internal carotid arteries) and posterior circulation (from vertebral arteries), which connect via the [[e22300e8|Circle of Willis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Can be affected by a wide range of pathologies including [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], [[be057cfc|tumors]], trauma, infection, and neurodegenerative diseases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the functional localization within the brain (e.g., motor/sensory homunculus, language areas) and the vascular territories is crucial for solving clinical neurology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the command center of the body, where intricate networks of neurons process information and control function, with specific regions highly specialized for distinct tasks, making the clinical presentation of brain lesions highly predictable based on their location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"1777e176\": {\n    \"title\": \"Brain Death\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Coma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e is the irreversible cessation of all functions of the entire brain, including the brainstem. It is a legal and clinical definition of death, distinct from a persistent vegetative state where brainstem functions may be intact.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCriteria:\u003c/b\u003e Diagnosis requires evidence of an irreversible cause of coma, absence of confounding factors (e.g., hypothermia, drug intoxication), and the absence of all brainstem reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Reflexes Tested:\u003c/b\u003e Pupillary light reflex, corneal reflex, oculocephalic reflex (doll\u0027s eyes), oculovestibular reflex (cold caloric), gag reflex, and cough reflex must all be absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eApnea Test:\u003c/b\u003e A definitive test where the patient is disconnected from the ventilator to see if a rise in PaCO\u003csub\u003e2\u003c/sub\u003e stimulates a spontaneous respiratory effort. Absence of breathing despite a high PaCO\u003csub\u003e2\u003c/sub\u003e confirms apnea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion:\u003c/b\u003e In brain death, [[3eca3f19|cerebral perfusion pressure (CPP)]] is zero, meaning there is no cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEthical/Legal Status:\u003c/b\u003e A patient who meets the criteria for brain death is legally and medically deceased, even if their heart continues to beat with mechanical ventilation. This allows for the cessation of life support and consideration of organ donation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e signifies the irreversible loss of function of the entire brain, including the brainstem, which is confirmed by the absence of all brainstem reflexes and a positive apnea test, establishing legal death despite ongoing cardiac activity on life support.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_defined_by\",\n        \"to\": \"absence_of_brainstem_reflexes\"\n      },\n      {\n        \"type\": \"is_confirmed_by\",\n        \"to\": \"apnea_test\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\": \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"e9a47751\": {\n    \"title\": \"Brain Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e is damage to the brain that can result from a traumatic force (Traumatic Brain Injury, TBI) or a non-traumatic event (e.g., stroke, anoxia). The clinical effects depend on the mechanism, location, and severity of the injury.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTraumatic Brain Injury (TBI):\u003c/b\u003e Includes concussions, contusions, [[22b22e08|diffuse axonal injury]], and intracranial hemorrhages (epidural, subdural). Caused by external forces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Traumatic Brain Injury:\u003c/b\u003e Includes [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], anoxic brain injury (e.g., from cardiac arrest), infections, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary vs. Secondary Injury:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePrimary Injury:\u003c/b\u003e The initial damage that occurs at the moment of impact or insult (e.g., shearing of axons, laceration of vessels).\u003cbr\u003e - \u003cb\u003eSecondary Injury:\u003c/b\u003e A cascade of molecular and inflammatory events that occur in the hours and days following the primary injury (e.g., cerebral edema, excitotoxicity, inflammation), which often worsens the overall outcome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e The neurological deficits from a stroke are highly predictable based on the affected [[105efab1|arterial supply]] and the function of the brain region it perfuses (e.g., [[143bb23d|MCA stroke]] causing contralateral face/arm weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the vascular territories of the major cerebral arteries ([[830c856c|ACA]], [[143bb23d|MCA]], [[b6a2cc31|PCA]]) is essential for localizing stroke lesions based on clinical symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e encompasses a spectrum of damage from various causes, with the final clinical outcome determined not only by the initial insult but also by the subsequent cascade of secondary injury processes like edema and inflammation, which are major targets for neuroprotective therapies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      {\n        \"type\": \"can_be_localized_by\",\n        \"to\": \"105efab1\"\n      }\n    ]\n  },\n  \"582d8572\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentral View:\u003c/b\u003e Shows the cerebral peduncles (midbrain), the bulging pons, and the pyramids (medulla). Cranial nerves can be seen exiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsal View:\u003c/b\u003e Shows the superior and inferior colliculi (midbrain) and the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"contains_nuclei_for\",\n        \"to\": \"cranial_nerves\"\n      }\n    ]\n  },\n  \"32ba61d1\": {\n    \"title\": \"Brainstem and Cerebellar Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrainstem and Cerebellar Syndromes\u003c/b\u003e are collections of neurological signs and symptoms that result from lesions (typically strokes or tumors) affecting specific anatomical locations within the brainstem or cerebellum. Their presentations are highly predictable based on the structures involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLateral Medullary (Wallenberg) Syndrome:\u003c/b\u003e Caused by a PICA stroke. Presents with vertigo, nystagmus, ipsilateral ataxia, dysphagia, hoarseness, ipsilateral Horner syndrome, ipsilateral facial pain/temp loss, and contralateral body pain/temp loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Pontine Syndrome:\u003c/b\u003e Caused by an AICA stroke. Similar to Wallenberg but includes ipsilateral facial paralysis (CN VII) and deafness (CN VIII), and lacks dysphagia/hoarseness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Medullary Syndrome:\u003c/b\u003e Caused by an ASA stroke. Presents with contralateral hemiparesis, contralateral loss of proprioception/vibration, and ipsilateral tongue deviation (CN XII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Can cause various brainstem and cerebellar syndromes due to its demyelinating plaques. A classic MS-related syndrome is \u003cmark\u003e[[58c684bd|internuclear ophthalmoplegia (INO)]]\u003c/mark\u003e from a lesion in the medial longitudinal fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Learn to differentiate the lateral syndromes: PICA (medulla) involves CN IX/X (dysphagia/hoarseness), while AICA (pons) involves CN VII/VIII (facial palsy/deafness).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical diagnosis of \u003cb\u003ebrainstem and cerebellar syndromes\u003c/b\u003e is a classic exercise in neuroanatomical localization, where a specific constellation of cranial nerve deficits, long tract signs, and cerebellar findings can pinpoint a lesion to a precise vascular territory or location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral_medullary_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"be057cfc\": {\n    \"title\": \"Brain Tumors\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain tumors\u003c/b\u003e are neoplasms originating in the intracranial tissues. They can be primary (arising from brain cells) or metastatic (spreading from cancers elsewhere in the body). Their clinical presentation depends on their location, size, and growth rate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAdult Primary Tumors:\u003c/b\u003e Most are supratentorial. In order of frequency: [[b6bbd0bc|Glioblastoma]], [[e98ea0ba|Meningioma]], [[03ecb69e|Schwannoma]], Oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChildhood Primary Tumors:\u003c/b\u003e Most are infratentorial. In order of frequency: Pilocytic astrocytoma, [[16d613bb|Medulloblastoma]], [[14365ef4|Ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastatic Tumors:\u003c/b\u003e More common than primary tumors. Often present as multiple, well-circumscribed lesions at the gray-white junction. Common primary sources are \u003cmark\u003eLung, Breast, Kidney, Melanoma, and Colon\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Symptoms:\u003c/b\u003e Headaches (often worse in the morning), seizures, and focal neurological deficits corresponding to the tumor\u0027s location.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A ring-enhancing lesion on MRI with contrast is a key finding. The differential includes [[b6bbd0bc|glioblastoma]], metastasis, and abscess. A \u0027butterfly\u0027 appearance crossing the corpus callosum is classic for glioblastoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe classification and prognosis of \u003cb\u003ebrain tumors\u003c/b\u003e differ significantly between adults and children, with adults more commonly developing aggressive supratentorial gliomas and children typically having more benign infratentorial tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e98ea0ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"03ecb69e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"14365ef4\"\n      }\n    ]\n  },\n  \"af9d783c\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCross Sections:\u003c/b\u003e Recognizing the key structures in cross sections of the midbrain, pons, and medulla is essential for localizing brainstem strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHerniation Syndromes:\u003c/b\u003e The brainstem is vulnerable to compression during [[8c0728b7|herniation syndromes]], which can lead to coma and death (e.g., Duret hemorrhages from central herniation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"is_compressed_in\",\n        \"to\": \"8c0728b7\"\n      }\n    ]\n  },\n  \"0f0fbfa0\": {\n    \"title\": \"Branch Retinal Vein Occlusion (BRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Occlusion (BRVO)\u003c/b\u003e is the blockage of a small vein in the retina, leading to hemorrhage, edema, and potential vision loss in the quadrant of the retina drained by that vein.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly occurs at an \u003cmark\u003earteriovenous (AV) crossing\u003c/mark\u003e, where a hardened, atherosclerotic retinal arteriole compresses the adjacent, thinner-walled venule, leading to turbulent flow and thrombus formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral vision loss, which may be described as a scotoma (blind spot) or blurry vision in a specific part of the visual field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Fundoscopic exam reveals \u003cmark\u003esectoral (quadrantic) retinal hemorrhages\u003c/mark\u003e, venous engorgement, and cotton-wool spots confined to the area drained by the occluded vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from Central Retinal Vein Occlusion (CRVO), which involves the entire retina and has a more dramatic \\\"blood and thunder\\\" appearance. BRVO is localized to a quadrant. The key association is hypertension causing AV nicking.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Occlusion\u003c/b\u003e is a consequence of systemic vascular disease playing out in the eye, where a stiff arteriole compresses a venule at a crossing point, causing a localized \u0027traffic jam\u0027 of blood that results in a sectoral retinal hemorrhage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Arteriolar Sclerosis); B --\u003e C(Compression of Vein at AV Crossing); C --\u003e D(Thrombus Formation); D --\u003e E(Branch Retinal Vein Occlusion); E --\u003e F(Sectoral Hemorrhage \u0026 Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"b69e35b5\"\n      }\n    ]\n  },\n  \"2fcee185\": {\n    \"title\": \"Brimonidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is a highly selective \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used as a topical eye drop to lower intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Has a dual mechanism. It primarily \u003cmark\u003edecreases aqueous humor synthesis\u003c/mark\u003e by stimulating Œ±\u003csub\u003e2\u003c/sub\u003e receptors on the ciliary body. It also \u003cmark\u003eincreases uveoscleral outflow\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A common agent for the long-term management of [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include allergic conjunctivitis, hyperemia (redness), and pruritus (itching). Systemic side effects are possible due to absorption and include dry mouth, sedation, and fatigue. Unlike apraclonidine, it does not cause mydriasis and can be used in angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[c1f67280|apraclonidine]] but is more selective for the Œ±\u003csub\u003e2\u003c/sub\u003e receptor and has a lower incidence of allergic reactions and tachyphylaxis, making it more suitable for long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e agonists like brimonidine and clonidine act as sympatholytics, reducing sympathetic outflow. In the eye, this leads to decreased aqueous humor production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is an effective glaucoma medication that lowers intraocular pressure through a dual mechanism of decreasing aqueous humor production and increasing its outflow, all mediated by its selective Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brimonidine] --\u003e B(Stimulates Œ±2 Receptors); B --\u003e C(‚Üì Aqueous Humor Synthesis); B --\u003e D(‚Üë Uveoscleral Outflow); C \u0026 D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"c1f67280\"\n      }\n    ]\n  },\n  \"4dff096f\": {\n    \"title\": \"Broad-Spectrum Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are antiepileptic drugs (AEDs) that are effective against a wide variety of seizure types, including both focal and generalized seizures (e.g., tonic-clonic, absence, myoclonic).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Agents:\u003c/b\u003e The main broad-spectrum agents are \u003cmark\u003e[[valproic_acid|Valproic acid]]\u003c/mark\u003e, \u003cmark\u003e[[08d19a8f|Lamotrigine]]\u003c/mark\u003e, \u003cmark\u003e[[2341f9c0|Levetiracetam]]\u003c/mark\u003e, and \u003cmark\u003e[[e1f5066c|Topiramate]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e They are the drugs of choice when the seizure type is unclear or when a patient has multiple seizure types (e.g., Lennox-Gastaut syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eValproic Acid:\u003c/b\u003e Very broad spectrum, effective for almost all seizure types. Mechanism involves Na\u003csup\u003e+\u003c/sup\u003e channel blockade, T-type Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade, and increasing GABA levels. Highly teratogenic (neural tube defects).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLamotrigine:\u003c/b\u003e Broad spectrum, but must be titrated slowly to reduce the risk of Stevens-Johnson syndrome (SJS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevetiracetam:\u003c/b\u003e Very commonly used due to its favorable side effect profile and broad efficacy. Unique mechanism involving synaptic vesicle protein 2A (SV2A).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a question asks for the best initial treatment for a patient with generalized tonic-clonic seizures, a broad-spectrum agent like valproic acid or levetiracetam is a strong choice. Valproic acid is also a first-line option for myoclonic seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are the versatile workhorses of epilepsy treatment, effective against both focal and generalized seizures, making them ideal for initial empirical therapy or for patients with complex epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_class_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"08d19a8f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2341f9c0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e1f5066c\"\n      }\n    ]\n  },\n  \"7f6ed344\": {\n    \"title\": \"Broca\u0027s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, also known as expressive aphasia, is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [[a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and effortful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Repetition is impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca (mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-speech planning center. The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Broca\u0027s Area] --\u003e B(Impaired Speech Production); B --\u003e C(Nonfluent, Telegraphic Speech); A --Spares--\u003e D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"a3bbace2\": {\n    \"title\": \"Broca\u0027s Area\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is a region in the frontal lobe of the dominant hemisphere (usually the left) of the brain with functions linked to speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the \u003cmark\u003einferior frontal gyrus\u003c/mark\u003e of the dominant hemisphere (Brodmann areas 44 and 45).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Responsible for the motor planning and execution of speech. It coordinates the movements of the larynx, tongue, and lips necessary for articulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Damage to this area results in [[7f6ed344|Broca\u0027s aphasia]] (expressive aphasia), characterized by nonfluent, agrammatical speech with intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection:\u003c/b\u003e It is connected to [[wernicke_area|Wernicke\u0027s area]] (language comprehension) by a bundle of nerve fibers called the arcuate fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke affecting the left MCA is the most common cause of damage to Broca\u0027s area. Because of its proximity to the primary motor cortex, [[7f6ed344|Broca\u0027s aphasia]] is often accompanied by contralateral weakness of the face and arm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is the brain\u0027s \u0027speech production factory,\u0027 translating thoughts and concepts from Wernicke\u0027s area into the precise motor commands needed for fluent articulation; a lesion here breaks the production line, resulting in expressive aphasia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Wernicke\u0027s Area - Comprehension] --Arcuate Fasciculus--\u003e B(Broca\u0027s Area); B --Motor Plan--\u003e C(Primary Motor Cortex); C --\u003e D(Speech Articulation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_connected_to\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n  },\n  \"d24a5ff0\": {\n    \"title\": \"Bromocriptine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is an ergot derivative that acts as a \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is used to treat conditions associated with hyperprolactinemia and [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates dopamine D\u003csub\u003e2\u003c/sub\u003e receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Endocrinology):\u003c/b\u003e Treats hyperprolactinemia and prolactinomas by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the anterior pituitary, which inhibits prolactin secretion. Also used for acromegaly as it can suppress GH secretion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used as an adjunctive therapy in [[58c8ea03|Parkinson disease]] to stimulate dopamine receptors in the striatum. It is an ergot derivative and is less commonly used now than non-ergot agonists (e.g., pramipexole, ropinirole) due to its side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, vomiting, postural hypotension, and headache. As an ergot derivative, it can cause pulmonary fibrosis and vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bromocriptine is a classic treatment for prolactinomas. Remember that dopamine tonically inhibits prolactin release, so a dopamine agonist will lower prolactin levels.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is a dopamine D\u003csub\u003e2\u003c/sub\u003e agonist that leverages dopamine\u0027s inhibitory control over prolactin to treat hyperprolactinemia and supplements dopamine signaling in the basal ganglia to treat Parkinson disease, though its use is limited by its ergot-related side effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"acromegaly\"\n      }\n    ]\n  },\n  \"4792bc68\": {\n    \"title\": \"Brown-S√©quard Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is a rare neurological condition caused by \u003ci\u003ehemisection of the spinal cord\u003c/i\u003e, resulting in a characteristic pattern of ipsilateral motor and proprioceptive loss, and contralateral pain and temperature sensory loss below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Typically caused by trauma, such as a penetrating injury (e.g., stab wound) or a tumor compressing one half of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at and below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMotor:\u003c/b\u003e Ipsilateral spastic paralysis below the lesion (corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensation:\u003c/b\u003e Ipsilateral loss of proprioception, vibration, and fine touch below the lesion ([[e7f5cbbe|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSensation:\u003c/b\u003e Contralateral loss of pain and temperature sensation, typically beginning 1-2 segments below the lesion (spinothalamic tract damage, as fibers decussate in the spinal cord).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficits at the Level of the Lesion:\u003c/b\u003e\u003cbr\u003e - Ipsilateral flaccid paralysis (LMN damage at that level).\u003cbr\u003e - Ipsilateral complete loss of all sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This syndrome is a classic test of spinal cord tract anatomy. The key is remembering which tracts cross in the medulla (dorsal columns, corticospinal) versus the spinal cord (spinothalamic). If the lesion is above T1, an ipsilateral [[c19010a3|Horner syndrome]] may also be present.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is the ultimate clinical demonstration of spinal cord neuroanatomy, creating a striking dissociation of deficits where one side of the body loses motor function and proprioception, while the other side loses the ability to feel pain and temperature, all due to a unilateral cord lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord Hemisection at T10]; A --\u003e B(Ipsilateral (Right) Deficits); B --\u003e C(Loss of Motor, Proprioception, Vibration below T10); B --\u003e D(Flaccid paralysis at T10); A --\u003e E(Contralateral (Left) Deficits); E --\u003e F(Loss of Pain \u0026 Temperature below T10);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"spinal_cord_hemisection\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10043,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"ac55d026\": {\n    \"title\": \"Br"
      }, {
        "text": "achioradialis Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sp"
      }, {
        "text": "inal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex"
      }, {
        "text": "\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow and supination of the forearm when the brachioradialis tendon"
      }, {
        "text": " is tapped at the styloid process of the radius. It is used to test the integrity of the \u003cmark\u003eC5 and C6"
      }, {
        "text": "\u003c/mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC6\u003c/b\u003e nerve root, with a contribution from C5. Mnemonic: C"
      }, {
        "text": "5, \u003cb\u003e6\u003c/b\u003e, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the brachioradialis muscle"
      }, {
        "text": ". The afferent signal travels via the radial nerve to the C5/C6 spinal cord segments, synapses with a"
      }, {
        "text": " motor neuron, and the efferent signal returns via the radial nerve to cause muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/"
      }, {
        "text": "Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C6 root or a"
      }, {
        "text": " peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a"
      }, {
        "text": " stroke or spinal cord injury above the C5/C6 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The brachioradialis reflex,"
      }, {
        "text": " along with the biceps reflex, is a key part of assessing the C5 and C6 nerve roots.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a specific test for the C5-"
      }, {
        "text": "C6 nerve roots, elicited by tapping the distal radius, which provides valuable information for localizing lesions within the cervical spine and brachial"
      }, {
        "text": " plexus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Brachioradialis Tendon]"
      }, {
        "text": " --\u003e B(Stretch Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C5/C6 Spinal"
      }, {
        "text": " Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Elbow Flexion/Forearm Supination);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \""
      }, {
        "text": "to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_"
      }, {
        "text": "root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"a584135d\": {\n    \"title\": \"Brain\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrain"
      }, {
        "text": "\u003c/b\u003e is the central organ of the human nervous system, responsible for thought, memory, emotion, touch, motor skills, vision, breathing"
      }, {
        "text": ", temperature, hunger, and every process that regulates our body. It is composed of the cerebrum, cerebellum, and brain"
      }, {
        "text": "stem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Develops from the rostr"
      }, {
        "text": "al part of the neural tube, which differentiates into the forebrain (prosencephalon), midbrain (mesencephalon), and"
      }, {
        "text": " hindbrain (rhombencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Parts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebrum:\u003c/b\u003e"
      }, {
        "text": " The largest part, divided into two hemispheres, responsible for higher cognitive functions.\u003cbr\u003e - \u003cb\u003eCerebellum:\u003c/b\u003e Located"
      }, {
        "text": " under the cerebrum, coordinates muscle movements and balance.\u003cbr\u003e - \u003cb\u003eBrainstem:\u003c/b\u003e Connects the cerebrum and"
      }, {
        "text": " cerebellum to the spinal cord, controlling many automatic functions like breathing and heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied"
      }, {
        "text": " by the anterior circulation (from internal carotid arteries) and posterior circulation (from vertebral arteries), which connect via the [[e"
      }, {
        "text": "22300e8|Circle of Willis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Can be affected by a"
      }, {
        "text": " wide range of pathologies including [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|"
      }, {
        "text": "hemorrhagic strokes]], [[be057cfc|tumors]], trauma, infection, and neurodegenerative diseases."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the functional localization within the brain (e.g., motor/sensory hom"
      }, {
        "text": "unculus, language areas) and the vascular territories is crucial for solving clinical neurology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the command center of the body, where intricate networks of neurons process"
      }, {
        "text": " information and control function, with specific regions highly specialized for distinct tasks, making the clinical presentation of brain lesions highly predictable based on their"
      }, {
        "text": " location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"develops_from\",\n        \"to\": \"neural_tube\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_affected_by\",\n        \"to\": \"c5da3c"
      }, {
        "text": "57\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n"
      }, {
        "text": "        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"177"
      }, {
        "text": "7e176\": {\n    \"title\": \"Brain Death\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Com"
      }, {
        "text": "a\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e is the irreversible cessation of"
      }, {
        "text": " all functions of the entire brain, including the brainstem. It is a legal and clinical definition of death, distinct from a"
      }, {
        "text": " persistent vegetative state where brainstem functions may be intact.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCriteria"
      }, {
        "text": ":\u003c/b\u003e Diagnosis requires evidence of an irreversible cause of coma, absence of confounding factors (e.g., hypothermia, drug"
      }, {
        "text": " intoxication), and the absence of all brainstem reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Reflexes Tested:\u003c/b\u003e Pupillary light reflex,"
      }, {
        "text": " corneal reflex, oculocephalic reflex (doll\u0027s eyes), oculovestibular reflex (cold caloric), gag"
      }, {
        "text": " reflex, and cough reflex must all be absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eApnea Test:\u003c/b\u003e A definitive test where the patient is disconnected from the"
      }, {
        "text": " ventilator to see if a rise in PaCO\u003csub\u003e2\u003c/sub\u003e stimulates a spontaneous respiratory effort. Absence of breathing despite a high PaCO\u003csub\u003e2\u003c/sub\u003e confirms apnea"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion:\u003c/b\u003e In brain death, [[3eca3f19|cerebral perfusion"
      }, {
        "text": " pressure (CPP)]] is zero, meaning there is no cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEthical/Legal Status"
      }, {
        "text": ":\u003c/b\u003e A patient who meets the criteria for brain death is legally and medically deceased, even if their heart continues to beat with"
      }, {
        "text": " mechanical ventilation. This allows for the cessation of life support and consideration of organ donation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Brain death\u003c/b\u003e signifies the irreversible loss of function of the entire brain, including the brainstem, which is confirmed by the absence of all brainstem reflexes"
      }, {
        "text": " and a positive apnea test, establishing legal death despite ongoing cardiac activity on life support.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_defined_by\",\n        \"to\": \"absence_of_brain"
      }, {
        "text": "stem_reflexes\"\n      },\n      {\n        \"type\": \"is_confirmed_by\",\n        \"to\":"
      }, {
        "text": " \"apnea_test\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\":"
      }, {
        "text": " \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"e9a4"
      }, {
        "text": "7751\": {\n    \"title\": \"Brain Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Tra"
      }, {
        "text": "uma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e is"
      }, {
        "text": " damage to the brain that can result from a traumatic force (Traumatic Brain Injury, TBI) or a non-traumatic event"
      }, {
        "text": " (e.g., stroke, anoxia). The clinical effects depend on the mechanism, location, and severity of the injury.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTraumatic Brain Injury (TBI):\u003c/b\u003e Includes conc"
      }, {
        "text": "ussions, contusions, [[22b22e08|diffuse axonal injury]], and intracranial hemorrhages (epid"
      }, {
        "text": "ural, subdural). Caused by external forces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Traumatic Brain Injury:\u003c/b\u003e Includes [["
      }, {
        "text": "c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], an"
      }, {
        "text": "oxic brain injury (e.g., from cardiac arrest), infections, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary vs. Secondary Injury:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003ePrimary Injury:\u003c/b\u003e The initial damage that occurs at the moment of impact or insult (e.g., shearing of"
      }, {
        "text": " axons, laceration of vessels).\u003cbr\u003e - \u003cb\u003eSecondary Injury:\u003c/b\u003e A cascade of molecular and inflammatory events"
      }, {
        "text": " that occur in the hours and days following the primary injury (e.g., cerebral edema, excitotoxicity, inflammation),"
      }, {
        "text": " which often worsens the overall outcome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e The neurological deficits from a stroke are highly predictable based on the affected"
      }, {
        "text": " [[105efab1|arterial supply]] and the function of the brain region it perfuses (e.g., [["
      }, {
        "text": "143bb23d|MCA stroke]] causing contralateral face/arm weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the vascular territories"
      }, {
        "text": " of the major cerebral arteries ([[830c856c|ACA]], [[143bb23"
      }, {
        "text": "d|MCA]], [[b6a2cc31|PCA]]) is essential for localizing stroke lesions based on clinical symptoms"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e encompasses a spectrum of damage from various"
      }, {
        "text": " causes, with the final clinical outcome determined not only by the initial insult but also by the subsequent cascade of secondary injury processes like"
      }, {
        "text": " edema and inflammation, which are major targets for neuroprotective therapies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"c5da3c57\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e0"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"can_be_localized_by\",\n        \"to\":"
      }, {
        "text": " \"105efab1\"\n      }\n    ]\n  },\n  \"582d8"
      }, {
        "text": "572\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that"
      }, {
        "text": " is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the"
      }, {
        "text": " pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending ("
      }, {
        "text": "motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nucle"
      }, {
        "text": "i:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains"
      }, {
        "text": " the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control"
      }, {
        "text": " in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentral View:\u003c/b\u003e Shows the cerebral peduncles (midbrain), the bulging"
      }, {
        "text": " pons, and the pyramids (medulla). Cranial nerves can be seen exiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsal View:\u003c/b\u003e Shows the superior"
      }, {
        "text": " and inferior colliculi (midbrain) and the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above"
      }, {
        "text": " the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII);"
      }, {
        "text": " and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body"
      }, {
        "text": ", housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e"
      }, {
        "text": " D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed"
      }, {
        "text": "_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"contains_nuclei_for\",\n        \"to\": \"cranial_nerves\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"32ba61d1\": {\n    \"title"
      }, {
        "text": "\": \"Brainstem and Cerebellar Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrainstem and Cerebellar Syndromes\u003c/b\u003e are collections of neurological signs"
      }, {
        "text": " and symptoms that result from lesions (typically strokes or tumors) affecting specific anatomical locations within the brainstem or cerebellum. Their"
      }, {
        "text": " presentations are highly predictable based on the structures involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLateral"
      }, {
        "text": " Medullary (Wallenberg) Syndrome:\u003c/b\u003e Caused by a PICA stroke. Presents with vertigo, nystagmus, ips"
      }, {
        "text": "ilateral ataxia, dysphagia, hoarseness, ipsilateral Horner syndrome, ipsilateral facial pain/temp loss, and contralateral body"
      }, {
        "text": " pain/temp loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Pontine Syndrome:\u003c/b\u003e Caused by an AICA stroke. Similar to Wall"
      }, {
        "text": "enberg but includes ipsilateral facial paralysis (CN VII) and deafness (CN VIII), and lacks dysphagia/hoarseness."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Medullary Syndrome:\u003c/b\u003e Caused by an ASA stroke. Presents with contralateral hemiparesis, contralateral"
      }, {
        "text": " loss of proprioception/vibration, and ipsilateral tongue deviation (CN XII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Can"
      }, {
        "text": " cause various brainstem and cerebellar syndromes due to its demyelinating plaques. A classic MS-related syndrome is \u003cmark\u003e[["
      }, {
        "text": "58c684bd|internuclear ophthalmoplegia (INO)]]\u003c/mark\u003e from a lesion in the medial"
      }, {
        "text": " longitudinal fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Learn to differentiate the lateral syndromes: PICA (med"
      }, {
        "text": "ulla) involves CN IX/X (dysphagia/hoarseness), while AICA (pons) involves CN VII/"
      }, {
        "text": "VIII (facial palsy/deafness).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical diagnosis"
      }, {
        "text": " of \u003cb\u003ebrainstem and cerebellar syndromes\u003c/b\u003e is a classic exercise in neuroanatomical localization, where a specific constellation of cranial"
      }, {
        "text": " nerve deficits, long tract signs, and cerebellar findings can pinpoint a lesion to a precise vascular territory or location.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral"
      }, {
        "text": "_medullary_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"lateral_pontine_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_be_caused_by\",\n        \"to\": \"45dd6d19\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"be057cfc\": {\n    \"title\": \"Brain Tumors"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain tumors\u003c/b\u003e are neoplasms originating in the intracranial"
      }, {
        "text": " tissues. They can be primary (arising from brain cells) or metastatic (spreading from cancers elsewhere in the body). Their"
      }, {
        "text": " clinical presentation depends on their location, size, and growth rate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAdult"
      }, {
        "text": " Primary Tumors:\u003c/b\u003e Most are supratentorial. In order of frequency: [[b6bbd0bc"
      }, {
        "text": "|Glioblastoma]], [[e98ea0ba|Meningioma]], [[03ecb69e|Schw"
      }, {
        "text": "annoma]], Oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChildhood Primary Tumors:\u003c/b\u003e Most are infratentorial. In order of frequency"
      }, {
        "text": ": Pilocytic astrocytoma, [[16d613bb|Medulloblastoma]], [[14"
      }, {
        "text": "365ef4|Ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastatic Tumors:\u003c/b\u003e More common than"
      }, {
        "text": " primary tumors. Often present as multiple, well-circumscribed lesions at the gray-white junction. Common primary sources are"
      }, {
        "text": " \u003cmark\u003eLung, Breast, Kidney, Melanoma, and Colon\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Symptoms:\u003c/b\u003e Head"
      }, {
        "text": "aches (often worse in the morning), seizures, and focal neurological deficits corresponding to the tumor\u0027s location.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A ring-enhancing lesion on MRI with contrast is a key finding. The differential includes [[b6bbd0bc|glio"
      }, {
        "text": "blastoma]], metastasis, and abscess. A \u0027butterfly\u0027 appearance crossing the corpus callosum is classic for glioblastoma.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe classification and prognosis of \u003cb\u003ebrain tumors\u003c/b\u003e differ significantly between adults and children, with adults"
      }, {
        "text": " more commonly developing aggressive supratentorial gliomas and children typically having more benign infratentorial tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6bbd"
      }, {
        "text": "0bc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e"
      }, {
        "text": "98ea0ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"03ecb69e\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"14365ef4\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "af9d783c\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain"
      }, {
        "text": " that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla"
      }, {
        "text": " oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. "
      }, {
        "text": "\u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal"
      }, {
        "text": " cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3."
      }, {
        "text": " \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles,"
      }, {
        "text": " and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCross Sections:\u003c/b\u003e Recognizing"
      }, {
        "text": " the key structures in cross sections of the midbrain, pons, and medulla is essential for localizing brainstem strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHern"
      }, {
        "text": "iation Syndromes:\u003c/b\u003e The brainstem is vulnerable to compression during [[8c0728b7|herniation syndromes]],"
      }, {
        "text": " which can lead to coma and death (e.g., Duret hemorrhages from central herniation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CN"
      }, {
        "text": "s above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX"
      }, {
        "text": "-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain"
      }, {
        "text": " centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A"
      }, {
        "text": " --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_compressed_in\",\n        \"to\": \"8"
      }, {
        "text": "c0728b7\"\n      }\n    ]\n  },\n  \"0f0fb"
      }, {
        "text": "fa0\": {\n    \"title\": \"Branch Retinal Vein Occlusion (BRVO)\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Oc"
      }, {
        "text": "clusion (BRVO)\u003c/b\u003e is the blockage of a small vein in the retina, leading to hemorrhage, edema, and potential vision"
      }, {
        "text": " loss in the quadrant of the retina drained by that vein.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly occurs at an \u003cmark\u003earteriovenous (AV) crossing\u003c/mark\u003e, where a hardened"
      }, {
        "text": ", atherosclerotic retinal arteriole compresses the adjacent, thinner-walled venule, leading to turbulent flow and thrombus formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Risk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Sudden, painless, unilateral vision loss, which may be described as a scotoma (blind spot) or blurry"
      }, {
        "text": " vision in a specific part of the visual field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Fundoscopic exam reveals \u003cmark\u003esector"
      }, {
        "text": "al (quadrantic) retinal hemorrhages\u003c/mark\u003e, venous engorgement, and cotton-wool spots confined to the area"
      }, {
        "text": " drained by the occluded vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from Central Retinal Vein Occlusion (CR"
      }, {
        "text": "VO), which involves the entire retina and has a more dramatic \\\"blood and thunder\\\" appearance. BRVO is localized to a"
      }, {
        "text": " quadrant. The key association is hypertension causing AV nicking.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003eBranch Retinal Vein Occlusion\u003c/b\u003e is a consequence of systemic vascular disease playing out in the eye, where"
      }, {
        "text": " a stiff arteriole compresses a venule at a crossing point, causing a localized \u0027traffic jam\u0027 of blood that results in a sectoral"
      }, {
        "text": " retinal hemorrhage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Ar"
      }, {
        "text": "teriolar Sclerosis); B --\u003e C(Compression of Vein at AV Crossing); C --\u003e D(Thrombus Formation); D --\u003e E"
      }, {
        "text": "(Branch Retinal Vein Occlusion); E --\u003e F(Sectoral Hemorrhage \u0026 Edema);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"differentiated_from\",\n        \"to\": \"b69e35b5\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"2fcee185\": {\n    \"title\": \"Brimonidine\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is a highly selective \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used as"
      }, {
        "text": " a topical eye drop to lower intraocular pressure (IOP) in the treatment of [[5ea7b74"
      }, {
        "text": "1|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Has a dual mechanism. It primarily \u003cmark\u003edecreases aqueous humor synthesis\u003c/mark\u003e by stimulating Œ±"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e receptors on the ciliary body. It also \u003cmark\u003eincreases uveoscleral outflow\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A common agent for the long-term management of [[5ea7b74"
      }, {
        "text": "1|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include allergic conjunctivitis, hyperemia"
      }, {
        "text": " (redness), and pruritus (itching). Systemic side effects are possible due to absorption and include dry mouth, sedation"
      }, {
        "text": ", and fatigue. Unlike apraclonidine, it does not cause mydriasis and can be used in angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison"
      }, {
        "text": ":\u003c/b\u003e Similar to [[c1f67280|apraclonidine]] but is more selective for"
      }, {
        "text": " the Œ±\u003csub\u003e2\u003c/sub\u003e receptor and has a lower incidence of allergic reactions and tachyphylaxis, making it more suitable for"
      }, {
        "text": " long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e agonists like brimonidine and"
      }, {
        "text": " clonidine act as sympatholytics, reducing sympathetic outflow. In the eye, this leads to decreased aqueous humor production."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is an effective glaucoma medication that lowers intra"
      }, {
        "text": "ocular pressure through a dual mechanism of decreasing aqueous humor production and increasing its outflow, all mediated by its selective Œ±\u003csub\u003e2\u003c/sub\u003e-"
      }, {
        "text": "adrenergic agonism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brimonidine] --\u003e B"
      }, {
        "text": "(Stimulates Œ±2 Receptors); B --\u003e C(‚Üì Aqueous Humor Synthesis); B --\u003e D(‚Üë Uveoscleral Out"
      }, {
        "text": "flow); C \u0026 D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"c1f67"
      }, {
        "text": "280\"\n      }\n    ]\n  },\n  \"4dff096f\": {\n    \"title\": \""
      }, {
        "text": "Broad-Spectrum Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are"
      }, {
        "text": " antiepileptic drugs (AEDs) that are effective against a wide variety of seizure types, including both focal and generalized seizures"
      }, {
        "text": " (e.g., tonic-clonic, absence, myoclonic).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Agents:\u003c/b\u003e The main broad-spectrum agents are \u003cmark\u003e[[valproic_acid"
      }, {
        "text": "|Valproic acid]]\u003c/mark\u003e, \u003cmark\u003e[[08d19a8f|Lamotrigine]]\u003c/"
      }, {
        "text": "mark\u003e, \u003cmark\u003e[[2341f9c0|Levetiracetam]]\u003c/mark\u003e, and \u003cmark\u003e[[e"
      }, {
        "text": "1f5066c|Topiramate]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e They are the drugs"
      }, {
        "text": " of choice when the seizure type is unclear or when a patient has multiple seizure types (e.g., Lennox-Gastaut syndrome)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eValproic Acid:\u003c/b\u003e Very broad spectrum, effective for almost all seizure types. Mechanism involves Na\u003csup\u003e"
      }, {
        "text": "+\u003c/sup\u003e channel blockade, T-type Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade, and increasing GABA levels. Highly teratogenic ("
      }, {
        "text": "neural tube defects).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLamotrigine:\u003c/b\u003e Broad spectrum, but must be titrated slowly to reduce the risk of Stevens-Johnson syndrome ("
      }, {
        "text": "SJS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevetiracetam:\u003c/b\u003e Very commonly used due to its favorable side effect profile and broad efficacy"
      }, {
        "text": ". Unique mechanism involving synaptic vesicle protein 2A (SV2A).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If"
      }, {
        "text": " a question asks for the best initial treatment for a patient with generalized tonic-clonic seizures, a broad-spectrum agent like"
      }, {
        "text": " valproic acid or levetiracetam is a strong choice. Valproic acid is also a first-line option"
      }, {
        "text": " for myoclonic seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants"
      }, {
        "text": "\u003c/b\u003e are the versatile workhorses of epilepsy treatment, effective against both focal and generalized seizures, making them ideal for initial empirical therapy"
      }, {
        "text": " or for patients with complex epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_class_of\",\n        \"to\": \"f91a0c"
      }, {
        "text": "fa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valpro"
      }, {
        "text": "ic_acid\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "08d19a8f\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"2341f9c0\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"e1f5066c\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"7f6ed344\": {\n    \"title\": \"Broca\u0027"
      }, {
        "text": "s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, also known as expressive aphasia,"
      }, {
        "text": " is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [["
      }, {
        "text": "a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle"
      }, {
        "text": " Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and effort"
      }, {
        "text": "ful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Repetition is impaired"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient"
      }, {
        "text": " Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca ("
      }, {
        "text": "mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles"
      }, {
        "text": " to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e"
      }, {
        "text": " is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-speech planning center."
      }, {
        "text": " The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Lesion in Broca\u0027s Area] --\u003e B(Impaired Speech Production); B --\u003e C(Non"
      }, {
        "text": "fluent, Telegraphic Speech); A --Spares--\u003e D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_"
      }, {
        "text": "lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143"
      }, {
        "text": "bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        "
      }, {
        "text": "\"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "3bbace2\": {\n    \"title\": \"Broca\u0027s Area\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\","
      }, {
        "text": "\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is a region in the frontal lobe of the dominant hemisphere (usually the left) of the brain with"
      }, {
        "text": " functions linked to speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the \u003c"
      }, {
        "text": "mark\u003einferior frontal gyrus\u003c/mark\u003e of the dominant hemisphere (Brodmann areas 44 and 45"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Responsible for the motor planning and execution of speech. It coordinates the movements of the larynx"
      }, {
        "text": ", tongue, and lips necessary for articulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the"
      }, {
        "text": " [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Damage"
      }, {
        "text": " to this area results in [[7f6ed344|Broca\u0027s aphasia]] (expressive aphasia),"
      }, {
        "text": " characterized by nonfluent, agrammatical speech with intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection:\u003c/b\u003e It is connected to [["
      }, {
        "text": "wernicke_area|Wernicke\u0027s area]] (language comprehension) by a bundle of nerve fibers called the arcuate fasciculus"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke affecting the left MCA is the most common cause of damage to Broca\u0027s area."
      }, {
        "text": " Because of its proximity to the primary motor cortex, [[7f6ed344|Broca\u0027s aphasia]]"
      }, {
        "text": " is often accompanied by contralateral weakness of the face and arm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Broca\u0027s area\u003c/b\u003e is the brain\u0027s \u0027speech production factory,\u0027 translating thoughts and concepts from Wernicke\u0027s area into the"
      }, {
        "text": " precise motor commands needed for fluent articulation; a lesion here breaks the production line, resulting in expressive aphasia.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Wernicke\u0027s Area - Comprehension] --Arcuate Fasciculus--\u003e B(Bro"
      }, {
        "text": "ca\u0027s Area); B --Motor Plan--\u003e C(Primary Motor Cortex); C --\u003e D(Speech Articulation);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \""
      }, {
        "text": "7f6ed344\"\n      },\n      {\n        \"type\": \"is_supplied_by\","
      }, {
        "text": "\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_connected_to\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d24a5ff0\": {\n    \"title\": \"Bromocriptine\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is an ergot derivative that acts as a \u003ci\u003edopamine D"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is used to treat conditions associated with hyperprolactinemia and [[58c8"
      }, {
        "text": "ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stim"
      }, {
        "text": "ulates dopamine D\u003csub\u003e2\u003c/sub\u003e receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Endocrinology):\u003c/b\u003e Treats"
      }, {
        "text": " hyperprolactinemia and prolactinomas by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the anterior pituitary, which inhibits prol"
      }, {
        "text": "actin secretion. Also used for acromegaly as it can suppress GH secretion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used"
      }, {
        "text": " as an adjunctive therapy in [[58c8ea03|Parkinson disease]] to stimulate dopamine receptors in the striatum. It"
      }, {
        "text": " is an ergot derivative and is less commonly used now than non-ergot agonists (e.g., pramipexole"
      }, {
        "text": ", ropinirole) due to its side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, vomiting, postural"
      }, {
        "text": " hypotension, and headache. As an ergot derivative, it can cause pulmonary fibrosis and vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Bromocriptine is a classic treatment for prolactinomas. Remember that dopamine tonically inhibits prolactin release, so a dopamine"
      }, {
        "text": " agonist will lower prolactin levels.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is"
      }, {
        "text": " a dopamine D\u003csub\u003e2\u003c/sub\u003e agonist that leverages dopamine\u0027s inhibitory control over prolactin to treat hyperprolactinemia and"
      }, {
        "text": " supplements dopamine signaling in the basal ganglia to treat Parkinson disease, though its use is limited by its ergot-related side effects.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"acromegaly\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"4792bc68\": {\n    \"title\": \"Brown-S√©qu"
      }, {
        "text": "ard Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is a rare neurological condition"
      }, {
        "text": " caused by \u003ci\u003ehemisection of the spinal cord\u003c/i\u003e, resulting in a characteristic pattern of ipsilateral motor and proprioceptive loss, and"
      }, {
        "text": " contralateral pain and temperature sensory loss below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Typically caused by trauma, such as a penetrating injury (e.g., stab wound) or a tumor"
      }, {
        "text": " compressing one half of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at and below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Motor:\u003c/b\u003e Ipsilateral spastic paralysis below the lesion (corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "ensation:\u003c/b\u003e Ipsilateral loss of proprioception, vibration, and fine touch below the lesion ([[e7f5cb"
      }, {
        "text": "be|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eSensation:\u003c/b\u003e Contralateral loss of pain and temperature sensation, typically beginning 1-2 segments below the lesion (spin"
      }, {
        "text": "othalamic tract damage, as fibers decussate in the spinal cord).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficits at the Level of the"
      }, {
        "text": " Lesion:\u003c/b\u003e\u003cbr\u003e - Ipsilateral flaccid paralysis (LMN damage at that level).\u003cbr\u003e - Ipsilateral complete"
      }, {
        "text": " loss of all sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This syndrome is a classic test of spinal cord tract anatomy. The"
      }, {
        "text": " key is remembering which tracts cross in the medulla (dorsal columns, corticospinal) versus the spinal cord (spin"
      }, {
        "text": "othalamic). If the lesion is above T1, an ipsilateral [[c19010a3|Horner syndrome]] may"
      }, {
        "text": " also be present.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e"
      }, {
        "text": " is the ultimate clinical demonstration of spinal cord neuroanatomy, creating a striking dissociation of deficits where one side of the body loses"
      }, {
        "text": " motor function and proprioception, while the other side loses the ability to feel pain and temperature, all due to a unilateral cord"
      }, {
        "text": " lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord Hemisection at T10"
      }, {
        "text": "]; A --\u003e B(Ipsilateral (Right) Deficits); B --\u003e C(Loss of Motor, Proprioception, Vibration below T1"
      }, {
        "text": "0); B --\u003e D(Flaccid paralysis at T10); A --\u003e E(Contralateral (Left) Deficits);"
      }, {
        "text": " E --\u003e F(Loss of Pain \u0026 Temperature below T10);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by\",\n        \"to\": \"spinal_cord_hemisection\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_"
      }, {
        "text": "tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \""
      }, {
        "text": "e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07"
      }, {
        "text": "eecef1\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1PLnodOYY0VJuqjIgrui49lniV015L2xT"
      },
      "role": "user",
      "tokenCount": 1761
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"901f3180\": {\n    \"title\": \"Bulbar Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e refers to a set of clinical signs resulting from damage to the \u003cu\u003elower motor neurons (LMNs)\u003c/u\u003e of the cranial nerves originating in the brainstem (medulla oblongata, or \u0027bulb\u0027). Specifically, it involves cranial nerves IX (glossopharyngeal), X (vagus), XI (accessory), and XII (hypoglossal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by LMN lesions of cranial nerves IX, X, XI, and XII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by \u003cmark\u003eflaccid weakness\u003c/mark\u003e of the muscles of the mouth, pharynx, and larynx. This leads to dysarthria (slurred speech), dysphagia (difficulty swallowing), drooling, and a hoarse or nasal voice.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e On examination, there is tongue wasting and \u003cmark\u003efasciculations\u003c/\u0027mark\u003e (LMN signs), a diminished or absent gag reflex, and the palate may not elevate symmetrically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be seen in [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]], Guillain-Barr√© syndrome, myasthenia gravis, and brainstem strokes or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from \u003cb\u003epseudobulbar palsy\u003c/b\u003e, which is caused by \u003cu\u003eupper motor neuron (UMN)\u003c/u\u003e lesions. Pseudobulbar palsy presents with a spastic dysarthria, an exaggerated gag reflex, and emotional lability (pseudobulbar affect), without tongue atrophy or fasciculations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e is a manifestation of lower motor neuron damage to the lower cranial nerves, resulting in a flaccid paralysis of the oral, pharyngeal, and laryngeal muscles, which must be distinguished from the spastic paralysis of the same muscles seen in the upper motor neuron condition, pseudobulbar palsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"glossopharyngeal_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"accessory_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"pseudobulbar_palsy\"\n      }\n    ]\n  },\n  \"181a22b1\": {\n    \"title\": \"Bupivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a long-acting, amide-type \u003ci\u003elocal anesthetic\u003c/i\u003e commonly used for regional anesthesia, such as epidurals for labor and spinal anesthesia for surgical procedures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action, making it suitable for prolonged procedures and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Widely used for epidural analgesia, spinal anesthesia, and peripheral nerve blocks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e The most notable adverse effect is \u003cmark\u003esevere cardiotoxicity\u003c/mark\u003e. It is more cardiotoxic than other local anesthetics. Accidental intravascular injection can lead to severe ventricular arrhythmias and cardiovascular collapse that is difficult to resuscitate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember bupivacaine for its long duration of action and its significant risk of cardiotoxicity. This risk is a major consideration in its clinical use and dosing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a potent, long-acting amide anesthetic favored for epidurals and nerve blocks, but its use is shadowed by a significant risk of severe cardiotoxicity if accidentally injected systemically.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"5b2b854f\": {\n    \"title\": \"Buprenorphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a semi-synthetic opioid that acts as a \u003ci\u003epartial agonist\u003c/i\u003e at the Œº-opioid receptor and an antagonist at the Œ∫-opioid receptor. It is used for both pain management and the treatment of opioid use disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a \u003cmark\u003epartial Œº-opioid agonist\u003c/mark\u003e, it binds with high affinity but has lower intrinsic activity than full agonists like morphine. This creates a \u0027ceiling effect\u0027 on respiratory depression, making it safer in overdose than full agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Opioid Use Disorder):\u003c/b\u003e Used for opioid detoxification and maintenance therapy. It can precipitate withdrawal if given to a patient who is currently using full opioids due to its high affinity and lower intrinsic activity. Often co-formulated with naloxone (Suboxone) to deter IV abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Pain):\u003c/b\u003e Effective for moderate to severe chronic pain, available in various formulations including transdermal patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its effects are not easily reversed by naloxone due to its high affinity for the Œº-receptor, requiring higher doses of the antagonist.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept for buprenorphine is \u0027partial agonist.\u0027 This explains its ceiling effect on respiratory depression and its ability to precipitate withdrawal in an opioid-dependent individual.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a unique opioid that acts as a partial agonist, providing analgesia and mitigating withdrawal symptoms with a lower risk of respiratory depression, but its high receptor affinity means it can displace full agonists and precipitate withdrawal if not initiated carefully.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"partial_mu_opioid_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"opioid_use_disorder\"\n      }\n    ]\n  },\n  \"34217723\": {\n    \"title\": \"Butorphanol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a synthetic opioid analgesic that functions as a \u003ci\u003emixed agonist-antagonist\u003c/i\u003e. It is primarily used for the management of moderate to severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a \u003cmark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e and a \u003cmark\u003eŒº-opioid receptor partial agonist or weak antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnalgesic Effect:\u003c/b\u003e The Œ∫-agonist activity provides strong analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Like other mixed agonist-antagonists, it exhibits a ceiling effect for respiratory depression, making it potentially safer in overdose compared to full Œº-agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for moderate to severe pain, particularly in labor (less neonatal respiratory depression) and for postoperative pain. Also available as a nasal spray for [[c8833bae|migraines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause sedation, nausea, and psychotomimetic effects (e.g., hallucinations, dysphoria) due to Œ∫-receptor agonism. It can precipitate withdrawal symptoms in patients physically dependent on full Œº-opioid agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that mixed agonist-antagonists like butorphanol and nalbuphine can precipitate withdrawal in opioid-dependent patients. Their primary analgesic effect comes from Œ∫-agonism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a mixed-action opioid that provides potent analgesia through Œ∫-receptor agonism while having a limited effect on Œº-receptors, which gives it a better safety profile regarding respiratory depression but also the potential to induce withdrawal in opioid-dependent individuals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"kappa_opioid_agonist\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"mu_opioid_partial_agonist_antagonist\"\n      },\n      {\n        \"type\": \"can_precipitate\",\n        \"to\": \"opioid_withdrawal\"\n      }\n    ]\n  },\n  \"ca6ee143\": {\n    \"title\": \"Cabergoline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pharmacology\",\n      \"Hypothalamic and Pituitary Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is a long-acting ergot derivative that is a potent \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is the first-line treatment for hyperprolactinemia and prolactin-secreting [[5f3188bd|pituitary adenomas]] (prolactinomas).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the [[76ba7f2e|anterior pituitary]], mimicking the natural inhibitory effect of dopamine on prolactin secretion. This leads to a decrease in serum prolactin levels and can cause shrinkage of prolactinomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eFirst-line treatment\u003c/u\u003e for prolactinomas and hyperprolactinemia. Also used in [[acromegaly]] (can suppress GH secretion) and [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long half-life, allowing for once or twice weekly dosing, which improves patient compliance compared to [[d24a5ff0|bromocriptine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, headache, postural hypotension. Less nausea than bromocriptine. High doses have been associated with valvular heart disease, but this is rare at the doses used for hyperprolactinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cabergoline is preferred over [[d24a5ff0|bromocriptine]] for treating prolactinomas due to its higher efficacy, better side-effect profile, and more convenient dosing schedule.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is the superior dopamine agonist for treating hyperprolactinemia, effectively suppressing prolactin secretion and shrinking pituitary tumors by powerfully stimulating D\u003csub\u003e2\u003c/sub\u003e receptors, with the clinical advantage of a long half-life and better tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cabergoline] --\u003e B(Stimulates D2 Receptors on Lactotrophs); B --\u003e C(‚Üì Prolactin Secretion); C --\u003e D(‚Üì Serum Prolactin \u0026 Tumor Shrinkage);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is_preferred_over\",\n        \"to\": \"d24a5ff0\"\n      }\n    ]\n  },\n  \"cbb4285c\": {\n    \"title\": \"Caf√©-au-lait Spots\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Pigmented Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaf√©-au-lait spots\u003c/b\u003e are well-demarcated, hyperpigmented macules or patches on the skin, with a color resembling \u0027coffee with milk.\u0027 While a few small spots can be normal, the presence of multiple, large spots is a hallmark of several genetic syndromes, most notably Neurofibromatosis Type 1.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Flat, pigmented birthmarks with a light brown color and distinct borders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF-1):\u003c/b\u003e The presence of \u003cmark\u003esix or more\u003c/mark\u003e caf√©-au-lait spots greater than 5 mm in diameter in prepubertal individuals (or \u003e15 mm in postpubertal individuals) is a key diagnostic criterion for NF-1. The spots in NF-1 typically have smooth borders (\u0027coast of California\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMcCune-Albright Syndrome:\u003c/b\u003e Characterized by a triad of fibrous dysplasia of bone, endocrine abnormalities (like precocious puberty), and large, unilateral caf√©-au-lait spots with irregular, jagged borders (\u0027coast of Maine\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Can also be seen in tuberous sclerosis, Fanconi anemia, and other syndromes, but are most strongly associated with NF-1.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Multiple caf√©-au-lait spots in a child should prompt a thorough evaluation for other signs of Neurofibromatosis Type 1, such as axillary freckling, Lisch nodules, and neurofibromas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile often benign, multiple \u003cb\u003ecaf√©-au-lait spots\u003c/b\u003e are a crucial dermatological clue to underlying systemic genetic disorders, with the number and border characteristics (smooth in NF-1, irregular in McCune-Albright) helping to narrow the differential diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"mccune_albright_syndrome\"\n      }\n    ]\n  },\n  \"24d36d58\": {\n    \"title\": \"Calcitonin Gene-Related Peptide (CGRP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCalcitonin Gene-Related Peptide (CGRP)\u003c/b\u003e is a 37-amino acid neuropeptide that is widely distributed in the central and peripheral nervous systems. It is a potent vasodilator and is critically involved in pain transmission, particularly in the pathophysiology of [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a potent arterial vasodilator and a neurotransmitter/neuromodulator in pain pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e During a migraine attack, CGRP is released from trigeminal nerve endings. This release causes vasodilation of cranial blood vessels and promotes neurogenic inflammation, contributing to the pain of a migraine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Target:\u003c/b\u003e CGRP and its receptor have become major targets for migraine therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug Classes Targeting CGRP:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[4770b8a2|Anti-CGRP Monoclonal Antibodies]]\u003c/b\u003e (e.g., erenumab, galcanezumab): Used for migraine \u003cu\u003eprophylaxis\u003c/u\u003e.\u003cbr\u003e2. \u003cb\u003eGepants\u003c/b\u003e (e.g., ubrogepant, rimegepant): Small molecule CGRP receptor antagonists used for \u003cu\u003eacute\u003c/u\u003e treatment of migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The central role of CGRP in migraine pathophysiology is a high-yield concept. Understand that blocking the CGRP pathway, either with monoclonal antibodies for prevention or gepants for acute attacks, is a modern, targeted approach to migraine treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCalcitonin Gene-Related Peptide (CGRP)\u003c/b\u003e is a key player in the generation of migraine pain, acting as both a powerful vasodilator and a pain-signaling molecule in the trigeminal system, making its blockade a highly effective strategy for migraine therapy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C(Vasodilation \u0026 Neurogenic Inflammation); C --\u003e D(Migraine Pain);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"4770b8a2\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"gepants\"\n      }\n    ]\n  },\n  \"e4b8298b\": {\n    \"title\": \"Capsaicin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e is the active component of chili peppers and is used topically as an analgesic for neuropathic and musculoskeletal pain. It works by interacting with the transient receptor potential vanilloid 1 (TRPV1) receptor on nociceptive nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Initially, capsaicin activates TRPV1 receptors (also known as capsaicin receptors), causing an influx of calcium and the release of substance P, which leads to a burning sensation. With repeated application, it causes \u003cmark\u003edesensitization\u003c/-mark\u003e of the nerve fibers and \u003cmark\u003edepletion of substance P\u003c/mark\u003e, resulting in an analgesic effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically for neuropathic pain (e.g., postherpetic neuralgia, diabetic neuropathy) and musculoskeletal pain (e.g., osteoarthritis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as a low-concentration over-the-counter cream or a high-concentration prescription patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is a localized burning, stinging, or erythema at the application site, which typically diminishes with continued use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key mechanism to remember is the initial activation followed by desensitization and depletion of substance P from sensory nerve endings.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e paradoxically relieves pain by first causing it; its initial stimulation of pain receptors leads to their eventual desensitization and the depletion of substance P, effectively silencing the pain signals from the affected area.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Topical Capsaicin] --\u003e B(Activates TRPV1 Receptors); B --\u003e C(Initial Release of Substance P); C --\u003e D(Burning Sensation); B --Repeated Application--\u003e E(Desensitization \u0026 Depletion of Substance P); E --\u003e F(Analgesia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"acts_on_receptor\",\n        \"to\": \"trpv1_receptor\"\n      },\n      {\n        \"type\": \"depletes\",\n        \"to\": \"substance_p\"\n      }\n    ]\n  },\n  \"a5ec55b5\": {\n    \"title\": \"Caput Succedaneum\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a benign, edematous swelling of the soft tissues of a newborn\u0027s scalp that is present at birth. It is caused by pressure on the infant\u0027s head from the cervix or vaginal wall during a prolonged or difficult delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The edema is located in the subcutaneous tissue, \u003cu\u003esuperficial to the periosteum\u003c/u\u003e of the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A soft, puffy, and sometimes ecchymotic swelling on the scalp. A key feature is that it \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Present at birth and typically resolves spontaneously within a few days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a1721d6f|cephalohematoma]].\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Soft, pits on pressure, crosses suture lines, resolves quickly.\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm, does \u003cu\u003enot\u003c/u\u003e cross suture lines (subperiosteal), resolves over weeks to months, may calcify.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ability to cross suture lines is the most important feature for distinguishing caput succedaneum from a cephalohematoma on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a benign and self-resolving scalp edema in newborns resulting from birth trauma, easily identified by its soft consistency and its ability to cross cranial suture lines, distinguishing it from the more localized and potentially complicated cephalohematoma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a1721d6f\"\n      }\n    ]\n  },\n  \"c1ad76f4\": {\n    \"title\": \"Carbachol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a \u003ci\u003echolinomimetic agent\u003c/i\u003e that acts as a non-selective agonist at both muscarinic and nicotinic acetylcholine receptors. It is primarily used in ophthalmology to treat glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a direct cholinergic agonist, it mimics the effects of [[6a005559|acetylcholine]]. In the eye, it stimulates muscarinic (M\u003csub\u003e3\u003c/sub\u003e) receptors on the ciliary muscle and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Effects:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eMiosis:\u003c/b\u003e Contraction of the sphincter pupillae muscle causes pupillary constriction.\u003cbr\u003e 2. \u003cb\u003e‚Üì IOP:\u003c/b\u003e Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically to treat [[5ea7b741|open-angle glaucoma]] and to produce miosis during ophthalmic surgery. It is less commonly used than pilocarpine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResistance to AChE:\u003c/b\u003e Carbachol is resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action than acetylcholine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember carbachol as a direct-acting cholinomimetic that lowers IOP by increasing trabecular outflow, a mechanism shared with pilocarpine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a potent, long-acting acetylcholine mimic that effectively lowers intraocular pressure in glaucoma by contracting the ciliary muscle to open up the trabecular meshwork drainage channels.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cholinomimetic_agent\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"muscarinic_receptors\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"nicotinic_receptors\"\n      }\n    ]\n  },\n  \"eddd2bc5\": {\n    \"title\": \"Carbamazepine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbamazepine\u003c/b\u003e is a narrow-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e drug that works by blocking voltage-gated sodium channels. It is also used as a mood stabilizer and for the treatment of neuropathic pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in their inactivated state, which prolongs the refractory period of the neuron and prevents repetitive firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e First-line treatment for \u003cmark\u003efocal seizures\u003c/mark\u003e (both simple and complex) and generalized tonic-clonic seizures.\u003cbr\u003e - \u003cb\u003eNeuropathic Pain:\u003c/b\u003e First-line treatment for \u003cmark\u003etrigeminal neuralgia\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Diplopia, ataxia, SIADH (hyponatremia), and skin rashes. Two serious, rare side effects are \u003cmark\u003eagranulocytosis\u003c/mark\u003e and \u003cmark\u003eaplastic anemia\u003c/mark\u003e, requiring monitoring of CBC. It is also a potent inducer of cytochrome P450 enzymes, leading to many drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Associated with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Carbamazepine is the drug of choice for trigeminal neuralgia. Remember its major hematologic side effects (agranulocytosis, aplastic anemia) and its induction of the P450 system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbamazepine\u003c/b\u003e is a cornerstone therapy for focal seizures and trigeminal neuralgia, acting by stabilizing inactivated sodium channels, but its use requires careful monitoring due to the risk of severe hematologic toxicity and its potent induction of hepatic enzymes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"trigeminal_neuralgia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"focal_seizures\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"agranulocytosis\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"aplastic_anemia\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"siadh\"\n      }\n    ]\n  },\n  \"541cd176\": {\n    \"title\": \"Carbidopa/Levodopa\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e (trade name Sinemet) is the most effective and widely used combination drug for the symptomatic treatment of [[58c8ea03|Parkinson disease]]. Levodopa is a metabolic precursor to dopamine, while carbidopa is a peripheral DOPA decarboxylase inhibitor.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLevodopa (L-DOPA):\u003c/b\u003e Can cross the [[dd47b9cc|blood-brain barrier]] (unlike dopamine) and is converted to [[90adc821|dopamine]] in the CNS by DOPA decarboxylase, replenishing the depleted dopamine stores in the striatum.\u003cbr\u003e - \u003cb\u003eCarbidopa:\u003c/b\u003e Inhibits peripheral DOPA decarboxylase. This prevents the conversion of L-DOPA to dopamine in the periphery, which \u003cmark\u003eincreases the bioavailability of L-DOPA in the brain\u003c/mark\u003e and \u003cmark\u003ereduces peripheral side effects\u003c/mark\u003e (like nausea and arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e The cornerstone of treatment for [[58c8ea03|Parkinson disease]], particularly effective for bradykinesia and rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, hallucinations, postural hypotension. Long-term use is associated with motor fluctuations (\u0027on-off\u0027 phenomenon) and dyskinesias (involuntary movements).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rationale for the combination is key: Carbidopa acts as a \u0027bodyguard\u0027 for Levodopa, ensuring more of it reaches the brain where it\u0027s needed, while minimizing side effects elsewhere in the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e combination is a brilliant pharmacological strategy that overcomes the blood-brain barrier by using a precursor (Levodopa) and then protecting that precursor from peripheral breakdown (with Carbidopa) to effectively deliver dopamine to the deficient basal ganglia in Parkinson\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral DOPA Decarboxylase--\u003e B(Dopamine - Periphery); C[Carbidopa] --x B; A --\u003e D(Crosses BBB); D --\u003e E[L-DOPA in CNS]; E --Central DOPA Decarboxylase--\u003e F(Dopamine - CNS); F --\u003e G(Treats Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_combined_with\",\n        \"to\": \"carbidopa\"\n      }\n    ]\n  },\n  \"e1e7ac22\": {\n    \"title\": \"Carotid-Cavernous Fistula\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula (CCF)\u003c/b\u003e is an abnormal communication between the internal carotid artery and the [[c260efc8|cavernous sinus]]. This creates a high-flow, high-pressure arteriovenous shunt within the sinus, leading to a characteristic set of signs and symptoms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be traumatic (e.g., from a basal skull fracture) or spontaneous (e.g., from a ruptured intracavernous carotid aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arterial blood from the internal carotid artery flows directly into the low-pressure [[c260efc8|cavernous sinus]]. This increases pressure in the sinus and reverses blood flow in the veins that drain into it, particularly the superior ophthalmic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e The classic triad is \u003cmark\u003epulsatile exophthalmos\u003c/mark\u003e (protruding, pulsating eye), \u003cmark\u003eocular bruit\u003c/mark\u003e (a whooshing sound heard over the eye), and \u003cmark\u003echemosis\u003c/mark\u003e (conjunctival edema and redness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Symptoms:\u003c/b\u003e Patients also develop ophthalmoplegia (paralysis of eye muscles) due to dysfunction of cranial nerves III, IV, and VI, which all traverse the cavernous sinus. There may also be sensory loss in the V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e distribution.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a pulsating eye and an audible bruit over the eye after head trauma is pathognomonic for a carotid-cavernous fistula.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula\u003c/b\u003e creates a high-pressure vascular storm within the cavernous sinus, engorging the orbital veins and compressing the cranial nerves that pass through it, resulting in the dramatic clinical picture of a pulsating, red, and paralyzed eye.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --Fistula--\u003e B(Cavernous Sinus); B --\u003e C(‚Üë Pressure in Sinus); C --\u003e D(Reversal of flow in Superior Ophthalmic Vein); D --\u003e E(Pulsatile Exophthalmos, Chemosis, Bruit); C --\u003e F(Compression of CN III, IV, V1, V2, VI); F --\u003e G(Ophthalmoplegia, Sensory Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"pulsatile_exophthalmos\"\n      }\n    ]\n  },\n  \"6696dd3a\": {\n    \"title\": \"Carteolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used as a topical eye drop to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This leads to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker, similar to [[ae28be6c|timolol]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include stinging and burning. Systemic absorption can occur, potentially causing bradycardia, hypotension, fatigue, and bronchoconstriction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution in patients with asthma, COPD, bradycardia, or heart block due to its non-selective Œ≤-blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all non-selective beta-blockers used for glaucoma, carteolol\u0027s main mechanism is decreasing aqueous humor production. Be aware of the potential for systemic side effects, especially bronchospasm in patients with reactive airway disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective beta-blocker that effectively treats glaucoma by turning down the \u0027faucet\u0027 of aqueous humor production in the ciliary body, but its systemic absorption carries the risk of Œ≤-blockade side effects throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"decreases_production_of\",\n        \"to\": \"aqueous_humor\"\n      }\n    ]\n  },\n  \"85f03b02\": {\n    \"title\": \"Cataracts\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecataract\u003c/b\u003e is a painless, progressive opacification or clouding of the normally clear lens of the eye, which leads to a decrease in vision. It is the leading cause of blindness worldwide.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Involves the denaturation and aggregation of lens proteins (crystallins), leading to loss of transparency and light scattering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e \u003cmark\u003eIncreased age\u003c/mark\u003e is the most common risk factor. Others include smoking, excessive alcohol use, excessive sunlight (UV) exposure, prolonged glucocorticoid use, trauma, and infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Disease Associations:\u003c/b\u003e \u003cmark\u003eDiabetes mellitus\u003c/mark\u003e (due to sorbitol accumulation via aldose reductase), classic galactosemia, galactokinase deficiency, and myotonic dystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive blurring of vision, glare (especially at night with oncoming headlights), and often a myopic shift (nearsightedness). On exam, there is loss of the red reflex and the lens appears opaque.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The definitive treatment is surgical removal of the opacified lens and replacement with an artificial intraocular lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the association with diabetes and galactosemia, where excess sugars are converted to osmotically active polyols (sorbitol, galactitol) in the lens, causing hydropic swelling and opacification.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCataracts\u003c/b\u003e represent a clouding of the eye\u0027s lens due to protein aggregation, most commonly as a part of aging, which scatters light and causes progressive, painless vision loss that can only be definitively treated by surgical lens replacement.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"galactosemia\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"cataract_surgery\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9643,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"901f3180\": {\n    \"title"
      }, {
        "text": "\": \"Bulbar Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e refers to a set of clinical signs resulting from damage to the"
      }, {
        "text": " \u003cu\u003elower motor neurons (LMNs)\u003c/u\u003e of the cranial nerves originating in the brainstem (medulla oblong"
      }, {
        "text": "ata, or \u0027bulb\u0027). Specifically, it involves cranial nerves IX (glossopharyngeal), X (vagus), XI"
      }, {
        "text": " (accessory), and XII (hypoglossal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Caused by LMN lesions of cranial nerves IX, X, XI, and XII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Characterized by \u003cmark\u003eflaccid weakness\u003c/mark\u003e of the muscles of the mouth, pharynx, and larynx. This"
      }, {
        "text": " leads to dysarthria (slurred speech), dysphagia (difficulty swallowing), drooling, and a hoarse or"
      }, {
        "text": " nasal voice.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e On examination, there is tongue wasting and \u003cmark\u003efasciculations\u003c/"
      }, {
        "text": "\u0027mark\u003e (LMN signs), a diminished or absent gag reflex, and the palate may not elevate symmetrically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Can be seen in [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]],"
      }, {
        "text": " Guillain-Barr√© syndrome, myasthenia gravis, and brainstem strokes or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Differentiate from \u003cb\u003epseudobulbar palsy\u003c/b\u003e, which is caused by \u003cu\u003eupper motor neuron (UMN)\u003c/u\u003e"
      }, {
        "text": " lesions. Pseudobulbar palsy presents with a spastic dysarthria, an exaggerated gag reflex, and emotional l"
      }, {
        "text": "ability (pseudobulbar affect), without tongue atrophy or fasciculations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e is a manifestation of lower motor neuron damage to the lower cranial nerves, resulting in a"
      }, {
        "text": " flaccid paralysis of the oral, pharyngeal, and laryngeal muscles, which must be distinguished from the spastic paralysis"
      }, {
        "text": " of the same muscles seen in the upper motor neuron condition, pseudobulbar palsy.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign"
      }, {
        "text": "_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"affects_cranial_nerves\",\n        \"to\": \"glossopharyngeal_nerve\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"vagus_"
      }, {
        "text": "nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\","
      }, {
        "text": "\n        \"to\": \"accessory_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves"
      }, {
        "text": "\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"differentiated_from\",\n        \"to\": \"pseudobulbar_palsy\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"181a22b1\": {\n    \"title\": \""
      }, {
        "text": "Bupivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a long-acting, amide-type"
      }, {
        "text": " \u003ci\u003elocal anesthetic\u003c/i\u003e commonly used for regional anesthesia, such as epidurals for labor and spinal anesthesia for surgical procedures.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve"
      }, {
        "text": " membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i"
      }, {
        "text": "\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action, making it suitable for prolonged"
      }, {
        "text": " procedures and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Widely used for epidural analgesia, spinal anesthesia, and peripheral"
      }, {
        "text": " nerve blocks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e The most notable adverse effect is \u003cmark\u003esevere cardiotoxicity\u003c/"
      }, {
        "text": "mark\u003e. It is more cardiotoxic than other local anesthetics. Accidental intravascular injection can lead to severe ventricular arrhythmias and"
      }, {
        "text": " cardiovascular collapse that is difficult to resuscitate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember bupivacaine for its long"
      }, {
        "text": " duration of action and its significant risk of cardiotoxicity. This risk is a major consideration in its clinical use and dosing"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a potent, long-acting amide"
      }, {
        "text": " anesthetic favored for epidurals and nerve blocks, but its use is shadowed by a significant risk of severe cardiotoxicity if"
      }, {
        "text": " accidentally injected systemically.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"5b2b854f\": {\n    \""
      }, {
        "text": "title\": \"Buprenorphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Psychiatry\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a semi-synthetic opioid that"
      }, {
        "text": " acts as a \u003ci\u003epartial agonist\u003c/i\u003e at the Œº-opioid receptor and an antagonist at the Œ∫-opioid receptor."
      }, {
        "text": " It is used for both pain management and the treatment of opioid use disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e As a \u003cmark\u003epartial Œº-opioid agonist\u003c/mark\u003e, it binds with high affinity but"
      }, {
        "text": " has lower intrinsic activity than full agonists like morphine. This creates a \u0027ceiling effect\u0027 on respiratory depression, making it safer"
      }, {
        "text": " in overdose than full agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Opioid Use Disorder):\u003c/b\u003e Used for opioid detoxification and maintenance therapy. It can"
      }, {
        "text": " precipitate withdrawal if given to a patient who is currently using full opioids due to its high affinity and lower intrinsic activity. Often"
      }, {
        "text": " co-formulated with naloxone (Suboxone) to deter IV abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Pain):\u003c/b\u003e Effective"
      }, {
        "text": " for moderate to severe chronic pain, available in various formulations including transdermal patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its"
      }, {
        "text": " effects are not easily reversed by naloxone due to its high affinity for the Œº-receptor, requiring higher doses of the"
      }, {
        "text": " antagonist.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept for buprenorphine is \u0027partial agonist.\u0027"
      }, {
        "text": " This explains its ceiling effect on respiratory depression and its ability to precipitate withdrawal in an opioid-dependent individual.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a unique opioid that acts as a partial agonist, providing"
      }, {
        "text": " analgesia and mitigating withdrawal symptoms with a lower risk of respiratory depression, but its high receptor affinity means it can displace full"
      }, {
        "text": " agonists and precipitate withdrawal if not initiated carefully.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_anal"
      }, {
        "text": "gesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"partial_"
      }, {
        "text": "mu_opioid_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"opioid_use_disorder\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "34217723\": {\n    \"title\": \"Butorphanol\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a synthetic opioid analgesic that functions as a \u003ci\u003emixed agonist-ant"
      }, {
        "text": "agonist\u003c/i\u003e. It is primarily used for the management of moderate to severe pain.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a \u003cmark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e and a \u003c"
      }, {
        "text": "mark\u003eŒº-opioid receptor partial agonist or weak antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnalgesic Effect:\u003c/b\u003e The Œ∫-agonist"
      }, {
        "text": " activity provides strong analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Like other mixed agonist-antagonists, it exhibits"
      }, {
        "text": " a ceiling effect for respiratory depression, making it potentially safer in overdose compared to full Œº-agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e Used for moderate to severe pain, particularly in labor (less neonatal respiratory depression) and for postoperative pain. Also"
      }, {
        "text": " available as a nasal spray for [[c8833bae|migraines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e"
      }, {
        "text": " Can cause sedation, nausea, and psychotomimetic effects (e.g., hallucinations, dysphoria) due to Œ∫-receptor"
      }, {
        "text": " agonism. It can precipitate withdrawal symptoms in patients physically dependent on full Œº-opioid agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that mixed agonist-antagonists like butorphanol and nalbuphine can precipitate withdrawal in opioid-dependent patients. Their"
      }, {
        "text": " primary analgesic effect comes from Œ∫-agonism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBut"
      }, {
        "text": "orphanol\u003c/b\u003e is a mixed-action opioid that provides potent analgesia through Œ∫-receptor agonism while having a limited"
      }, {
        "text": " effect on Œº-receptors, which gives it a better safety profile regarding respiratory depression but also the potential to induce withdrawal in opioid-dependent individuals"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"acts_as\",\n        \"to\": \"kappa_opioid_agonist\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"mu_opioid_partial"
      }, {
        "text": "_agonist_antagonist\"\n      },\n      {\n        \"type\": \"can_precipitate\","
      }, {
        "text": "\n        \"to\": \"opioid_withdrawal\"\n      }\n    ]\n  },\n  \"ca6"
      }, {
        "text": "ee143\": {\n    \"title\": \"Cabergoline\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Hypothalamic and Pituitary Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaberg"
      }, {
        "text": "oline\u003c/b\u003e is a long-acting ergot derivative that is a potent \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e"
      }, {
        "text": ". It is the first-line treatment for hyperprolactinemia and prolactin-secreting [[5f"
      }, {
        "text": "3188bd|pituitary adenomas]] (prolactinomas).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the [["
      }, {
        "text": "76ba7f2e|anterior pituitary]], mimicking the natural inhibitory effect of dopamine on prolactin secretion. This leads to a decrease"
      }, {
        "text": " in serum prolactin levels and can cause shrinkage of prolactinomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eFirst-line treatment\u003c/u\u003e for prol"
      }, {
        "text": "actinomas and hyperprolactinemia. Also used in [[acromegaly]] (can suppress GH secretion) and [["
      }, {
        "text": "58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long half-life, allowing for once"
      }, {
        "text": " or twice weekly dosing, which improves patient compliance compared to [[d24a5ff0|bromocriptine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Nausea, headache, postural hypotension. Less nausea than bromocriptine. High doses have been associated with valv"
      }, {
        "text": "ular heart disease, but this is rare at the doses used for hyperprolactinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Cabergoline is preferred over [[d24a5ff0|bromocriptine]] for treating prol"
      }, {
        "text": "actinomas due to its higher efficacy, better side-effect profile, and more convenient dosing schedule.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is the superior dopamine agonist for treating hyperprolactinemia, effectively suppressing prolactin secretion and"
      }, {
        "text": " shrinking pituitary tumors by powerfully stimulating D\u003csub\u003e2\u003c/sub\u003e receptors, with the clinical advantage of a long half-life and better"
      }, {
        "text": " tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cabergoline] --\u003e B(Stimulates D2"
      }, {
        "text": " Receptors on Lactotrophs); B --\u003e C(‚Üì Prolactin Secretion); C --\u003e D(‚Üì Serum"
      }, {
        "text": " Prolactin \u0026 Tumor Shrinkage);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"5f3188bd\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_preferred_over\",\n        \"to\": \"d24a5"
      }, {
        "text": "ff0\"\n      }\n    ]\n  },\n  \"cbb4285c\": {\n    \"title\":"
      }, {
        "text": " \"Caf√©-au-lait Spots\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"D"
      }, {
        "text": "ermatology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"Pigmented Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCaf√©-au-lait spots\u003c/b\u003e are well-demarcated, hyperpigmented macules or"
      }, {
        "text": " patches on the skin, with a color resembling \u0027coffee with milk.\u0027 While a few small spots can be normal, the"
      }, {
        "text": " presence of multiple, large spots is a hallmark of several genetic syndromes, most notably Neurofibromatosis Type 1.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Flat, pigmented birthmarks with a light brown color and distinct borders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuro"
      }, {
        "text": "fibromatosis Type 1 (NF-1):\u003c/b\u003e The presence of \u003cmark\u003esix or more\u003c/mark\u003e caf√©-au-lait"
      }, {
        "text": " spots greater than 5 mm in diameter in prepubertal individuals (or \u003e15 mm in postpubertal individuals) is a key"
      }, {
        "text": " diagnostic criterion for NF-1. The spots in NF-1 typically have smooth borders (\u0027coast of California\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMcCune-Al"
      }, {
        "text": "bright Syndrome:\u003c/b\u003e Characterized by a triad of fibrous dysplasia of bone, endocrine abnormalities (like precocious puberty), and large"
      }, {
        "text": ", unilateral caf√©-au-lait spots with irregular, jagged borders (\u0027coast of Maine\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations"
      }, {
        "text": ":\u003c/b\u003e Can also be seen in tuberous sclerosis, Fanconi anemia, and other syndromes, but are most strongly associated with NF-1.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Multiple caf√©-au-lait spots in a child should prompt a thorough evaluation for other signs of Neuro"
      }, {
        "text": "fibromatosis Type 1, such as axillary freckling, Lisch nodules, and neurofibromas.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eWhile often benign, multiple \u003cb\u003ecaf√©-au-lait spots\u003c/b\u003e are a"
      }, {
        "text": " crucial dermatological clue to underlying systemic genetic disorders, with the number and border characteristics (smooth in NF-1, irregular in McC"
      }, {
        "text": "une-Albright) helping to narrow the differential diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"mccune_albright_syndrome\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"24d36d58\": {\n    \"title"
      }, {
        "text": "\": \"Calcitonin Gene-Related Peptide (CGRP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCalcit"
      }, {
        "text": "onin Gene-Related Peptide (CGRP)\u003c/b\u003e is a 37-amino acid neuropeptide that is widely distributed in the central and peripheral nervous"
      }, {
        "text": " systems. It is a potent vasodilator and is critically involved in pain transmission, particularly in the pathophysiology of [[c8833bae"
      }, {
        "text": "|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a potent arterial"
      }, {
        "text": " vasodilator and a neurotransmitter/neuromodulator in pain pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e During"
      }, {
        "text": " a migraine attack, CGRP is released from trigeminal nerve endings. This release causes vasodilation of cranial blood vessels and promotes"
      }, {
        "text": " neurogenic inflammation, contributing to the pain of a migraine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Target:\u003c/b\u003e CGRP and its receptor"
      }, {
        "text": " have become major targets for migraine therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug Classes Targeting CGRP:\u003c/b\u003e\u003cbr\u003e1. "
      }, {
        "text": "\u003cb\u003e[[4770b8a2|Anti-CGRP Monoclonal Antibodies]]\u003c/b\u003e (e.g., er"
      }, {
        "text": "enumab, galcanezumab): Used for migraine \u003cu\u003eprophylaxis\u003c/u\u003e.\u003cbr\u003e2. \u003cb\u003eGep"
      }, {
        "text": "ants\u003c/b\u003e (e.g., ubrogepant, rimegepant): Small molecule CGRP receptor antagonists used"
      }, {
        "text": " for \u003cu\u003eacute\u003c/u\u003e treatment of migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The central role of CGRP in migraine"
      }, {
        "text": " pathophysiology is a high-yield concept. Understand that blocking the CGRP pathway, either with monoclonal antibodies for prevention or gep"
      }, {
        "text": "ants for acute attacks, is a modern, targeted approach to migraine treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCalcitonin"
      }, {
        "text": " Gene-Related Peptide (CGRP)\u003c/b\u003e is a key player in the generation of migraine pain, acting as both a powerful"
      }, {
        "text": " vasodilator and a pain-signaling molecule in the trigeminal system, making its blockade a highly effective strategy for migraine therapy.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C("
      }, {
        "text": "Vasodilation \u0026 Neurogenic Inflammation); C --\u003e D(Migraine Pain);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"c"
      }, {
        "text": "8833bae\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \""
      }, {
        "text": "4770b8a2\"\n      },\n      {\n        \"type\": \"is_targeted"
      }, {
        "text": "_by\",\n        \"to\": \"gepants\"\n      }\n    ]\n  },\n  \"e"
      }, {
        "text": "4b8298b\": {\n    \"title\": \"Capsaicin\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e is the active component of chili peppers and is used topically as an analgesic for"
      }, {
        "text": " neuropathic and musculoskeletal pain. It works by interacting with the transient receptor potential vanilloid 1 (TRPV1) receptor"
      }, {
        "text": " on nociceptive nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Initially"
      }, {
        "text": ", capsaicin activates TRPV1 receptors (also known as capsaicin receptors), causing an influx of calcium and the"
      }, {
        "text": " release of substance P, which leads to a burning sensation. With repeated application, it causes \u003cmark\u003edesensitization\u003c/"
      }, {
        "text": "-mark\u003e of the nerve fibers and \u003cmark\u003edepletion of substance P\u003c/mark\u003e, resulting in an analgesic effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e Used topically for neuropathic pain (e.g., postherpetic neuralgia, diabetic neuropathy)"
      }, {
        "text": " and musculoskeletal pain (e.g., osteoarthritis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as a low-concentration over-the-counter cream or"
      }, {
        "text": " a high-concentration prescription patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is a localized burning,"
      }, {
        "text": " stinging, or erythema at the application site, which typically diminishes with continued use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key mechanism"
      }, {
        "text": " to remember is the initial activation followed by desensitization and depletion of substance P from sensory nerve endings.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e paradoxically relieves pain by first causing it; its initial stimulation of pain receptors leads"
      }, {
        "text": " to their eventual desensitization and the depletion of substance P, effectively silencing the pain signals from the affected area.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Topical Capsaicin] --\u003e B(Activates TRPV1 Receptors);"
      }, {
        "text": " B --\u003e C(Initial Release of Substance P); C --\u003e D(Burning Sensation); B --Repeated Application--\u003e"
      }, {
        "text": " E(Desensitization \u0026 Depletion of Substance P); E --\u003e F(Analgesia);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropath"
      }, {
        "text": "ic_pain\"\n      },\n      {\n        \"type\": \"acts_on_receptor\",\n        \"to\": \""
      }, {
        "text": "trpv1_receptor\"\n      },\n      {\n        \"type\": \"depletes\",\n        \"to\": \"substance"
      }, {
        "text": "_p\"\n      }\n    ]\n  },\n  \"a5ec55b5\": {\n    \"title\": \""
      }, {
        "text": "Caput Succedaneum\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaput succedane"
      }, {
        "text": "um\u003c/b\u003e is a benign, edematous swelling of the soft tissues of a newborn\u0027s scalp that is present at birth"
      }, {
        "text": ". It is caused by pressure on the infant\u0027s head from the cervix or vaginal wall during a prolonged or difficult delivery.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The edema is located in the subcutaneous tissue, \u003cu\u003esuperficial to the peri"
      }, {
        "text": "osteum\u003c/u\u003e of the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A soft, puffy, and sometimes ecchymotic swelling on the scalp. A"
      }, {
        "text": " key feature is that it \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Present at birth and"
      }, {
        "text": " typically resolves spontaneously within a few days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a1"
      }, {
        "text": "721d6f|cephalohematoma]].\u003cbr\u003e - \u003cb\u003eCaput Succedaneum"
      }, {
        "text": ":\u003c/b\u003e Soft, pits on pressure, crosses suture lines, resolves quickly.\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm"
      }, {
        "text": ", does \u003cu\u003enot\u003c/u\u003e cross suture lines (subperiosteal), resolves over weeks to months, may calcify.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The ability to cross suture lines is the most important feature for distinguishing caput succedaneum from a ce"
      }, {
        "text": "phalohematoma on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a"
      }, {
        "text": " benign and self-resolving scalp edema in newborns resulting from birth trauma, easily identified by its soft consistency and its ability"
      }, {
        "text": " to cross cranial suture lines, distinguishing it from the more localized and potentially complicated cephalohematoma.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from"
      }, {
        "text": "\",\n        \"to\": \"a1721d6f\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"c1ad76f4\": {\n    \"title\": \"Carbachol\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a \u003ci\u003echolinomimetic agent\u003c/i\u003e that acts as a non-selective agonist at both mus"
      }, {
        "text": "carinic and nicotinic acetylcholine receptors. It is primarily used in ophthalmology to treat glaucoma.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a direct cholinergic agonist, it mimics the effects of [[6a"
      }, {
        "text": "005559|acetylcholine]]. In the eye, it stimulates muscarinic (M\u003csub\u003e3\u003c/sub\u003e)"
      }, {
        "text": " receptors on the ciliary muscle and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Effects:\u003c/b\u003e\u003cbr\u003e "
      }, {
        "text": "1. \u003cb\u003eMiosis:\u003c/b\u003e Contraction of the sphincter pupillae muscle causes pupillary constriction.\u003cbr\u003e 2. \u003cb\u003e‚Üì"
      }, {
        "text": " IOP:\u003c/b\u003e Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, lowering"
      }, {
        "text": " intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically to treat [[5ea7b741|open-angle glaucoma]] and"
      }, {
        "text": " to produce miosis during ophthalmic surgery. It is less commonly used than pilocarpine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResistance to"
      }, {
        "text": " AChE:\u003c/b\u003e Carbachol is resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action than"
      }, {
        "text": " acetylcholine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember carbachol as a direct-acting cholinomimetic that lowers"
      }, {
        "text": " IOP by increasing trabecular outflow, a mechanism shared with pilocarpine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a potent, long-acting acetylcholine mimic that effectively lowers intraocular pressure in glaucoma"
      }, {
        "text": " by contracting the ciliary muscle to open up the trabecular meshwork drainage channels.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"cholinomimetic_agent\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_as"
      }, {
        "text": "_agonist_at\",\n        \"to\": \"muscarinic_receptors\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"nicotinic_"
      }, {
        "text": "receptors\"\n      }\n    ]\n  },\n  \"eddd2bc5\": {\n    \"title"
      }, {
        "text": "\": \"Carbamazepine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Carbamazepine\u003c/b\u003e is a narrow-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e drug that works by blocking voltage-gated sodium channels. It"
      }, {
        "text": " is also used as a mood stabilizer and for the treatment of neuropathic pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in their inactivated state, which prolongs the refractory"
      }, {
        "text": " period of the neuron and prevents repetitive firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e First-line treatment"
      }, {
        "text": " for \u003cmark\u003efocal seizures\u003c/mark\u003e (both simple and complex) and generalized tonic-clonic seizures.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eNeuropathic Pain:\u003c/b\u003e First-line treatment for \u003cmark\u003etrigeminal neuralgia\u003c/mark"
      }, {
        "text": "\u003e.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Dipl"
      }, {
        "text": "opia, ataxia, SIADH (hyponatremia), and skin rashes. Two serious, rare side effects are \u003cmark\u003eag"
      }, {
        "text": "ranulocytosis\u003c/mark\u003e and \u003cmark\u003eaplastic anemia\u003c/mark\u003e, requiring monitoring of CBC. It is also a potent"
      }, {
        "text": " inducer of cytochrome P450 enzymes, leading to many drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Associated"
      }, {
        "text": " with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Carb"
      }, {
        "text": "amazepine is the drug of choice for trigeminal neuralgia. Remember its major hematologic side effects (agranulocytosis, aplastic anemia)"
      }, {
        "text": " and its induction of the P450 system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbamazepine"
      }, {
        "text": "\u003c/b\u003e is a cornerstone therapy for focal seizures and trigeminal neuralgia, acting by stabilizing inactivated sodium channels, but its use requires"
      }, {
        "text": " careful monitoring due to the risk of severe hematologic toxicity and its potent induction of hepatic enzymes.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "trigeminal_neuralgia\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"focal_seizures\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_adverse_effect\",\n        \"to\": \"agranulocytosis\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"causes_adverse_effect\",\n        \"to\": \"aplastic_anemia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"siadh\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"541cd176\": {\n    \"title\": \"Carbidopa/Levodopa\","
      }, {
        "text": "\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e (trade name Sinemet) is the most effective and widely used combination"
      }, {
        "text": " drug for the symptomatic treatment of [[58c8ea03|Parkinson disease]]. Levodopa is a metabolic"
      }, {
        "text": " precursor to dopamine, while carbidopa is a peripheral DOPA decarboxylase inhibitor.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLevodopa (L-DOPA):\u003c/b\u003e Can"
      }, {
        "text": " cross the [[dd47b9cc|blood-brain barrier]] (unlike dopamine) and is converted to [["
      }, {
        "text": "90adc821|dopamine]] in the CNS by DOPA decarboxylase, replenishing the depleted"
      }, {
        "text": " dopamine stores in the striatum.\u003cbr\u003e - \u003cb\u003eCarbidopa:\u003c/b\u003e Inhibits peripheral DOPA decarboxylase."
      }, {
        "text": " This prevents the conversion of L-DOPA to dopamine in the periphery, which \u003cmark\u003eincreases the bioavailability of L"
      }, {
        "text": "-DOPA in the brain\u003c/mark\u003e and \u003cmark\u003ereduces peripheral side effects\u003c/mark\u003e (like nausea"
      }, {
        "text": " and arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e The cornerstone of treatment for [[58c8ea03|Parkinson disease]],"
      }, {
        "text": " particularly effective for bradykinesia and rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, hallucinations, postural"
      }, {
        "text": " hypotension. Long-term use is associated with motor fluctuations (\u0027on-off\u0027 phenomenon) and dyskinesias ("
      }, {
        "text": "involuntary movements).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rationale for the combination is key: Carbidopa acts"
      }, {
        "text": " as a \u0027bodyguard\u0027 for Levodopa, ensuring more of it reaches the brain where it\u0027s needed, while minimizing"
      }, {
        "text": " side effects elsewhere in the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCarbidopa/Levodopa"
      }, {
        "text": "\u003c/b\u003e combination is a brilliant pharmacological strategy that overcomes the blood-brain barrier by using a precursor (Levodopa) and"
      }, {
        "text": " then protecting that precursor from peripheral breakdown (with Carbidopa) to effectively deliver dopamine to the deficient basal ganglia in Parkinson\u0027"
      }, {
        "text": "s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral DOPA Decarboxylase--\u003e B("
      }, {
        "text": "Dopamine - Periphery); C[Carbidopa] --x B; A --\u003e D(Crosses BBB);"
      }, {
        "text": " D --\u003e E[L-DOPA in CNS]; E --Central DOPA Decarboxylase--\u003e F(Dopamine -"
      }, {
        "text": " CNS); F --\u003e G(Treats Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_precursor_to\",\n        \"to\": \"90adc821\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_combined_with\",\n        \"to\": \"carbidopa\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"e1e7ac22\": {\n    \"title\": \"Carotid-"
      }, {
        "text": "Cavernous Fistula\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula (CCF)\u003c/b\u003e is an abnormal communication"
      }, {
        "text": " between the internal carotid artery and the [[c260efc8|cavernous sinus]]. This creates a high-flow,"
      }, {
        "text": " high-pressure arteriovenous shunt within the sinus, leading to a characteristic set of signs and symptoms.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be traumatic (e.g., from a basal skull fracture) or spontaneous (e"
      }, {
        "text": ".g., from a ruptured intracavernous carotid aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arterial blood from"
      }, {
        "text": " the internal carotid artery flows directly into the low-pressure [[c260efc8|cavernous sinus]]."
      }, {
        "text": " This increases pressure in the sinus and reverses blood flow in the veins that drain into it, particularly the superior ophthalmic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Tri"
      }, {
        "text": "ad:\u003c/b\u003e The classic triad is \u003cmark\u003epulsatile exophthalmos\u003c/mark\u003e (protruding, pulsating eye), \u003cmark\u003eocular"
      }, {
        "text": " bruit\u003c/mark\u003e (a whooshing sound heard over the eye), and \u003cmark\u003echemosis\u003c/mark\u003e (conj"
      }, {
        "text": "unctival edema and redness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Symptoms:\u003c/b\u003e Patients also develop ophthalmoplegia (paralysis of eye"
      }, {
        "text": " muscles) due to dysfunction of cranial nerves III, IV, and VI, which all traverse the cavernous sinus. There"
      }, {
        "text": " may also be sensory loss in the V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e distribution.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " combination of a pulsating eye and an audible bruit over the eye after head trauma is pathognomonic for a carotid-cavernous fistula."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula\u003c/b\u003e"
      }, {
        "text": " creates a high-pressure vascular storm within the cavernous sinus, engorging the orbital veins and compressing the cranial nerves that"
      }, {
        "text": " pass through it, resulting in the dramatic clinical picture of a pulsating, red, and paralyzed eye.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Internal Carotid Artery] --Fistula--\u003e B(Cavernous Sinus); B --\u003e C(‚Üë"
      }, {
        "text": " Pressure in Sinus); C --\u003e D(Reversal of flow in Superior Ophthalmic Vein); D --\u003e E(Pulsatile Exophthal"
      }, {
        "text": "mos, Chemosis, Bruit); C --\u003e F(Compression of CN III, IV, V1, V2, VI); F --\u003e"
      }, {
        "text": " G(Ophthalmoplegia, Sensory Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"aff"
      }, {
        "text": "ects\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"causes\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"pulsatile_exophthalmos\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6696dd3a\": {\n    \"title\": \"Carteolol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used as"
      }, {
        "text": " a topical eye drop to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open"
      }, {
        "text": "-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both"
      }, {
        "text": " Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This leads to a \u003cmark\u003edecrease"
      }, {
        "text": " in aqueous humor production\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker,"
      }, {
        "text": " similar to [[ae28be6c|timolol]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent"
      }, {
        "text": " for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects include stinging and burning. Systemic absorption can occur, potentially causing bradycardia, hypotension, fatigue, and bronchoconstriction.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution in patients with asthma, COPD, bradycardia, or heart block"
      }, {
        "text": " due to its non-selective Œ≤-blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all non-selective beta-blockers used"
      }, {
        "text": " for glaucoma, carteolol\u0027s main mechanism is decreasing aqueous humor production. Be aware of the potential for systemic side effects,"
      }, {
        "text": " especially bronchospasm in patients with reactive airway disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarte"
      }, {
        "text": "olol\u003c/b\u003e is a non-selective beta-blocker that effectively treats glaucoma by turning down the \u0027faucet\u0027 of aqueous humor production in the"
      }, {
        "text": " ciliary body, but its systemic absorption carries the risk of Œ≤-blockade side effects throughout the body.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"decreases_production_of\",\n        \"to\": \"aqueous_humor\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"85f03b02\": {\n    \"title\":"
      }, {
        "text": " \"Cataracts\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens"
      }, {
        "text": " Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecataract\u003c/b\u003e is a painless, progressive"
      }, {
        "text": " opacification or clouding of the normally clear lens of the eye, which leads to a decrease in vision. It is the"
      }, {
        "text": " leading cause of blindness worldwide.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In"
      }, {
        "text": "volves the denaturation and aggregation of lens proteins (crystallins), leading to loss of transparency and light scattering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk"
      }, {
        "text": " Factors:\u003c/b\u003e \u003cmark\u003eIncreased age\u003c/mark\u003e is the most common risk factor. Others include smoking, excessive alcohol use, excessive"
      }, {
        "text": " sunlight (UV) exposure, prolonged glucocorticoid use, trauma, and infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Disease Associations:\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eDiabetes mellitus\u003c/mark\u003e (due to sorbitol accumulation via aldose reductase), classic galactosemia, gal"
      }, {
        "text": "actokinase deficiency, and myotonic dystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive blurring of vision, glare"
      }, {
        "text": " (especially at night with oncoming headlights), and often a myopic shift (nearsightedness). On exam, there is loss"
      }, {
        "text": " of the red reflex and the lens appears opaque.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The definitive treatment is surgical removal of the op"
      }, {
        "text": "acified lens and replacement with an artificial intraocular lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the association with"
      }, {
        "text": " diabetes and galactosemia, where excess sugars are converted to osmotically active polyols (sorbitol, galactitol) in"
      }, {
        "text": " the lens, causing hydropic swelling and opacification.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Cataracts\u003c/b\u003e represent a clouding of the eye\u0027s lens due to protein aggregation, most commonly as a part"
      }, {
        "text": " of aging, which scatters light and causes progressive, painless vision loss that can only be definitively treated by surgical lens replacement.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_associated_with\",\n        \"to\": \"diabetes_mellitus\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"galactosemia\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"cat"
      }, {
        "text": "aract_surgery\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1z9e6h9L1FRaHESQjFZINO8564IdO3Pma"
      },
      "role": "user",
      "tokenCount": 1913
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"1c4d7e8f\": {\n    \"title\": \"Cauda Equina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e (Latin for \\\"horse\u0027s tail\\\") is the bundle of spinal nerves and spinal nerve rootlets, consisting of the second through fifth lumbar nerve pairs, the first through fifth sacral nerve pairs, and the coccygeal nerve, all of which arise from the lumbar enlargement and the conus medullaris of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e Comprises the nerve roots from L2 to Co1 that descend through the lumbar cistern (subarachnoid space) below the termination of the spinal cord proper (conus medullaris, typically at L1-L2).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e These nerve roots provide motor and sensory innervation to the lower extremities, perineum, and pelvic organs (including the bladder and anal sphincters).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Compression of these nerve roots leads to \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLumbar Puncture:\u003c/b\u003e The cauda equina floats in the cerebrospinal fluid of the lumbar cistern, which is the target for a lumbar puncture. The needle is typically inserted at the L3-L4 or L4-L5 interspace to avoid injuring the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the spinal cord ends at L1-L2 in adults. The collection of nerve roots continuing down the vertebral canal below this level is the cauda equina.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e is the collection of descending lumbar and sacral nerve roots that resemble a horse\u0027s tail, filling the subarachnoid space below the end of the spinal cord; its compression results in the surgical emergency known as cauda equina syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"compression_of_causes\",\n        \"to\": \"2904b5c8\"\n      },\n      {\n        \"type\": \"is_located_inferior_to\",\n        \"to\": \"conus_medullaris\"\n      }\n    ]\n  },\n  \"2904b5c8\": {\n    \"title\": \"Cauda Equina Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a neurosurgical emergency caused by severe compression of the [[1c4d7e8f|cauda equina]], the bundle of nerve roots at the lower end of the spinal canal. This compression leads to a constellation of debilitating symptoms requiring urgent surgical decompression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a massive midline lumbar disc herniation. Other causes include spinal stenosis, tumors, trauma, and epidural abscess or hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by a combination of symptoms including \u003cmark\u003esevere low back pain\u003c/mark\u003e, radicular pain in one or both legs, and \u003cmark\u003esaddle anesthesia\u003c/mark\u003e (loss of sensation in the perineum, buttocks, and inner thighs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Symptoms:\u003c/b\u003e The most critical signs are \u003cmark\u003ebowel and/or bladder dysfunction\u003c/mark\u003e (e.g., urinary retention or incontinence) and loss of the [[ce2052d6|anal wink reflex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor/Sensory Deficits:\u003c/b\u003e Patients typically have asymmetric, flaccid paralysis or weakness in the lower extremities (LMN signs) and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eUrgent surgical decompression\u003c/u\u003e is required to relieve the pressure on the nerve roots and prevent permanent paralysis and incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of low back pain, saddle anesthesia, and new-onset urinary retention is the classic triad for Cauda Equina Syndrome and warrants immediate surgical consultation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a critical condition where compression of the lumbosacral nerve roots leads to a devastating loss of lower extremity and pelvic floor function; its hallmark \u0027red flag\u0027 symptoms of saddle anesthesia and bladder/bowel dysfunction signal the need for immediate surgical intervention to prevent permanent disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Massive Lumbar Disc Herniation] --Compresses--\u003e B(Cauda Equina); B --\u003e C(Saddle Anesthesia); B --\u003e D(Bowel/Bladder Dysfunction); B --\u003e E(Lower Extremity Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_compression_of\",\n        \"to\": \"1c4d7e8f\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"saddle_anesthesia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"bowel_and_bladder_dysfunction\"\n      },\n      {\n        \"type\": \"requires\",\n        \"to\": \"surgical_decompression\"\n      }\n    ]\n  },\n  \"3fa071ef\": {\n    \"title\": \"Caudate Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a C-shaped nucleus that is a key component of the [[ed462927|basal ganglia]]. Together with the putamen, it forms the striatum, which is the main input station for the basal ganglia circuits involved in motor control and cognitive functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A large C-shaped structure with a head, body, and tail that follows the curve of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The caudate is primarily involved in the \u003cmark\u003ecognitive\u003c/mark\u003e aspects of movement, including motor planning and procedural learning. It also plays a role in reward and motivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStriatum:\u003c/b\u003e The caudate and putamen are collectively known as the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Atrophy of the caudate nucleus is the hallmark pathological finding in \u003cmark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Finding:\u003c/b\u003e The degeneration of the caudate head in Huntington disease leads to the characteristic appearance of \u003cmark\u003eenlarged lateral ventricles\u003c/mark\u003e on brain imaging (ex vacuo ventriculomegaly).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between caudate atrophy and [[ffd7e743|Huntington disease]] is extremely high-yield. A brain scan showing \u0027boxcar\u0027 ventricles due to a shrunken caudate in a patient with chorea is classic for Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a critical part of the basal ganglia\u0027s cognitive loop, and its profound atrophy in [[ffd7e743|Huntington disease]] is directly responsible for both the characteristic motor (chorea) and cognitive (dementia) decline seen in the disorder.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Caudate Nucleus] --Atrophy in Huntington\u0027s Disease--\u003e B(Enlarged Lateral Ventricles); A --Part of Striatum--\u003e C(Receives Cortical Input); C --\u003e D(Modulates Motor \u0026 Cognitive Function);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"forms_striatum_with\",\n        \"to\": \"putamen\"\n      },\n      {\n        \"type\": \"atrophies_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n  },\n  \"c260efc8\": {\n    \"title\": \"Cavernous Sinus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCavernous Sinus\u003c/b\u003e is a paired dural venous sinus located on either side of the sella turcica of the sphenoid bone. It is a unique venous structure because several critical cranial nerves and the internal carotid artery pass directly through it.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Mnemonic \u003cb\u003eO TOM CAT\u003c/b\u003e (from superior to inferior on lateral wall, then medially):\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003eculomotor n. (CN III)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003erochlear n. (CN IV)\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003ephthalmic n. (CN V\u003csub\u003e1\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eaxillary n. (CN V\u003csub\u003e2\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003earotid artery (internal)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003ebducens n. (CN VI)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003e (ignore)\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation of CN VI:\u003c/b\u003e The [[dd11dde6|abducens nerve (CN VI)]] is the only nerve that runs freely within the sinus, next to the internal carotid artery, making it particularly vulnerable to injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e Receives venous blood from the superior and inferior ophthalmic veins and drains into the superior and inferior petrosal sinuses, which then drain to the internal jugular vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[9a089fd7|Cavernous Sinus Syndrome]]:\u003c/b\u003e A mass effect (e.g., tumor, aneurysm) causing ophthalmoplegia, decreased corneal sensation, and Horner syndrome.\u003cbr\u003e - \u003cb\u003e[[a830692a|Cavernous Sinus Thrombosis]]:\u003c/b\u003e A blood clot in the sinus, often from a spreading facial or sinus infection, causing similar symptoms plus signs of infection and venous congestion (proptosis, chemosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Any patient presenting with multiple cranial nerve palsies involving eye movement (CN III, IV, VI) should raise suspicion for a lesion in the cavernous sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCavernous Sinus\u003c/b\u003e is a critical neurovascular crossroads where cranial nerves controlling eye movement and facial sensation travel alongside the internal carotid artery, making it a \u0027danger zone\u0027 where pathology can cause a complex ophthalmoplegia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cavernous Sinus]; A --\u003e B(CN III); A --\u003e C(CN IV); A --\u003e D(CN V1/V2); A --\u003e E(CN VI); A --\u003e F(Internal Carotid Artery);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"21f1c955\"\n      },\n      {\n        \"type\": \"pathology_causes\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"pathology_causes\",\n        \"to\": \"a830692a\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"dd11dde6\"\n      }\n    ]\n  },\n  \"9a089fd7\": {\n    \"title\": \"Cavernous Sinus Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is a clinical constellation of signs and symptoms resulting from any pathological process that affects the contents of the [[c260efc8|cavernous sinus]], leading to multiple cranial nerve palsies and potentially venous congestion of the orbit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by mass effect from tumors (e.g., [[5f3188bd|pituitary adenoma]]), aneurysms of the internal carotid artery, [[a830692a|cavernous sinus thrombosis]], or inflammation (e.g., Tolosa-Hunt syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A combination of:\u003cbr\u003e - \u003cb\u003eOphthalmoplegia:\u003c/b\u003e Paralysis of eye movements due to involvement of CN III, IV, and VI.\u003cbr\u003e - \u003cb\u003eSensory Loss:\u003c/b\u003e Decreased sensation in the forehead and cheek due to involvement of CN V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003ePupillary Changes:\u003c/b\u003e Can have a dilated pupil (CN III compression) or a constricted pupil (Horner syndrome from sympathetic plexus damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVenous Congestion:\u003c/b\u003e If caused by thrombosis or a fistula, may see proptosis (bulging eye) and chemosis (conjunctival swelling).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to recognizing this syndrome is the involvement of \u003cu\u003emultiple\u003c/u\u003e cranial nerves that all pass through one specific anatomical location: the [[c260efc8|cavernous sinus]]. The [[dd11dde6|abducens nerve (CN VI)]] is often the first nerve affected due to its medial location within the sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is the clinical manifestation of a \u0027mass lesion\u0027 within the cavernous sinus, presenting as a complex ophthalmoplegia with facial sensory loss, a direct result of compressing the tightly packed cranial nerves III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e2\u003c/sub\u003e, and VI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_pathology_in\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"a830692a\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"5f3188bd\"\n      }\n    ]\n  },\n  \"a830692a\": {\n    \"title\": \"Cavernous Sinus Thrombosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is the formation of a blood clot within the [[c260efc8|cavernous sinus]], a rare but life-threatening condition that is most often caused by a contiguous spread of infection from the face, sinuses, or teeth.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly a septic thrombosis resulting from infection. The most common pathogen is \u003cmark\u003e\u003ci\u003eStaphylococcus aureus\u003c/i\u003e\u003c/mark\u003e. Infection can spread from the \u0027danger triangle\u0027 of the face, sphenoid or ethmoid sinuses, or dental abscesses via the valveless facial venous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The thrombus obstructs venous drainage and causes inflammation, leading to increased pressure within the sinus and compression of its contents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with severe headache, high fever, and signs of [[9a089fd7|cavernous sinus syndrome]]: ophthalmoplegia (CN III, IV, VI palsy), periorbital edema, proptosis, and chemosis. The [[dd11dde6|abducens nerve (CN VI)]] is often affected first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI with magnetic resonance venography (MRV) is the imaging modality of choice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Requires prompt initiation of broad-spectrum IV antibiotics and consideration of anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a recent facial furuncle or sinusitis who develops a severe headache, fever, and unilateral eye swelling with impaired eye movements is the classic presentation for cavernous sinus thrombosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is a septic clot in the brain\u0027s central venous drainage system, typically seeded by a facial infection, which rapidly evolves into a neuro-ophthalmologic emergency with high fever, headache, and paralysis of eye movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Facial/Sinus Infection] --Staph. aureus--\u003e B(Spread via Valveless Veins); B --\u003e C(Cavernous Sinus); C --\u003e D(Thrombosis \u0026 Inflammation); D --\u003e E(Cavernous Sinus Syndrome);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      }\n    ]\n  },\n  \"714f15fc\": {\n    \"title\": \"Central Post-Stroke Pain Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Stroke\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e, also known as thalamic pain syndrome or Dejerine-Roussy syndrome, is a chronic neuropathic pain condition that develops after a [[c5da3c57|stroke]], most classically one affecting the [[afc0a64b|thalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a stroke (usually ischemic) affecting the somatosensory pathways, particularly the ventroposterolateral (VPL) nucleus of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Pain does not occur immediately after the stroke. There is typically an initial loss of sensation (numbness) in the affected area, with the pain developing weeks to months later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by severe, persistent, and often debilitating pain on the side of the body contralateral to the stroke. The pain is often described as burning, aching, or lancinating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e \u003cmark\u003eAllodynia\u003c/mark\u003e (pain provoked by a normally non-painful stimulus, like light touch) and \u003cmark\u003ehyperalgesia\u003c/mark\u003e (exaggerated pain response to a painful stimulus) are hallmarks of the condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Very difficult to treat. Options include antidepressants (TCAs like [[c6814506|amitriptyline]]), anticonvulsants (e.g., gabapentin, pregabalin), and in refractory cases, deep brain stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of a stroke who later develops severe, burning pain and allodynia on the previously numb side of their body is the classic presentation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e is a cruel paradox of sensory processing, where a thalamic stroke that initially causes numbness later gives rise to intractable neuropathic pain and allodynia due to maladaptive plasticity in the damaged central sensory pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"allodynia\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"c6814506\"\n      }\n    ]\n  },\n  \"3334840f\": {\n    \"title\": \"Central Retinal Artery Occlusion (CRAO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery Occlusion (CRAO)\u003c/b\u003e is an ophthalmologic emergency characterized by the sudden, painless, and profound loss of monocular vision due to obstruction of the central retinal artery, which supplies the inner retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a thromboembolism. The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. Other sources include cardiogenic emboli (e.g., from atrial fibrillation) or giant cell arteritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion of the artery leads to acute ischemia of the inner two-thirds of the retina, causing rapid and irreversible death of ganglion cells and other neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, severe monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic fundoscopic finding is a \u003cmark\u003epale retina\u003c/mark\u003e (due to ischemia and edema) with a \u003cmark\u003e\\\"cherry-red spot\\\"\u003c/mark\u003e at the fovea. The cherry-red spot represents the intact choroidal circulation (supplied by the posterior ciliary arteries) visible through the thinned, ischemic fovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of sudden, painless, profound monocular vision loss and a \\\"cherry-red spot\\\" on fundoscopy is pathognomonic for CRAO. It is essentially a stroke of the eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery Occlusion\u003c/b\u003e is an acute ischemic stroke of the retina, where an embolus blocks its main arterial supply, leading to sudden, devastating vision loss and the iconic fundoscopic image of a pale retina with a contrasting \u0027cherry-red\u0027 macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Embolus from Carotid/Heart] --\u003e B(Occlusion of Central Retinal Artery); B --\u003e C(Inner Retinal Ischemia); C --\u003e D(Pale Retina); C --\u003e E(Cherry-Red Spot at Fovea); D \u0026 E --\u003e F(Sudden, Painless Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_artery_occlusion\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"thromboembolism\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cherry_red_spot\"\n      },\n      {\n        \"type\": \"is_a_form_of\",\n        \"to\": \"ischemic_stroke\"\n      }\n    ]\n  },\n  \"b69e35b5\": {\n    \"title\": \"Central Retinal Vein Occlusion (CRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Vein Occlusion (CRVO)\u003c/b\u003e is a common retinal vascular disorder characterized by the blockage of the central retinal vein at the optic nerve head, leading to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary mechanism is thrombosis of the central retinal vein, often at the lamina cribrosa where the vein is compressed by a sclerotic central retinal artery with which it shares a common adventitial sheath.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyperlipidemia, and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral blurring or loss of vision. The severity can range from mild to severe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The fundoscopic exam is dramatic and described as a \u003cmark\u003e\\\"blood and thunder\\\"\u003c/mark\u003e appearance. It shows diffuse, widespread retinal hemorrhages in all four quadrants, venous dilation and tortuosity, cotton-wool spots, and optic disc swelling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from CRAO: CRVO is a venous \u0027backup\u0027 problem, leading to a hemorrhagic appearance (\u0027blood and thunder\u0027), while CRAO is an arterial \u0027blockage\u0027 problem, leading to a pale, ischemic appearance (\u0027cherry-red spot\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Vein Occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a thrombus in the central retinal vein causes a dramatic, widespread backup of blood, resulting in the classic \u0027blood and thunder\u0027 hemorrhagic retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Compression of Central Retinal Vein); B --\u003e C(Thrombosis); C --\u003e D(Central Retinal Vein Occlusion); D --\u003e E(Venous Stasis \u0026 ‚Üë Pressure); E --\u003e F(Diffuse Retinal Hemorrhages \u0026 Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_vein_occlusion\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  },\n  \"350f1c8b\": {\n    \"title\": \"Central Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Vestibular Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates from a problem within the central nervous system, specifically the brainstem or cerebellum. It is generally more serious than peripheral vertigo.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions in the brainstem or cerebellum, such as [[c5da3c57|stroke]] (e.g., lateral medullary syndrome), [[45dd6d19|multiple sclerosis]], tumors, or migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e The nystagmus in central vertigo can be in any direction (horizontal, torsional, or \u003cmark\u003epurely vertical/downbeat\u003c/mark\u003e). It is often non-fatigable and may change direction with gaze. It is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Often accompanied by other neurological signs that point to a central lesion, such as [[9914d433|diplopia]], dysmetria, [[9767fd6b|ataxia]], dysarthria, or focal weakness/sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset can be sudden or gradual, and the vertigo is often constant and less intense than in peripheral causes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of \u003cmark\u003epurely vertical nystagmus\u003c/mark\u003e is a red flag and is highly specific for a central cause of vertigo. Also, look for other \u0027central\u0027 neurological signs (the \u00275 D\u0027s\u0027: Dizziness, Diplopia, Dysarthria, Dysphagia, Dysmetria).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sign of a CNS lesion, not an inner ear problem. It is distinguished from peripheral vertigo by its associated neurological deficits and a nystagmus that is often vertical and does not suppress with visual fixation, indicating a more ominous underlying cause like a brainstem stroke.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5811ad9e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\"\n      }\n    ]\n  },\n  \"bad81d37\": {\n    \"title\": \"Central Transtentorial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation\u003c/b\u003e is a type of brain herniation where downward displacement of the cerebral hemispheres, basal ganglia, diencephalon, and midbrain occurs through the tentorial notch. It is typically caused by a diffuse increase in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by conditions that increase intracranial pressure symmetrically, such as diffuse cerebral edema, hydrocephalus, or midline tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The downward pressure causes a sequential caudal displacement of brainstem structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Progression:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eEarly:\u003c/b\u003e Altered level of consciousness, small reactive pupils (diencephalic compression).\u003cbr\u003e2. \u003cb\u003eLater:\u003c/b\u003e Mid-position, fixed pupils; decorticate then decerebrate posturing (midbrain/pons compression).\u003cbr\u003e3. \u003cb\u003eTerminal:\u003c/b\u003e Coma, loss of all brainstem reflexes, respiratory arrest (medulla compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuret Hemorrhages:\u003c/b\u003e A key pathological finding is the presence of \u003cmark\u003eDuret hemorrhages\u003c/mark\u003e, which are secondary brainstem hemorrhages in the pons and midbrain caused by stretching and tearing of perforating arteries during the downward displacement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a rostrocaudal deterioration. Look for a progressive decline in consciousness accompanied by changes in pupillary response and motor posturing, often culminating in fatal brainstem hemorrhages (Duret hemorrhages).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation\u003c/b\u003e is a devastating downward spiral of the brainstem through the tentorial notch, leading to a predictable sequence of neurological decline from altered consciousness to posturing and death, often marked by the characteristic Duret hemorrhages from vascular shearing.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Downward Displacement of Diencephalon/Midbrain); B --\u003e C(Compression of Brainstem); C --\u003e D(Rupture of Paramedian Arteries); D --\u003e E(Duret Hemorrhages);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"duret_hemorrhages\"\n      },\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"c0b7a1ca\"\n      }\n    ]\n  },\n  \"a1721d6f\": {\n    \"title\": \"Cephalohematoma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal collection of blood on the scalp of a newborn, caused by the rupture of blood vessels between the skull and the periosteum during birth. It is a common birth trauma, especially with forceps or vacuum-assisted delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The hemorrhage is located \u003cu\u003edeep to the periosteum\u003c/u\u003e (subperiosteal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A firm, well-demarcated swelling on the scalp. A key feature is that it \u003cmark\u003edoes \u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, as the periosteum is firmly attached at the sutures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e May not be present at birth but develops over the first few hours to days. It resolves slowly over weeks to months.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The breakdown of the collected red blood cells can lead to \u003cmark\u003ejaundice\u003c/mark\u003e (indirect hyperbilirubinemia). Rarely, it may become calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a5ec55b5|caput succedaneum]].\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm, does \u003cu\u003enot\u003c/u\u003e cross suture lines, appears hours after birth, resolves slowly.\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Soft, crosses suture lines, present at birth, resolves quickly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to cross suture lines is the most important feature for distinguishing a cephalohematoma from a caput succedaneum on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal bleed confined by cranial suture lines, appearing as a firm scalp swelling in a newborn after a difficult delivery; its key distinguishing feature is its respect for suture boundaries, and its main complication is neonatal jaundice.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a5ec55b5\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"neonatal_jaundice\"\n      }\n    ]\n  },\n  \"fa8656bd\": {\n    \"title\": \"Cerebellar Tonsillar Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is a life-threatening type of brain herniation where the cerebellar tonsils are displaced downward through the foramen magnum, leading to compression of the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a mass or pressure increase in the posterior fossa (e.g., cerebellar tumor, hemorrhage, or edema). It can also be iatrogenically caused by performing a lumbar puncture in the setting of high intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The herniating tonsils directly compress the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e This is a rapidly fatal event. Compression of the medullary cardiorespiratory centers leads to \u003cmark\u003ebradycardia, respiratory arrest, and death\u003c/mark\u003e. Patients may also present with headache, neck stiffness, and loss of consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Malformation:\u003c/b\u003e This type of herniation is the defining feature of [[b96a6a07|Chiari I and II malformations]], although in those congenital conditions, the process is chronic rather than acute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic scenario is a patient with signs of increased intracranial pressure (headache, papilledema) who undergoes a lumbar puncture and then rapidly deteriorates with respiratory arrest. This highlights the danger of LP in the setting of unevaluated increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is the most lethal form of brain herniation, as the downward displacement of the cerebellar tonsils through the foramen magnum directly compresses the vital cardiorespiratory centers in the medulla, leading to swift respiratory and cardiac arrest.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Posterior Fossa Pressure] --\u003e B(Cerebellar Tonsils Displace Downward); B --\u003e C(Through Foramen Magnum); C --Compresses--\u003e D(Medulla Oblongata); D --\u003e E(Cardiorespiratory Arrest);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"b96a6a07\"\n      },\n      {\n        \"type\": \"can_be_precipitated_by\",\n        \"to\": \"lumbar_puncture\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"1c4d7e8f\": {\n    \"title\": \"Ca"
      }, {
        "text": "uda Equina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Sp"
      }, {
        "text": "inal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e (Latin for \\\"horse\u0027s tail\\\") is the"
      }, {
        "text": " bundle of spinal nerves and spinal nerve rootlets, consisting of the second through fifth lumbar nerve pairs, the first through fifth"
      }, {
        "text": " sacral nerve pairs, and the coccygeal nerve, all of which arise from the lumbar enlargement and the conus medullaris of the spinal"
      }, {
        "text": " cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e Comprises the nerve roots from"
      }, {
        "text": " L2 to Co1 that descend through the lumbar cistern (subarachnoid space) below the termination of the spinal cord proper"
      }, {
        "text": " (conus medullaris, typically at L1-L2).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e These nerve roots provide motor"
      }, {
        "text": " and sensory innervation to the lower extremities, perineum, and pelvic organs (including the bladder and anal sphincters).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Significance:\u003c/b\u003e Compression of these nerve roots leads to \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome"
      }, {
        "text": "]]\u003c/mark\u003e, a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLumbar Puncture:\u003c/b\u003e The cauda equina floats"
      }, {
        "text": " in the cerebrospinal fluid of the lumbar cistern, which is the target for a lumbar puncture. The needle is typically inserted at"
      }, {
        "text": " the L3-L4 or L4-L5 interspace to avoid injuring the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that the spinal cord ends at L1-L2 in adults. The collection of nerve roots continuing"
      }, {
        "text": " down the vertebral canal below this level is the cauda equina.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Cauda Equina\u003c/b\u003e is the collection of descending lumbar and sacral nerve roots that resemble a horse\u0027s tail, filling"
      }, {
        "text": " the subarachnoid space below the end of the spinal cord; its compression results in the surgical emergency known as cauda equina syndrome.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"compression"
      }, {
        "text": "_of_causes\",\n        \"to\": \"2904b5c8\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_inferior_to\",\n        \"to\": \"conus_medullaris\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"2904b5c8\": {\n    \"title\": \"Cauda Equina Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Emergency"
      }, {
        "text": " Medicine\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a neurosurgical emergency caused by severe"
      }, {
        "text": " compression of the [[1c4d7e8f|cauda equina]], the bundle of nerve roots at"
      }, {
        "text": " the lower end of the spinal canal. This compression leads to a constellation of debilitating symptoms requiring urgent surgical decompression.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a massive midline lumbar disc herniation. Other causes include spinal"
      }, {
        "text": " stenosis, tumors, trauma, and epidural abscess or hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by a combination of symptoms"
      }, {
        "text": " including \u003cmark\u003esevere low back pain\u003c/mark\u003e, radicular pain in one or both legs, and \u003cmark\u003esaddle anesthesia\u003c/mark"
      }, {
        "text": "\u003e (loss of sensation in the perineum, buttocks, and inner thighs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Symptoms:\u003c/b\u003e The"
      }, {
        "text": " most critical signs are \u003cmark\u003ebowel and/or bladder dysfunction\u003c/mark\u003e (e.g., urinary retention or"
      }, {
        "text": " incontinence) and loss of the [[ce2052d6|anal wink reflex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor/"
      }, {
        "text": "Sensory Deficits:\u003c/b\u003e Patients typically have asymmetric, flaccid paralysis or weakness in the lower extremities (LMN signs) and sensory loss."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eUrgent surgical decompression\u003c/u\u003e is required to relieve the pressure on the nerve roots and prevent permanent"
      }, {
        "text": " paralysis and incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of low back pain, saddle anesthesia, and new"
      }, {
        "text": "-onset urinary retention is the classic triad for Cauda Equina Syndrome and warrants immediate surgical consultation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a critical condition where compression of the lumbosacral nerve roots leads"
      }, {
        "text": " to a devastating loss of lower extremity and pelvic floor function; its hallmark \u0027red flag\u0027 symptoms of saddle anesthesia and bladder"
      }, {
        "text": "/bowel dysfunction signal the need for immediate surgical intervention to prevent permanent disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Massive Lumbar Disc Herniation] --Compresses--\u003e B(Cauda Equina); B"
      }, {
        "text": " --\u003e C(Saddle Anesthesia); B --\u003e D(Bowel/Bladder Dysfunction); B --\u003e E(Lower"
      }, {
        "text": " Extremity Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_"
      }, {
        "text": "by_compression_of\",\n        \"to\": \"1c4d7e8f\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"saddle_anesthesia\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"presents_with\",\n        \"to\": \"bowel_and_bladder_dysfunction\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"requires\",\n        \"to\": \"surgical_decompression\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"3fa071ef\": {\n    \"title\": \"Caudate Nucle"
      }, {
        "text": "us\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Movement"
      }, {
        "text": " Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a C-shaped nucleus that"
      }, {
        "text": " is a key component of the [[ed462927|basal ganglia]]. Together with the putamen, it forms the stri"
      }, {
        "text": "atum, which is the main input station for the basal ganglia circuits involved in motor control and cognitive functions.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A large C-shaped structure with a head, body, and tail that follows"
      }, {
        "text": " the curve of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The caudate is primarily involved in the \u003cmark\u003ecognitive\u003c/"
      }, {
        "text": "mark\u003e aspects of movement, including motor planning and procedural learning. It also plays a role in reward and motivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStri"
      }, {
        "text": "atum:\u003c/b\u003e The caudate and putamen are collectively known as the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e At"
      }, {
        "text": "rophy of the caudate nucleus is the hallmark pathological finding in \u003cmark\u003e[[ffd7e743|Huntington disease"
      }, {
        "text": "]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Finding:\u003c/b\u003e The degeneration of the caudate head in Huntington disease leads to the"
      }, {
        "text": " characteristic appearance of \u003cmark\u003eenlarged lateral ventricles\u003c/mark\u003e on brain imaging (ex vacuo ventriculomegaly).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The association between caudate atrophy and [[ffd7e743|Huntington disease]] is"
      }, {
        "text": " extremely high-yield. A brain scan showing \u0027boxcar\u0027 ventricles due to a shrunken caudate in a patient with chore"
      }, {
        "text": "a is classic for Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is"
      }, {
        "text": " a critical part of the basal ganglia\u0027s cognitive loop, and its profound atrophy in [[ffd7e743|Hunting"
      }, {
        "text": "ton disease]] is directly responsible for both the characteristic motor (chorea) and cognitive (dementia) decline seen in the disorder.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Caudate Nucleus] --Atrophy in Huntington\u0027s Disease--\u003e B(En"
      }, {
        "text": "larged Lateral Ventricles); A --Part of Striatum--\u003e C(Receives Cortical Input); C --\u003e D"
      }, {
        "text": "(Modulates Motor \u0026 Cognitive Function);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"forms_striatum_with\",\n        \"to\": \"putamen\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"atrophies_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"c260efc8\": {\n    \"title\": \"Cavernous Sin"
      }, {
        "text": "us\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Ven"
      }, {
        "text": "ous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Cavernous Sinus\u003c/b\u003e is a paired dural venous sinus located on either side of the sella turcica of"
      }, {
        "text": " the sphenoid bone. It is a unique venous structure because several critical cranial nerves and the internal carotid artery pass directly"
      }, {
        "text": " through it.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Mnemonic \u003cb\u003eO"
      }, {
        "text": " TOM CAT\u003c/b\u003e (from superior to inferior on lateral wall, then medially):\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003e"
      }, {
        "text": "culomotor n. (CN III)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003erochlear n. (CN IV)\u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003eO\u003c/b\u003ephthalmic n. (CN V\u003csub\u003e1\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eaxillary n. (CN"
      }, {
        "text": " V\u003csub\u003e2\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003earotid artery (internal)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003ebducens n. ("
      }, {
        "text": "CN VI)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003e (ignore)\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation of CN VI:\u003c/b\u003e The [[dd"
      }, {
        "text": "11dde6|abducens nerve (CN VI)]] is the only nerve that runs freely within the sinus"
      }, {
        "text": ", next to the internal carotid artery, making it particularly vulnerable to injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e Receives venous"
      }, {
        "text": " blood from the superior and inferior ophthalmic veins and drains into the superior and inferior petrosal sinuses, which then drain"
      }, {
        "text": " to the internal jugular vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[9a08"
      }, {
        "text": "9fd7|Cavernous Sinus Syndrome]]:\u003c/b\u003e A mass effect (e.g., tumor, aneurysm)"
      }, {
        "text": " causing ophthalmoplegia, decreased corneal sensation, and Horner syndrome.\u003cbr\u003e - \u003cb\u003e[[a8306"
      }, {
        "text": "92a|Cavernous Sinus Thrombosis]]:\u003c/b\u003e A blood clot in the sinus, often from a spreading facial"
      }, {
        "text": " or sinus infection, causing similar symptoms plus signs of infection and venous congestion (proptosis, chemosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Any patient presenting with multiple cranial nerve palsies involving eye movement (CN III, IV, VI) should raise"
      }, {
        "text": " suspicion for a lesion in the cavernous sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCavernous"
      }, {
        "text": " Sinus\u003c/b\u003e is a critical neurovascular crossroads where cranial nerves controlling eye movement and facial sensation travel alongside the internal carotid artery"
      }, {
        "text": ", making it a \u0027danger zone\u0027 where pathology can cause a complex ophthalmoplegia.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Cavernous Sinus]; A --\u003e B(CN III); A --\u003e C(CN IV); A --\u003e D(CN"
      }, {
        "text": " V1/V2); A --\u003e E(CN VI); A --\u003e F(Internal Carotid Artery);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2"
      }, {
        "text": "1f1c955\"\n      },\n      {\n        \"type\": \"pathology_causes"
      }, {
        "text": "\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"pathology_causes"
      }, {
        "text": "\",\n        \"to\": \"a830692a\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"contains\",\n        \"to\": \"dd11dde6\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"9a089fd7\": {\n    \"title\": \"Cavernous Sinus Syndrome\",\n"
      }, {
        "text": "    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is a clinical constellation of"
      }, {
        "text": " signs and symptoms resulting from any pathological process that affects the contents of the [[c260efc8|ca"
      }, {
        "text": "vernous sinus]], leading to multiple cranial nerve palsies and potentially venous congestion of the orbit.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by mass effect from tumors (e.g., [["
      }, {
        "text": "5f3188bd|pituitary adenoma]]), aneurysms of the internal carotid artery, [[a"
      }, {
        "text": "830692a|cavernous sinus thrombosis]], or inflammation (e.g., Tolosa-Hunt syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e A combination of:\u003cbr\u003e - \u003cb\u003eOphthalmoplegia:\u003c/b\u003e Paralysis of eye movements due to involvement of CN"
      }, {
        "text": " III, IV, and VI.\u003cbr\u003e - \u003cb\u003eSensory Loss:\u003c/b\u003e Decreased sensation in the forehead and"
      }, {
        "text": " cheek due to involvement of CN V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003ePupillary Changes:\u003c/b\u003e Can"
      }, {
        "text": " have a dilated pupil (CN III compression) or a constricted pupil (Horner syndrome from sympathetic plexus damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVen"
      }, {
        "text": "ous Congestion:\u003c/b\u003e If caused by thrombosis or a fistula, may see proptosis (bulging eye) and chemosis (conj"
      }, {
        "text": "unctival swelling).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to recognizing this syndrome is the involvement of \u003cu\u003emultiple\u003c/u\u003e"
      }, {
        "text": " cranial nerves that all pass through one specific anatomical location: the [[c260efc8|cavernous sinus]]. The [["
      }, {
        "text": "dd11dde6|abducens nerve (CN VI)]] is often the first nerve affected due to its medial"
      }, {
        "text": " location within the sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e"
      }, {
        "text": " is the clinical manifestation of a \u0027mass lesion\u0027 within the cavernous sinus, presenting as a complex ophthalmoplegia with facial"
      }, {
        "text": " sensory loss, a direct result of compressing the tightly packed cranial nerves III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, and VI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_pathology_in\",\n        \"to\": \"c260efc8\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ophthalmoplegia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\":"
      }, {
        "text": " \"a830692a\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_caused_by\",\n        \"to\": \"5f3188bd\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"a830692a\": {\n    \"title\": \""
      }, {
        "text": "Cavernous Sinus Thrombosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous"
      }, {
        "text": " Sinus Thrombosis\u003c/b\u003e is the formation of a blood clot within the [[c260efc8|cavernous sinus]], a"
      }, {
        "text": " rare but life-threatening condition that is most often caused by a contiguous spread of infection from the face, sinuses, or teeth"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly a septic thrombosis"
      }, {
        "text": " resulting from infection. The most common pathogen is \u003cmark\u003e\u003ci\u003eStaphylococcus aureus\u003c/i\u003e\u003c/mark\u003e. Infection can spread from the \u0027"
      }, {
        "text": "danger triangle\u0027 of the face, sphenoid or ethmoid sinuses, or dental abscesses via the valveless facial venous"
      }, {
        "text": " system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The thrombus obstructs venous drainage and causes inflammation, leading to increased"
      }, {
        "text": " pressure within the sinus and compression of its contents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with severe headache, high"
      }, {
        "text": " fever, and signs of [[9a089fd7|cavernous sinus syndrome]]: ophthalmoplegia ("
      }, {
        "text": "CN III, IV, VI palsy), periorbital edema, proptosis, and chemosis. The [[dd11dde6|ab"
      }, {
        "text": "ducens nerve (CN VI)]] is often affected first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI with magnetic resonance venography ("
      }, {
        "text": "MRV) is the imaging modality of choice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Requires prompt initiation of broad-spectrum IV"
      }, {
        "text": " antibiotics and consideration of anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a recent facial furuncle or sinusitis"
      }, {
        "text": " who develops a severe headache, fever, and unilateral eye swelling with impaired eye movements is the classic presentation for cavernous sinus thrombosis.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is a septic clot in the brain"
      }, {
        "text": "\u0027s central venous drainage system, typically seeded by a facial infection, which rapidly evolves into a neuro-ophthalmologic emergency with"
      }, {
        "text": " high fever, headache, and paralysis of eye movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Facial/"
      }, {
        "text": "Sinus Infection] --Staph. aureus--\u003e B(Spread via Valveless Veins); B --\u003e C(Ca"
      }, {
        "text": "vernous Sinus); C --\u003e D(Thrombosis \u0026 Inflammation); D --\u003e E(Cavernous Sinus Syndrome);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"9a08"
      }, {
        "text": "9fd7\"\n      },\n      {\n        \"type\": \"is_an_infection_of\",\n        \""
      }, {
        "text": "to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"714f15fc\": {\n    \"title\": \"Central Post-Stroke"
      }, {
        "text": " Pain Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Stroke\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e, also known as thalamic pain syndrome"
      }, {
        "text": " or Dejerine-Roussy syndrome, is a chronic neuropathic pain condition that develops after a [[c5"
      }, {
        "text": "da3c57|stroke]], most classically one affecting the [[afc0a64b|thalamus]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a stroke ("
      }, {
        "text": "usually ischemic) affecting the somatosensory pathways, particularly the ventroposterolateral (VPL) nucleus of the [[afc0a6"
      }, {
        "text": "4b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Pain does not occur immediately after the stroke. There is typically an"
      }, {
        "text": " initial loss of sensation (numbness) in the affected area, with the pain developing weeks to months later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Characterized by severe, persistent, and often debilitating pain on the side of the body contralateral to the stroke. The pain is often described as burning,"
      }, {
        "text": " aching, or lancinating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e \u003cmark\u003eAllodynia\u003c/mark\u003e (pain provoked"
      }, {
        "text": " by a normally non-painful stimulus, like light touch) and \u003cmark\u003ehyperalgesia\u003c/mark\u003e (exaggerated pain response"
      }, {
        "text": " to a painful stimulus) are hallmarks of the condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Very difficult to treat. Options include antidepressants"
      }, {
        "text": " (TCAs like [[c6814506|amitriptyline]]), anticonvulsants (e.g., gabapentin,"
      }, {
        "text": " pregabalin), and in refractory cases, deep brain stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history"
      }, {
        "text": " of a stroke who later develops severe, burning pain and allodynia on the previously numb side of their body is the"
      }, {
        "text": " classic presentation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e is a"
      }, {
        "text": " cruel paradox of sensory processing, where a thalamic stroke that initially causes numbness later gives rise to intractable neuropathic pain and"
      }, {
        "text": " allodynia due to maladaptive plasticity in the damaged central sensory pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        "
      }, {
        "text": "\"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "_lesion_in\",\n        \"to\": \"afc0a64b\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"presents_with\",\n        \"to\": \"allodynia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"c6814506\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"3334840f\": {\n    \"title"
      }, {
        "text": "\": \"Central Retinal Artery Occlusion (CRAO)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery"
      }, {
        "text": " Occlusion (CRAO)\u003c/b\u003e is an ophthalmologic emergency characterized by the sudden, painless, and profound loss of mon"
      }, {
        "text": "ocular vision due to obstruction of the central retinal artery, which supplies the inner retina.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a thromboembolism. The most frequent source is an"
      }, {
        "text": " atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. Other sources include cardiogenic emboli (e."
      }, {
        "text": "g., from atrial fibrillation) or giant cell arteritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion of the artery"
      }, {
        "text": " leads to acute ischemia of the inner two-thirds of the retina, causing rapid and irreversible death of ganglion cells and other"
      }, {
        "text": " neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, severe monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The"
      }, {
        "text": " classic fundoscopic finding is a \u003cmark\u003epale retina\u003c/mark\u003e (due to ischemia and edema) with a \u003cmark\u003e\\\""
      }, {
        "text": "cherry-red spot\\\"\u003c/mark\u003e at the fovea. The cherry-red spot represents the intact choroidal circulation"
      }, {
        "text": " (supplied by the posterior ciliary arteries) visible through the thinned, ischemic fovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The triad of sudden, painless, profound monocular vision loss and a \\\"cherry-red spot\\\" on"
      }, {
        "text": " fundoscopy is pathognomonic for CRAO. It is essentially a stroke of the eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCentral Retinal Artery Occlusion\u003c/b\u003e is an acute ischemic stroke of the retina, where an embolus blocks its"
      }, {
        "text": " main arterial supply, leading to sudden, devastating vision loss and the iconic fundoscopic image of a pale retina with a contrasting"
      }, {
        "text": " \u0027cherry-red\u0027 macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Embolus from"
      }, {
        "text": " Carotid/Heart] --\u003e B(Occlusion of Central Retinal Artery); B --\u003e C(Inner Retinal Ischemia); C --\u003e D("
      }, {
        "text": "Pale Retina); C --\u003e E(Cherry-Red Spot at Fovea); D \u0026 E --\u003e F(Sudden,"
      }, {
        "text": " Painless Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"retinal_artery_occlusion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by\",\n        \"to\": \"thromboembolism\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"presents_with\",\n        \"to\": \"cherry_red_spot\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_form_of\",\n        \"to\": \"ischemic_stroke\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"b69e35b5\": {\n    \"title\":"
      }, {
        "text": " \"Central Retinal Vein Occlusion (CRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal"
      }, {
        "text": " Vein Occlusion (CRVO)\u003c/b\u003e is a common retinal vascular disorder characterized by the blockage of the central retinal vein at"
      }, {
        "text": " the optic nerve head, leading to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary mechanism is thrombosis of the central retinal vein, often at"
      }, {
        "text": " the lamina cribrosa where the vein is compressed by a sclerotic central retinal artery with which it shares a common adventitial sheath.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyper"
      }, {
        "text": "lipidemia, and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral blurring or loss of vision. The severity can"
      }, {
        "text": " range from mild to severe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The fundoscopic exam is dramatic and described as a \u003cmark\u003e\\\"blood"
      }, {
        "text": " and thunder\\\"\u003c/mark\u003e appearance. It shows diffuse, widespread retinal hemorrhages in all four quadrants, venous dilation and"
      }, {
        "text": " tortuosity, cotton-wool spots, and optic disc swelling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from"
      }, {
        "text": " CRAO: CRVO is a venous \u0027backup\u0027 problem, leading to a hemorrhagic appearance (\u0027blood and thunder\u0027), while CRAO is an"
      }, {
        "text": " arterial \u0027blockage\u0027 problem, leading to a pale, ischemic appearance (\u0027cherry-red spot\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCentral Retinal Vein Occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a throm"
      }, {
        "text": "bus in the central retinal vein causes a dramatic, widespread backup of blood, resulting in the classic \u0027blood and thunder\u0027 hemorrhagic"
      }, {
        "text": " retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Compression"
      }, {
        "text": " of Central Retinal Vein); B --\u003e C(Thrombosis); C --\u003e D(Central Retinal Vein Occlusion); D"
      }, {
        "text": " --\u003e E(Venous Stasis \u0026 ‚Üë Pressure); E --\u003e F(Diffuse Retinal Hemorrhages \u0026 Edema);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"retinal_vein_occlusion\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n"
      }, {
        "text": "        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"3334840f\"\n      }\n    ]\n  },\n  \"350"
      }, {
        "text": "f1c8b\": {\n    \"title\": \"Central Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Vestibular Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates"
      }, {
        "text": " from a problem within the central nervous system, specifically the brainstem or cerebellum. It is generally more serious than peripheral vertigo.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions in the brainstem or cerebellum, such as"
      }, {
        "text": " [[c5da3c57|stroke]] (e.g., lateral medullary syndrome), [[45"
      }, {
        "text": "dd6d19|multiple sclerosis]], tumors, or migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e The"
      }, {
        "text": " nystagmus in central vertigo can be in any direction (horizontal, torsional, or \u003cmark\u003epurely vertical/"
      }, {
        "text": "downbeat\u003c/mark\u003e). It is often non-fatigable and may change direction with gaze. It is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Often accompanied by other neurological signs that point to a central lesion, such as [[9"
      }, {
        "text": "914d433|diplopia]], dysmetria, [[9767fd6b|ata"
      }, {
        "text": "xia]], dysarthria, or focal weakness/sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset can be sudden"
      }, {
        "text": " or gradual, and the vertigo is often constant and less intense than in peripheral causes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " presence of \u003cmark\u003epurely vertical nystagmus\u003c/mark\u003e is a red flag and is highly specific for a central"
      }, {
        "text": " cause of vertigo. Also, look for other \u0027central\u0027 neurological signs (the \u00275 D\u0027s\u0027: Dizziness, Dipl"
      }, {
        "text": "opia, Dysarthria, Dysphagia, Dysmetria).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e"
      }, {
        "text": " is a sign of a CNS lesion, not an inner ear problem. It is distinguished from peripheral vertigo by its associated neurological deficits"
      }, {
        "text": " and a nystagmus that is often vertical and does not suppress with visual fixation, indicating a more ominous underlying cause"
      }, {
        "text": " like a brainstem stroke.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"vertigo\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5811ad"
      }, {
        "text": "9e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_"
      }, {
        "text": "in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"bad81d37\": {\n    \"title\": \"Central Transtent"
      }, {
        "text": "orial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hern"
      }, {
        "text": "iation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral transt"
      }, {
        "text": "entorial herniation\u003c/b\u003e is a type of brain herniation where downward displacement of the cerebral hemispheres, basal ganglia, di"
      }, {
        "text": "encephalon, and midbrain occurs through the tentorial notch. It is typically caused by a diffuse increase in intracranial pressure.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by conditions that increase"
      }, {
        "text": " intracranial pressure symmetrically, such as diffuse cerebral edema, hydrocephalus, or midline tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:"
      }, {
        "text": "\u003c/b\u003e The downward pressure causes a sequential caudal displacement of brainstem structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Progression:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eEarly:\u003c/b\u003e Altered level of consciousness, small reactive pupils (diencephalic compression).\u003cbr\u003e"
      }, {
        "text": "2. \u003cb\u003eLater:\u003c/b\u003e Mid-position, fixed pupils; decorticate then decerebrate posturing ("
      }, {
        "text": "midbrain/pons compression).\u003cbr\u003e3. \u003cb\u003eTerminal:\u003c/b\u003e Coma, loss of all brainstem reflexes, respiratory"
      }, {
        "text": " arrest (medulla compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuret Hemorrhages:\u003c/b\u003e A key pathological finding is the presence of \u003cmark\u003eD"
      }, {
        "text": "uret hemorrhages\u003c/mark\u003e, which are secondary brainstem hemorrhages in the pons and midbrain caused by stretching and tearing of perfor"
      }, {
        "text": "ating arteries during the downward displacement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a rostrocaudal deterioration. Look"
      }, {
        "text": " for a progressive decline in consciousness accompanied by changes in pupillary response and motor posturing, often culminating in fatal brainstem hemorrh"
      }, {
        "text": "ages (Duret hemorrhages).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation"
      }, {
        "text": "\u003c/b\u003e is a devastating downward spiral of the brainstem through the tentorial notch, leading to a predictable sequence of neurological decline"
      }, {
        "text": " from altered consciousness to posturing and death, often marked by the characteristic Duret hemorrhages from vascular shearing.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Downward Displacement of Diencephalon/Mid"
      }, {
        "text": "brain); B --\u003e C(Compression of Brainstem); C --\u003e D(Rupture of Paramedian Arteries); D --\u003e E("
      }, {
        "text": "Duret Hemorrhages);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"causes\",\n        \"to\": \"duret_hemorrhages\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"c0b7a"
      }, {
        "text": "1ca\"\n      }\n    ]\n  },\n  \"a1721d6f\": {\n    \"title\":"
      }, {
        "text": " \"Cephalohematoma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperi"
      }, {
        "text": "osteal collection of blood on the scalp of a newborn, caused by the rupture of blood vessels between the skull and the periosteum during"
      }, {
        "text": " birth. It is a common birth trauma, especially with forceps or vacuum-assisted delivery.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The hemorrhage is located \u003cu\u003edeep to the periosteum\u003c/u\u003e (subperiosteal).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Presentation:\u003c/b\u003e A firm, well-demarcated swelling on the scalp. A key feature is that it \u003c"
      }, {
        "text": "mark\u003edoes \u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, as the periosteum is firmly attached at the sutures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming"
      }, {
        "text": ":\u003c/b\u003e May not be present at birth but develops over the first few hours to days. It resolves slowly over weeks to months.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCom"
      }, {
        "text": "plications:\u003c/b\u003e The breakdown of the collected red blood cells can lead to \u003cmark\u003ejaundice\u003c/mark\u003e (indirect"
      }, {
        "text": " hyperbilirubinemia). Rarely, it may become calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [["
      }, {
        "text": "a5ec55b5|caput succedaneum]].\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm"
      }, {
        "text": ", does \u003cu\u003enot\u003c/u\u003e cross suture lines, appears hours after birth, resolves slowly.\u003cbr\u003e - \u003cb\u003eCaput"
      }, {
        "text": " Succedaneum:\u003c/b\u003e Soft, crosses suture lines, present at birth, resolves quickly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability"
      }, {
        "text": " to cross suture lines is the most important feature for distinguishing a cephalohematoma from a caput succedaneum on an"
      }, {
        "text": " exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal bleed"
      }, {
        "text": " confined by cranial suture lines, appearing as a firm scalp swelling in a newborn after a difficult delivery; its key distinguishing feature is its respect"
      }, {
        "text": " for suture boundaries, and its main complication is neonatal jaundice.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46"
      }, {
        "text": "ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \""
      }, {
        "text": "a5ec55b5\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"neon"
      }, {
        "text": "atal_jaundice\"\n      }\n    ]\n  },\n  \"fa8656bd\": {\n    \"title"
      }, {
        "text": "\": \"Cerebellar Tonsillar Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eC"
      }, {
        "text": "erebellar tonsillar herniation\u003c/b\u003e is a life-threatening type of brain herniation where the cerebellar tonsils are displaced"
      }, {
        "text": " downward through the foramen magnum, leading to compression of the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Caused by a mass or pressure increase in the posterior fossa (e.g., cerebellar tumor, hemorrhage, or edema"
      }, {
        "text": "). It can also be iatrogenically caused by performing a lumbar puncture in the setting of high intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e The herniating tonsils directly compress the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e This is a rapidly"
      }, {
        "text": " fatal event. Compression of the medullary cardiorespiratory centers leads to \u003cmark\u003ebradycardia, respiratory arrest, and death\u003c/mark\u003e."
      }, {
        "text": " Patients may also present with headache, neck stiffness, and loss of consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Malformation:\u003c/b\u003e This"
      }, {
        "text": " type of herniation is the defining feature of [[b96a6a07|Chiari I and II malformations]],"
      }, {
        "text": " although in those congenital conditions, the process is chronic rather than acute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic scenario"
      }, {
        "text": " is a patient with signs of increased intracranial pressure (headache, papilledema) who undergoes a lumbar puncture and then rapidly"
      }, {
        "text": " deteriorates with respiratory arrest. This highlights the danger of LP in the setting of unevaluated increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is the most lethal form of brain herniation, as"
      }, {
        "text": " the downward displacement of the cerebellar tonsils through the foramen magnum directly compresses the vital cardiorespiratory centers in the medulla,"
      }, {
        "text": " leading to swift respiratory and cardiac arrest.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Posterior Fossa Pressure] --\u003e B(C"
      }, {
        "text": "erebellar Tonsils Displace Downward); B --\u003e C(Through Foramen Magnum); C --Compresses--\u003e D(Med"
      }, {
        "text": "ulla Oblongata); D --\u003e E(Cardiorespiratory Arrest);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"8c0728"
      }, {
        "text": "b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"med"
      }, {
        "text": "ulla_oblongata\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"b96a6a07\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_precipitated_by\",\n        \"to\": \"lumbar_puncture\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }],
    "pendingInputs": [{
      "text": "",
      "role": "user"
    }]
  }
}